Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 98.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria Yes No 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favorable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 15.8 25.6 13.3 8.5 6.2 4.3 4.6 4.5 6.5 7.3 0.2 0.0 0.2 3.0 5.1 2.7 18.3 8.2 6.2 0.0 6.7 5.5 3.5 4.7 10.8 0.0 1.8 7.5 0.2 5.4 5.7 12.6 10.8 7.3 1.4 10.1 3.1 0.0 0.5 0.0 25.0 0.0 1.0 8.3 8.4 0.3 2.1 1.7 1.6 0.5 1.4 0.0 2.6 21.7 0.4 0.0 4.9 8.8 2.7 4.1 4.1 2.2 1.6 0.0 3.2 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 8.9 28.6 1.5 8.9 5.6 6.3 8.1 7.6 0.0 7.9 14.0 15.7 9.1 0.0 1.8 9.2 9.2 1.0 0.0 1.5 2.5 9.3 5.2 3.5 98.3 1.2 11.1 2.9 19.6 1.8 5.4 17.5 1.5 11.8 0.0 2.4 8.7 2.6 2.9 23.0 7.8 2.2 19.4 21.6 6.4 1.5 4.1 4.2 2.2 1.5 3.7 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713946-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 20.1 11.6 12.4 15.0 18.1 10.7 22.0 6.7 16.0 28.9 34.3 29.1 12.1 11.9 26.6 16.9 21.4 20.8 30.9 14.2 10.3 8.4 9.9 6.7 13.8 8.7 24.1 9.4 24.2 12.2 27.7 14.5 13.6 17.1 27.3 15.8 19.4 14.6 18.0 10.8 14.2 17.0 66.6 14.3 10.8 21.9 9.8 21.2 5.8 19.5 11.4 9.1 35.8 31.9 3.1 3.1 1.1 5.0 2.4 2.6 1.6 7.2 16.1 17.2 20.8 25.3 30.9 6.3 12.7 19.9 14.9 12.6 12.6 9.4 11.9 7.3 16.8 15.3 14.0 8.7 11.7 11.0 7.4 5.4 7.8 27.4 10.7 17.3 11.9 10.9 22.5 12.9 26.6 16.5 20.8 20.6 15.4 43.5 9.5 18.1 13.7 15.1 9.8 19.1 11.3 11.9 17.5 22.3 12.8 15.1 8.5 16.1 20.1 21.3 8.3 10.2 10.5 16.2 11.0 23.6 57.2 14.8 21.8 19.9 2.9 6.8 15.9 23.5 9.9 18.1 0.2 2.1 1.1 2.0 1.2 2.6 3.1 2.0 1.9 2.0 1.4 1.9 1.7 0.2 2.4 5.0 3.1 0.9 1.6 12.4 18.1 6.7 16.0 10.3 8.4 24.1 9.4 17.1 21.2 8.9 9.9 4.2 6.4 8.1 6.2 5.8 12.7 5.3 5.7 14.0 11.8 11.3 1.7 12.6 3.1 14.3 15.4 0.0 9.5 3.5 27.8 8.1 2.3 13.4 13.7 9.5 21.2 20.3 13.7 7.4 25.9 6.5 5.0 3.6 15.7 15.7 14.3 20.3 24.1 8.4 9.7 19.4 21.0 11.9 13.6 5.9 12.7 7.9 19.1 6.4 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801785-124836670 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Ciliated cells: 22.7;Collecting duct cells: 22.7;monocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 18.4 17.3 16.1 13.1 16.5 14.3 17.0 16.3 20.5 15.6 14.8 10.6 8.1 13.7 16.0 13.3 17.9 13.9 11.2 13.2 15.1 14.5 18.6 19.9 12.5 15.4 13.1 14.4 15.1 11.8 17.5 13.9 17.7 15.9 13.5 14.5 8.5 14.9 13.5 32.2 19.1 20.8 14.4 16.1 20.3 13.2 11.1 12.1 23.9 20.5 16.0 17.4 16.2 16.2 12.2 13.9 18.5 15.2 7.8 12.2 7.7 14.2 9.8 10.6 14.4 13.7 13.6 9.1 14.7 23.3 17.7 16.4 7.8 13.8 16.0 12.6 15.9 9.6 16.1 16.5 13.8 18.7 13.9 11.4 12.1 8.1 9.7 17.5 20.8 12.8 14.8 16.9 17.4 31.5 19.2 13.3 14.3 12.6 11.1 14.3 9.3 15.9 18.6 9.0 12.9 9.1 12.9 11.1 9.7 13.0 7.2 7.3 13.4 11.7 11.4 15.9 11.1 9.3 14.4 11.4 9.5 7.6 11.1 17.5 11.6 10.7 15.5 12.5 10.3 6.7 18.5 11.4 10.4 8.9 15.2 12.2 12.1 10.3 12.1 13.9 12.2 11.2 12.1 4.6 7.8 12.0 9.4 11.9 7.7 16.1 16.5 16.3 20.5 15.1 14.5 13.1 14.4 15.9 12.1 23.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 11.4 22.7 0.0 14.6 14.9 11.6 0.0 0.0 0.0 0.0 11.0 10.8 0.0 0.0 11.6 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 36.1 0.0 0.0 7.8 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.6 1.5 3.3 2.7 5.2 4.1 2.2 4.7 3.7 7.3 4.5 8.4 6.3 5.8 3.2 2.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 12.7 3.6 5.9 2.0 10.2 1.8 4.0 4.4 1.6 0.2 6.3 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 0.8 15.6 2.2 1.3 0.9 2.9 1.4 1.4 16.0 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 3.0 4.8 2.9 5.7 1.6 14.6 8.0 17.8 1.4 0.0 3.5 21.6 5.5 6.6 5.7 1.3 5.3 10.5 0.0 6.3 1.0 4.3 3.8 8.1 20.8 4.6 11.1 5.8 4.9 1.6 2.7 6.4 1.7 3.3 5.4 5.8 12.3 5.2 10.5 7.1 15.1 15.8 6.5 7.2 0.7 3.8 1.6 5.3 4.4 7.0 1.7 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656461 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 43.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 7.7;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 2.1" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "SCLC-21H: 21.5;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoli rim, Mitotic chromosome" "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 1.1 3.8 9.4 1.1 17.4 1.1 1.0 25.9 43.6 1.0 1.2 0.8 0.0 1.3 1.0 1.0 1.0 1.0 1.0 1.0 9.7 9.9 1.1 1.0 1.1 1.0 5.3 12.2 1.0 2.2 1.0 7.0 1.0 9.4 1.0 1.1 0.3 1.0 1.0 1.0 1.1 1.2 1.1 1.6 1.0 2.0 1.7 1.9 0.0 1.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.4 25.9 26.8 9.7 9.9 5.3 12.2 9.4 1.9 0.0 0.0 0.0 0.0 0.0 7.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.1 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 7.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.5 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.1 3.3 0.0 4.7 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.8 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.2 0.7 0.0 0.3 0.8 0.4 1.1 0.1 0.1 0.3 1.7 0.1 2.5 0.5 3.2 0.1 0.1 0.0 1.1 0.1 0.1 0.1 0.2 5.6 0.1 0.2 0.1 3.2 4.8 8.9 2.1 0.5 0.2 0.1 4.6 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 6 "Muller glia cells: 16.4;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" Yes NA "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.5 0.0 0.5 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 0.0 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 12.0;SH-SY5Y: 27.6" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 12.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 15.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 0.0 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 91.6" "Group enriched" "Detected in many" 7 "Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 3.8 8.1 3.9 3.5 4.8 3.8 4.2 3.1 6.6 5.0 6.8 6.6 11.7 2.8 5.4 9.3 6.3 7.2 6.6 4.1 3.4 3.9 8.2 3.0 3.6 3.2 3.5 3.4 5.9 5.9 11.2 6.2 6.3 5.4 6.8 3.8 7.7 8.2 5.9 2.6 6.8 3.9 8.6 3.4 4.6 5.4 91.6 3.5 8.4 9.9 4.9 4.4 7.8 3.5 5.7 5.4 7.1 2.3 11.2 6.3 4.6 23.0 15.0 24.5 16.3 5.2 10.5 27.4 4.7 10.3 13.7 14.2 12.9 17.7 12.8 14.9 8.1 19.3 10.6 19.6 21.4 15.2 10.7 29.0 18.7 18.7 27.8 10.6 9.0 6.3 11.0 16.2 12.0 9.9 21.0 14.3 18.7 16.0 10.4 13.2 9.1 26.2 13.6 17.3 16.8 10.3 27.1 27.7 20.0 14.1 5.9 16.4 23.5 9.3 7.3 15.2 25.1 11.0 7.0 6.8 12.8 17.6 6.1 10.1 20.8 10.9 26.2 14.2 10.4 11.4 7.1 2.3 5.7 4.5 1.3 3.4 5.7 5.7 6.3 5.4 3.0 5.1 2.8 1.4 11.2 0.9 3.0 3.6 4.6 3.9 4.8 3.1 6.6 3.4 3.9 3.5 3.4 5.4 3.5 0.0 8.5 1.9 5.9 3.0 4.9 5.0 12.7 1.4 5.7 8.7 0.0 12.8 16.6 7.0 249.1 3.6 4.6 0.0 5.2 6.0 4.1 6.6 1.1 3.4 4.4 0.0 2.4 6.2 2.7 264.5 9.8 5.3 6.8 6.4 8.7 4.4 4.8 7.0 10.6 18.1 8.7 0.0 5.8 150.8 30.0 2.4 7.0 4.1 8.4 6.8 AIDA "C1orf80, FLJ12806" ENSG00000186063 "Axin interactor, dorsalization associated" Q96BJ3 1 222668013-222713210 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027935 Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA027935: AB_10602226" "unprognostic (2.33e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (2.63e-2)" "unprognostic (7.28e-2)" "unprognostic (2.58e-2)" "unprognostic (2.26e-2)" "unprognostic (2.73e-1)" "unprognostic (4.43e-2)" "unprognostic (2.09e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.28e-1)" "unprognostic (2.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" 37.7 20.7 22.6 20.2 28.1 9.8 33.7 19.8 20.4 28.7 32.6 13.3 20.1 13.7 22.3 32.7 31.5 17.9 22.7 43.2 21.6 23.8 27.9 27.6 30.5 25.0 25.2 17.0 25.4 21.0 16.4 22.5 26.0 25.7 29.6 20.5 13.7 16.1 24.9 20.2 14.9 19.5 33.3 27.5 24.9 19.7 23.1 22.5 21.1 30.5 13.5 27.9 42.0 39.7 14.2 6.7 4.4 4.4 3.3 9.1 3.8 18.2 14.1 16.8 18.0 47.8 45.2 18.4 34.3 36.8 24.6 22.7 16.0 15.7 9.8 17.4 40.5 19.0 11.3 20.7 22.7 30.1 14.6 7.6 12.4 17.0 15.3 25.2 15.2 7.3 27.4 20.4 29.2 28.4 26.6 29.9 12.6 18.7 13.9 46.1 6.8 9.9 9.4 41.9 20.8 30.3 10.8 47.4 14.2 28.4 12.4 11.1 18.6 22.9 13.6 20.8 27.1 11.1 9.5 23.7 33.2 16.4 32.1 40.3 10.4 19.5 8.8 30.8 9.6 32.5 4.4 2.6 2.6 5.7 4.0 4.9 13.7 7.3 6.2 2.4 14.2 7.6 5.8 1.5 3.3 4.4 6.7 9.1 3.8 22.6 28.1 19.8 20.4 21.6 23.8 25.2 17.0 25.7 22.5 20.8 37.5 39.7 31.9 28.8 17.4 7.5 15.3 38.8 20.5 31.4 31.4 17.3 24.9 34.0 14.2 47.6 16.2 23.3 32.8 46.9 47.4 44.9 3.5 31.0 28.3 22.3 34.7 44.8 32.3 16.7 55.8 29.7 35.4 74.9 21.2 22.9 42.9 21.0 47.7 42.5 13.4 32.3 50.5 35.9 15.1 26.5 7.6 24.0 19.0 25.1 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 20.5 24.2 22.5 19.4 25.5 16.1 21.2 22.8 27.9 21.2 19.4 17.4 13.4 16.1 22.3 15.9 18.5 19.2 18.4 14.4 20.1 17.9 22.7 14.9 18.5 24.3 22.4 23.2 24.3 16.2 28.0 20.3 20.3 19.2 19.5 20.3 16.1 17.8 21.3 13.7 17.5 18.5 22.9 19.0 28.6 20.2 22.9 24.2 25.9 26.0 9.1 20.5 22.2 22.7 7.3 6.1 24.4 10.3 5.1 7.9 3.0 8.7 10.5 7.0 4.9 9.3 11.8 13.0 10.2 11.0 11.4 13.7 11.4 5.3 7.5 6.9 8.1 9.9 9.3 9.0 8.5 15.6 6.2 7.7 6.4 10.3 5.5 8.8 4.6 10.6 9.9 10.7 10.4 12.9 12.8 9.1 9.2 4.1 3.8 11.8 6.3 8.6 6.9 4.6 12.2 3.6 5.7 23.0 3.9 9.5 5.6 2.4 7.2 11.7 5.5 9.7 45.2 13.4 5.2 8.0 8.8 7.3 7.5 9.4 4.7 5.0 9.2 11.7 5.6 8.5 3.6 7.3 8.8 6.7 10.3 6.1 6.0 6.5 7.2 6.1 7.3 7.9 7.0 24.4 5.1 9.3 4.6 4.9 3.0 22.5 25.5 22.8 27.9 20.1 17.9 22.4 23.2 19.2 24.2 3.0 10.5 23.8 8.2 6.3 24.2 7.7 10.2 18.7 13.6 5.2 15.7 11.8 1.7 8.1 10.1 10.0 11.8 0.0 6.2 9.3 8.2 12.9 9.3 11.1 14.2 31.8 6.9 16.0 28.9 8.5 14.1 22.0 5.0 21.6 10.6 10.9 7.0 14.8 13.1 4.5 23.0 19.4 9.9 15.1 25.3 6.8 11.7 17.3 10.3 9.8 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 140000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 15.0 10.0 28.3 46.8 23.5 14.0 36.1 18.1 22.4 21.1 27.2 28.0 14.5 0.0 18.5 14.1 8.8 11.3 8.8 61.1 19.4 0.0 10.6 2.9 14.9 23.8 11.5 0.0 0.0 17.1 14.4 16.4 11.8 15.6 16.8 0.0 0.0 0.0 18.5 9.9 0.6 0.0 19.1 11.1 8.5 9.0 32.1 0.0 20.0 11.5 9.6 11.5 0.0 10.0 10.5 22.7 18.0 0.6 20.4 6.1 18.9 7.0 12.4 0.0 0.0 0.0 3.3 0.0 9.8 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 14.9 24.0 11.8 48.6 23.0 22.4 35.5 25.5 20.1 33.0 40.1 21.6 364.8 64.6 31.9 24.9 14.7 17.8 0.0 12.1 88.6 30.8 28.6 6.9 69.5 42.5 23.8 20.8 20.9 9.4 29.5 23.6 7.4 52.3 12.6 22.1 96.8 15.1 8.6 35.0 241.4 12.2 19.4 17.3 1.0 3.1 14.1 185.9 2.5 43.7 34.8 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" Yes No 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.5 0.5 3.5 14.7 7.4 7.6 0.7 3.9 8.8 3.0 18.5 4.4 0.7 3.5 4.6 3.4 0.8 9.9 2.4 24.1 5.6 3.1 2.3 6.8 2.8 7.5 6.9 2.5 8.0 7.0 3.4 0.3 6.0 0.4 1.3 7.3 4.6 19.1 2.6 3.6 2.9 8.3 5.5 1.6 3.9 2.4 0.4 63.4 0.4 1.0 9.4 16.7 2.2 18.1 0.1 5.8 9.8 5.6 0.9 0.3 1.4 0.5 0.6 43.8 12.5 2.6 28.6 7.1 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 0.0 12.0 9.3 17.7 6.6 72.2 19.0 5.1 0.0 7.9 7.0 100.1 1.2 3.3 14.2 0.8 8.4 22.7 0.0 8.9 3.9 7.1 4.4 12.7 50.8 4.4 259.0 20.7 16.5 4.7 0.8 8.6 3.7 23.6 58.7 8.7 81.4 11.6 14.0 9.6 1.6 259.1 12.9 17.6 0.4 3.2 9.5 1.3 17.0 3.3 8.0 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 944.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 29.3 26.1 44.9 21.9 34.1 39.6 27.2 19.5 31.8 19.4 26.3 14.8 30.3 26.1 19.2 27.5 31.7 24.6 26.0 63.6 32.9 26.7 25.9 38.4 18.5 26.7 35.2 31.8 17.2 40.3 12.6 20.6 25.7 29.8 25.4 12.2 18.1 48.8 24.0 94.2 21.6 24.8 25.4 27.6 18.9 25.9 42.2 27.3 18.5 32.5 45.7 17.0 23.5 25.5 54.9 107.5 74.0 80.1 43.1 52.8 80.4 41.4 97.5 23.2 34.3 18.5 21.1 26.6 20.1 15.8 18.3 20.9 40.0 36.6 13.1 22.5 17.7 20.2 24.2 9.3 25.7 6.6 19.2 70.6 19.6 43.3 60.3 20.8 14.6 17.4 23.4 23.5 18.7 15.3 11.9 29.3 17.9 26.7 38.2 18.9 74.7 35.5 24.2 21.9 40.3 72.8 14.8 22.1 26.3 16.7 37.3 29.2 47.4 21.7 34.3 39.4 16.7 41.9 35.6 17.4 35.6 28.5 38.1 37.7 18.7 7.8 16.5 37.4 22.3 28.4 70.1 80.1 74.0 45.3 63.7 42.8 54.9 46.4 49.5 64.6 51.6 45.2 43.5 40.5 43.1 59.3 107.5 52.8 80.4 44.9 34.1 19.5 31.8 32.9 26.7 35.2 31.8 29.8 27.3 119.1 121.6 108.7 168.5 132.0 55.6 277.3 203.8 155.2 153.6 188.5 19.6 436.4 442.7 236.1 329.1 152.3 247.2 186.9 293.4 435.1 217.2 291.4 105.2 427.2 386.6 31.8 182.7 139.3 155.4 944.1 168.2 179.2 248.0 315.6 205.6 112.3 274.1 235.0 154.9 400.2 53.7 103.5 220.7 379.1 245.5 163.2 425.4 121.6 237.2 254.5 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell type enriched" "Detected in many" 21 "Hepatocytes: 4646.2" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 52.5;OE19: 40.2" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 230000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.3 3.4 0.8 0.0 8.6 10.3 0.1 1.4 3.0 0.4 1.4 2.0 1.8 0.1 0.4 4.2 2.9 1.3 0.9 1.0 0.4 5.8 1.3 0.3 1.9 52.5 1.8 1.3 0.1 8.3 0.8 0.5 1.8 4.3 2.0 1.5 0.0 9.6 1.2 0.2 0.2 0.4 0.2 40.2 3.8 0.2 1.3 3.9 0.8 1.0 0.0 0.1 1.5 0.6 2.3 1.9 1.4 0.2 1.7 0.5 1.0 0.5 0.2 2.0 1.6 0.2 1.1 0.6 1.6 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 26.8 12.4 18.0 36.0 24.2 0.0 0.6 219.1 60.2 18.2 10.4 0.0 1.5 10.0 27.6 0.7 12.2 37.1 23.3 27.7 3.3 31.0 52.1 0.0 4646.2 15.9 0.0 68.2 70.0 110.5 1.1 65.9 16.0 21.9 1.0 138.3 9.1 26.8 17.3 22.6 45.5 0.6 12.9 18.6 0.7 1.0 45.8 7.8 12.1 44.2 29.8 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.9 11.1 9.4 13.8 12.7 7.1 5.0 15.2 11.7 25.8 15.8 7.0 4.3 10.6 6.3 9.9 8.3 9.8 12.0 8.4 12.5 8.5 24.2 5.3 10.1 16.7 11.3 10.5 12.8 6.4 8.8 13.9 8.2 6.3 15.7 7.9 7.0 7.4 11.7 11.5 10.2 12.1 2.7 14.7 10.2 11.9 11.5 6.6 14.2 3.6 16.4 8.8 12.7 11.3 18.0 4.4 11.6 16.7 9.1 15.0 16.2 7.8 11.1 8.3 6.7 8.4 12.5 9.0 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 11.9 16.4 13.9 9.0 14.1 17.4 7.1 22.9 33.5 11.4 17.4 27.5 18.3 33.2 14.5 5.0 9.0 15.5 0.0 12.7 15.1 10.4 8.9 9.2 9.6 11.6 25.4 8.6 11.1 8.1 6.0 16.7 9.5 10.1 8.2 12.6 16.9 11.3 15.2 20.1 14.7 22.1 6.5 14.4 54.6 39.2 15.4 14.1 16.0 14.4 8.8 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 41.9;Horizontal cells: 42.9;Muller glia cells: 26.1;Rod photoreceptor cells: 10.3" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.5;SCLC-21H: 7.8;SH-SY5Y: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.5 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.0 0.0 7.8 26.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 0.0 0.0 0.0 0.1 0.0 41.9 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 42.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.7 0.0 10.3 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.1 APEX1 "APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1" ENSG00000100823 "Apurinic/apyrimidinic endodeoxyribonuclease 1" P27695 14 20455191-20457772 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000956, HPA002564, CAB004294, CAB047307" Supported Supported Nucleoplasm Yes No 98000 Nucleoplasm "CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174" "unprognostic (2.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.55e-2)" "unprognostic (4.74e-3)" "unprognostic (1.97e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (4.21e-2)" "unprognostic (3.14e-2)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-2)" "unprognostic (2.54e-1)" "unprognostic (7.08e-2)" 43.9 52.8 30.6 33.2 32.5 55.6 43.6 24.1 44.9 38.5 41.9 37.3 28.4 44.1 53.2 30.1 40.7 42.9 46.4 34.4 28.0 27.4 44.4 61.3 31.8 44.5 30.2 31.1 64.7 48.4 31.8 21.7 29.4 34.4 36.1 39.8 36.0 35.5 38.9 53.2 41.2 37.6 40.9 30.1 51.0 41.7 20.9 28.3 73.2 51.2 38.5 48.4 41.8 32.7 35.0 53.0 1.5 23.7 20.6 32.5 38.4 44.6 54.9 49.3 45.4 34.7 50.1 42.5 42.0 45.2 62.6 54.3 40.0 44.4 86.3 37.5 32.0 33.5 47.9 58.6 44.4 58.2 38.5 25.0 34.9 32.5 66.7 36.5 110.9 36.3 51.7 49.0 40.7 40.4 50.2 52.2 35.7 40.5 28.4 50.1 43.5 71.0 46.7 48.5 50.7 49.7 79.0 55.4 36.2 52.5 60.3 59.5 37.8 45.5 56.8 45.1 36.3 34.5 50.2 33.7 33.0 55.4 33.2 39.1 38.2 66.1 58.2 14.8 70.5 41.7 0.1 23.7 1.5 19.0 20.5 25.9 35.0 23.8 22.6 46.8 31.4 32.5 28.3 1.5 20.6 12.4 53.0 14.1 38.4 30.6 32.5 24.1 44.9 28.0 27.4 30.2 31.1 34.4 28.3 59.6 45.2 101.2 74.7 94.4 52.3 42.8 86.6 72.3 79.6 64.6 39.3 161.9 127.6 119.2 16.8 57.5 33.9 0.0 91.3 165.4 86.9 49.2 78.7 65.2 158.8 27.0 115.1 39.3 80.7 4.0 74.5 109.4 60.8 100.0 78.8 68.5 83.2 73.7 60.5 126.7 45.4 51.8 136.6 6.3 43.7 84.8 84.9 76.1 136.8 42.5 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227737-57273468 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 20.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011138, HPA073477" Approved Uncertain "Mitotic spindle,Centrosome" Yes No 28000 "Mitotic spindle, Centrosome" "HPA011138: AB_1844959, HPA073477: AB_2797272" "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favorable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 18.3 14.0 20.9 15.3 17.9 13.7 22.5 25.2 23.7 18.5 15.7 12.8 16.8 12.6 19.2 14.5 21.0 16.0 13.2 23.7 15.8 15.4 17.0 14.3 15.3 24.3 15.4 18.8 24.0 38.2 28.4 20.4 14.1 18.8 15.7 14.4 11.0 18.0 22.2 40.5 19.9 14.5 20.5 16.7 15.0 16.3 10.5 15.7 20.9 20.0 15.2 18.9 17.7 20.8 20.7 12.0 2.5 3.9 4.7 3.5 1.7 14.9 6.5 6.4 23.2 11.0 15.5 13.5 7.9 4.9 8.0 9.2 7.6 9.0 24.3 3.3 12.2 12.6 3.0 17.1 13.7 13.8 18.3 7.6 13.7 10.4 8.0 11.9 30.4 10.1 11.4 12.5 10.2 11.1 16.1 12.7 15.3 4.6 15.3 9.0 5.1 23.9 7.5 10.0 10.6 11.2 0.8 26.0 13.0 14.1 8.4 6.5 13.8 10.9 16.4 10.4 9.0 8.0 19.8 12.0 13.3 9.4 19.3 15.3 14.1 20.6 17.1 14.4 14.7 8.6 1.6 3.9 2.5 2.6 3.0 3.5 11.3 2.8 2.4 7.2 20.7 2.6 1.9 1.0 4.7 2.5 12.0 1.1 1.7 20.9 17.9 25.2 23.7 15.8 15.4 15.4 18.8 18.8 15.7 47.6 39.2 44.5 41.0 47.1 39.5 88.3 45.9 20.1 55.7 40.1 29.5 40.0 49.7 52.3 22.7 58.0 26.9 0.0 52.6 38.3 45.7 34.4 22.0 37.6 46.6 49.3 43.8 35.6 50.8 15.5 67.6 54.0 18.6 85.6 35.9 55.2 46.8 11.5 71.5 43.7 52.2 51.8 38.7 40.0 39.4 60.9 23.5 30.5 44.7 23.4 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.6 7.6 3.6 5.6 0.7 0.6 7.0 2.0 0.6 2.5 1.6 4.9 4.5 0.8 5.2 0.8 2.6 6.5 1.8 1.9 0.5 0.0 6.8 0.1 5.0 3.1 1.2 0.0 0.8 0.5 3.1 3.2 1.3 1.3 0.8 0.3 7.0 0.0 1.0 12.4 4.2 0.0 3.8 3.1 10.9 3.9 2.9 2.9 2.0 3.9 10.5 7.4 5.8 2.0 3.4 1.4 8.6 1.1 1.9 1.9 0.1 6.3 4.1 0.0 0.1 0.3 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.9 0.0 0.5 3.3 7.1 1.6 0.0 20.1 3.4 3.5 19.6 0.4 0.0 2.2 2.1 0.7 3.9 0.0 2.1 0.7 1.3 1.1 0.0 1.3 0.4 3.2 0.0 1.3 0.0 2.5 2.0 0.0 5.0 0.0 3.6 3.5 1.1 8.6 7.8 1.4 23.7 6.5 1.5 8.1 7.7 2.6 0.5 0.0 4.3 0.6 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 18.6;Ductal cells: 23.6;Pancreatic endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 12.4;BEWO: 23.4;CACO-2: 14.8;HEK 293: 20.2;MCF7: 20.9;SK-BR-3: 20.2" HPA069694 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA069694: AB_2686173" "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.5 0.1 1.7 5.6 0.4 0.2 7.5 0.3 0.4 2.2 10.6 0.6 29.3 1.2 2.6 13.0 5.7 6.1 11.5 0.3 0.3 0.4 18.2 0.9 3.9 0.3 0.3 0.3 0.9 14.6 4.5 5.2 22.4 1.2 10.0 5.7 1.9 28.4 24.8 0.3 1.4 3.6 1.2 0.3 6.7 4.3 3.0 0.3 0.7 15.2 2.4 4.9 2.0 1.8 0.2 0.7 0.2 0.4 0.1 2.2 0.3 12.4 0.1 0.2 0.1 0.0 0.2 23.4 0.1 1.5 0.0 0.1 14.8 6.7 0.1 0.8 0.0 0.2 9.3 4.4 10.7 0.1 0.0 20.2 0.0 0.3 0.1 0.0 0.0 0.2 0.1 4.7 0.1 0.2 0.3 0.0 0.2 0.4 0.3 0.0 20.9 0.0 0.0 3.1 9.4 0.0 0.0 0.0 0.2 5.7 8.5 1.3 0.0 0.0 20.2 0.4 5.3 8.7 0.1 0.1 0.0 0.7 0.1 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 0.7 2.2 0.3 1.7 0.4 0.3 0.4 0.3 0.4 0.3 0.3 1.2 0.3 3.0 12.2 0.0 18.6 0.6 0.4 0.8 5.1 4.0 6.8 17.4 3.9 16.5 0.0 23.6 2.3 1.0 2.6 0.0 9.4 0.9 1.3 16.8 0.0 0.0 2.7 0.0 6.9 0.0 0.6 2.5 0.3 0.0 0.0 0.0 7.6 0.5 23.2 3.5 0.4 1.4 0.3 0.0 0.7 0.0 3.9 0.3 5.8 1.0 12.3 15.6 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ASH2L "ASH2, ASH2L1, ASH2L2, Bre2" ENSG00000129691 "ASH2 like histone lysine methyltransferase complex subunit" Q9UBL3 8 38105242-38144076 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042289 Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "HPA042289: AB_10795608" "unprognostic (9.39e-2)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (5.40e-3)" "unprognostic (2.87e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.10e-2)" "unprognostic (9.73e-3)" "prognostic favorable (4.25e-4)" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.54e-1)" 22.3 17.0 24.2 16.7 26.7 24.0 19.7 26.1 28.2 20.9 20.0 21.9 14.7 14.5 20.8 16.1 21.6 18.2 19.6 20.6 21.0 23.4 21.0 20.6 16.0 21.4 20.3 26.8 24.1 30.1 28.3 13.9 24.3 23.1 19.4 20.9 16.0 18.1 20.0 31.8 18.8 23.0 21.8 20.1 20.3 18.8 41.7 16.0 36.2 19.5 15.3 24.1 20.1 17.4 12.6 17.0 33.9 16.6 16.6 13.2 11.4 14.1 7.5 12.6 12.6 9.1 11.4 16.2 14.4 15.2 18.2 16.1 8.0 6.4 16.0 12.3 12.1 9.1 8.5 16.2 8.1 17.3 6.2 7.3 65.0 8.0 16.9 13.2 10.5 13.2 9.8 7.7 8.4 9.4 9.2 14.2 15.0 43.5 12.4 17.7 8.2 27.7 13.1 16.4 12.6 4.8 11.5 14.0 6.9 9.4 10.7 5.8 10.4 10.7 7.0 11.6 13.1 8.5 12.3 11.1 11.3 11.4 16.0 11.4 11.8 14.8 14.2 11.5 13.7 15.5 18.2 13.9 33.9 11.1 16.6 11.8 12.5 12.5 13.1 17.0 12.6 13.2 12.1 11.8 16.6 15.0 9.7 13.0 11.4 24.2 26.7 26.1 28.2 21.0 23.4 20.3 26.8 23.1 16.0 11.9 18.6 12.7 7.9 6.2 12.1 15.3 10.2 25.4 17.0 12.2 9.8 31.2 6.6 17.1 6.6 11.3 10.6 0.0 25.1 31.4 12.7 5.3 18.5 10.2 20.4 6.4 10.4 13.5 18.9 11.2 21.6 14.8 21.9 29.7 10.5 14.8 16.9 7.0 19.4 13.2 14.9 12.9 9.5 30.1 32.2 5.9 25.9 15.0 11.4 6.5 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 137.5;Proximal tubular cells: 442.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol Yes NA 51000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.6 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.6 0.0 1.6 15.9 0.1 0.0 0.5 0.3 0.3 0.3 1.1 0.0 0.2 1.8 9.5 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 2.0 0.2 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 0.0 0.0 0.9 0.0 0.0 22.8 0.3 2.5 0.0 0.0 8.7 3.9 0.0 38.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 6.8 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 442.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 32.2;Spermatogonia: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Yes No Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.6 9.1 0.2 1.0 3.8 4.2 2.2 4.7 6.8 4.4 3.4 12.9 4.1 2.0 3.2 8.8 6.2 3.2 8.6 2.9 5.4 7.8 5.2 3.0 0.1 15.2 6.4 0.4 0.4 7.0 2.4 0.9 2.4 12.7 12.1 10.9 3.1 2.8 16.9 7.5 5.6 3.5 1.9 11.6 18.2 6.2 1.2 5.1 5.6 5.0 4.8 2.7 2.5 5.5 5.2 6.8 1.9 5.9 7.9 8.3 7.6 3.6 3.8 16.3 2.6 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 3.0 2.6 13.3 3.2 4.1 18.5 2.7 0.0 4.0 3.4 3.5 0.0 13.2 0.0 2.7 12.9 2.9 2.2 0.0 2.5 20.4 3.9 1.6 3.5 0.5 7.3 11.1 0.0 2.5 3.2 4.6 3.4 7.2 6.8 10.8 4.5 3.9 2.9 2.9 2.1 0.3 19.9 0.0 6.2 32.2 35.1 4.0 6.6 5.3 9.3 1.4 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 644.1;Intestinal endocrine cells: 855.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Cell line enhanced" "Detected in many" "BEWO: 39.9;SuSa: 49.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.1 0.3 12.3 2.6 1.2 3.2 39.9 4.4 3.5 3.8 9.1 8.1 4.6 0.1 2.0 0.2 20.8 3.4 7.3 1.1 6.3 29.1 7.1 0.4 3.6 2.9 22.6 2.6 6.9 5.5 19.8 10.6 24.7 0.7 0.7 7.1 2.8 23.2 0.5 0.8 7.9 1.6 8.8 3.3 2.6 2.3 8.2 5.2 0.5 0.9 5.5 5.6 5.7 10.3 17.3 49.4 6.0 1.9 0.7 1.1 5.9 3.7 2.0 18.3 7.7 2.1 3.6 1.4 3.2 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 393.1 144.2 7.7 234.8 180.1 3.7 604.8 73.9 128.5 135.4 52.4 0.0 136.7 1.7 158.3 2.8 136.2 500.9 0.0 108.1 256.8 236.1 644.1 77.3 21.2 99.6 1.6 855.0 28.8 13.4 2.5 16.1 211.8 165.4 55.1 427.3 12.1 155.6 312.1 1.1 1.2 2.5 97.0 421.2 0.3 2.1 177.2 351.7 6.9 216.0 169.1 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 18.2 51.9 43.9 13.8 47.7 9.9 15.9 23.6 54.1 13.1 19.9 13.5 20.9 16.2 13.8 30.2 33.6 17.9 14.8 52.6 39.8 45.2 52.0 19.9 14.5 11.8 39.7 44.9 10.4 12.4 21.8 28.8 17.2 39.6 21.4 20.3 10.8 15.7 18.1 31.8 14.7 16.8 16.1 29.4 9.7 17.8 14.0 23.0 14.7 34.1 25.2 15.3 16.6 17.0 14.7 35.0 39.2 34.5 17.9 28.5 23.9 62.0 12.9 26.5 16.6 17.7 18.8 18.7 48.0 22.1 29.4 24.6 14.8 21.9 5.1 20.1 28.7 28.2 23.4 14.4 22.4 39.8 22.1 9.9 5.4 17.9 12.0 32.5 5.3 19.8 13.5 16.4 20.6 15.6 32.5 18.4 13.6 11.9 15.7 42.2 15.0 15.4 12.0 19.1 22.6 15.5 12.0 22.0 8.1 39.1 24.6 33.2 14.6 30.9 20.1 41.3 25.0 28.5 15.7 29.6 44.2 32.3 21.1 30.7 16.8 12.1 7.2 44.2 10.8 24.5 32.2 34.5 37.3 18.6 33.6 15.7 14.7 20.1 20.0 35.0 14.5 15.1 16.8 39.2 17.9 33.3 26.7 28.5 23.9 43.9 47.7 23.6 54.1 39.8 45.2 39.7 44.9 39.6 23.0 50.6 50.0 34.2 59.3 85.5 56.9 137.6 43.3 182.0 63.7 78.5 51.1 84.1 310.0 120.5 149.9 33.7 68.6 93.5 42.7 73.5 53.9 61.4 40.4 40.0 114.2 82.6 52.2 20.3 37.5 68.5 30.5 59.4 75.9 57.7 39.8 86.6 96.8 63.1 47.7 271.8 92.4 12.9 27.8 77.2 60.9 120.9 172.2 35.9 33.7 102.9 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "AUTS2, activator of transcription and developmental regulator" Q8WXX7 7 69598296-70793495 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.6;naive B-cell: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 10.3 7.3 29.3 11.6 30.3 9.3 20.3 14.3 19.1 10.5 14.0 17.3 4.1 8.9 10.5 12.4 13.7 8.0 16.6 5.6 22.2 12.9 14.6 19.7 14.7 6.1 14.8 12.3 17.2 6.0 9.9 17.4 5.7 18.9 14.6 13.1 9.9 52.1 8.3 14.9 23.3 18.8 13.6 10.2 8.2 11.3 10.0 20.6 10.5 6.7 7.9 8.9 13.0 10.8 11.6 3.2 0.8 0.2 1.5 2.2 0.7 0.1 2.5 28.1 1.5 1.8 1.1 0.3 1.7 0.0 0.1 0.1 9.5 0.1 4.1 0.6 1.7 0.1 9.1 3.4 3.8 0.8 18.6 7.5 2.0 2.6 0.1 0.8 0.0 0.1 2.9 5.2 4.2 1.0 1.0 0.0 4.5 0.1 2.2 2.4 1.6 0.4 0.8 20.0 6.2 0.0 27.4 13.7 11.6 0.0 4.1 38.5 20.9 1.8 3.1 0.0 12.7 26.3 0.0 0.0 0.1 9.4 3.0 17.2 0.0 0.0 14.2 0.0 0.0 0.0 0.8 0.2 0.2 1.6 0.1 2.2 8.6 1.1 1.5 0.7 11.6 0.2 0.9 0.5 1.5 0.1 3.2 0.2 0.7 29.3 30.3 14.3 19.1 22.2 12.9 14.8 12.3 18.9 20.6 17.9 31.0 10.7 17.8 25.3 35.0 19.0 10.2 12.0 19.4 8.7 15.7 1.0 5.0 9.8 26.8 8.3 16.3 0.0 1.1 0.1 11.3 21.3 0.0 24.5 0.7 60.4 27.7 16.0 3.1 14.8 14.7 4.3 16.9 1.0 20.8 14.3 2.6 14.0 13.8 9.8 22.5 25.8 7.4 11.3 15.4 14.1 1.1 19.2 22.7 20.3 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "HDLM-2: 27.0;Karpas-707: 22.4;SiHa: 28.7;U-266/70: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Yes No Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: AB_2680074" "prognostic favorable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.9 13.6 0.3 7.2 2.6 5.5 0.7 2.4 2.6 1.5 2.2 2.8 7.2 3.9 5.6 4.8 8.0 4.4 0.9 4.1 1.0 27.0 0.2 0.5 7.1 3.6 6.3 0.3 11.6 9.6 3.2 3.4 4.3 7.1 4.1 0.0 0.5 22.4 0.9 3.3 0.0 3.0 0.3 6.0 5.7 1.8 2.7 1.4 6.9 8.2 0.0 0.4 28.7 14.7 0.7 0.5 5.1 3.0 6.9 4.9 5.1 7.6 0.9 21.3 8.3 4.0 9.1 0.5 3.7 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 17.9 53.0 18.6 32.7 41.4 1.7 2.4 25.5 18.7 31.8 12.2 0.0 0.3 8.3 26.4 9.3 39.0 55.4 0.0 58.8 5.9 33.8 37.5 36.9 31.7 13.9 7.9 20.6 35.6 31.1 1.3 12.4 45.8 38.8 36.9 31.6 2.3 42.1 35.1 4.2 17.7 0.5 6.5 57.5 0.5 1.2 53.3 1.1 14.6 22.9 44.4 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 129.1;Late spermatids: 176.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Yes No "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.6 4.4 5.6 2.4 0.1 0.0 7.3 2.9 0.1 8.5 5.0 3.5 14.4 0.0 4.1 6.4 4.2 0.4 8.0 2.2 7.3 0.0 7.2 0.1 0.0 10.8 3.2 0.0 0.0 0.2 5.0 1.3 0.0 13.7 8.1 1.4 4.4 0.0 7.4 5.7 0.1 0.0 2.5 0.1 1.0 0.0 4.0 0.0 6.0 1.3 0.5 4.3 8.7 0.0 0.2 7.7 0.2 3.6 6.7 1.7 11.2 10.4 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 20.8 12.3 2.2 15.3 3.1 14.2 8.9 28.1 14.7 15.9 19.2 7.9 1.9 3.3 11.2 129.1 9.8 8.7 0.0 14.1 2.1 5.8 19.6 5.8 8.2 2.4 1.6 7.5 16.0 7.9 176.1 4.6 2.1 3.3 1.8 10.4 19.0 17.4 6.2 5.6 41.7 31.7 0.0 7.5 15.3 17.8 1.6 2.1 5.7 9.0 26.7 BIRC5 "API4, EPR-1, survivin" ENSG00000089685 "Baculoviral IAP repeat containing 5" O15392 17 78214186-78225636 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Protease inhibitor, Repressor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.6;testis: 51.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.9;Erythroid cells: 116.8;Extravillous trophoblasts: 134.7;Spermatocytes: 133.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 14.0" "Lineage enriched" "Detected in many" 6 "T-cells: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA002830, CAB004270" Enhanced Supported "Cytokinetic bridge" Yes Yes "Cytokinetic bridge" "CAB004270: AB_628302, HPA002830: AB_1857672" "unprognostic (8.04e-2)" "unprognostic (3.51e-2)" "unprognostic (4.48e-3)" "unprognostic (2.72e-3)" "unprognostic (3.37e-1)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.28e-6)" "prognostic unfavorable (4.49e-4)" "unprognostic (3.56e-3)" "unprognostic (4.53e-3)" "unprognostic (2.87e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" 2.3 1.5 0.4 14.1 0.7 20.8 5.3 0.7 0.6 1.9 4.8 0.3 0.2 4.6 0.9 1.4 13.4 0.4 2.2 2.4 0.5 0.4 1.3 2.2 2.4 9.7 0.6 0.2 0.9 0.8 0.0 0.4 6.1 0.5 0.9 5.2 0.2 2.1 0.2 0.6 3.5 4.7 2.4 0.7 6.3 3.2 51.4 0.3 61.6 0.5 14.4 11.7 2.0 3.2 2.5 0.8 0.5 0.0 2.2 14.0 3.0 32.0 30.0 27.1 29.3 1.7 2.8 10.0 24.7 13.9 35.3 23.2 24.5 12.7 33.1 10.1 14.3 26.7 17.1 27.4 15.8 30.9 11.1 38.0 21.8 17.7 28.8 0.2 20.9 16.4 0.9 1.1 19.5 14.5 5.1 24.9 25.0 27.3 28.0 27.1 18.6 44.6 20.0 20.1 22.7 52.8 23.3 44.0 25.5 8.3 11.9 33.5 23.1 18.9 21.5 16.8 13.8 28.4 19.9 9.3 42.7 37.9 18.4 35.1 20.3 16.3 38.2 15.6 8.8 37.1 0.0 0.0 0.0 0.7 0.0 0.2 2.5 4.3 2.8 0.8 0.3 0.0 0.4 0.5 2.2 0.0 0.3 14.0 3.0 0.4 0.7 0.7 0.6 0.5 0.4 0.6 0.2 0.5 0.3 0.0 30.7 18.5 1.0 7.2 0.5 2.0 5.1 4.0 17.0 0.0 0.0 17.0 0.0 1.2 73.9 0.6 1.8 116.8 0.0 134.7 7.2 0.9 9.2 1.6 43.1 0.0 2.9 11.1 11.1 29.8 2.8 11.5 1.7 0.0 3.4 0.4 0.4 3.4 0.7 0.0 0.5 6.5 1.0 133.1 40.7 5.6 16.0 7.5 15.2 4.0 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Approved Supported "Golgi apparatus,Vesicles,Mitotic spindle" Yes No "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: AB_2686710" "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 15.0 16.7 10.3 20.7 14.4 18.4 16.1 21.9 13.7 16.2 13.0 15.3 15.6 8.7 17.2 13.9 13.2 13.1 11.7 11.4 9.8 7.3 14.1 14.8 12.5 16.1 13.9 11.8 23.6 24.8 32.5 17.4 14.1 14.8 11.3 13.6 11.5 14.7 17.1 20.9 14.9 16.0 12.5 13.3 16.1 13.9 13.0 14.4 23.1 21.5 9.2 17.2 16.2 12.0 3.8 2.8 10.6 2.4 2.3 3.4 0.7 15.3 12.8 11.9 5.1 9.4 13.4 7.2 6.8 9.6 8.4 8.0 8.8 3.6 16.4 5.4 12.7 9.6 7.1 16.7 10.1 10.4 13.2 7.6 22.3 8.1 7.3 5.2 20.6 7.9 8.9 4.9 13.1 11.7 6.8 12.4 3.7 18.1 7.1 7.7 5.9 10.3 4.8 8.0 5.8 7.6 10.5 19.3 5.6 6.1 15.8 8.9 13.6 13.4 7.0 6.2 9.5 4.6 7.4 19.4 8.8 9.9 5.9 10.4 9.5 13.3 22.0 6.4 10.2 5.7 10.6 1.6 0.9 2.7 1.2 3.4 1.7 2.1 2.3 1.3 3.8 2.3 2.6 2.7 2.3 2.4 2.8 1.6 0.7 10.3 14.4 21.9 13.7 9.8 7.3 13.9 11.8 14.8 14.4 29.8 26.2 37.9 25.6 40.9 59.4 42.2 30.6 10.7 35.2 34.9 180.6 28.6 1.7 22.3 35.8 45.7 44.5 0.0 26.8 18.3 30.5 38.3 29.9 44.3 26.3 65.2 31.2 46.1 58.6 13.7 42.0 32.8 21.9 31.5 36.3 39.9 28.2 25.9 55.5 19.2 89.9 38.8 42.4 52.0 44.5 47.9 31.8 56.8 37.0 38.9 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BOP1 KIAA0124 ENSG00000261236 "Block of proliferation 1" Q14137 8 144262102-144291370 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 4.8 4.3 5.7 7.7 5.9 7.8 6.4 6.3 6.9 2.0 3.9 1.6 2.0 5.1 2.7 1.5 6.8 2.6 4.8 5.1 5.5 2.8 6.2 2.3 6.6 4.1 6.7 2.7 17.5 5.1 2.2 3.2 4.3 2.9 1.5 1.5 5.8 3.0 19.0 7.4 4.5 4.9 2.0 4.8 4.4 8.3 3.3 6.3 3.9 6.7 4.5 3.5 6.9 5.2 6.4 2.5 4.7 3.5 5.7 2.5 12.5 24.6 3.4 14.5 2.0 2.3 12.6 8.7 1.8 8.8 5.5 18.6 7.3 15.3 14.9 3.3 3.3 10.1 6.2 10.3 2.0 13.4 24.8 19.2 14.9 14.1 4.6 8.5 10.6 4.5 5.1 7.4 6.7 1.7 5.5 14.2 19.3 5.1 3.4 32.0 22.8 10.9 8.3 12.9 67.8 17.5 5.1 23.3 3.6 8.4 19.1 7.6 9.3 12.1 5.9 1.7 8.9 8.1 10.3 8.1 25.0 10.9 24.9 4.9 3.1 12.8 6.0 13.8 10.6 0.0 4.7 2.5 4.4 4.7 4.8 5.2 4.9 5.7 6.4 4.5 4.4 4.1 0.2 3.5 4.0 4.1 4.2 2.5 8.9 6.1 13.4 13.8 0.5 10.2 6.7 10.2 2.7 6.8 10.4 0.0 21.5 5.0 24.4 8.9 8.7 7.0 0.0 18.7 35.1 9.3 10.0 10.3 13.1 19.1 14.3 25.8 3.7 6.4 15.5 9.8 7.5 0.0 11.8 9.2 13.7 20.3 8.6 9.2 13.6 4.2 12.9 4.3 10.4 60.5 0.1 14.9 8.7 21.6 11.6 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Group enriched" "Detected in many" 4 "Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026815 Uncertain Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 4.0 3.5 6.1 4.6 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.3 5.3 14.2 2.9 2.1 6.9 5.4 5.0 2.5 9.7 9.2 2.7 9.0 2.2 3.2 0.2 12.8 4.5 0.4 0.3 9.2 6.4 0.5 4.1 7.2 5.9 4.9 5.7 4.6 10.3 7.6 7.2 4.6 1.9 10.1 15.7 2.7 1.3 4.3 2.3 4.4 5.2 2.3 2.1 2.2 2.7 6.4 3.2 5.8 6.2 6.4 6.0 1.9 2.9 7.3 3.0 5.1 5.5 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 8.9 1.6 1.9 2.8 2.3 0.0 1.6 0.0 4.0 2.3 0.0 0.0 9.1 0.0 1.8 4.3 3.6 1.0 23.3 1.4 9.1 3.5 0.6 3.5 0.8 8.2 0.0 1.2 2.5 6.7 2.5 2.0 13.2 3.3 31.5 3.0 0.2 1.1 1.5 1.1 0.6 0.0 12.9 2.0 75.1 82.4 1.1 4.6 3.8 5.3 1.4 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1, RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 12.1 11.8 15.2 11.0 15.9 9.2 8.2 21.7 25.9 10.4 9.6 24.7 11.0 11.8 11.0 7.0 9.1 15.4 10.5 10.6 16.4 19.1 10.0 9.8 11.3 11.2 19.1 14.5 14.4 20.8 18.0 16.6 9.3 18.3 12.1 6.9 13.2 15.8 11.0 21.8 12.4 12.3 12.5 21.2 12.0 10.5 11.1 14.8 9.9 9.7 6.1 9.5 8.9 7.6 3.3 6.4 4.0 7.4 4.9 3.6 2.8 7.3 16.6 7.1 15.6 6.4 7.2 7.5 11.1 6.8 9.5 7.7 11.7 11.3 5.8 10.9 7.2 4.6 15.0 8.5 7.1 5.2 15.7 9.4 6.8 8.6 5.4 7.2 8.1 15.0 6.9 5.9 5.7 7.0 4.8 6.8 11.8 8.1 4.4 4.6 22.9 9.5 10.3 5.4 12.2 17.9 17.1 5.0 5.7 4.7 17.9 23.1 17.2 11.1 8.8 9.4 3.5 20.2 11.3 10.0 7.4 6.4 13.9 8.5 8.9 6.7 5.3 8.9 6.7 10.0 0.7 2.3 4.0 3.6 2.2 2.5 3.2 2.5 3.5 2.5 3.3 3.4 2.9 1.0 4.9 7.4 6.4 3.1 2.8 15.2 15.9 21.7 25.9 16.4 19.1 19.1 14.5 18.3 14.8 3.0 5.1 5.9 5.9 6.6 16.4 7.2 2.5 12.0 6.8 3.5 15.7 10.2 3.3 5.0 1.9 6.8 8.6 0.0 6.0 7.4 6.6 6.4 2.3 10.2 6.1 28.6 9.2 9.8 5.4 0.7 6.1 6.4 8.5 4.6 10.2 8.3 4.2 7.0 4.2 5.6 18.4 0.0 7.3 7.0 13.6 7.8 7.8 10.7 9.0 4.1 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "BRX1, biogenesis of ribosomes" Q8TDN6 5 34915376-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA039614: AB_10963698" "prognostic unfavorable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favorable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.9 18.4 20.4 15.6 24.0 30.6 23.7 24.9 24.1 16.4 14.4 10.7 18.9 11.9 18.1 18.2 23.4 17.6 11.9 16.4 15.8 15.2 17.0 18.6 14.0 22.2 21.1 15.6 19.4 13.4 15.6 19.1 24.5 20.9 15.9 16.5 7.7 15.7 14.5 19.7 15.9 13.3 22.9 18.6 17.0 14.7 13.4 21.9 17.0 16.6 14.2 23.1 21.6 21.7 22.9 14.0 4.1 10.4 15.0 22.1 16.2 14.8 14.7 15.0 20.7 6.5 9.3 29.6 18.4 13.0 24.9 15.9 20.0 19.7 32.8 9.5 10.9 27.7 12.4 26.2 18.9 28.3 17.6 25.9 21.9 35.2 17.8 17.9 34.8 15.2 11.2 12.3 22.9 20.7 7.6 11.4 17.2 38.3 10.0 16.2 16.1 24.1 38.1 24.2 17.6 21.6 21.6 27.2 14.1 14.3 17.3 18.2 16.3 38.0 26.7 17.1 12.4 16.7 21.5 6.8 19.1 20.9 13.7 35.1 9.1 19.4 41.6 16.5 40.1 23.7 4.1 8.5 4.0 14.4 7.9 20.4 22.9 17.7 18.1 10.7 18.0 22.1 19.6 0.5 15.0 10.4 14.0 16.4 16.2 20.4 24.0 24.9 24.1 15.8 15.2 21.1 15.6 20.9 21.9 26.8 30.7 36.9 76.5 96.6 20.2 18.6 15.3 46.8 48.9 22.7 11.8 108.4 41.4 38.0 10.5 32.1 8.4 23.3 37.3 80.2 49.4 31.2 18.6 11.5 37.1 20.6 20.2 16.5 12.9 6.8 36.5 20.6 30.4 33.3 17.8 15.1 37.9 10.5 27.3 26.6 34.1 6.5 35.4 54.6 70.7 83.7 105.5 31.6 29.0 66.5 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Group enriched" "Detected in some" 19 "Early spermatids: 100.4;Late spermatids: 53.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in some" 8 "RT4: 27.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.3 27.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.2 2.5 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.9 100.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 53.9 0.6 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.4 0.8 0.0 0.0 0.2 3.7 0.9 2.8 0.1 0.0 0.0 0.8 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Group enriched" "Detected in many" 7 "Spermatocytes: 66.9;Spermatogonia: 28.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.8 11.1 35.5 14.1 0.9 2.5 11.5 20.8 11.7 22.3 19.4 16.2 8.4 19.8 11.7 7.5 20.5 24.7 33.5 11.3 24.3 17.0 18.0 28.9 28.7 15.0 0.0 26.1 15.9 0.5 0.6 13.6 12.8 4.4 16.1 22.9 24.9 21.1 22.2 7.4 20.4 15.9 24.0 18.4 12.7 21.9 29.2 15.0 6.8 11.1 23.2 14.3 12.8 12.3 4.5 16.2 14.3 13.5 9.3 17.1 18.1 17.0 18.4 11.1 18.8 32.4 9.1 29.3 22.2 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 3.0 1.4 0.8 0.3 0.7 0.4 0.4 0.0 0.0 3.4 0.0 0.0 1.3 0.0 0.3 2.5 0.0 0.3 0.0 0.0 5.1 0.4 0.2 0.0 0.2 4.3 0.0 0.0 1.3 0.6 2.4 1.4 1.5 0.0 0.0 1.4 0.0 0.8 0.8 0.4 0.0 0.1 6.5 0.0 66.9 28.8 0.3 0.7 0.8 1.7 0.4 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23, rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 113.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 16.6 23.4 16.3 15.0 18.8 19.6 18.3 12.3 20.6 17.5 19.3 17.9 19.5 18.3 19.1 30.6 17.5 24.1 23.1 34.2 16.0 17.5 28.1 36.3 16.1 18.3 25.3 17.5 19.3 27.9 14.3 21.8 22.1 16.4 16.5 19.8 20.3 25.1 25.6 52.2 19.3 21.6 21.2 18.7 18.7 18.9 97.0 16.5 22.1 25.8 22.6 22.7 18.7 14.8 43.9 49.0 14.4 18.3 30.1 37.6 31.4 22.2 24.6 9.0 71.4 12.4 11.1 15.0 15.4 13.9 19.9 16.3 34.0 30.1 26.0 8.1 16.5 34.3 16.0 20.7 14.9 18.4 18.2 24.0 11.3 28.7 13.7 15.7 31.7 16.6 10.0 17.2 17.5 15.9 10.1 12.8 21.5 44.7 48.2 17.2 35.1 19.9 43.6 21.5 51.7 28.3 17.8 17.6 113.3 22.0 16.1 27.3 20.5 20.6 55.0 22.8 9.3 34.6 25.4 13.7 17.2 21.9 21.7 32.9 16.7 29.2 43.7 39.4 24.2 35.9 11.5 17.1 14.4 30.7 18.3 34.3 43.9 35.5 33.6 31.5 38.0 37.6 34.4 3.2 30.1 16.2 49.0 37.3 31.4 16.3 18.8 12.3 20.6 16.0 17.5 25.3 17.5 16.4 16.5 41.7 53.9 0.0 0.0 0.0 0.0 0.0 0.0 144.6 78.5 43.6 0.0 64.0 82.9 81.2 0.0 0.0 0.0 0.0 122.2 66.3 0.0 0.0 43.0 0.0 62.2 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 36.9 0.0 0.0 97.5 0.0 0.0 82.3 0.0 0.0 0.0 0.0 0.0 0.0 89.2 0.0 0.0 0.0 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137174 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.3;skeletal muscle: 37.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;granulocytes: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 18.7;WM-115: 18.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" Yes NA "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 1.0 2.3 2.4 7.6 0.6 8.9 0.7 4.1 2.6 11.5 6.7 6.7 1.7 5.3 2.8 5.3 2.5 2.1 29.3 2.8 2.5 1.5 0.7 2.3 0.9 10.4 1.3 1.2 1.0 0.8 3.5 3.5 6.1 5.4 3.5 3.6 1.6 10.0 37.1 0.8 2.7 19.4 10.7 0.7 5.9 10.0 6.3 0.0 1.6 8.6 0.8 10.3 8.6 0.5 1.2 2.9 0.3 0.4 0.4 0.1 0.8 1.2 4.8 0.8 7.0 9.7 2.1 3.6 2.5 5.6 7.4 0.3 0.0 0.0 0.0 6.7 9.3 0.0 2.0 1.2 5.2 0.0 1.7 0.0 0.6 0.2 1.5 0.0 0.4 5.6 4.3 8.6 0.7 4.2 2.4 2.0 0.1 12.1 12.2 0.1 0.1 0.6 1.0 0.0 0.0 3.4 18.7 0.0 0.0 0.0 6.2 10.8 2.3 0.0 4.8 3.6 0.0 12.2 5.5 8.9 0.0 0.0 9.3 1.1 0.5 0.0 5.3 0.0 18.8 2.9 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.7 0.4 0.1 1.2 0.1 0.1 2.3 7.6 0.7 4.1 2.8 2.5 10.4 1.3 6.1 6.3 0.0 0.0 0.0 0.2 0.2 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.9 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 1.7 0.0 0.0 2.5 0.0 42.6 1.1 0.5 0.0 1.8 0.0 0.0 0.2 0.0 3.2 0.0 0.0 12.9 3.9 12.5 5.1 0.6 0.1 0.0 0.0 0.1 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921188-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 11.5 13.4 6.0 11.5 7.2 6.0 17.5 5.0 8.9 7.8 7.9 4.6 5.3 4.0 11.0 5.4 11.7 9.3 10.0 17.6 5.9 6.8 8.0 18.6 7.1 7.4 5.8 6.5 11.8 15.9 10.6 5.4 11.3 7.4 8.0 6.8 4.8 9.6 7.9 31.7 9.2 5.0 12.6 6.3 9.9 7.3 8.9 4.6 20.1 7.1 11.9 12.9 7.3 10.1 4.0 9.3 0.9 3.4 4.5 5.5 2.2 11.9 14.8 8.2 11.6 6.1 6.9 16.8 12.2 6.4 19.3 14.1 20.4 3.1 22.0 11.1 9.1 13.2 7.9 24.9 17.8 15.2 7.9 27.1 20.5 10.4 22.9 10.6 14.6 9.0 8.9 11.6 18.0 16.4 4.2 13.2 12.9 26.0 4.9 12.7 20.4 15.3 14.7 6.4 37.3 15.6 18.3 11.2 14.0 10.7 10.2 16.5 10.0 8.1 7.4 14.2 6.6 8.6 12.9 10.2 11.2 13.3 7.6 17.7 5.7 7.4 47.6 3.8 14.8 11.7 0.0 3.4 0.9 3.9 3.4 5.5 3.8 2.5 3.1 5.4 4.0 1.3 3.0 0.3 4.5 3.1 9.3 3.1 2.2 6.0 7.2 5.0 8.9 5.9 6.8 5.8 6.5 7.4 4.6 0.0 3.8 8.9 21.5 27.5 2.5 2.5 5.1 4.0 5.7 1.8 3.9 19.5 3.3 20.9 6.2 7.1 1.4 0.0 14.8 19.5 10.6 9.6 2.3 6.6 10.6 0.0 5.2 4.3 1.0 3.4 7.5 5.3 8.5 7.2 5.5 3.4 18.6 0.0 6.7 8.4 2.8 6.5 17.3 6.5 26.9 22.1 24.4 5.0 9.9 23.5 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 12.7;testis: 44.7" "Group enriched" "Detected in some" 97 "Early spermatids: 967.9;Late spermatids: 1530.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 127 "basophil: 12.7" "Lineage enriched" "Detected in single" 127 "granulocytes: 12.7" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043022 Approved Mitochondria Yes NA Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.4 1.1 0.4 0.9 1.2 0.2 1.0 0.8 3.3 0.4 0.7 0.0 1.0 0.3 0.3 1.5 1.2 0.3 0.3 0.5 0.4 1.3 0.5 0.3 0.2 0.2 0.4 0.9 3.2 0.9 0.2 1.2 0.3 4.1 1.1 0.4 0.6 1.8 1.1 0.2 0.4 0.6 0.7 2.0 0.3 0.4 44.7 0.0 0.0 3.3 0.0 0.2 0.4 1.9 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.8 3.3 0.4 1.3 0.4 0.9 4.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 967.9 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1530.3 8.3 0.0 1.7 0.0 0.8 0.0 0.1 0.0 4.9 0.0 0.0 12.9 0.0 10.2 7.8 0.0 0.0 0.0 0.6 0.3 C12orf66 FLJ32549 ENSG00000174206 "Chromosome 12 open reading frame 66" Q96MD2 12 64186316-64222296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046743, HPA052855" Uncertain Supported "Lysosomes,Cytokinetic bridge" Yes No Lysosomes "Cytokinetic bridge" "HPA046743: AB_2679782, HPA052855: AB_2681973" "unprognostic (7.44e-3)" "unprognostic (2.38e-1)" "unprognostic (6.20e-2)" "unprognostic (2.70e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (7.46e-2)" "unprognostic (4.07e-2)" 6.0 9.7 6.9 6.0 14.5 2.9 10.2 4.4 11.5 5.7 5.1 15.7 4.5 5.8 4.9 9.4 7.9 7.5 4.7 4.2 7.5 6.8 10.2 15.3 5.2 9.4 21.7 6.8 7.6 13.9 14.8 5.6 3.9 9.4 4.6 6.0 4.3 6.4 6.0 9.1 10.3 5.2 4.5 12.3 8.6 5.5 6.0 11.7 5.7 10.5 6.0 8.6 6.3 6.0 8.4 4.4 0.4 2.7 3.7 10.3 4.4 4.9 7.9 1.5 4.3 4.1 7.0 4.2 2.7 3.4 4.1 2.6 2.5 4.0 15.7 3.9 2.2 6.7 5.8 6.4 4.9 4.5 11.9 4.3 5.7 1.9 2.3 5.4 6.1 3.4 5.3 8.4 5.4 9.8 4.7 2.9 11.1 7.8 10.5 4.1 9.5 7.0 5.4 7.2 5.9 6.3 3.5 4.6 12.0 6.2 5.8 3.6 3.6 4.5 6.2 4.4 4.1 10.1 4.0 2.3 4.1 2.8 4.1 2.6 14.1 11.5 8.8 6.3 5.4 4.6 0.4 2.7 0.2 3.7 2.5 6.2 8.4 6.9 5.4 4.4 7.5 9.8 9.1 0.3 3.7 1.7 3.1 10.3 4.4 6.9 14.5 4.4 11.5 7.5 6.8 21.7 6.8 9.4 11.7 3.0 2.4 10.0 7.5 2.2 2.3 2.8 10.2 1.4 6.8 8.7 2.0 5.4 8.3 3.4 9.7 3.7 1.6 0.0 4.5 3.3 2.4 3.8 1.1 10.2 4.2 0.0 4.1 1.3 4.3 5.7 4.4 4.1 1.7 1.0 2.5 2.0 2.7 3.5 1.8 9.9 1.3 0.0 3.2 3.9 9.3 3.8 1.5 6.9 3.5 3.8 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 70.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.6 0.0 0.1 0.0 21.7 0.0 0.0 1.6 0.0 17.6 0.2 2.3 0.0 1.1 0.0 4.8 0.0 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.6 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.7 0.0 1.0 0.0 0.0 70.5 6.1 0.0 0.0 0.0 0.0 0.1 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 26.3;Late spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.6;SH-SY5Y: 11.5" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.5 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.4 4.9 1.1 2.6 2.5 6.5 7.5 1.4 2.6 11.6 2.0 0.2 3.9 2.3 2.5 0.8 1.8 5.0 1.0 8.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 2.3 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.5 3.4 0.4 3.9 1.8 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 0.0 1.7 0.0 4.6 2.5 3.7 0.3 0.0 2.7 5.7 0.0 2.0 1.3 1.7 3.4 26.3 1.0 5.9 0.0 2.9 1.4 1.5 3.9 9.2 0.0 1.1 1.6 7.5 0.0 0.0 35.6 0.9 1.0 1.7 1.0 5.4 5.2 2.8 3.5 1.8 2.1 5.2 6.5 2.5 11.1 4.2 2.6 1.3 0.5 3.0 4.7 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Group enriched" "Detected in some" 88 "Early spermatids: 590.0;Late spermatids: 956.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.6 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 590.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 956.8 7.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 5.3 0.5 0.0 6.5 0.0 8.4 6.1 0.0 0.0 0.0 0.6 0.1 C1orf123 FLJ20580 ENSG00000162384 "Chromosome 1 open reading frame 123" Q9NWV4 1 53214099-53220617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" Yes No 380000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 32.6 21.4 27.8 19.1 29.4 12.9 26.3 16.4 25.4 29.2 33.2 25.0 22.7 15.4 34.0 28.9 25.7 32.2 22.7 28.8 24.3 22.3 26.9 29.3 20.3 18.3 24.7 26.3 33.5 17.5 21.0 20.1 22.5 23.7 31.7 24.7 24.0 16.6 33.5 44.4 14.3 16.9 48.4 22.5 18.4 23.4 26.0 23.8 18.9 26.0 18.0 19.4 28.9 26.0 25.5 38.4 31.5 39.1 30.5 36.5 26.4 11.7 12.8 16.9 15.4 39.3 50.5 15.0 17.7 18.9 18.0 19.5 10.9 10.2 18.3 14.9 21.4 17.5 4.7 10.4 17.4 21.9 23.5 17.7 18.6 9.9 16.3 38.8 21.4 12.3 32.7 19.0 19.2 20.4 27.3 29.3 22.7 19.2 5.1 22.5 19.8 26.2 20.1 28.2 14.5 20.4 19.2 21.5 14.4 20.8 12.0 14.3 13.8 16.7 15.4 16.7 28.7 11.0 21.9 18.3 20.9 12.3 14.4 17.2 7.5 10.8 20.6 16.8 21.4 16.0 28.3 32.1 31.5 30.4 39.1 27.7 25.5 30.2 31.7 38.4 23.6 33.7 33.4 13.0 30.5 31.8 25.9 36.5 26.4 27.8 29.4 16.4 25.4 24.3 22.3 24.7 26.3 23.7 23.8 11.9 22.3 30.6 23.2 14.7 32.1 41.2 20.4 42.8 25.0 36.6 2.0 51.1 86.2 35.5 86.3 45.6 23.9 0.0 31.5 63.6 57.4 21.8 30.1 40.4 58.2 17.5 27.0 35.6 28.2 159.2 74.5 32.0 33.7 43.3 31.3 44.6 30.1 36.6 92.6 79.1 28.3 64.7 60.5 49.3 36.1 13.7 39.0 20.8 32.6 18.0 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 48.9;Late spermatids: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA010019, HPA075399" Approved Approved "Nucleoli rim,Mitotic chromosome,Intermediate filaments" Yes No "Nucleoli rim, Mitotic chromosome, Intermediate filaments" "HPA010019: AB_1078885, HPA075399: " "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.62e-4)" 3.7 6.6 8.3 4.9 9.0 5.6 3.1 7.6 10.0 5.5 6.0 11.3 5.4 6.1 6.0 6.9 6.6 4.0 5.9 3.8 8.8 5.8 5.0 5.0 5.6 4.2 6.6 4.9 5.8 5.3 2.2 4.4 5.6 5.0 6.6 1.8 5.8 10.2 6.5 3.6 23.7 5.5 7.5 5.2 7.0 9.0 17.5 5.6 5.2 4.0 5.2 6.4 5.4 4.4 5.0 4.3 9.9 4.9 4.7 5.7 3.9 11.9 9.7 4.5 7.8 1.4 1.4 10.2 6.8 1.6 6.2 4.1 5.2 12.6 3.4 8.4 2.1 5.0 9.9 1.9 6.3 1.8 6.4 14.1 2.3 16.6 5.4 2.9 4.0 5.6 3.1 3.0 3.2 1.2 1.9 3.0 5.5 13.8 2.7 2.2 9.2 7.4 10.2 4.1 4.5 15.6 9.2 5.3 6.2 3.6 4.3 9.4 12.5 5.3 9.5 5.4 1.4 6.6 5.2 5.0 6.7 7.1 9.8 7.0 4.5 6.1 6.0 5.8 10.9 5.4 9.9 4.9 2.6 5.3 4.4 5.4 5.0 4.9 5.7 3.2 4.7 5.3 5.0 1.1 4.7 3.1 4.3 1.7 3.9 8.3 9.0 7.6 10.0 8.8 5.8 6.6 4.9 5.0 5.6 0.0 10.6 1.5 3.4 6.6 6.2 1.8 5.1 9.4 5.7 8.7 3.9 4.7 1.7 7.6 48.9 3.6 5.1 23.3 5.9 11.7 5.0 4.2 5.7 4.7 3.6 12.7 4.1 1.8 1.8 101.9 2.6 2.7 3.3 8.2 7.0 3.0 6.1 2.9 1.4 1.1 7.4 0.0 4.1 11.2 6.6 6.0 4.1 3.8 6.9 4.4 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970728 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 224.5" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 1615.7;Peritubular cells: 1885.2;Sertoli cells: 2257.2;Smooth muscle cells: 2337.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 79.3;fHDF/TERT166: 128.9;U-138 MG: 82.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" Yes No 110000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 38.6 17.4 6.7 33.4 11.1 0.0 26.6 11.9 9.1 83.1 141.0 6.0 111.4 12.6 82.3 59.8 122.8 45.8 46.3 20.1 7.7 5.0 33.5 39.6 26.1 12.9 8.7 8.5 76.3 6.9 4.1 17.8 57.4 8.9 87.8 25.1 10.9 12.4 133.3 15.3 12.9 39.2 224.5 8.5 35.9 64.5 29.7 9.7 2.1 20.3 14.1 5.3 205.3 70.4 0.1 0.2 4.3 0.2 0.4 0.2 5.9 12.1 8.0 18.1 15.9 62.7 50.9 17.9 71.6 79.3 24.6 27.3 14.5 0.3 0.0 17.1 128.9 16.4 2.9 11.5 21.3 33.5 0.1 3.9 0.4 9.5 9.8 41.3 0.0 0.0 39.0 15.9 27.5 15.6 37.8 20.7 0.0 0.0 0.1 36.7 0.0 0.0 0.2 21.6 0.0 2.8 0.1 16.1 0.0 5.0 3.3 3.1 7.9 25.1 3.3 9.6 57.0 0.7 0.1 55.2 82.7 14.5 15.7 24.3 0.0 0.0 0.0 28.7 0.0 61.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 4.3 0.4 0.0 0.0 0.0 5.9 6.7 11.1 11.9 9.1 7.7 5.0 8.7 8.5 8.9 9.7 20.8 21.2 22.4 285.3 373.4 156.1 350.6 211.5 9.4 25.0 41.8 5.9 146.5 19.9 303.7 58.2 355.4 0.0 23.3 20.1 802.8 618.3 367.0 4.7 529.8 38.7 87.4 3.5 505.2 24.5 42.4 1615.7 35.2 318.9 11.8 0.9 180.9 118.9 0.0 1885.2 249.0 13.7 2257.2 2337.7 6.8 10.3 150.2 231.4 15.0 0.2 28.3 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CAMSAP1 "DKFZp434F195, FLJ31228" ENSG00000130559 "Calmodulin regulated spectrin associated protein 1" Q5T5Y3 9 135808487-135907228 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 320.0;Rod photoreceptor cells: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020527, HPA024161" Approved Supported "Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "HPA020527: , HPA024161: AB_1845967" "unprognostic (3.18e-3)" "unprognostic (4.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.57e-2)" "unprognostic (6.00e-2)" "unprognostic (1.43e-2)" "unprognostic (1.79e-3)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" "prognostic favorable (3.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (2.66e-3)" 8.0 8.6 12.4 6.5 15.7 10.5 8.3 23.9 21.7 7.6 6.3 14.3 7.2 4.1 9.5 6.9 22.0 9.8 6.5 9.2 11.2 10.8 5.2 4.8 8.2 6.6 10.4 9.9 13.5 9.5 8.9 9.4 6.5 12.2 8.0 4.7 24.2 7.3 8.6 32.7 10.4 4.3 8.6 10.3 6.2 6.2 20.8 9.2 10.0 5.7 14.4 11.4 7.6 10.0 2.4 1.1 3.8 1.6 1.0 2.1 1.2 9.3 13.7 22.7 16.0 5.3 4.6 11.1 7.5 6.3 8.2 6.3 12.0 8.2 4.3 10.9 9.5 10.6 19.1 11.9 8.2 6.3 14.6 6.6 6.2 15.4 6.0 8.1 10.8 9.4 6.2 10.4 10.5 14.5 7.9 9.2 9.6 12.8 9.4 10.7 16.6 10.0 6.7 13.0 11.2 10.0 19.7 18.9 10.5 8.3 11.5 24.8 24.4 9.7 7.1 10.5 7.8 9.9 9.0 11.3 15.7 12.4 11.5 12.8 4.7 8.8 11.8 10.2 7.4 9.0 3.8 1.5 0.3 1.1 1.6 2.1 2.4 1.8 1.7 0.9 0.5 1.3 1.9 0.5 1.0 1.3 1.1 1.4 1.2 12.4 15.7 23.9 21.5 11.2 10.8 10.4 9.9 12.2 9.2 6.0 3.8 6.0 12.6 20.1 32.5 12.2 5.1 16.0 15.9 3.5 320.0 10.0 0.0 10.2 8.6 7.9 3.0 23.3 7.6 3.1 5.4 12.1 5.8 7.3 9.4 15.9 12.1 4.9 9.2 13.6 5.5 8.9 11.8 10.0 3.8 16.5 12.6 3.5 5.6 3.8 218.3 12.9 9.0 16.3 32.4 27.7 4.7 3.2 3.8 24.1 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394748-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 121.1" "Cell type enhanced" "Detected in many" 10 "granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" Yes No 6700000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 44.3 4.9 10.1 18.3 10.8 32.4 17.6 3.3 7.6 19.9 13.8 17.6 17.7 6.8 14.0 16.0 52.3 12.9 25.2 4.1 8.5 6.5 35.4 2.9 44.3 26.9 14.7 4.8 10.6 8.9 40.3 5.2 15.6 11.9 15.0 11.0 7.6 22.5 19.3 2.6 39.2 11.5 9.9 17.6 10.9 25.9 8.4 10.0 21.2 31.5 28.1 40.2 27.0 31.1 50.1 121.1 79.0 97.4 48.3 9.7 67.5 22.8 11.0 0.0 1.0 7.8 17.0 11.8 8.7 0.9 8.6 8.5 1.3 81.3 2.9 12.4 16.3 9.1 26.7 0.0 17.1 3.7 17.6 0.6 8.2 20.2 4.8 6.1 4.6 116.7 14.7 13.2 7.8 9.7 0.4 5.6 16.9 0.9 6.8 5.9 19.3 12.3 54.3 3.4 17.1 14.6 12.3 1.3 1.3 32.6 11.4 0.1 0.1 10.9 14.7 84.8 6.3 6.1 58.0 21.6 18.4 4.0 0.6 0.3 0.1 0.6 1.2 41.7 61.9 0.2 79.0 97.4 58.2 1.1 36.4 3.4 50.1 9.7 3.7 121.1 37.1 2.8 1.3 14.1 48.3 10.3 84.1 9.6 67.5 10.1 10.8 3.3 7.6 8.5 6.5 14.7 4.8 11.9 10.0 17.9 29.8 86.2 131.0 107.6 0.5 1.1 63.7 9.4 23.9 300.1 0.0 25.0 179.1 90.0 3.2 5.8 101.1 0.0 81.2 260.0 55.7 64.5 535.8 0.9 1102.8 1.6 27.6 3.1 175.5 12.5 43.4 306.0 140.0 603.3 55.7 37.8 257.6 119.4 21.2 88.5 1.1 12.9 23.5 6.3 40.4 148.2 29.9 59.9 86.5 209.1 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 54.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 8.6 21.6 16.6 7.1 24.2 4.1 13.2 20.5 24.8 10.0 13.2 10.9 7.5 5.0 11.7 12.5 5.1 9.2 8.1 13.6 25.9 22.2 10.2 7.1 9.0 9.2 13.1 16.6 14.1 7.8 12.7 22.8 9.8 20.0 11.8 15.9 8.4 22.6 8.2 11.3 3.7 6.3 9.7 13.7 8.0 6.0 10.1 11.5 7.3 13.2 2.9 8.3 9.0 6.3 1.8 1.1 0.2 0.7 1.8 4.7 0.7 3.0 5.9 20.3 7.5 6.2 7.5 3.4 4.2 7.4 4.6 6.1 3.7 7.6 7.8 11.0 5.6 8.3 1.7 5.1 1.4 9.2 12.4 4.1 6.9 5.0 6.7 5.3 11.4 0.0 6.8 5.4 4.2 6.1 9.1 7.3 9.2 3.7 17.2 11.4 4.5 15.8 6.5 10.4 4.3 4.7 10.9 16.5 6.0 9.4 8.5 7.7 26.3 6.5 12.1 4.1 15.4 3.1 7.2 3.8 11.6 9.2 9.5 6.0 16.5 15.4 16.3 6.3 2.7 7.5 0.0 0.6 0.2 1.9 0.7 4.7 1.8 2.8 2.3 1.1 1.7 2.9 2.2 0.0 1.8 0.6 1.0 1.7 0.7 16.6 24.2 20.5 24.8 25.9 22.2 13.1 16.6 20.0 11.5 26.8 22.9 6.9 5.2 4.0 54.4 17.1 17.8 18.7 17.0 19.2 17.7 9.7 3.3 4.5 2.7 13.3 12.0 0.0 4.8 4.6 9.3 11.8 10.3 10.9 7.4 63.5 6.9 17.2 11.5 4.7 10.6 5.6 23.6 2.8 27.6 25.0 6.1 8.6 9.2 8.8 28.9 19.4 7.1 6.3 11.9 4.0 14.1 7.2 14.1 3.7 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834302-191847255 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 384.1;Alveolar cells type 2: 70.0;Club cells: 150.2;granulocytes: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 9.9;neutrophil: 8.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 28.2;HEL: 20.6;HUVEC TERT2: 64.0;LHCN-M2: 99.1;TIME: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" Yes No 160000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: AB_2684688" "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.45e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 60.3 8.9 4.9 10.1 8.3 1.8 37.8 2.8 6.1 26.1 32.6 2.8 14.5 3.9 23.9 17.4 18.2 19.5 45.3 46.5 7.1 5.3 15.9 10.4 57.9 20.1 8.9 5.6 20.4 7.6 3.2 4.3 11.6 5.8 19.3 8.9 9.8 6.9 11.2 35.7 3.8 10.6 39.3 7.1 52.9 8.8 7.2 4.4 0.3 34.5 20.1 2.8 33.2 34.5 0.1 1.0 9.9 0.8 0.4 0.1 39.0 0.0 3.5 1.2 0.0 0.1 0.6 0.0 0.7 0.6 0.1 0.2 0.0 0.0 0.0 4.5 28.2 0.0 0.6 0.0 5.5 0.4 0.0 0.0 20.6 0.2 7.8 8.0 0.0 0.0 1.5 3.6 0.6 1.7 0.4 64.0 0.0 7.4 0.0 99.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 26.0 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 8.9 0.4 0.4 1.0 0.1 39.0 4.9 8.3 2.8 6.1 7.1 5.3 8.9 5.6 5.8 4.4 384.1 70.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 150.2 0.0 0.0 0.1 5.0 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 170.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Group enriched" "Detected in many" 4 "Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol Yes NA "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.2 3.5 1.5 3.1 12.0 18.6 2.4 13.4 15.9 15.4 12.3 0.1 2.6 0.0 3.9 13.7 5.4 5.7 2.0 2.7 6.2 16.7 6.4 0.5 3.7 0.1 1.0 0.0 0.0 2.6 0.3 10.7 1.4 7.4 9.3 1.4 0.0 0.1 4.5 9.2 1.1 5.4 1.2 3.8 15.5 2.6 2.9 23.9 5.1 5.2 0.8 1.1 10.2 12.5 19.5 0.8 3.7 1.4 6.4 10.0 0.8 11.2 12.9 0.6 0.2 0.0 10.4 0.3 17.9 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 0.0 2.7 0.0 23.4 63.1 0.2 0.2 5.1 5.3 11.4 0.0 0.0 0.9 8.3 3.3 0.5 11.3 1.1 0.0 0.6 0.2 7.7 36.1 5.7 0.0 7.4 0.0 0.0 8.6 3.7 1.1 62.7 5.6 62.4 36.1 8.9 1.4 2.1 1.1 71.1 0.0 0.4 0.0 20.3 0.4 0.2 40.8 0.2 1.3 2.9 11.5 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666364-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 11.3 10.9 10.9 16.0 14.1 20.2 10.2 11.3 17.0 10.3 11.5 8.0 8.9 16.2 9.1 6.4 25.2 9.2 9.1 9.1 12.1 9.0 10.6 12.1 8.7 18.8 12.4 11.9 8.4 12.0 9.4 8.4 11.2 11.8 13.1 6.4 5.7 13.0 9.9 12.7 29.8 11.8 10.3 9.1 17.7 11.4 13.4 12.4 9.8 9.2 13.1 16.6 10.6 14.7 12.8 12.6 10.2 9.2 11.9 11.2 5.9 12.4 24.7 6.7 12.0 4.9 4.9 13.5 14.3 6.8 20.6 11.4 21.8 7.5 12.9 7.6 8.5 11.6 16.4 13.9 16.1 7.7 6.6 21.4 20.0 11.0 17.3 7.5 15.3 13.1 7.2 8.7 18.9 8.5 4.5 14.5 14.0 19.0 6.9 9.6 13.6 15.2 16.6 16.1 9.5 25.0 18.2 12.7 8.3 6.5 11.4 16.5 21.3 13.1 27.0 11.7 7.9 19.5 12.7 9.9 29.8 17.4 11.9 19.7 18.2 10.5 13.0 10.7 15.0 16.9 1.9 7.8 10.2 11.2 8.4 7.0 10.3 9.7 9.6 7.4 12.8 10.7 9.6 3.5 11.9 9.2 12.6 9.5 5.9 10.9 14.1 11.3 17.0 12.1 9.0 12.4 11.9 11.8 12.4 20.8 13.4 25.0 19.6 28.2 5.7 6.2 10.2 26.8 25.0 12.2 2.0 19.0 16.6 24.5 1.0 19.6 12.7 23.3 18.6 32.2 11.4 18.3 18.5 10.9 21.5 17.5 6.9 14.1 11.0 0.9 12.7 18.2 15.1 33.3 13.4 12.9 26.4 13.6 12.7 10.2 7.1 6.5 15.6 31.2 46.5 30.1 17.4 29.9 17.0 18.6 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553086-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.5;HEL: 14.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 2.5 2.5 5.8 5.5 7.5 4.0 3.6 8.2 7.8 4.1 2.4 1.1 6.9 1.9 11.6 5.8 2.4 4.6 3.4 2.6 4.9 4.1 2.8 1.3 2.5 2.4 3.4 7.6 6.3 3.4 4.2 7.8 7.3 6.6 3.4 2.5 2.0 1.9 7.4 2.4 4.9 2.2 7.1 6.1 1.5 3.1 20.4 3.3 20.2 4.3 1.4 2.2 2.5 2.8 1.6 0.7 5.1 0.6 0.4 1.8 0.2 1.7 0.9 2.2 2.1 1.2 2.6 1.4 1.4 1.1 1.4 1.5 0.6 0.8 9.5 0.7 0.8 2.5 0.4 0.9 1.3 1.5 2.0 0.9 14.8 1.5 1.3 1.8 2.1 1.9 1.5 2.6 1.1 2.1 1.0 0.6 5.4 0.4 2.6 1.6 0.7 4.1 1.9 1.7 0.8 2.1 4.9 1.6 0.3 1.0 1.4 3.1 1.5 2.8 1.0 3.6 1.9 1.1 1.5 1.1 2.9 1.6 0.8 0.9 1.4 1.7 6.2 1.2 1.2 2.0 5.1 0.6 0.0 0.8 0.6 1.8 0.7 0.7 0.7 0.7 1.6 0.5 0.9 0.5 0.4 0.4 0.7 0.6 0.2 5.8 7.5 8.2 7.8 4.9 4.1 3.4 7.6 6.6 3.3 0.0 6.9 0.0 5.3 2.5 24.3 7.0 0.0 17.4 9.1 3.5 15.7 4.8 5.0 2.0 152.4 2.6 2.7 0.0 3.1 3.6 1.9 0.5 1.1 0.8 1.6 9.5 1.2 2.5 0.3 134.7 5.5 1.1 0.0 1.8 2.6 11.2 2.0 0.0 5.6 1.4 44.6 12.9 2.1 149.3 27.2 2.9 4.7 0.7 3.6 2.6 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621818 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 8.4 7.5 9.3 7.6 11.7 6.5 12.0 31.0 15.1 11.7 11.0 9.6 7.6 5.9 12.7 12.7 6.7 12.9 7.6 8.4 9.8 6.4 9.2 4.6 7.7 10.1 10.8 10.6 14.7 7.1 10.1 32.9 7.6 11.0 9.7 9.4 7.8 9.1 10.9 11.9 5.7 7.7 11.1 11.2 8.7 8.0 8.6 12.9 11.9 12.1 5.7 10.2 11.0 9.7 2.6 1.1 7.0 2.2 5.0 14.1 2.7 5.5 1.9 6.2 3.7 9.3 5.6 4.9 7.1 6.5 9.4 8.3 4.3 4.4 15.5 1.6 3.8 6.1 3.1 3.4 6.5 10.5 5.5 4.2 9.7 8.6 4.9 6.6 12.4 3.6 5.4 9.4 7.8 5.5 8.3 5.9 7.9 9.0 2.4 7.2 4.5 9.9 7.9 10.1 4.7 7.7 3.3 5.3 8.3 5.6 1.9 2.3 4.3 8.6 5.5 5.3 5.5 1.9 5.4 3.2 7.0 5.5 6.5 9.6 5.0 5.3 8.3 5.2 14.2 5.5 7.0 1.5 3.3 4.3 1.9 5.6 2.6 7.4 5.3 1.1 1.7 8.6 6.2 0.3 5.0 2.2 1.0 14.1 2.7 9.3 11.7 31.0 15.1 9.8 6.4 10.8 10.6 11.0 12.9 20.8 19.9 24.5 21.3 25.0 66.8 26.9 25.5 57.6 35.2 21.0 102.1 17.7 24.9 17.3 158.6 28.7 8.0 23.3 9.1 11.3 30.0 13.3 33.5 7.5 16.2 49.3 20.2 27.0 26.2 74.4 50.0 20.8 25.3 43.3 9.4 34.0 13.6 10.2 44.9 16.5 99.9 32.3 30.2 49.7 45.4 25.7 13.7 47.3 13.6 9.5 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.5 16.1 20.0 12.0 0.2 0.0 18.6 5.9 6.1 12.0 7.0 19.5 18.7 0.1 23.7 6.7 3.3 23.7 14.7 14.3 7.5 28.8 8.7 0.9 16.0 13.1 1.6 0.2 1.9 0.0 7.6 3.4 9.9 7.1 3.7 10.5 4.2 2.7 1.4 29.4 7.8 2.4 7.3 20.3 16.8 11.7 8.4 3.9 8.5 7.0 9.9 12.5 15.2 8.1 3.7 8.0 17.7 3.6 8.4 2.3 20.0 8.5 5.9 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 20.8 6.4 0.9 7.8 7.8 31.0 2.2 7.6 2.7 9.1 1.8 58.9 5.4 0.0 7.3 2.3 4.2 14.2 0.0 8.1 3.5 2.3 8.5 5.8 15.3 1.6 1.6 9.2 6.2 1.2 0.9 0.6 0.6 8.5 0.0 9.6 28.9 11.9 14.0 0.7 5.1 47.8 0.0 2.3 0.9 1.6 12.3 4.1 0.7 10.9 10.3 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 21.0 28.7 7.1 20.5 5.8 9.6 9.7 14.2 11.1 26.1 14.0 24.4 14.2 25.8 27.2 7.7 18.6 19.8 24.0 17.1 12.0 9.1 26.6 13.1 12.7 34.0 19.2 20.5 22.5 10.9 13.0 24.1 15.3 3.8 19.3 14.2 41.9 13.3 12.7 24.9 30.8 31.3 28.7 12.5 41.3 21.0 10.7 64.9 9.1 9.0 16.1 10.4 9.1 21.1 16.6 4.7 21.3 8.2 12.6 26.0 16.0 35.3 30.7 11.2 16.5 27.9 21.3 22.2 31.4 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 0.0 2.1 3.0 15.4 32.7 9.3 0.4 2.5 0.0 4.5 1.8 7.9 15.9 6.6 20.4 19.7 6.8 2.6 0.0 10.4 14.1 9.5 18.2 4.7 2.4 16.0 3.2 6.9 3.7 2.8 10.6 10.6 7.9 15.1 4.6 4.9 3.6 13.7 3.5 5.6 5.4 7.9 19.4 20.2 37.1 19.1 27.0 6.9 6.1 9.7 15.5 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 610.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.6 40.6 55.8 49.6 2.9 5.0 131.7 26.0 19.5 68.6 58.1 60.0 55.4 36.1 31.7 23.9 78.7 37.0 56.1 56.8 77.0 35.4 27.7 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.3 27.4 6.3 36.6 35.4 27.6 28.7 55.8 55.9 27.2 23.7 31.0 19.5 25.8 28.7 40.2 37.0 25.1 21.7 28.4 17.9 44.7 21.1 19.2 32.8 40.3 20.9 15.3 15.3 49.7 27.6 64.9 14.4 26.6 50.4 21.2 34.9 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 0.0 0.3 5.2 4.8 10.2 4.2 1.5 2.5 13.4 4.5 5.2 2.0 53.5 1.7 5.3 63.8 1.8 2.9 46.7 1.2 610.8 11.3 3.6 2.3 3.0 50.4 0.0 1.2 6.2 6.0 9.4 2.8 4.4 3.3 3.6 4.6 2.8 2.5 0.0 2.5 4.3 2.9 6.5 3.1 28.8 70.2 6.4 34.7 4.4 11.5 2.7 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105078-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.2;testis: 73.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "T-reg: 17.8" "Lineage enriched" "Detected in many" 6 "T-cells: 17.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 2.0 1.1 0.4 21.0 0.4 24.7 2.5 0.3 0.6 1.8 5.5 0.5 0.2 5.2 1.0 1.5 11.3 0.5 1.6 1.2 0.4 0.4 1.0 1.0 1.9 12.0 0.4 0.3 0.8 0.7 0.0 0.4 6.7 0.4 1.1 6.3 0.4 2.1 0.6 0.4 3.6 5.1 2.0 1.3 5.2 3.0 73.9 0.2 70.2 0.8 10.3 16.0 1.8 3.4 1.8 2.3 0.7 0.1 3.0 17.8 1.8 28.7 25.3 41.6 10.3 1.9 3.8 22.1 23.8 15.3 36.9 30.4 40.9 17.7 26.7 17.3 15.4 21.6 35.5 39.3 20.2 34.9 27.7 21.1 34.6 29.6 23.2 0.5 25.7 22.3 1.4 2.7 15.9 20.3 7.2 25.0 33.0 34.9 42.9 27.8 20.9 29.3 37.5 30.7 12.4 15.0 34.3 58.9 27.1 11.6 20.3 25.9 17.5 32.6 17.7 21.5 34.0 30.7 25.7 13.0 18.4 31.2 20.2 45.3 19.1 28.7 47.5 12.0 58.9 25.9 0.0 0.1 0.6 0.1 0.0 0.2 1.8 3.9 4.1 2.3 0.9 0.0 0.1 0.7 3.0 0.0 0.1 17.8 1.8 0.4 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.2 0.0 1.1 7.8 1.0 4.2 0.0 0.3 0.0 1.4 2.3 0.0 0.0 26.7 0.0 0.4 102.4 0.4 1.7 163.5 0.2 106.5 1.1 1.7 0.0 0.8 25.3 0.0 2.9 3.1 10.7 30.4 4.0 4.2 0.0 3.6 5.5 0.0 0.5 1.7 1.8 0.0 0.2 0.0 0.0 88.2 36.6 5.4 13.6 3.2 12.4 2.0 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641087-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 534.1;Pancreatic endocrine cells: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 96.3;WM-115: 134.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 52.0 11.6 9.7 6.0 9.7 0.7 22.8 3.4 7.7 15.4 8.9 15.4 19.9 8.4 18.8 23.1 37.7 11.8 31.0 23.9 10.8 8.8 14.5 68.1 22.2 3.7 12.4 5.6 6.5 31.5 83.2 16.6 38.1 10.0 30.7 6.8 24.8 25.6 21.7 2.0 43.6 10.4 16.5 12.6 12.9 19.2 4.0 7.5 9.0 17.1 23.1 23.6 21.4 22.1 3.0 3.4 0.8 0.0 0.0 0.9 0.3 48.7 19.5 6.5 0.2 20.0 21.1 14.0 77.2 28.8 9.0 5.3 21.9 37.8 0.0 35.1 40.1 15.1 35.7 0.7 21.0 16.2 0.1 3.9 0.0 4.8 22.2 4.8 0.3 0.7 11.9 4.1 12.7 4.9 21.3 15.4 0.0 0.0 0.1 71.0 20.6 0.0 2.8 11.9 20.2 21.5 0.1 20.6 1.1 41.9 30.1 1.1 25.5 0.9 18.3 48.0 16.5 11.1 1.0 64.4 44.3 12.3 19.2 52.4 96.3 57.5 0.1 37.9 0.6 134.1 0.8 0.0 0.0 0.9 0.0 0.1 3.0 0.4 0.2 3.4 2.5 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.3 9.7 9.7 3.4 7.7 10.8 8.8 12.4 5.6 10.0 7.5 169.7 99.5 5.9 202.5 179.8 2.2 68.0 124.9 78.9 155.8 118.7 2.0 6.4 26.6 534.1 0.2 134.5 22.2 0.0 128.5 1.1 63.9 195.1 27.8 148.1 60.6 0.0 54.3 108.1 18.0 0.9 3.7 17.9 49.0 3.6 40.4 66.7 367.2 54.7 54.1 42.3 2.0 129.4 220.1 0.2 19.0 306.9 2.1 7.0 62.1 326.2 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4273772-4305350 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 13.7 39.3 20.8 12.0 15.9 23.6 10.4 6.1 22.3 14.4 28.3 8.1 24.3 18.5 21.9 41.9 12.2 16.5 9.1 36.9 17.5 7.3 6.0 5.7 12.8 24.5 7.9 17.0 11.6 18.4 8.3 19.2 23.5 9.3 16.4 24.2 14.1 8.3 22.4 2.0 9.2 19.6 45.5 14.0 16.5 11.1 5.2 8.6 6.2 18.5 6.9 13.6 22.3 16.3 3.9 2.1 4.6 1.0 9.1 14.8 5.4 0.0 0.0 32.3 0.0 5.6 0.8 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.2 0.0 0.0 4.1 0.9 29.5 0.0 49.7 0.8 0.3 0.0 0.2 0.1 12.6 2.7 10.8 4.9 0.0 22.3 0.2 0.0 0.9 3.4 71.8 6.3 0.0 0.0 16.6 13.3 0.2 0.0 0.0 47.0 23.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.1 2.3 0.0 9.4 0.0 0.0 1.2 12.2 0.0 0.1 9.1 0.0 4.1 1.0 4.6 9.1 0.2 13.7 3.9 13.0 11.0 2.1 1.5 8.2 9.8 1.5 9.1 0.1 1.0 14.8 5.4 20.8 15.9 6.1 22.3 17.5 7.3 7.9 17.0 9.3 8.6 56.6 49.3 25.1 24.4 94.8 6.8 305.9 0.0 9.4 43.3 12.2 0.0 2.6 0.0 2.5 0.7 38.4 26.9 46.7 59.7 1.7 135.6 5.7 54.3 0.8 12.0 3.2 62.3 17.8 13.3 0.9 48.6 38.9 37.1 6.4 146.6 155.3 32.6 35.1 116.7 1.0 3.7 25.8 50.5 0.7 3.6 34.6 5.3 61.2 109.0 7.0 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNQ FAM58A ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587919-153600045 "Disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 61.3;Extravillous trophoblasts: 78.8;Syncytiotrophoblasts: 101.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 3.1 5.7 4.2 6.1 12.8 4.2 9.7 3.7 11.1 4.5 5.2 6.4 4.2 6.1 3.7 10.5 5.1 5.1 4.0 14.7 7.9 6.5 6.3 5.0 10.9 9.5 6.1 4.1 9.5 3.0 6.4 6.4 7.3 5.7 6.1 3.5 8.0 6.8 10.3 4.0 5.0 4.9 6.7 7.3 5.4 2.7 7.4 3.9 4.9 4.2 8.7 5.2 4.5 7.4 1.9 6.8 2.3 1.1 4.8 1.4 19.8 15.5 6.0 21.3 11.0 5.6 9.4 12.0 10.5 11.4 11.7 14.9 7.1 16.1 23.2 12.7 17.2 12.9 19.8 11.4 11.8 9.8 20.1 3.9 9.3 11.4 9.7 13.6 9.4 7.4 10.2 7.7 8.5 5.2 9.7 8.4 4.8 7.8 9.7 23.1 9.5 16.6 7.6 21.5 26.2 10.8 9.7 8.4 8.7 8.5 7.9 10.4 6.2 9.7 14.0 6.4 3.5 12.4 6.9 10.1 14.3 22.3 18.1 11.2 10.6 20.4 9.1 21.2 7.4 0.0 2.3 6.8 4.0 2.1 1.8 7.4 3.7 2.8 1.9 6.2 4.0 2.8 1.4 1.1 1.0 1.9 4.8 1.4 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 7.0 0.0 36.5 61.3 22.4 0.0 0.0 0.0 0.0 32.2 78.8 0.0 0.0 2.3 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 39.7 0.0 0.0 27.4 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 101.1 0.0 0.0 0.0 CCNYL1 FLJ40432 ENSG00000163249 "Cyclin Y like 1" Q8N7R7 2 207711540-207761839 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 41.9" HPA046825 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA046825: AB_10963934" "unprognostic (2.59e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (1.20e-3)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-3)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-2)" "unprognostic (7.12e-3)" "unprognostic (7.99e-2)" "unprognostic (3.92e-2)" "unprognostic (8.08e-2)" "unprognostic (7.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.96e-3)" 17.5 8.0 9.8 12.2 10.7 10.6 14.5 4.8 12.8 12.6 18.1 11.2 11.5 13.3 8.8 8.2 24.6 8.0 10.0 11.7 8.0 7.2 15.9 18.4 14.5 11.9 9.1 10.1 6.3 21.6 6.9 8.3 16.8 9.3 7.9 16.4 7.9 12.1 10.0 10.1 5.8 16.3 10.8 11.7 12.1 14.8 18.3 8.1 10.9 14.4 6.6 13.9 10.8 13.9 4.1 1.8 4.6 3.8 1.9 2.7 0.9 11.8 5.1 6.9 9.9 9.4 10.6 41.9 7.3 12.4 7.6 8.3 23.0 11.2 4.5 7.0 13.3 18.5 8.3 8.2 13.5 7.4 1.6 6.2 6.0 5.9 19.3 8.8 5.6 7.2 5.0 5.6 9.3 10.7 6.8 24.5 5.4 2.9 4.8 10.0 6.0 4.9 5.0 13.7 5.1 5.7 4.2 6.9 3.6 8.1 8.9 1.6 5.4 9.0 3.8 11.0 17.5 3.5 14.2 13.0 8.6 8.7 10.8 4.9 2.7 3.7 6.9 9.7 6.4 7.3 1.7 3.8 1.5 1.1 1.9 1.4 1.2 1.9 1.9 1.8 4.1 1.5 2.7 4.6 1.9 1.7 1.7 1.3 0.9 9.8 10.7 4.8 12.8 8.0 7.2 9.1 10.1 9.3 8.1 3.0 15.5 8.5 12.6 10.9 5.7 7.0 2.5 1.4 6.8 22.7 9.8 11.1 1.7 5.7 7.7 11.7 30.0 0.0 12.6 29.2 8.9 12.4 5.7 13.2 14.5 4.8 9.2 21.5 16.1 7.4 2.6 14.3 8.5 20.8 7.5 9.7 10.6 67.0 3.5 9.8 12.9 0.0 9.2 17.0 7.8 9.3 6.4 7.2 6.0 16.0 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350766-30355361 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 24.6 33.0 23.6 27.8 24.4 17.8 22.5 27.6 43.4 24.2 25.4 27.4 31.8 25.8 32.3 29.0 23.1 30.0 35.6 27.4 23.1 23.7 24.8 18.2 22.3 30.2 23.2 27.3 29.7 30.9 46.3 30.3 22.3 20.3 25.8 21.3 20.8 27.4 40.7 31.7 22.0 22.6 28.1 20.6 32.0 24.5 23.4 19.8 26.8 29.8 25.9 36.5 22.9 19.9 38.2 28.1 51.3 39.0 29.2 37.6 29.9 21.7 26.5 22.4 20.2 18.7 17.8 19.0 24.2 29.2 27.6 29.7 20.2 26.3 33.6 30.0 26.3 25.4 24.0 22.8 28.4 22.2 19.9 26.8 14.2 25.1 23.7 26.9 20.1 26.3 19.1 24.1 30.6 19.7 19.0 28.6 25.2 16.0 25.9 27.6 52.3 27.7 17.1 30.1 17.0 15.7 41.1 18.6 25.3 22.4 21.9 18.4 35.2 16.2 28.7 16.3 19.3 27.2 16.3 20.4 31.9 22.2 16.0 21.1 43.5 31.6 30.9 21.8 18.7 26.0 36.3 26.3 46.2 31.7 30.8 25.1 36.2 25.8 29.4 23.3 38.2 21.8 26.9 51.3 29.2 39.0 28.1 37.6 29.9 23.6 24.4 27.6 43.4 23.1 23.7 23.2 27.3 20.3 19.8 29.8 25.3 41.6 42.3 25.5 27.7 23.3 38.2 32.1 18.2 34.9 19.6 52.1 51.4 70.2 14.8 35.4 46.6 23.3 84.6 47.7 31.5 34.5 47.3 12.4 61.0 11.1 31.7 24.5 37.6 11.3 32.8 32.5 37.1 107.4 29.5 41.6 75.5 63.1 33.6 64.1 25.0 38.8 44.3 34.6 43.2 26.6 74.1 50.1 29.2 46.0 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Uncertain "Vesicles,Mitotic spindle" Yes Yes Vesicles "Mitotic spindle" "HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 12.1 8.7 15.1 27.7 23.3 26.0 28.8 49.6 21.1 13.0 14.7 12.8 4.6 14.9 17.0 10.3 11.7 13.0 18.6 7.5 15.7 12.5 13.3 11.0 33.0 42.8 21.9 12.5 17.3 5.7 7.5 21.0 30.3 13.8 11.0 12.0 7.7 7.4 10.2 6.2 19.8 16.8 14.8 14.7 24.5 14.1 6.3 22.3 33.3 18.7 20.8 31.6 15.3 16.3 4.5 1.3 1.5 1.8 9.3 15.5 5.9 29.0 62.7 8.4 13.9 10.3 10.1 4.2 14.4 21.6 24.1 18.0 10.9 42.1 20.3 6.2 14.7 59.6 42.5 11.3 23.9 11.4 7.8 12.2 10.9 20.1 13.1 41.2 8.4 5.6 9.9 19.2 22.3 26.4 8.2 13.3 10.2 7.0 53.5 14.2 23.3 26.3 12.3 6.2 19.9 26.8 13.8 23.8 14.5 16.4 2.7 6.0 13.1 34.1 32.6 16.7 7.5 11.0 4.4 11.0 12.9 15.7 23.4 19.0 13.1 20.6 8.2 6.6 8.3 12.4 1.5 1.4 0.0 13.6 1.8 12.7 3.5 13.6 13.7 1.3 4.5 11.4 13.2 0.1 9.3 0.9 0.7 15.5 5.9 15.1 23.3 49.6 21.1 15.7 12.5 21.9 12.5 13.8 22.3 8.9 23.7 9.0 5.5 10.0 13.9 6.8 7.6 0.0 3.4 7.0 2.0 5.3 0.0 7.8 0.5 24.0 3.8 23.3 4.2 14.2 13.6 4.7 1.1 11.6 24.4 3.2 7.5 12.9 11.6 1.0 6.6 10.6 16.9 5.4 7.9 8.3 10.4 2.9 8.5 9.4 2.4 0.0 11.3 1.0 11.5 9.8 3.0 25.4 3.5 3.4 CDC42 "CDC42Hs, G25K" ENSG00000070831 "Cell division cycle 42" P60953 1 22052627-22092946 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004360, HPA069590" Approved Supported "Microtubules,Cytokinetic bridge" Yes No 42000000 "Microtubules, Cytokinetic bridge" "CAB004360: AB_627233, HPA069590: AB_2732138" "unprognostic (9.40e-2)" "unprognostic (1.37e-1)" "unprognostic (9.45e-3)" "unprognostic (5.11e-2)" "unprognostic (1.73e-1)" "unprognostic (9.72e-2)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.09e-1)" "unprognostic (7.92e-3)" "unprognostic (1.86e-2)" "unprognostic (3.90e-2)" "unprognostic (9.41e-2)" "unprognostic (9.72e-3)" "unprognostic (2.71e-1)" "unprognostic (3.88e-2)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" 76.4 42.0 42.2 45.8 45.9 103.1 44.1 48.8 51.3 46.4 56.1 63.0 27.7 42.1 93.6 33.5 62.0 40.5 42.9 36.3 43.7 56.8 66.3 67.2 55.0 60.3 48.5 33.9 59.0 35.2 30.7 33.0 83.6 55.7 44.1 56.6 40.5 72.9 35.3 38.8 50.1 61.7 52.0 61.7 66.9 45.4 34.6 24.8 60.3 44.4 48.8 60.1 50.8 45.8 25.3 36.0 67.9 71.4 29.4 36.3 48.6 54.9 26.2 46.0 39.8 55.0 58.0 49.3 59.5 56.9 66.3 61.6 31.5 67.0 44.6 46.8 73.4 25.2 35.9 43.0 65.7 79.7 59.0 33.2 77.3 36.0 37.1 48.3 66.3 64.2 53.4 71.8 61.6 36.2 42.2 95.9 27.4 43.2 49.3 77.7 23.1 41.6 53.4 30.4 39.6 32.2 35.0 53.8 41.6 57.5 51.2 33.4 30.5 53.1 41.4 44.0 56.4 43.8 38.3 83.6 48.9 46.3 63.0 35.3 27.4 55.0 51.0 43.0 72.5 49.9 46.3 45.6 52.3 33.9 60.0 33.0 25.3 36.3 34.5 36.0 24.1 26.6 35.0 67.9 29.4 71.4 23.5 33.7 48.6 42.2 45.9 48.8 51.3 43.7 56.8 48.5 33.9 55.7 24.8 56.6 53.3 299.3 307.1 400.2 108.9 75.0 244.5 108.4 77.3 296.6 17.7 318.6 318.3 390.0 31.7 256.2 289.3 163.5 384.6 411.9 258.9 275.0 161.5 189.6 399.8 100.1 288.4 275.0 518.9 30.8 146.2 467.3 401.5 678.1 236.6 81.4 449.7 298.1 166.6 387.6 48.7 232.8 315.6 117.2 101.6 486.6 461.3 388.8 206.6 388.9 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 86.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.4 17.6 21.3 15.1 1.1 2.3 19.5 27.8 8.3 24.4 29.5 20.0 11.4 20.6 17.4 5.9 14.1 37.1 18.4 12.6 24.3 10.9 14.5 16.7 21.0 17.9 0.7 22.8 10.3 0.6 0.9 28.2 16.9 2.6 7.3 14.2 30.5 19.3 11.8 13.3 33.1 5.5 17.5 15.1 6.5 24.4 51.9 19.4 4.0 28.7 14.6 13.1 25.3 86.7 8.6 17.4 17.6 19.8 6.1 17.6 25.2 28.8 32.9 8.1 17.5 39.7 15.2 15.1 19.2 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 0.0 1.3 2.2 1.1 3.8 0.0 0.6 0.0 0.0 1.2 0.0 0.0 12.0 0.0 1.2 1.4 0.5 1.1 23.3 0.6 27.7 2.4 1.1 0.0 0.9 6.8 0.0 0.0 1.8 1.3 0.2 2.6 1.3 0.0 0.0 1.7 0.3 1.2 2.9 0.7 0.2 0.3 12.9 1.0 11.4 23.0 1.4 14.0 2.5 4.6 2.0 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500893-91525764 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: AB_2674807" "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 2.5 3.7 5.7 7.6 8.9 15.4 4.3 19.4 10.3 2.5 4.2 1.4 0.9 4.2 2.8 2.6 4.7 1.7 2.6 1.9 6.8 5.2 3.6 2.3 5.1 11.7 4.0 4.7 3.7 2.4 2.2 12.3 7.9 5.2 2.7 6.8 2.3 2.5 2.3 1.0 6.8 4.9 3.3 5.9 15.1 2.6 21.2 4.7 18.7 2.5 4.5 12.0 4.2 3.0 1.6 3.5 0.1 1.6 2.4 6.5 2.1 14.2 4.2 27.6 7.8 0.6 3.7 8.8 5.4 4.3 10.7 11.7 8.9 5.1 9.9 7.6 3.4 9.3 6.2 18.1 6.1 14.8 16.4 15.5 15.0 12.2 4.1 1.0 16.3 5.5 1.9 1.8 9.8 5.6 1.9 4.1 13.9 19.8 14.5 7.3 5.2 14.0 14.6 22.9 7.8 10.1 17.3 22.9 6.3 4.6 10.7 21.9 8.6 17.1 4.7 9.6 7.1 4.4 8.0 3.4 12.1 10.7 9.4 8.1 5.3 6.7 26.5 4.3 15.9 4.4 0.0 1.6 0.0 5.9 1.2 5.2 1.5 4.5 5.6 3.5 1.6 2.5 5.1 0.1 2.4 0.3 2.1 6.5 2.1 5.7 8.9 19.4 10.3 6.8 5.2 4.0 4.7 5.2 4.7 0.0 0.6 2.2 1.1 5.3 7.6 1.3 0.0 1.4 1.2 1.8 0.0 5.3 3.3 1.1 28.3 2.8 0.2 0.0 2.2 5.1 4.6 0.7 4.6 0.0 2.2 3.2 0.0 3.1 1.8 12.9 0.9 1.0 3.3 1.0 1.3 1.3 1.0 1.1 0.7 0.1 4.7 6.5 3.1 28.4 20.6 3.1 1.8 5.1 2.9 0.9 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 22.0;Early spermatids: 29.6;Extravillous trophoblasts: 12.3;Late spermatids: 14.4;Sertoli cells: 12.9;Spermatocytes: 45.9;Spermatogonia: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.8 14.1 13.1 10.9 1.1 2.0 8.7 16.7 9.9 14.6 14.6 12.0 6.8 17.6 7.2 6.9 15.8 13.6 18.2 8.5 21.6 6.6 5.2 18.0 10.2 6.4 0.3 8.0 8.8 1.1 0.5 10.2 6.9 1.4 10.5 10.6 14.2 20.4 13.3 5.8 22.4 3.8 13.4 10.3 6.2 11.6 14.5 6.4 4.1 8.1 5.5 5.9 14.1 6.8 6.6 6.6 7.5 3.9 7.2 10.9 17.5 20.5 15.4 3.4 6.9 18.7 7.8 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.0 0.6 0.8 0.5 1.0 0.4 22.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.2 29.6 0.0 0.0 0.0 0.0 12.3 0.4 0.4 0.0 0.0 3.3 0.0 0.0 1.3 1.9 14.4 1.1 1.2 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.5 0.3 12.9 0.7 45.9 28.1 0.6 1.4 1.9 1.2 0.4 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 44.5;TIME: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.9 4.2 11.0 2.9 5.4 14.3 7.8 11.1 15.7 9.8 9.3 2.5 2.9 7.4 7.7 8.0 5.3 4.5 6.5 6.9 13.4 7.8 5.0 10.6 2.8 3.5 11.7 5.6 6.1 10.3 7.1 14.5 26.2 17.4 44.5 6.3 7.7 6.0 22.1 3.0 5.3 8.8 4.8 2.4 7.3 9.3 5.9 6.3 11.6 4.2 5.7 3.9 6.5 6.1 8.1 8.7 4.6 5.1 53.3 8.7 3.3 4.6 6.0 8.5 6.5 7.9 3.3 2.4 6.4 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 14.9 6.2 24.4 8.9 23.8 10.8 8.9 5.1 9.4 10.3 8.7 15.7 10.0 0.0 4.6 2.7 42.9 6.0 0.0 3.2 25.8 15.5 10.4 17.4 8.9 10.5 4.8 14.5 35.6 15.3 3.2 9.2 9.4 16.9 7.2 7.4 20.2 5.7 3.5 8.9 6.9 9.2 6.5 27.8 6.5 7.6 22.6 11.4 27.7 5.5 11.8 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT/enhancer binding protein beta" P17676 20 50190734-50192689 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" 7 "Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 8 "granulocytes: 13.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 56.9 54.7 7.0 35.9 9.9 21.1 34.4 1.8 6.2 22.8 25.2 6.4 8.0 8.0 19.4 11.2 19.2 21.7 20.2 33.6 8.4 4.4 15.3 92.5 51.3 20.4 9.5 3.0 33.6 18.6 4.1 7.4 75.1 7.7 21.1 5.0 14.0 14.6 11.7 121.9 23.9 19.4 12.6 9.5 40.3 15.3 14.3 8.1 1.5 46.1 25.3 10.7 30.8 30.6 0.4 1.2 13.6 6.1 0.4 0.5 0.5 7.4 3.4 0.3 4.1 19.3 7.6 33.5 10.1 16.0 7.0 6.2 3.4 6.9 4.9 19.4 4.1 34.4 10.2 1.0 9.9 4.7 3.5 2.5 1.5 4.4 5.0 23.8 2.4 9.8 8.1 26.3 8.9 15.8 14.6 0.9 5.1 7.1 9.1 4.3 2.8 1.1 5.3 2.1 7.1 9.9 3.5 1.0 5.5 2.3 1.8 2.0 1.3 8.4 20.9 45.0 2.3 5.5 13.8 1.3 14.6 11.1 12.4 9.7 19.4 8.0 4.3 26.6 5.6 6.3 5.9 3.0 9.1 0.4 5.3 0.1 0.4 0.4 0.5 1.2 0.3 0.3 0.2 13.6 0.4 6.1 0.0 0.2 0.5 7.0 9.9 1.8 6.2 8.4 4.4 9.5 3.0 7.7 8.1 32.8 78.5 51.8 281.2 643.3 2.2 40.0 84.1 21.4 31.8 43.6 0.0 157.2 26.6 27.6 4.6 30.6 66.5 0.0 11.5 550.7 468.0 220.5 50.7 350.5 326.4 3.2 64.1 81.0 362.0 5.0 120.0 403.2 205.8 1.8 77.9 46.2 16.6 52.6 90.5 50.0 3.3 155.2 658.6 0.7 9.1 699.3 1179.1 63.8 45.7 245.2 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 52.8;HMC-1: 51.4;REH: 22.8" "Low region specificity" "Detected in all" "CAB016395, HPA035813" Enhanced Supported "Nucleoplasm,Vesicles,Midbody ring" Yes No Nucleoplasm "Vesicles, Midbody ring" "CAB016395: AB_2086271, HPA035813: AB_2674797" "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favorable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 27.0 4.9 26.5 21.0 35.2 49.5 14.6 23.6 35.7 11.7 12.2 10.1 4.5 7.1 11.6 5.1 16.3 10.6 12.9 26.8 24.0 14.9 3.8 3.6 20.8 31.4 11.0 20.0 35.7 3.8 2.2 6.7 6.6 11.6 11.2 13.8 8.5 9.1 10.0 14.8 6.5 18.9 17.3 15.8 22.7 9.4 5.9 15.0 36.9 6.8 6.3 20.9 13.0 11.0 22.7 23.1 51.0 27.2 30.6 31.9 22.9 0.0 0.0 13.0 0.0 2.0 0.7 1.4 1.9 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 1.8 0.0 0.1 10.6 3.2 52.8 0.2 0.0 0.5 15.1 51.4 0.8 0.1 0.1 0.0 0.2 1.8 19.0 2.4 22.0 16.2 0.0 18.6 11.0 5.2 0.0 0.0 22.8 13.9 4.7 0.9 0.0 1.9 0.1 0.0 0.0 13.8 4.4 0.0 10.3 0.0 2.4 0.7 8.1 0.0 8.4 7.6 2.5 0.8 18.3 5.8 25.4 18.1 37.8 25.3 24.9 31.9 21.5 25.2 27.7 23.1 22.7 26.6 24.7 51.0 30.6 27.2 16.4 25.8 22.9 26.5 35.2 23.6 33.9 24.0 14.9 11.0 20.0 11.6 15.0 148.9 136.7 93.8 3.2 17.6 71.9 103.5 7.6 6.7 34.2 12.2 96.2 1.0 13.3 1.4 110.6 43.2 3.5 0.0 1.8 0.7 43.6 7.5 123.7 2.4 77.4 127.1 57.0 17.2 242.8 76.2 103.3 121.5 109.6 224.6 40.3 91.1 1.8 14.0 84.1 0.4 90.1 51.8 23.0 3.4 12.1 12.7 1.6 176.6 20.4 1.4 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.6 18.5 39.9 20.8 1.5 2.0 15.6 20.2 8.3 12.2 12.0 14.7 20.2 31.1 12.0 11.2 11.0 20.3 24.6 13.2 20.7 27.1 15.4 25.5 28.4 20.9 0.2 36.1 14.0 0.7 1.0 17.5 20.2 3.5 12.7 14.3 23.0 18.6 21.7 12.4 21.3 14.4 35.3 9.8 8.2 22.7 56.4 10.2 11.9 8.1 18.7 25.5 27.3 18.2 10.5 22.2 21.7 13.8 16.7 22.1 26.0 18.3 41.7 14.3 15.4 29.9 9.6 26.1 19.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 0.0 1.9 40.2 1.2 8.2 3.2 1.9 2.5 26.8 14.8 0.0 0.0 9.1 0.0 1.8 32.4 2.8 1.3 303.7 0.4 74.0 7.7 1.0 1.1 1.9 26.4 1.6 0.0 9.8 11.2 9.4 1.1 9.9 1.7 0.0 5.3 1.1 0.5 0.0 2.8 0.0 2.8 0.0 0.3 20.9 88.3 4.8 4.2 10.9 15.5 0.9 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189548-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.8;testis: 37.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036494 Approved Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favorable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavorable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 4.0 1.9 2.9 15.2 3.1 19.1 5.5 2.1 3.0 3.9 4.7 1.2 0.7 4.2 2.9 3.1 7.7 2.5 2.8 4.4 2.7 2.1 1.9 2.2 3.6 11.1 2.6 3.7 3.6 1.6 1.6 2.7 6.8 1.8 2.4 5.5 1.6 3.0 1.5 3.6 6.0 4.0 2.4 2.6 6.2 2.5 37.3 1.8 31.8 1.8 10.2 12.2 3.1 4.3 12.1 6.1 2.5 3.6 7.5 9.8 4.2 18.4 5.7 26.8 20.9 1.7 5.6 14.3 9.1 9.7 20.3 22.0 7.8 23.5 39.7 10.9 5.3 11.8 13.8 17.5 21.0 26.0 12.0 12.0 9.2 9.8 7.7 0.6 13.3 9.5 2.2 4.3 13.2 14.6 5.8 6.8 21.7 16.3 15.8 15.6 10.3 42.8 19.1 23.2 6.0 4.9 26.7 35.3 30.6 6.4 6.8 18.5 24.7 10.0 6.8 8.0 15.2 9.5 9.0 3.3 10.1 17.0 13.4 22.6 19.5 29.5 31.8 15.6 27.0 19.1 0.6 1.8 2.5 4.5 3.0 7.3 11.8 7.6 5.7 2.8 12.1 9.8 8.3 0.4 7.5 3.6 6.1 8.7 4.2 2.9 3.1 2.1 3.0 2.7 2.1 2.6 3.7 1.8 1.8 0.0 1.6 22.3 12.1 32.5 3.6 2.2 5.1 13.4 6.8 0.0 0.0 23.0 0.0 5.8 21.9 5.7 1.2 70.0 7.9 41.3 7.8 4.5 4.7 0.8 15.0 0.0 1.2 5.5 5.6 22.4 3.4 11.0 8.5 5.4 7.2 5.2 5.5 2.9 4.6 2.9 3.0 19.4 6.6 122.1 250.2 16.8 8.4 13.1 13.0 6.2 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 96.8;Spermatogonia: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.1 6.2 33.0 16.6 0.9 0.8 5.7 2.6 2.6 8.3 6.4 6.2 1.4 12.6 5.3 1.9 1.5 0.9 21.3 0.2 5.2 0.0 27.0 2.9 1.6 12.2 9.3 3.0 0.0 2.4 0.8 10.0 5.8 0.9 4.6 32.1 5.1 0.0 2.4 0.5 23.6 10.0 32.4 20.5 0.0 17.0 1.2 1.4 1.9 4.7 17.7 13.5 6.6 0.1 1.5 15.9 0.1 7.4 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.3 0.0 4.1 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 0.0 2.4 6.0 17.3 0.9 40.2 3.7 28.1 4.0 6.8 1.8 3.9 11.5 26.6 7.1 12.4 3.6 48.0 0.0 20.1 10.7 2.9 19.6 5.7 43.9 5.4 11.1 37.8 1.3 2.2 6.1 8.1 2.7 8.5 1.0 52.7 28.8 13.5 96.8 11.0 31.1 13.8 25.8 15.6 48.8 116.2 2.3 5.4 4.3 71.8 42.2 CEP131 "AZ1, AZI1, KIAA1118" ENSG00000141577 "Centrosomal protein 131" Q9UPN4 17 81189593-81222999 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024019 Approved Supported "Microtubules,Cytokinetic bridge,Centriolar satellite" Yes No "Microtubules, Cytokinetic bridge, Centriolar satellite" "HPA024019: AB_1845227" "unprognostic (1.56e-2)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (2.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (9.68e-5)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.33e-3)" "unprognostic (7.04e-2)" "unprognostic (8.82e-3)" "unprognostic (1.36e-2)" "unprognostic (8.48e-2)" "unprognostic (2.66e-1)" "unprognostic (7.32e-3)" 8.4 8.3 8.9 15.7 9.2 18.8 7.7 23.5 11.7 7.0 6.1 10.7 5.6 10.4 10.6 9.0 7.2 7.9 11.1 8.5 9.0 7.8 8.0 4.4 8.9 15.2 6.9 8.4 10.0 9.1 4.6 11.6 9.4 8.3 8.1 2.7 9.7 12.5 5.7 18.0 15.4 9.1 9.5 7.8 18.2 10.7 23.7 9.3 15.6 9.0 4.5 10.4 7.0 7.8 5.1 3.8 4.0 7.4 1.9 2.6 1.3 11.1 10.9 5.9 10.6 1.0 1.5 18.6 7.8 1.4 5.7 4.4 12.8 5.7 8.0 4.5 1.9 3.5 8.1 1.7 3.8 1.4 3.3 14.9 7.6 16.8 21.8 1.6 6.6 17.1 1.3 2.6 4.1 1.1 1.8 4.0 8.6 5.5 4.7 1.5 12.6 15.2 12.9 5.2 3.2 9.7 15.4 6.7 3.4 2.1 9.9 13.5 15.1 10.0 6.3 9.5 2.3 9.5 6.5 5.4 10.4 18.1 9.2 10.2 12.3 2.0 5.9 5.4 5.7 7.4 4.0 1.6 1.0 2.6 4.3 0.8 5.1 1.5 2.1 3.5 3.7 2.2 1.6 2.5 1.9 7.4 3.8 0.2 1.3 8.9 9.2 23.5 11.7 9.0 7.8 6.9 8.4 8.3 9.3 0.0 4.1 7.8 2.6 0.0 6.0 12.0 0.0 6.7 2.3 3.5 5.9 6.9 0.0 3.9 10.9 3.7 1.8 0.0 3.2 5.4 2.9 1.3 16.1 1.5 4.5 4.8 6.4 1.3 1.9 14.4 8.9 2.2 0.0 1.0 3.1 5.2 4.5 0.0 2.8 0.9 5.9 0.0 2.7 13.7 13.2 0.0 5.0 4.4 5.4 1.6 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Supported Centrosome,Cytosol Yes No "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 7.6 6.5 7.9 14.9 11.8 16.3 8.3 14.5 11.8 8.8 7.7 11.1 7.1 6.7 13.6 9.3 7.6 8.8 9.9 7.1 8.1 4.7 6.9 6.1 8.7 11.0 8.7 11.8 17.4 9.5 10.4 11.1 7.8 11.8 8.0 9.4 7.9 10.4 6.6 6.2 8.2 9.6 9.5 7.6 8.4 8.2 16.4 9.8 18.3 11.1 6.0 12.2 12.1 8.6 3.9 1.8 2.1 4.9 0.9 3.5 1.0 9.9 5.4 14.7 7.6 6.4 10.0 4.7 7.0 9.2 11.1 11.8 7.4 4.4 11.2 4.7 7.0 8.0 4.9 12.7 6.6 13.1 4.4 4.5 10.2 8.2 3.8 3.3 16.1 7.9 6.9 2.5 9.2 8.5 6.3 9.0 8.1 14.0 7.5 8.6 5.0 13.9 7.0 4.6 18.5 3.3 12.0 11.5 5.8 3.8 10.1 10.7 6.0 11.1 5.5 3.4 7.2 4.4 8.4 9.0 8.7 20.6 9.9 9.5 5.1 7.3 12.8 5.6 7.3 8.4 1.5 2.1 1.5 3.2 1.5 2.4 1.8 2.1 2.0 0.9 3.9 2.3 3.5 2.1 0.9 4.9 1.8 1.8 1.0 7.9 11.8 14.5 11.8 8.1 4.7 8.7 11.8 11.8 9.8 8.9 10.9 5.9 3.9 1.6 11.7 21.4 7.6 4.0 10.3 7.0 21.6 3.5 0.0 3.9 21.9 3.5 4.9 0.0 3.1 2.7 3.0 5.3 2.3 4.7 3.8 11.1 0.0 7.4 9.4 9.5 9.5 5.4 1.7 11.8 9.1 6.6 4.0 5.8 13.1 1.1 16.3 25.8 3.5 19.1 21.3 2.8 1.6 10.1 6.4 7.1 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.9 20.8 13.8 17.6 1.5 3.2 7.7 28.6 20.3 27.2 28.2 22.1 28.0 13.9 12.7 18.5 18.3 29.7 16.7 14.0 32.7 41.8 8.7 5.2 12.9 7.5 0.1 9.0 12.2 0.7 1.0 29.0 35.4 8.1 25.0 23.1 4.7 26.4 30.7 12.0 23.7 13.7 5.4 16.2 15.2 10.3 22.7 7.6 12.3 6.5 5.7 8.0 22.0 6.8 17.3 11.0 17.9 9.2 15.6 17.3 24.2 23.6 46.9 11.8 16.0 17.0 13.5 34.0 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 0.0 2.2 0.8 0.6 3.2 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.6 15.9 0.0 0.3 0.0 0.2 14.7 0.4 0.1 0.0 0.2 10.9 0.0 0.0 2.5 4.1 3.8 0.3 5.4 0.0 0.0 1.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 35.6 19.5 1.1 1.3 1.9 2.3 0.9 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 9.9 6.3 12.9 11.1 3.4 8.9 13.0 5.1 5.2 6.3 9.6 7.6 5.7 15.9 3.3 7.1 6.3 12.6 11.1 9.7 13.1 4.2 8.5 14.1 12.2 14.6 11.5 15.3 7.6 10.1 10.2 7.0 15.7 8.4 5.3 16.6 16.2 11.6 6.9 11.6 19.4 9.8 8.0 10.2 7.9 14.0 23.5 11.8 7.4 15.9 8.2 14.8 6.9 10.2 13.1 20.2 11.2 10.3 7.9 14.5 11.3 6.6 6.9 11.9 9.5 16.9 6.2 11.8 8.8 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 38.7 22.9 11.5 23.2 14.3 26.0 16.7 12.7 65.6 39.8 3.5 43.2 7.8 6.6 16.8 45.2 9.8 15.1 0.0 10.2 9.0 11.5 13.9 27.8 6.6 7.4 17.5 7.5 12.3 9.5 14.2 19.2 10.4 11.8 15.4 12.4 22.7 11.6 11.5 20.1 5.0 86.8 12.9 15.0 30.7 28.8 17.8 5.5 19.7 17.0 19.0 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266522 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;fallopian tube: 19.7;testis: 44.9" "Group enriched" "Detected in many" 11 "Ciliated cells: 397.5;Early spermatids: 589.3;Late spermatids: 341.5;Spermatocytes: 416.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 17.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.5" "Low region specificity" "Detected in some" "HPA041069, HPA066142" Enhanced Approved Midbody Yes No Midbody "HPA041069: AB_10805835, HPA066142: AB_2732739" "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favorable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.4 1.0 2.1 0.4 4.8 0.6 1.0 2.9 1.0 1.6 0.3 4.9 1.7 0.4 1.0 9.3 0.3 19.7 0.7 0.4 2.7 3.3 2.2 0.4 4.5 0.4 1.0 1.1 4.8 1.6 2.7 12.3 0.4 17.1 1.1 0.3 1.2 0.8 2.5 1.4 0.9 0.4 0.5 1.4 0.4 0.5 44.9 2.2 0.2 4.3 0.0 0.4 0.5 0.4 2.1 1.0 2.2 1.0 1.4 1.2 0.4 2.4 1.6 1.0 2.0 1.4 2.7 1.8 0.5 0.3 0.3 0.4 0.2 2.1 1.4 1.4 0.5 0.6 1.0 0.8 1.0 0.5 1.1 1.5 0.5 0.8 0.2 0.8 1.0 0.9 0.8 4.1 1.1 9.5 2.2 0.7 3.8 2.7 0.7 0.6 2.3 2.3 0.5 0.5 0.5 1.0 0.3 0.5 2.0 2.9 0.0 1.7 1.3 0.3 0.1 0.8 2.8 1.3 0.2 0.1 1.4 1.0 0.9 0.8 4.3 1.5 0.3 1.6 1.1 0.3 2.2 0.4 0.0 0.9 1.0 0.5 0.5 0.4 0.9 0.4 2.1 1.2 0.8 0.1 1.4 0.4 1.0 1.0 0.4 2.1 4.8 2.9 1.0 2.7 3.3 1.0 1.1 17.1 2.2 6.0 3.4 0.0 1.6 0.0 3.9 0.4 0.0 397.5 38.7 8.7 7.9 1.4 8.3 2.0 589.3 0.6 0.0 0.0 0.6 0.4 0.7 1.4 1.1 0.9 0.4 1.6 0.0 1.8 0.0 341.5 7.8 0.6 0.0 1.8 0.1 3.4 1.2 0.0 5.3 14.3 8.3 6.5 0.0 416.0 28.2 0.0 0.6 0.0 0.3 0.9 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314335-114337626 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 13.7 16.8 11.8 12.7 18.5 16.5 13.3 25.2 19.8 12.4 13.3 15.9 10.9 13.7 16.7 11.7 12.6 16.7 10.7 10.3 11.6 12.2 12.7 20.6 12.3 19.9 12.5 12.4 17.8 20.8 12.8 9.5 13.5 16.6 14.5 14.3 12.4 13.2 14.7 16.1 12.6 16.4 14.2 11.4 16.8 16.3 11.6 11.9 35.0 15.2 9.8 23.1 14.3 11.2 7.9 14.5 7.0 6.8 3.7 5.7 2.5 15.4 6.7 24.9 10.5 8.9 13.9 10.7 16.4 13.8 15.6 17.5 9.9 9.4 31.9 6.7 12.8 9.8 9.9 18.1 13.1 23.3 12.3 22.3 20.9 9.7 8.7 10.1 30.4 12.5 13.6 8.2 12.3 12.1 5.5 7.5 11.1 13.2 8.8 19.9 6.1 20.2 8.9 18.7 19.0 8.8 20.3 11.7 11.0 11.8 9.6 12.1 14.4 9.4 21.4 15.5 18.1 12.3 25.7 8.2 8.6 13.8 9.1 10.0 11.3 11.5 34.7 17.1 18.0 16.4 7.0 4.0 5.2 4.7 4.6 5.7 6.8 4.3 4.5 4.5 7.9 3.5 3.9 1.0 3.7 6.8 14.5 2.8 2.5 11.8 18.5 25.2 19.8 11.6 12.2 12.5 12.4 16.6 11.9 8.9 8.1 18.2 6.1 3.0 10.9 5.3 15.3 9.4 1.2 12.2 3.9 11.4 11.6 10.4 0.8 8.6 9.6 0.0 9.9 14.5 8.3 14.3 9.3 18.8 18.9 14.3 10.4 10.4 17.7 1.0 10.9 12.0 11.8 14.4 12.5 8.1 10.8 8.0 10.6 14.0 9.6 6.5 6.2 8.8 20.5 3.3 6.6 8.2 10.4 3.0 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody Yes No "Nucleoplasm, Midbody" "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.3 12.1 15.7 13.3 20.6 14.5 22.8 13.2 22.4 9.0 12.1 15.6 12.4 7.7 19.9 14.3 15.1 10.6 7.1 18.4 8.1 7.1 8.8 5.5 18.5 12.8 15.3 21.2 9.6 21.0 39.9 10.1 23.5 20.3 13.0 17.6 9.4 10.0 14.2 15.3 14.6 16.3 6.6 39.4 6.1 7.5 8.1 13.1 24.1 17.0 15.3 15.3 22.5 10.6 20.2 15.3 8.6 19.6 19.0 20.3 10.7 16.0 14.1 12.0 13.7 9.8 18.8 9.9 9.6 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 62.5 46.0 82.1 114.0 372.7 31.1 17.9 56.0 44.2 44.3 125.6 7.9 122.5 51.4 101.8 65.5 63.6 178.4 0.0 71.3 124.5 68.5 78.7 149.7 34.7 112.4 27.0 137.9 43.0 124.4 36.5 35.1 124.4 150.1 100.0 90.8 29.6 115.6 199.9 35.0 109.2 14.1 77.6 64.8 16.4 20.6 450.0 211.8 80.6 63.8 219.0 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282069 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 29.7 37.5 48.0 24.3 48.6 18.8 36.2 39.9 49.4 28.3 39.0 28.1 28.4 38.1 28.2 36.3 39.2 31.4 30.6 35.1 45.1 45.2 55.6 39.2 35.6 26.1 44.1 47.5 26.5 19.9 36.4 34.8 55.7 47.4 40.8 40.9 19.8 26.0 30.2 27.1 25.6 51.9 27.5 49.2 33.0 37.3 21.2 37.0 24.9 42.0 26.1 26.0 33.7 33.5 12.4 27.8 51.2 24.6 18.1 16.6 18.1 31.3 23.4 23.8 15.4 36.4 33.2 22.2 31.4 35.5 50.0 55.6 17.7 19.9 16.9 34.7 29.5 34.3 13.6 24.9 25.6 40.6 35.0 17.5 14.2 47.2 19.3 31.7 18.0 28.0 35.3 47.4 33.6 31.4 41.2 26.0 23.9 15.2 22.4 39.4 14.3 18.6 55.7 21.9 24.1 28.8 11.5 21.1 11.2 41.1 17.1 11.7 30.0 31.8 18.8 28.7 29.1 19.2 28.4 25.9 25.1 26.2 21.4 27.7 14.9 29.6 19.5 36.1 12.4 16.0 31.5 20.1 40.2 10.7 21.6 11.5 12.4 14.3 14.0 18.3 10.6 13.2 12.5 51.2 18.1 24.6 27.8 16.6 18.1 48.0 48.6 39.9 49.4 45.1 45.2 44.1 47.5 47.4 37.0 83.4 48.3 59.3 129.0 167.0 61.8 57.1 91.7 144.6 67.1 104.7 25.5 150.8 242.1 116.7 177.9 132.6 173.1 93.5 75.7 146.8 116.0 157.2 58.7 60.2 136.7 25.4 77.0 73.1 86.4 27.4 86.3 96.9 111.3 216.4 117.4 120.4 122.7 207.0 98.3 256.7 46.8 84.1 128.8 87.4 65.0 206.5 216.6 61.2 74.2 224.1 CISH "CIS, CIS-1, G18, SOCS" ENSG00000114737 "Cytokine inducible SH2 containing protein" Q9NSE2 3 50606490-50611831 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 49.7;Proximal tubular cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 82.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB034039, HPA040812" Approved Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "CAB034039: AB_2080282, HPA040812: AB_2677148" "unprognostic (2.36e-3)" "unprognostic (7.60e-3)" "unprognostic (2.89e-2)" "prognostic favorable (1.13e-5)" "unprognostic (8.54e-2)" "unprognostic (9.38e-2)" "prognostic favorable (6.98e-4)" "unprognostic (6.97e-3)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.65e-4)" "unprognostic (1.30e-2)" "prognostic favorable (3.53e-12)" "unprognostic (2.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" 11.8 2.8 0.8 9.7 1.9 3.7 38.0 0.6 1.1 5.2 7.5 0.7 15.6 5.9 6.8 5.9 7.4 4.5 6.4 20.8 1.3 1.0 26.1 36.2 20.5 6.4 1.2 0.2 10.6 11.3 1.9 8.6 47.6 3.8 5.6 5.3 2.8 18.4 19.6 54.0 7.0 6.3 2.8 3.5 7.6 5.5 2.5 1.4 13.8 31.3 7.1 7.0 5.9 5.4 0.4 2.8 7.3 4.0 0.8 23.3 8.1 0.6 0.2 0.7 1.5 0.1 0.9 0.6 0.1 0.1 0.1 0.1 0.6 0.1 0.0 0.5 0.2 0.3 0.7 1.2 1.0 0.0 82.0 0.2 4.9 0.4 0.6 0.5 0.6 6.0 3.9 0.4 0.1 0.3 0.0 0.1 0.5 19.3 0.1 0.1 3.7 1.0 4.4 0.7 2.2 0.7 0.4 0.3 5.0 1.6 0.7 0.4 1.2 0.2 10.0 0.1 0.2 5.6 4.0 0.1 0.2 0.6 0.7 0.3 0.1 0.1 0.0 0.1 5.9 0.1 7.3 4.0 5.3 14.3 2.4 22.2 0.4 23.3 17.8 2.8 0.1 18.3 17.5 3.5 0.8 1.5 1.8 13.9 8.1 0.8 1.9 0.6 1.1 1.3 1.0 1.2 0.2 3.8 1.4 3.0 29.7 0.0 7.1 7.1 0.5 10.9 0.0 1.4 11.4 17.4 0.0 7.6 49.7 10.0 0.8 3.0 5.8 0.0 14.1 3.8 6.1 2.7 1.1 6.0 11.2 0.0 2.4 2.5 13.2 0.2 7.8 18.8 1.7 23.4 8.4 0.0 10.1 7.0 3.5 40.0 0.1 12.9 5.1 0.5 1.4 7.9 13.3 20.1 12.3 4.2 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736607-112764677 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 38.3" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 1.5 0.7 0.6 9.2 0.6 13.4 1.3 0.7 0.6 0.6 1.8 0.0 0.3 1.5 0.5 1.4 3.8 0.7 0.1 2.3 0.6 0.5 0.7 0.7 1.2 5.3 0.6 0.2 0.6 0.6 0.0 0.5 3.2 0.2 0.6 2.4 0.0 1.0 0.0 0.6 1.5 2.4 0.9 0.6 2.2 0.9 9.0 0.1 38.3 0.6 5.9 6.0 0.9 0.7 1.0 0.8 1.8 0.7 1.6 1.8 0.4 20.1 4.0 15.9 7.2 0.9 1.5 3.2 16.7 13.9 17.4 16.6 3.8 5.9 13.8 6.9 6.5 21.7 7.8 9.1 8.8 29.3 19.2 4.0 23.0 5.6 3.2 0.0 10.8 13.8 0.4 0.8 21.8 12.4 4.5 7.9 10.1 6.1 20.2 14.1 2.9 13.1 4.1 6.8 8.6 13.2 9.5 16.7 3.6 2.9 7.9 8.8 5.5 6.8 5.6 5.8 6.2 5.5 5.0 5.6 19.3 15.0 15.3 12.2 4.3 8.4 11.8 8.3 7.8 30.2 0.8 0.5 0.7 0.5 0.7 0.4 0.9 1.2 1.1 0.5 1.0 0.5 0.7 1.8 1.6 0.7 0.8 1.8 0.4 0.6 0.6 0.7 0.6 0.6 0.5 0.6 0.2 0.2 0.1 3.0 1.1 0.8 1.6 3.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 8.9 0.4 0.3 0.0 0.0 5.4 0.0 0.0 1.8 2.1 0.8 0.0 1.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 31.7 32.2 1.5 0.8 1.5 1.0 0.9 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.7 7.3 15.9 8.4 1.1 2.1 5.9 18.0 5.0 13.2 17.7 11.5 8.2 18.7 5.8 4.8 9.6 8.8 15.5 6.2 20.7 12.8 7.0 26.3 15.9 5.1 0.0 21.5 15.5 0.4 0.2 22.7 1.6 1.5 7.1 11.2 17.7 13.0 12.6 5.7 22.6 4.9 15.0 6.0 5.2 14.4 24.1 5.6 2.7 14.5 5.9 6.9 15.6 4.8 3.1 11.2 4.1 8.5 5.1 19.0 14.4 11.6 20.0 4.7 11.4 19.7 6.0 15.4 15.3 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 0.0 0.3 1.5 4.6 4.9 7.9 1.1 2.5 0.0 3.4 0.0 11.8 5.5 0.0 1.3 6.2 1.9 0.4 0.0 0.6 33.9 3.9 1.4 1.1 0.0 14.0 1.6 1.2 3.7 3.2 4.9 2.3 6.5 3.3 15.4 1.6 6.6 0.9 1.9 0.4 0.0 96.1 6.5 2.5 71.5 133.3 1.8 8.7 5.1 4.1 2.6 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 1.4 0.4 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 1.3 0.0 0.0 0.0 28.6 1.4 5.8 0.0 0.7 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 0.0 0.0 0.0 0.2 0.5 0.7 5.3 0.0 5.3 1.2 3.5 0.0 0.2 1.7 0.0 17.1 0.7 0.0 0.0 0.2 0.0 1.6 5.3 0.0 0.0 0.1 0.0 0.0 3.1 0.8 10.8 25.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.9 3.7 0.0 6.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" Yes No 51000000 "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924" "unprognostic (1.56e-1)" "prognostic unfavorable (7.35e-4)" "prognostic favorable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavorable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.02e-4)" 39.5 45.7 47.4 35.1 57.6 30.7 57.9 59.1 83.6 38.1 45.0 25.1 47.7 27.9 38.7 52.3 32.1 30.9 34.1 39.9 47.1 53.7 48.6 46.0 46.5 60.7 53.9 59.3 29.8 23.3 96.1 30.0 51.5 57.0 38.9 48.9 22.7 28.6 54.4 44.2 30.5 27.7 45.8 47.8 28.0 34.2 29.4 28.8 28.0 43.7 26.6 31.2 37.1 40.6 10.0 24.6 13.9 24.6 12.3 15.6 13.1 47.4 71.8 35.4 35.0 59.8 48.8 40.5 51.0 53.8 45.7 47.8 44.0 29.2 33.0 58.6 72.4 50.6 31.3 52.8 42.4 61.1 35.5 28.4 54.1 45.4 68.2 45.7 37.0 31.3 46.1 26.0 69.5 44.8 36.0 50.5 16.9 53.9 46.8 71.2 84.6 21.9 11.0 30.5 43.4 41.9 19.5 59.3 40.0 51.2 67.3 31.8 37.8 31.6 20.7 30.2 47.8 49.2 23.3 64.5 83.9 50.1 40.0 52.2 36.8 51.7 30.5 61.5 25.1 51.2 10.5 20.9 13.9 12.7 24.6 15.6 10.0 11.7 13.7 24.6 9.1 10.0 11.0 13.4 12.3 20.7 16.1 14.5 13.1 47.4 57.6 59.1 83.6 47.1 53.7 53.9 59.3 57.0 28.8 92.3 94.7 38.0 37.2 56.7 86.7 68.8 86.6 72.3 81.9 73.3 56.9 86.9 23.2 67.8 20.6 66.0 118.0 93.5 84.2 40.6 77.3 84.0 65.9 162.9 151.0 81.0 115.9 156.5 173.7 53.1 68.4 90.2 50.6 62.3 109.9 47.7 89.2 73.7 88.1 105.0 55.3 77.6 61.2 51.7 37.2 69.4 90.3 33.1 108.8 72.3 CNFN PLAC8L2 ENSG00000105427 Cornifelin Q9BYD5 19 42387019-42390287 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4;Enterocytes: 33.5;Intestinal endocrine cells: 31.2;Paneth cells: 38.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 367.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 25.1;naive B-cell: 27.5" "Lineage enriched" "Detected in many" 11 "B-cells: 27.5" "Cell line enhanced" "Detected in many" "A549: 14.7;HEK 293: 21.0;MCF7: 10.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049073, HPA053997" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "HPA049073: AB_2680620, HPA053997: AB_2682337" "unprognostic (5.08e-2)" "unprognostic (4.21e-3)" "unprognostic (2.52e-1)" "unprognostic (7.22e-2)" "unprognostic (3.15e-2)" "unprognostic (8.35e-3)" "unprognostic (6.04e-2)" "unprognostic (2.06e-3)" "unprognostic (3.52e-1)" "unprognostic (9.44e-2)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (8.42e-2)" "unprognostic (4.83e-2)" "unprognostic (7.77e-3)" "prognostic favorable (4.02e-5)" "unprognostic (2.45e-1)" 0.4 0.3 0.2 0.2 0.8 0.2 2.5 0.2 0.2 58.9 0.5 0.2 0.2 0.2 4.4 1.4 268.7 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.6 0.3 0.2 39.0 0.3 0.5 37.3 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.9 0.2 323.6 276.3 0.2 85.7 27.5 2.4 0.5 2.0 0.0 0.7 1.0 4.7 14.7 0.3 1.3 0.7 0.7 0.2 0.8 0.3 0.3 0.3 0.8 1.3 4.1 6.6 0.2 1.0 1.9 1.2 1.8 0.1 0.0 21.0 0.3 5.5 1.5 0.0 0.0 0.0 1.5 3.3 0.8 0.0 0.1 0.0 3.8 0.8 0.2 0.0 10.0 0.0 0.1 5.4 6.4 4.4 1.7 0.3 2.2 1.4 1.8 2.2 6.4 2.7 4.1 1.9 2.3 5.0 2.1 0.0 0.0 4.5 0.1 0.0 4.8 5.7 2.7 0.0 1.7 0.2 0.0 2.0 0.0 0.7 1.5 0.2 25.1 0.5 0.5 2.4 27.5 0.2 0.4 0.5 0.0 0.3 0.5 0.0 1.0 0.2 0.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 2.1 11.5 15.0 4.0 0.0 0.8 2.5 6.7 9.1 31.4 0.0 0.2 6.6 7.5 0.6 5.2 33.5 0.0 2.2 0.2 1.0 15.2 4.6 0.8 4.7 0.0 31.2 3.7 4.5 3.2 4.9 5.5 3.3 4.6 21.3 0.1 3.6 38.6 4.2 9.0 0.0 0.0 4.8 0.5 14.2 11.3 0.2 0.0 28.2 20.4 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" Yes No 190000 Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424" "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 36.6 26.7 23.3 15.6 34.3 48.9 30.1 29.7 35.7 35.1 27.9 10.6 26.4 19.2 26.8 21.5 34.1 20.3 24.3 27.0 21.4 21.6 27.8 33.0 25.7 18.3 28.7 20.4 36.4 25.4 26.6 30.4 25.6 41.4 30.1 19.2 8.1 19.1 22.6 59.8 20.6 27.9 34.8 37.5 22.5 21.7 26.6 27.3 22.1 33.4 27.8 20.9 56.8 33.6 11.7 15.7 8.9 17.8 11.6 20.8 11.5 22.5 13.3 28.6 24.0 35.2 50.3 19.7 39.6 38.0 34.9 32.1 28.1 12.4 37.4 27.2 38.0 28.1 33.3 40.6 32.9 38.5 25.3 16.3 34.8 28.8 22.6 27.0 32.8 18.2 42.3 26.9 28.3 50.2 38.7 36.5 20.8 44.6 20.1 37.9 12.1 17.5 16.4 18.5 31.8 17.5 19.2 27.0 55.9 36.9 34.1 27.9 20.3 22.8 24.6 31.6 34.9 24.3 33.1 23.4 34.3 18.4 64.0 41.5 18.3 46.6 47.2 32.0 53.4 27.7 8.0 13.8 8.9 10.6 17.8 19.5 11.7 16.1 15.3 15.7 10.1 20.8 13.1 5.6 11.6 15.7 10.2 20.8 11.5 23.3 34.3 29.7 35.7 21.4 21.6 28.7 20.4 41.4 27.3 71.5 47.1 37.1 50.1 77.3 21.4 91.1 22.9 53.5 67.1 22.7 9.8 49.0 46.4 34.4 15.4 48.4 19.7 23.3 25.8 59.2 57.0 36.3 50.8 30.6 39.1 31.8 20.0 34.4 36.5 15.2 51.2 40.0 33.7 39.7 22.4 24.9 31.1 21.0 50.2 58.5 18.0 19.4 54.7 53.9 45.4 86.4 110.3 37.4 31.0 49.0 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 50.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 32.6" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.5 32.6 0.0 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 6.9 0.0 0.2 3.4 0.8 50.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 4.4 0.0 5.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.1 0.0 4.2 3.0 4.6 2.4 0.0 0.0 0.0 0.2 CPEB2 ENSG00000137449 "Cytoplasmic polyadenylation element binding protein 2" Q7Z5Q1 4 15002674-15070153 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072513 Approved Cytosol Yes No Cytosol "HPA072513: AB_2686529" "unprognostic (6.59e-2)" "unprognostic (4.21e-3)" "unprognostic (4.75e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-2)" "unprognostic (2.36e-2)" "unprognostic (5.67e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-1)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (8.62e-2)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" 10.0 7.5 18.5 6.0 21.5 23.0 13.6 11.5 21.0 8.8 11.5 28.7 13.2 9.6 8.2 9.4 13.6 7.1 10.7 7.8 17.4 16.2 13.5 18.9 9.5 6.4 27.2 17.4 7.9 5.4 23.8 6.4 7.4 16.4 10.2 10.7 20.7 8.9 21.9 7.1 23.0 9.5 10.8 21.7 6.6 10.8 37.4 27.6 3.6 6.1 7.8 7.2 8.3 12.6 0.4 0.7 2.4 0.4 1.3 1.6 0.3 1.3 8.3 0.8 0.3 6.2 11.4 1.4 4.6 3.1 2.9 2.1 0.2 1.6 0.8 0.9 4.2 5.4 1.5 1.8 1.0 1.8 2.3 0.6 0.2 6.4 1.4 2.9 0.3 1.1 5.6 5.5 7.0 6.8 3.6 2.6 0.1 0.1 6.0 11.8 0.6 0.1 1.8 0.8 2.4 1.2 0.1 0.6 0.3 25.2 1.1 0.7 4.6 1.5 1.0 4.7 3.9 0.6 5.3 5.1 10.4 0.9 6.5 2.5 3.9 0.5 0.4 8.5 4.7 3.8 0.0 0.4 1.7 0.5 0.4 1.6 0.1 0.8 0.5 0.7 0.4 0.9 0.3 2.4 1.3 0.2 0.3 0.2 0.3 18.5 21.5 11.5 21.0 17.4 16.2 27.2 17.4 16.4 27.6 29.8 13.9 5.8 9.4 76.2 7.6 18.3 15.3 1.4 6.8 29.6 25.5 1.1 1.7 3.5 47.6 11.4 23.2 0.0 4.2 1.2 11.0 8.7 10.4 21.2 9.1 14.3 9.8 12.9 15.4 15.5 5.8 12.2 50.6 2.8 10.9 6.1 5.9 11.9 7.8 10.3 19.0 0.0 13.4 14.7 3.1 113.2 1.1 6.4 6.6 14.4 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CTTNBP2 "C7orf8, CORTBP2, KIAA1758, Orf4" ENSG00000077063 "Cortactin binding protein 2" Q8WZ74 7 117710651-117874139 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 53.0;granulocytes: 134.2;Horizontal cells: 69.9;Muller glia cells: 122.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "non-classical monocyte: 9.6" "Lineage enriched" "Detected in single" 22 "monocytes: 9.6" "Group enriched" "Detected in some" 6 "HEL: 27.5;HMC-1: 36.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009151, HPA044654" Enhanced Approved "Midbody ring,Cytosol" Yes No "Midbody ring, Cytosol" "CAB009151: AB_2088281, HPA044654: AB_2679037" "unprognostic (6.28e-2)" "unprognostic (2.90e-1)" "unprognostic (5.11e-2)" "unprognostic (1.81e-3)" "unprognostic (1.21e-1)" "unprognostic (3.64e-1)" "unprognostic (7.38e-2)" "unprognostic (3.28e-4)" "unprognostic (3.83e-1)" "unprognostic (7.98e-2)" "unprognostic (7.93e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.71e-5)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.45e-3)" 11.2 3.9 10.7 1.8 17.6 0.7 4.7 8.3 15.5 10.7 3.9 22.1 2.0 3.3 11.4 9.4 14.0 7.2 6.6 2.4 13.5 9.1 11.5 3.8 3.2 1.0 16.2 9.9 5.4 13.1 21.9 5.8 3.4 15.5 6.6 5.0 5.0 5.2 4.0 1.1 2.5 3.3 9.5 14.3 4.2 1.8 2.2 16.8 0.0 9.8 1.7 2.1 4.8 4.9 0.0 0.4 0.0 9.6 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.0 27.5 0.2 0.0 0.1 0.0 36.6 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.1 5.2 0.0 3.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.5 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 10.7 17.6 8.3 15.3 13.5 9.1 16.2 9.9 15.5 16.8 3.0 4.5 0.0 3.0 1.6 26.3 2.9 10.2 1.4 6.8 7.0 53.0 2.5 1.7 4.0 1.1 8.7 0.5 0.0 3.8 1.2 2.3 1.4 134.2 1.0 7.0 69.9 1.7 26.4 7.5 2.7 0.9 6.4 6.8 1.8 0.5 122.7 0.8 2.6 1.1 14.3 3.3 0.0 3.5 0.4 0.4 0.3 0.9 0.7 6.0 1.1 CYLD "CYLD1, KIAA0849, USPL2" ENSG00000083799 "CYLD lysine 63 deubiquitinase" Q9NQC7 16 50742050-50801935 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011713, HPA050095" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No "Centriolar satellite" Nucleoplasm "CAB011713: AB_731794, HPA050095: AB_2681013" "unprognostic (9.83e-2)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" "unprognostic (2.83e-2)" "unprognostic (3.84e-1)" "unprognostic (5.06e-2)" "unprognostic (3.87e-2)" "unprognostic (3.24e-2)" "unprognostic (9.46e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (3.43e-2)" "unprognostic (6.83e-2)" "unprognostic (8.42e-2)" 9.3 16.2 13.9 22.9 26.4 51.1 9.1 14.2 20.9 9.2 10.3 18.8 12.8 10.2 16.1 8.1 15.3 8.5 13.3 12.7 15.7 17.0 9.4 13.2 15.6 30.7 16.3 14.3 11.5 12.2 20.3 27.8 9.8 20.0 11.0 12.7 13.3 12.6 10.9 31.7 12.4 14.2 12.5 16.3 23.4 12.4 22.6 13.7 16.9 16.2 8.0 29.3 14.1 12.6 9.2 10.2 31.4 9.8 13.6 19.1 10.2 9.3 2.9 3.4 3.8 5.4 7.8 3.1 13.8 20.2 14.4 8.5 2.4 4.4 10.7 5.0 13.5 15.7 3.6 4.0 8.4 21.5 47.2 6.1 5.3 5.2 2.0 10.7 5.3 25.3 8.5 6.8 17.4 18.2 13.7 5.8 7.6 2.2 9.4 20.1 1.4 5.2 7.7 3.6 2.9 4.9 4.7 6.9 10.3 4.7 3.2 4.4 3.3 11.7 4.0 3.4 5.4 4.0 6.7 6.5 24.7 5.6 8.6 5.6 24.8 23.5 12.0 18.1 6.0 5.2 31.4 8.6 20.8 10.7 9.8 12.9 9.2 15.8 14.4 10.2 6.2 14.7 11.4 19.4 13.6 9.5 6.2 19.1 10.2 13.9 26.4 14.2 20.9 15.7 17.0 16.3 14.3 20.0 13.7 41.7 25.6 39.6 48.8 106.7 75.4 32.7 25.5 12.0 19.4 17.4 88.4 5.4 5.0 18.3 32.8 37.9 13.4 46.7 16.5 3.8 37.2 52.3 78.5 22.1 19.0 63.5 29.9 21.5 32.3 24.7 23.6 47.1 70.9 34.3 10.3 22.6 15.2 18.7 19.8 10.3 49.3 6.5 34.4 52.6 13.8 135.9 3.4 73.4 12.0 56.3 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell type enriched" "Detected in some" 6 "Pancreatic endocrine cells: 33.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 10.0 1.2 1.0 2.1 0.0 0.1 2.8 0.3 0.3 0.4 0.2 0.7 12.7 0.7 0.8 0.2 0.4 14.1 0.3 3.2 0.0 1.3 1.0 0.2 12.5 6.6 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.7 0.1 1.0 0.4 2.2 0.8 19.6 0.4 0.7 0.5 2.0 1.5 1.5 1.3 1.7 0.5 0.7 0.3 1.0 2.1 1.8 0.5 0.7 4.0 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.8 0.6 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 0.0 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.0 4.5 5.2 0.0 0.4 0.0 1.1 0.5 0.0 0.4 0.0 5.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 33.8 0.0 0.4 0.5 0.5 0.0 0.2 1.9 0.3 0.0 0.0 0.0 0.2 1.1 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 250.0;Spermatocytes: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 3.0 3.8 0.7 0.6 0.9 1.4 0.3 1.5 3.0 2.3 0.9 3.1 1.1 0.9 2.6 1.3 3.1 0.8 1.6 2.3 2.1 2.0 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 0.5 1.3 2.9 1.7 6.5 2.0 2.4 4.2 3.0 3.0 3.1 2.9 1.1 4.7 3.7 1.2 0.2 4.4 2.8 1.9 3.3 1.5 2.5 1.4 2.5 0.6 1.8 2.2 4.7 3.0 3.7 7.7 3.1 1.3 4.4 3.9 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 3.0 13.0 34.9 16.3 13.9 5.8 3.6 0.0 14.7 5.7 8.7 11.8 12.2 3.3 5.4 250.0 8.5 4.5 46.7 12.9 31.0 7.6 10.6 30.1 5.4 13.9 3.2 14.3 7.4 8.8 57.4 14.4 14.2 11.8 9.0 18.6 1.9 10.7 7.0 8.9 4.4 15.5 12.9 8.2 291.4 77.1 11.0 8.0 21.5 15.8 11.4 DCTN1 ENSG00000204843 "Dynactin subunit 1" Q14203 2 74361154-74392087 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009108, HPA034635, HPA071875" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No 220000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: " "unprognostic (1.14e-1)" "unprognostic (7.19e-2)" "unprognostic (1.33e-3)" "unprognostic (4.08e-2)" "unprognostic (1.20e-1)" "unprognostic (2.67e-1)" "unprognostic (4.61e-3)" "unprognostic (2.11e-2)" "unprognostic (2.79e-1)" "unprognostic (3.73e-3)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.34e-7)" "unprognostic (5.41e-2)" "unprognostic (3.11e-1)" "unprognostic (7.86e-3)" "unprognostic (1.12e-3)" 20.7 21.1 36.0 13.7 54.6 11.1 14.0 45.9 70.9 23.5 17.1 37.8 8.9 11.8 18.5 9.8 22.9 19.7 15.1 37.7 39.5 35.8 13.5 10.0 18.9 10.9 37.7 40.3 21.9 15.2 70.2 21.6 17.2 54.6 16.5 14.0 13.2 23.5 21.7 39.5 19.9 13.7 26.5 32.2 12.4 16.0 25.5 26.7 9.4 17.0 9.5 12.8 17.2 18.0 11.6 12.1 12.9 15.8 9.8 16.7 15.5 19.1 22.5 21.1 22.0 38.8 29.0 17.1 30.9 32.3 39.5 28.2 29.9 14.8 26.4 12.7 64.2 21.8 19.2 25.8 39.3 30.2 32.9 26.0 27.4 18.1 25.1 30.0 14.9 34.0 34.7 19.2 42.9 25.6 27.1 33.7 24.2 11.8 18.9 29.7 16.4 27.1 15.5 22.8 23.5 24.0 24.4 37.2 18.9 21.9 11.9 26.1 23.1 17.3 20.8 18.6 19.2 13.4 10.9 25.5 36.0 26.1 15.4 23.0 11.7 9.3 24.0 33.7 24.4 25.2 7.3 11.4 12.9 16.7 14.2 13.5 11.6 9.5 12.4 12.1 8.6 6.8 7.5 9.8 9.8 15.8 9.6 8.1 15.5 36.0 54.6 45.9 70.9 39.5 35.8 37.7 40.3 54.6 26.7 29.8 20.1 9.7 8.2 9.0 26.0 50.1 12.7 12.0 15.9 27.9 23.6 24.7 16.6 19.4 5.8 25.5 38.3 23.3 17.1 23.3 20.8 9.2 28.8 17.0 24.6 85.8 16.0 25.8 15.9 3.9 41.4 16.7 15.1 27.9 26.4 15.6 21.6 24.6 48.8 16.1 43.6 19.4 27.1 28.4 35.7 10.3 21.1 13.8 20.7 9.5 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787400 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Supported "Plasma membrane,Actin filaments" Yes No 850000 "Plasma membrane, Actin filaments" "HPA070112: AB_2686229" "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 42.1 43.5 4.7 10.9 6.9 0.2 15.6 7.9 7.1 30.3 30.4 9.0 18.6 3.3 24.2 17.7 25.0 13.4 16.6 15.4 7.9 4.7 4.0 3.3 8.9 5.1 12.9 3.4 26.4 2.2 2.1 4.0 6.6 12.7 21.8 9.1 30.7 6.4 19.3 5.2 6.1 10.1 34.3 19.7 3.4 14.1 8.3 7.5 0.0 8.6 12.8 4.1 29.0 18.3 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 16.3 61.7 61.0 0.2 24.0 45.1 10.5 15.1 0.0 0.0 0.0 0.0 32.3 2.1 0.0 0.0 0.1 14.4 12.9 0.1 0.0 0.1 0.0 26.8 0.0 0.0 43.3 0.1 18.5 0.5 17.0 12.1 0.1 0.1 5.1 9.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 6.9 0.1 0.0 0.0 0.0 9.9 0.0 0.0 0.8 0.9 0.0 0.0 0.6 16.8 3.7 8.5 3.3 0.7 1.3 0.0 15.2 0.0 17.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.7 6.9 7.9 7.1 7.9 4.7 12.9 3.4 12.7 7.5 3.0 2.9 0.0 2.4 11.2 3.1 23.3 2.5 4.0 1.2 0.0 0.0 0.5 0.0 0.5 6.9 21.3 2.0 0.0 1.5 0.4 84.7 4.1 1.1 3.0 1.1 0.0 1.2 24.5 2.1 4.0 58.4 1.5 21.9 0.0 0.7 19.0 1.5 1.7 83.1 0.9 2.9 38.8 68.4 0.9 0.9 7.5 0.8 1.3 0.6 3.3 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814650-117832379 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA035400: AB_10672091, HPA041056: AB_2677277" "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 35.3 21.3 20.5 28.7 26.0 17.4 31.2 27.1 25.6 31.2 27.9 16.7 21.6 20.9 32.0 22.9 27.8 28.5 21.3 22.9 19.6 19.1 32.0 40.3 24.1 35.0 25.5 22.9 36.3 29.5 21.0 25.9 25.0 25.0 25.0 30.3 11.5 24.2 26.6 37.0 24.9 26.3 28.3 30.8 46.5 26.2 22.9 31.1 40.7 31.3 23.9 37.6 37.6 23.7 22.2 20.5 9.4 18.5 17.2 23.6 16.3 22.0 10.0 15.0 13.5 8.9 8.0 24.8 13.1 10.4 18.1 16.0 24.6 14.6 32.5 21.5 10.8 16.8 17.1 29.0 16.9 26.8 16.5 20.3 31.0 9.4 24.7 12.4 41.4 16.2 8.3 15.7 23.0 23.3 9.2 10.8 16.9 33.8 14.1 13.8 13.7 22.6 21.6 37.6 18.7 15.2 19.7 23.4 28.4 12.0 13.1 14.4 24.5 15.2 16.8 17.0 15.9 10.6 22.9 8.3 16.2 23.9 11.4 23.5 16.3 20.2 90.0 11.9 19.6 7.2 6.2 13.8 9.4 16.2 17.3 20.6 22.2 19.3 18.5 12.5 19.1 23.6 20.7 3.6 17.2 18.5 20.5 15.0 16.3 20.5 26.0 27.1 25.6 19.6 19.1 25.5 22.9 25.0 31.1 89.3 53.4 123.6 65.7 171.3 131.1 44.8 122.3 89.7 94.4 115.1 78.5 95.4 99.5 87.4 10.8 105.7 49.3 23.3 99.4 101.8 89.3 52.4 108.5 162.0 78.1 77.9 54.6 103.7 79.2 10.1 98.7 99.7 87.7 93.8 85.3 76.8 106.8 59.6 97.6 93.5 118.7 64.7 108.2 111.4 127.7 140.4 74.3 107.1 93.0 50.8 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956128-68985073 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 515.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 14000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 37.5 16.0 10.0 26.6 13.3 46.8 24.4 8.0 11.8 18.5 20.1 7.2 16.2 13.3 18.7 13.7 28.3 20.1 17.6 19.1 11.4 8.0 25.1 48.0 25.9 24.4 14.9 7.2 30.2 27.9 15.6 20.7 22.8 18.3 14.0 17.6 5.9 18.0 17.8 61.2 22.5 18.5 19.0 20.4 43.5 19.0 12.9 13.3 27.1 18.1 24.1 25.8 33.2 22.4 12.6 11.5 17.1 17.3 7.7 15.0 6.2 33.1 19.7 11.5 35.6 10.4 13.8 24.4 22.8 18.4 29.5 25.1 63.7 22.8 50.0 14.1 18.9 13.9 29.6 44.3 28.4 39.6 15.5 31.2 35.0 14.0 26.4 22.3 83.2 33.3 14.1 37.0 35.2 59.0 13.7 21.4 18.8 66.6 25.0 20.7 15.1 32.6 18.1 31.5 15.8 42.1 29.2 18.9 24.6 19.6 17.9 23.9 25.6 20.5 45.5 26.6 14.5 25.8 17.5 22.0 17.3 24.6 23.2 40.0 28.9 38.2 73.9 14.4 63.2 11.7 5.0 9.7 17.1 8.4 15.0 15.0 12.6 10.9 11.0 11.5 10.4 10.3 11.3 4.5 7.7 17.3 10.8 7.9 6.2 10.0 13.3 8.0 11.8 11.4 8.0 14.9 7.2 18.3 13.3 95.3 139.8 208.1 223.1 488.7 27.0 59.4 112.1 83.0 195.7 68.0 39.3 72.5 61.3 111.8 41.5 139.6 52.0 23.3 160.6 118.9 142.8 222.8 164.0 182.5 102.7 23.8 83.2 113.5 149.3 13.6 82.8 170.5 118.1 66.7 97.0 22.8 171.9 92.1 72.5 73.0 27.4 25.8 155.6 101.9 142.2 515.4 115.0 93.8 113.1 301.9 DDX27 "dJ686N3.1, DRS1" ENSG00000124228 "DEAD-box helicase 27" Q96GQ7 20 49219295-49244077 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047087 Uncertain Approved Nucleoli Yes No Nucleoli "HPA047087: AB_10964059" "unprognostic (4.47e-2)" "unprognostic (2.41e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (2.82e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (6.70e-7)" "unprognostic (2.28e-1)" "unprognostic (9.53e-2)" "unprognostic (2.74e-1)" "unprognostic (7.18e-2)" "unprognostic (5.84e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.26e-1)" "unprognostic (4.32e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" 22.0 22.5 21.9 33.0 23.2 40.9 23.6 34.8 26.3 24.3 26.4 16.3 20.4 23.2 26.2 19.1 26.5 23.9 27.1 19.2 22.6 17.3 25.9 21.0 20.1 32.3 19.9 18.8 37.4 27.3 25.9 25.6 23.9 21.2 22.0 22.1 14.4 22.9 24.3 32.9 27.8 33.6 20.0 20.7 34.1 22.9 25.0 24.0 30.6 23.5 19.4 35.3 24.0 27.2 30.4 28.0 22.2 24.2 18.2 26.7 18.6 20.2 19.3 9.9 7.6 11.0 10.2 28.2 13.5 11.1 42.6 19.8 62.7 22.7 24.1 25.2 10.9 37.0 28.8 22.0 21.6 31.7 8.5 12.9 18.3 16.2 30.4 16.2 23.1 21.5 10.8 25.4 24.8 19.1 9.7 7.0 19.0 24.9 13.4 13.8 13.6 24.3 30.6 18.7 24.8 25.1 21.0 24.6 22.2 15.4 15.7 12.9 15.3 37.6 54.4 22.6 14.3 28.8 26.9 8.8 27.4 24.1 22.9 28.0 15.3 16.5 31.6 17.5 18.5 17.6 11.1 19.8 22.2 21.7 21.2 22.8 29.4 20.6 19.7 23.3 30.4 26.7 20.3 8.1 18.2 24.2 28.0 26.3 18.6 21.9 23.2 34.8 26.3 22.6 17.3 19.9 18.8 21.2 24.0 26.8 43.1 49.7 41.1 31.7 24.0 22.7 20.4 40.2 45.5 31.4 13.7 49.9 16.6 46.3 131.4 24.2 38.6 0.0 38.0 41.7 28.8 24.4 110.8 20.3 29.9 27.0 29.7 12.3 16.4 107.1 36.8 41.8 18.6 43.3 30.5 32.3 46.2 37.4 31.8 34.2 27.6 25.8 29.7 67.4 60.0 28.1 62.4 50.1 43.2 37.1 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6, guanine nucleotide exchange factor" Q9H4E7 6 35297852-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 51.7" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 2.9 2.0 4.5 34.8 4.6 30.3 3.4 0.9 3.1 4.3 4.7 6.9 4.7 5.3 3.1 11.1 15.3 2.7 6.8 2.6 3.8 2.7 3.1 2.5 7.5 42.7 5.3 1.0 2.0 16.5 0.7 5.1 4.2 4.8 10.6 4.0 2.9 14.1 6.7 0.9 14.4 15.2 2.4 7.1 32.6 8.3 6.7 5.0 42.6 4.7 9.3 51.7 6.7 8.6 13.9 21.0 43.5 13.8 25.9 31.5 20.7 7.5 0.0 0.2 0.2 0.0 0.1 9.6 0.8 1.2 0.2 0.2 0.4 3.2 9.0 2.7 0.4 0.0 5.0 0.0 6.4 0.1 0.3 0.3 10.1 0.1 4.0 0.2 18.2 13.3 1.5 8.2 0.1 7.4 0.0 0.0 27.3 4.5 21.7 0.0 3.9 23.7 31.6 0.4 0.9 0.9 21.9 0.2 12.1 0.8 5.7 0.1 0.0 0.6 1.9 1.7 0.4 5.2 25.3 1.2 0.1 0.2 0.0 0.1 12.4 11.4 7.5 0.0 37.9 0.0 16.3 13.8 43.5 31.5 11.0 25.8 13.9 25.7 31.0 21.0 12.5 27.1 26.1 26.7 25.9 9.9 13.9 26.9 20.7 4.5 4.6 0.9 3.1 3.8 2.7 5.3 1.0 4.8 5.0 6.0 10.1 30.6 16.6 10.5 2.3 0.5 5.1 2.7 6.8 5.2 0.0 20.5 0.0 0.7 44.9 1.7 2.9 0.0 8.6 14.6 1.5 5.8 17.3 0.5 76.8 3.2 4.1 3.7 28.3 127.4 2.6 28.4 6.8 7.2 8.5 0.8 5.8 10.5 1.8 0.2 1.6 0.0 1.2 4.2 0.7 10.3 10.5 75.9 7.2 12.7 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 93.5;Horizontal cells: 104.9;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA065343: AB_2685476" "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 13.7 15.7 9.5 13.9 11.3 32.9 9.5 26.7 12.6 10.0 9.6 12.2 6.8 6.9 11.5 6.6 8.0 9.3 13.2 8.2 10.7 8.5 9.8 19.1 12.8 20.8 12.1 9.7 16.3 19.9 17.9 21.2 9.9 11.6 8.1 8.2 14.6 9.5 7.2 15.3 7.6 10.2 12.5 16.6 13.6 10.2 9.0 11.9 16.9 12.7 5.6 20.1 13.4 10.1 9.3 3.1 6.8 3.6 4.4 8.0 1.9 4.8 4.6 2.4 2.5 7.3 8.1 3.0 5.1 6.8 3.4 5.0 2.6 3.9 25.2 3.5 7.4 4.2 9.2 4.7 4.5 6.0 27.9 5.5 23.9 6.0 5.0 4.2 8.1 8.5 5.4 5.1 4.7 10.0 6.0 9.1 5.7 7.2 15.6 3.9 2.6 3.7 4.3 0.7 14.6 3.5 1.8 8.6 21.7 4.0 9.4 3.9 3.7 4.9 3.4 4.4 3.0 3.3 20.7 9.8 4.7 5.3 8.5 7.0 8.5 9.5 9.5 6.7 17.7 3.8 3.1 3.6 6.8 5.3 1.5 8.0 7.8 4.6 6.7 3.1 9.3 4.9 4.7 1.9 4.4 1.2 1.2 4.2 1.9 9.5 11.3 26.7 12.6 10.7 8.5 12.1 9.7 11.6 11.9 14.9 23.9 21.9 25.1 24.7 75.6 10.9 15.3 21.4 21.6 8.7 56.9 4.2 0.0 7.8 1.5 23.3 5.1 93.5 11.3 5.7 14.1 17.9 47.4 23.2 16.5 104.9 16.7 17.8 20.8 2.9 12.0 24.7 23.6 7.2 10.1 24.1 12.2 10.4 11.7 8.7 124.0 6.5 16.4 10.7 9.6 14.9 10.5 29.9 8.9 14.1 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DESI1 "D15Wsu75e, FAM152B, PPPDE2" ENSG00000100418 "Desumoylating isopeptidase 1" Q6ICB0 22 41598028-41621096 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Group enriched" "Detected in many" 5 "Early spermatids: 685.0;Late spermatids: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053415 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA053415: AB_2682141" "unprognostic (1.07e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-2)" "prognostic favorable (7.70e-4)" "unprognostic (2.31e-2)" "unprognostic (6.16e-3)" "unprognostic (8.75e-3)" "unprognostic (9.27e-2)" "unprognostic (3.97e-2)" "unprognostic (6.27e-2)" "unprognostic (1.80e-2)" "unprognostic (1.42e-1)" "unprognostic (2.31e-3)" "unprognostic (2.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" 12.9 14.5 24.6 12.6 25.4 8.4 13.4 17.0 33.3 11.7 11.9 22.8 9.5 14.5 10.4 15.1 19.7 11.3 11.5 30.3 24.3 19.7 19.5 69.2 14.0 13.2 23.5 16.3 12.7 13.2 15.7 10.0 11.8 18.3 13.4 14.0 9.7 13.2 14.4 14.6 15.9 16.1 14.5 22.4 11.3 12.6 29.2 19.0 9.7 9.7 14.6 16.8 10.8 9.2 6.2 7.4 10.6 12.5 2.8 7.3 5.5 7.0 7.6 7.6 10.4 10.7 12.9 4.3 14.4 9.3 13.4 9.9 10.0 4.5 27.2 10.0 16.6 7.1 10.4 20.1 16.1 14.1 12.2 15.3 6.1 14.1 8.4 13.2 23.9 8.3 11.0 18.8 16.4 15.4 11.0 20.2 9.5 17.7 30.9 10.6 9.0 5.4 7.3 7.5 26.7 11.5 7.4 3.2 27.8 16.8 4.6 5.4 2.8 13.9 15.3 9.8 9.0 5.0 7.8 20.4 9.9 7.2 10.4 7.0 11.4 8.8 13.0 24.6 10.6 13.1 9.5 9.3 10.6 5.0 12.5 6.4 6.2 6.2 5.9 7.4 5.4 5.6 6.5 5.5 2.8 8.2 4.4 7.3 5.5 24.6 25.4 17.0 33.3 24.3 19.7 23.5 16.3 18.3 19.0 8.9 13.9 25.3 26.2 7.7 21.3 44.5 10.2 6.7 9.1 8.7 5.9 24.8 33.2 44.8 685.0 20.4 35.5 0.0 26.0 35.1 19.1 35.6 10.4 60.6 45.6 20.6 18.9 16.0 22.9 303.8 17.5 21.6 13.5 65.9 16.1 16.2 45.9 21.8 9.9 43.5 8.8 25.8 18.2 109.0 21.3 11.5 69.9 20.8 23.8 53.6 DET1 FLJ10103 ENSG00000140543 "DET1, COP1 ubiquitin ligase partner" Q7L5Y6 15 88494440-88546675 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge, Cytosol" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 6.0 9.3 5.5 4.3 7.0 1.9 6.4 5.5 6.8 9.5 6.3 8.2 7.0 5.5 15.9 9.1 3.8 9.6 7.8 8.8 4.3 4.2 5.4 4.5 4.3 4.2 5.0 6.1 17.9 10.1 7.1 6.4 5.6 5.9 8.5 5.6 12.6 6.7 7.4 13.8 4.4 5.9 11.4 5.1 4.4 5.5 3.6 4.6 10.7 6.8 4.1 6.4 7.7 6.0 5.3 7.6 2.9 7.4 3.4 6.6 3.8 2.0 6.8 9.7 7.1 4.8 7.3 1.9 6.6 7.1 5.8 6.1 1.4 6.5 4.0 5.1 8.4 5.7 3.2 11.0 2.0 5.0 0.3 7.0 7.6 3.8 2.4 7.6 2.9 1.6 6.2 7.3 2.7 7.9 4.9 4.5 4.1 9.5 4.8 7.3 3.2 4.1 3.2 4.4 3.2 2.1 4.8 8.0 4.9 3.0 6.0 3.7 5.9 7.4 2.6 16.6 7.1 3.7 6.0 3.6 5.9 4.6 6.0 6.1 2.8 2.0 2.6 6.6 4.9 5.2 0.0 4.8 2.9 5.3 7.4 3.9 4.8 4.6 4.7 7.6 5.3 6.6 5.4 0.7 3.4 4.6 4.1 5.1 3.8 5.5 7.0 5.5 6.8 4.3 4.2 5.0 6.1 5.9 4.6 3.0 2.4 1.7 2.1 0.6 11.9 1.6 0.0 4.0 1.2 3.5 9.8 5.5 1.7 2.6 0.4 2.1 2.6 0.0 3.3 5.7 3.9 1.2 0.0 2.8 3.7 6.4 2.9 1.3 1.2 0.4 4.0 2.3 3.3 4.6 2.5 6.5 2.5 0.0 3.5 1.9 7.2 0.0 3.1 4.8 8.5 1.1 3.4 0.5 2.9 1.3 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.6 15.0 39.4 17.7 0.9 3.9 12.2 21.9 14.5 32.4 30.9 12.2 20.8 21.9 12.1 12.7 13.0 23.4 25.2 17.5 42.6 26.4 12.4 22.5 14.1 10.5 0.1 22.0 13.8 0.8 0.6 15.2 7.3 5.2 35.6 22.5 18.2 22.0 30.1 18.1 27.7 11.2 20.3 16.8 15.6 21.7 38.1 10.1 10.6 12.2 20.1 11.3 23.3 8.8 8.6 17.5 19.6 8.2 13.8 14.5 38.0 14.0 25.1 5.4 11.7 29.1 10.1 15.7 23.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 0.0 0.3 8.5 0.2 1.0 0.0 0.3 0.0 1.4 1.2 0.0 0.0 1.3 0.0 0.4 10.7 0.0 0.2 140.2 0.0 19.8 1.0 0.2 0.0 0.8 8.6 0.0 0.0 1.8 4.5 4.6 0.9 2.2 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 61.2 32.3 0.4 1.6 1.5 2.5 1.1 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 46.7;Spermatocytes: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.3 4.0 3.5 5.1 4.3 2.0 2.0 2.3 1.5 3.5 3.9 3.7 0.9 1.6 3.2 7.4 2.1 1.7 2.7 2.3 3.9 3.1 6.0 2.7 2.2 4.3 1.9 3.5 2.9 4.2 6.2 2.2 1.0 5.2 3.7 4.4 1.6 0.9 1.4 4.8 4.3 1.2 3.4 2.2 1.8 2.8 2.4 2.5 2.3 4.4 1.3 4.2 3.1 3.4 2.2 4.6 1.9 2.3 2.5 5.1 2.9 10.7 8.4 5.7 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 0.0 4.3 3.0 1.1 0.8 9.3 3.6 0.0 4.0 5.7 0.0 3.9 0.3 0.0 0.2 8.7 2.2 2.0 46.7 0.3 0.2 1.1 1.8 1.1 4.9 0.7 9.5 0.0 3.1 1.5 9.6 0.9 1.2 0.0 1.0 1.7 5.6 0.3 1.5 1.1 0.3 9.1 0.0 1.2 17.5 1.7 3.3 0.6 0.5 1.7 1.6 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 11.0 4.8 3.7 8.3 3.6 5.8 8.4 9.2 4.4 13.0 24.9 3.2 23.0 14.5 15.6 11.1 8.2 9.2 10.2 6.0 3.1 2.6 11.1 8.6 6.6 4.5 2.3 3.0 13.8 22.3 24.6 5.0 8.5 3.5 11.6 13.8 8.5 7.2 23.3 10.2 20.0 38.3 15.9 3.1 6.2 15.3 8.6 2.3 30.4 7.1 8.8 7.7 17.4 16.8 4.3 0.8 1.6 2.7 5.3 1.7 1.2 10.4 8.6 7.8 12.3 14.3 12.1 1.9 18.9 18.3 9.2 8.9 5.8 15.9 10.9 8.1 14.4 5.0 8.3 9.1 10.8 12.9 0.5 2.8 1.5 9.7 4.0 7.4 1.0 0.7 5.6 2.4 11.3 10.0 32.4 21.9 3.5 1.4 0.0 18.5 1.3 1.8 2.0 7.5 7.3 5.2 2.2 8.0 0.5 15.6 9.1 1.3 1.8 3.1 0.8 2.3 11.3 0.6 1.0 26.3 6.9 6.6 5.5 12.3 0.9 0.6 15.3 6.5 3.4 5.1 0.0 1.8 0.4 1.7 2.7 1.6 3.0 0.4 1.2 0.8 4.3 0.4 0.8 1.6 5.3 2.7 0.6 0.0 1.2 3.7 3.6 9.2 4.4 3.1 2.6 2.3 3.0 3.5 2.3 8.9 8.3 4.9 7.1 31.1 6.5 5.2 12.7 26.8 14.8 12.2 33.4 6.4 3.3 6.0 1.0 10.8 34.6 0.0 12.4 1.0 11.3 5.5 2.3 13.1 4.1 12.7 3.5 9.2 12.7 2.5 12.7 7.5 3.3 0.0 25.4 3.3 13.5 23.0 8.5 2.9 24.9 0.0 8.2 2.1 8.5 39.9 3.1 1.5 22.8 17.8 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791937-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Group enriched" "Detected in all" 7 "dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6" "Cell line enhanced" "Detected in all" "PC-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 15.2 16.3 15.8 19.0 18.0 31.6 16.0 15.5 19.9 16.4 24.2 15.4 20.5 14.0 23.3 21.3 18.8 20.6 18.6 20.6 14.6 15.3 15.6 18.7 18.2 17.7 14.5 17.6 20.1 24.1 18.2 17.8 18.3 15.1 23.5 32.0 16.1 21.0 21.6 45.0 21.8 19.6 32.6 13.8 21.2 20.7 36.9 11.8 25.2 21.1 19.4 21.7 30.1 16.1 3.2 14.2 41.0 16.6 1.0 3.4 4.5 20.4 10.9 11.3 10.7 8.7 9.4 11.8 7.7 12.5 25.0 22.7 34.5 33.6 8.5 25.3 11.2 39.9 15.5 9.9 16.5 16.6 4.6 12.4 9.2 11.5 22.0 17.7 18.0 15.4 9.4 15.6 16.3 15.8 11.5 14.6 12.4 8.5 8.7 14.8 27.2 14.7 27.9 7.6 11.6 74.6 11.9 14.0 8.8 12.5 9.8 10.6 9.6 15.7 12.8 16.1 9.2 12.7 28.9 8.5 15.0 11.2 14.5 18.4 9.5 6.1 10.5 32.8 11.6 12.8 4.8 16.6 21.6 1.4 6.9 1.4 3.2 1.9 2.4 14.2 2.7 3.4 1.6 41.0 1.0 4.2 5.5 2.7 4.5 15.8 18.0 15.5 19.9 14.6 15.3 14.5 17.6 15.1 11.8 14.9 18.5 22.9 37.2 22.7 18.5 17.9 12.7 24.1 21.6 24.4 3.9 56.0 43.1 57.6 31.1 21.1 32.8 0.0 66.5 35.6 23.6 31.5 5.8 16.8 62.7 19.1 21.4 22.7 26.5 10.6 26.2 33.7 15.1 86.6 70.1 42.1 70.4 51.8 25.5 33.4 24.1 0.0 24.5 77.5 33.7 24.1 48.3 18.1 31.6 54.5 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866283-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044502: AB_10960277, HPA053707: AB_2682236" "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 14.0 8.5 10.7 7.3 11.4 27.6 10.9 12.0 12.5 12.4 9.4 5.8 7.9 6.1 9.4 14.1 15.1 9.7 9.7 11.4 9.4 10.3 14.5 15.1 12.1 10.7 10.4 10.5 15.9 8.3 9.9 12.1 15.5 17.7 13.0 8.1 4.6 9.0 7.3 24.6 11.7 11.7 11.0 13.2 16.2 9.0 12.0 10.9 15.9 16.2 12.6 10.7 17.3 15.5 11.1 7.2 15.8 11.6 11.9 11.6 8.0 12.4 6.0 6.8 7.1 6.5 5.8 10.3 8.4 6.0 10.1 8.7 6.6 5.6 16.7 11.3 8.8 12.7 7.1 10.8 10.1 14.4 10.1 6.1 13.7 9.9 9.6 6.8 15.3 4.9 6.4 11.0 10.8 9.1 5.1 7.2 5.5 16.1 5.8 13.7 5.4 10.7 10.0 13.0 5.6 9.7 6.2 14.4 6.4 10.3 9.7 8.1 7.3 8.8 13.2 9.2 9.0 5.7 11.1 6.8 8.2 8.6 9.4 14.1 6.1 8.1 13.7 4.8 12.1 5.4 10.9 7.9 15.8 9.6 11.6 11.6 11.1 8.9 8.7 7.2 10.5 8.2 10.4 12.1 11.9 10.7 5.0 8.8 8.0 10.7 11.4 12.0 12.5 9.4 10.3 10.4 10.5 17.7 10.9 53.6 74.1 43.3 98.3 48.3 31.6 69.0 10.2 117.8 117.2 12.2 55.0 44.4 18.3 60.2 28.9 60.6 13.1 23.3 52.7 36.6 31.7 61.4 112.5 16.6 33.8 19.1 8.1 20.9 24.1 7.4 23.9 59.5 21.9 64.1 12.1 30.7 68.6 15.3 24.4 14.7 29.6 19.4 106.0 54.0 70.5 44.3 46.7 46.5 19.7 80.3 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072065 Enhanced Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA072065: AB_2686486" "prognostic unfavorable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 14.9 3.2 2.4 4.0 2.7 5.2 23.2 7.1 8.5 10.1 6.3 2.2 1.2 2.8 1.1 5.3 7.7 3.1 4.6 1.6 8.2 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.3 6.6 1.7 6.1 4.2 6.7 2.0 4.6 2.9 16.8 4.9 6.4 2.0 17.7 3.3 8.9 1.4 13.6 5.4 6.0 6.5 3.7 4.7 21.5 6.1 3.4 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.4 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 0.0 5.8 31.4 6.9 2.7 5.3 4.0 10.2 6.7 3.4 8.7 3.9 1.5 3.3 8.1 0.7 3.3 17.3 0.0 2.8 9.8 2.8 21.2 8.1 8.5 15.7 0.0 28.2 6.2 15.4 0.0 2.3 12.0 5.0 7.2 56.5 1.5 7.5 24.6 2.8 1.3 3.0 0.0 2.5 4.4 13.0 4.5 6.8 7.5 19.5 10.1 DPH2 DPH2L2 ENSG00000132768 "DPH2 homolog" Q9BQC3 1 43970000-43973369 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045796 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA045796: AB_2679456" "unprognostic (2.41e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-3)" "unprognostic (9.13e-3)" "unprognostic (3.83e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.17e-8)" "unprognostic (1.38e-1)" "unprognostic (1.81e-1)" "unprognostic (3.72e-1)" "unprognostic (2.49e-1)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.37e-4)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (6.37e-2)" 9.6 12.7 13.5 12.4 14.1 7.5 9.8 7.9 18.8 8.3 12.0 12.4 5.9 8.9 9.4 7.5 15.2 10.8 11.5 11.6 11.6 6.3 11.5 21.7 8.5 14.1 13.6 9.3 9.1 21.1 10.4 10.6 8.3 9.7 9.8 11.9 5.8 11.6 9.2 33.4 13.1 9.9 11.2 7.6 13.7 10.6 14.7 12.3 10.8 8.9 14.6 13.5 10.3 7.8 9.0 10.2 0.5 9.2 9.8 10.1 5.8 9.9 11.5 5.2 11.0 3.9 4.1 17.5 5.3 5.8 13.9 11.4 14.6 9.8 16.8 9.1 5.5 7.2 11.5 17.4 15.1 7.5 11.5 15.2 17.3 14.4 15.1 10.3 19.9 9.8 6.3 16.9 16.4 9.1 4.2 9.6 13.4 21.8 9.5 6.9 11.6 17.6 11.0 35.9 16.7 13.2 15.2 11.9 27.2 8.7 8.0 17.9 20.7 7.0 17.8 12.9 7.3 7.5 13.8 6.2 6.7 15.4 11.8 21.1 23.3 38.5 17.2 6.0 22.2 9.8 0.0 6.6 0.3 6.7 9.2 9.9 9.0 6.8 6.9 10.2 8.8 7.0 10.1 0.5 9.8 4.7 8.5 6.6 5.8 13.5 14.1 7.9 18.8 11.6 6.3 13.6 9.3 9.7 12.3 0.0 3.7 17.1 9.7 20.4 6.3 8.5 10.2 6.7 3.4 1.8 9.8 12.3 5.0 14.8 0.3 6.0 2.5 0.0 16.3 12.3 7.0 9.4 4.6 4.2 7.7 3.2 11.5 3.1 1.8 0.9 7.8 5.0 5.0 10.8 6.5 4.5 11.7 0.0 3.5 7.3 5.5 0.0 11.2 8.6 27.1 23.7 7.2 6.9 11.8 8.0 DPH7 "C9orf112, FLJ90634, RRT2, WDR85" ENSG00000148399 "Diphthamide biosynthesis 7" Q9BTV6 9 137554904-137578935 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022911 Uncertain Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA022911: AB_1858823" "unprognostic (1.43e-1)" "unprognostic (4.81e-2)" "unprognostic (3.41e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.60e-3)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (2.14e-2)" "unprognostic (9.48e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.30e-3)" "unprognostic (3.06e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.23e-4)" 8.2 12.7 12.1 14.0 16.4 8.2 10.7 15.9 17.8 13.3 12.7 21.5 14.3 5.9 14.2 17.8 9.4 18.2 10.3 12.6 14.0 7.6 11.1 11.0 10.4 13.0 19.1 11.5 17.3 20.8 14.1 14.9 10.5 12.8 15.6 11.9 10.8 16.1 15.4 9.6 13.5 12.2 14.6 9.0 16.0 11.8 10.1 18.6 11.2 13.8 5.8 13.9 10.9 11.7 10.8 14.2 15.6 9.2 9.3 13.5 8.8 7.1 7.5 12.2 10.9 8.8 6.7 14.1 7.1 6.9 12.0 10.2 14.9 7.1 14.0 12.8 7.4 8.9 17.1 14.1 12.1 9.6 11.2 16.5 5.9 10.1 5.4 10.0 13.2 12.7 6.9 10.8 8.0 15.2 9.8 15.9 11.1 11.8 7.5 8.3 20.2 10.0 14.4 14.0 25.8 15.9 17.9 6.4 11.4 9.9 6.7 13.9 12.6 10.9 9.3 7.9 7.7 13.4 13.1 7.5 9.5 7.7 10.9 13.6 6.2 11.9 15.6 4.9 9.1 8.9 15.6 8.9 9.7 10.9 9.2 11.6 10.8 13.5 12.7 10.4 9.5 11.5 11.7 2.3 9.3 6.4 14.2 9.3 8.8 12.1 16.4 15.9 17.8 14.0 7.6 19.1 11.5 12.8 18.6 6.0 14.0 13.7 10.0 14.8 19.0 12.6 5.1 9.4 7.9 1.8 47.1 18.3 3.3 8.7 1.3 11.7 5.1 0.0 8.1 11.4 11.8 10.7 10.4 5.8 10.5 15.9 6.4 8.6 5.7 4.5 15.3 6.9 8.5 10.8 10.6 17.1 10.1 8.0 14.9 4.2 57.2 19.4 13.0 20.5 25.6 16.6 10.2 16.2 13.9 9.1 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "Group enriched" "Detected in some" 4 "HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.2 1.1 1.0 1.4 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 2.1 0.0 5.1 0.7 0.0 0.3 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Group enriched" "Detected in many" 6 "Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 3.6 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 7.4 0.8 2.6 2.2 3.4 4.7 2.1 0.2 1.6 2.5 0.5 2.5 0.1 2.3 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 3.0 0.0 0.0 2.9 0.5 41.9 24.2 2.5 16.0 6.8 12.2 13.7 1.1 5.0 0.4 300.2 2.3 0.0 0.0 0.0 1.1 1.0 3.0 2.3 0.0 0.3 3.2 0.0 0.0 0.0 304.6 6.6 0.0 6.8 0.0 0.0 11.1 0.2 0.0 8.1 5.6 6.2 25.8 15.6 171.9 4.1 0.4 1.1 0.0 0.0 0.9 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 90.5;Spermatogonia: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.0 11.8 13.9 11.1 5.5 7.2 9.2 16.0 13.6 24.6 27.7 20.5 17.0 15.1 10.7 8.7 27.2 17.2 13.0 12.6 23.5 6.6 8.3 29.4 11.3 13.7 1.2 16.8 13.0 2.7 3.6 17.0 5.4 4.0 12.0 16.4 11.4 12.5 16.1 9.3 21.5 13.0 6.5 23.6 20.9 16.9 42.4 10.0 6.2 7.8 14.3 6.5 19.9 20.5 9.7 10.8 20.9 11.3 6.2 22.5 13.7 22.0 17.2 10.5 14.1 17.1 18.9 15.2 16.0 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 6.0 4.1 9.3 10.2 4.4 8.0 4.1 2.5 10.7 10.3 5.2 27.5 42.7 6.6 5.2 6.3 5.8 6.4 0.0 5.6 29.3 7.5 7.5 3.5 4.5 12.6 6.4 2.4 9.8 3.7 5.8 8.1 6.1 1.7 8.2 9.0 4.8 4.7 5.7 7.1 2.9 15.8 0.0 7.2 90.5 91.3 6.4 39.7 6.4 10.5 10.8 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522801-15663058 "Disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Yes No Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favorable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.72e-4)" "prognostic favorable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 7.2 5.0 22.8 10.5 91.0 9.3 7.7 6.7 18.4 6.8 10.5 7.8 4.5 7.2 8.0 12.5 7.2 6.9 7.9 12.0 15.0 18.0 11.3 5.0 8.4 16.9 18.5 10.3 7.3 6.7 13.1 8.5 9.3 13.7 8.1 10.9 13.4 6.7 10.1 15.4 7.1 7.6 11.9 9.4 10.2 7.6 5.5 17.2 9.3 7.8 2.7 19.4 8.6 8.1 17.8 17.9 8.1 7.1 26.9 12.1 6.6 15.8 6.9 5.9 12.7 8.7 9.9 9.1 8.2 10.7 19.7 17.9 9.1 7.4 22.5 22.1 11.6 16.3 5.5 11.6 8.7 18.0 14.4 15.5 15.8 9.0 13.5 15.2 15.9 13.5 9.4 13.4 10.0 14.9 9.0 17.3 15.5 14.9 5.6 11.8 18.6 16.5 25.3 4.1 13.5 10.0 19.6 11.6 17.5 18.4 16.6 12.1 5.1 6.4 15.4 19.3 14.3 11.1 10.2 7.9 11.2 7.3 11.5 15.0 15.1 28.9 15.8 5.2 14.1 21.1 5.9 5.9 8.1 12.1 7.1 8.0 13.7 10.3 10.4 6.4 17.8 9.8 7.9 6.8 26.9 4.9 17.9 6.9 6.6 22.8 91.0 6.7 18.4 15.0 18.0 18.5 10.3 13.7 17.2 11.9 9.9 44.3 12.8 25.8 42.2 26.6 17.8 9.4 6.8 14.0 55.0 37.3 31.5 32.0 38.0 30.8 18.0 0.0 31.0 15.5 19.0 10.2 54.2 4.5 46.0 23.8 13.3 16.0 15.1 14.5 9.5 25.1 35.4 33.3 15.2 31.7 24.9 8.6 14.5 53.8 136.7 6.5 24.2 17.4 12.7 19.3 14.0 27.9 17.5 9.3 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Vesicles" "HPA042214: AB_2677903" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.5 5.3 9.8 5.2 19.6 38.2 7.8 13.1 13.2 17.6 13.0 1.7 3.7 7.2 9.9 16.4 8.1 8.2 6.9 6.9 17.1 4.8 4.9 6.2 10.8 6.4 13.1 8.1 5.4 18.4 9.3 10.9 13.4 15.6 7.2 8.9 11.5 7.7 18.4 9.1 5.4 6.6 6.1 10.1 7.2 7.8 20.2 28.2 5.7 3.2 8.8 6.6 16.0 5.5 12.3 10.6 5.4 11.8 4.7 20.8 8.3 11.7 14.7 6.1 9.3 4.3 18.3 23.2 12.9 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 17.9 12.9 19.8 15.0 17.1 43.1 13.9 17.8 45.5 19.4 33.2 29.5 19.7 26.6 17.7 7.3 16.6 5.6 0.0 18.1 23.0 40.2 17.4 6.9 13.2 17.8 17.5 14.9 23.9 19.3 10.4 35.1 18.5 15.1 4.6 15.4 18.8 20.0 10.5 26.5 15.4 41.6 6.5 46.7 42.3 43.9 16.7 8.1 15.2 18.7 11.1 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 19.6 16.1 15.1 15.1 17.9 29.5 21.4 31.8 21.5 23.1 16.8 16.4 16.2 16.3 29.9 19.8 38.7 37.4 15.2 15.2 17.2 13.9 19.3 16.5 17.2 21.5 12.7 15.8 26.4 14.9 11.6 28.2 19.1 14.0 18.2 16.8 16.5 22.3 20.3 16.2 27.9 19.7 18.9 13.4 21.5 15.4 19.7 13.8 28.7 16.8 16.2 29.3 20.4 27.3 29.9 20.9 42.6 19.1 28.0 37.6 29.2 19.4 8.4 9.1 9.6 16.5 20.7 16.3 14.3 18.7 18.6 19.1 12.1 14.8 25.3 9.2 15.4 16.7 13.6 11.2 28.8 18.0 17.4 11.7 15.5 6.4 18.5 17.3 17.4 14.6 16.7 35.0 16.6 23.1 16.2 20.6 12.4 16.4 14.9 20.6 10.8 16.7 18.6 14.6 18.3 11.7 6.7 24.5 22.7 15.0 16.2 13.5 7.3 13.2 15.8 16.8 11.4 8.4 9.3 11.7 13.3 16.4 15.2 16.8 15.9 12.6 33.4 12.3 17.7 12.9 24.7 19.1 42.6 26.8 16.9 34.6 29.9 31.7 31.6 20.9 28.1 33.9 31.8 29.1 28.0 16.9 15.9 37.6 29.2 15.1 17.9 31.8 21.5 17.2 13.9 12.7 15.8 14.0 13.8 8.9 11.8 34.3 47.9 73.8 9.4 6.9 33.1 26.8 22.7 12.2 3.9 27.8 43.1 24.2 5.9 29.2 13.5 23.3 24.2 35.1 26.6 23.0 41.4 12.9 27.5 4.8 11.5 29.4 22.3 5.6 26.7 20.5 21.9 42.3 19.0 9.3 22.5 17.8 24.1 38.5 13.9 6.5 22.8 23.6 31.8 72.5 32.3 32.4 17.2 54.2 DUSP18 DUSP20 ENSG00000167065 "Dual specificity phosphatase 18" Q8NEJ0 22 30652051-30667890 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 103.5;Late spermatids: 252.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034070, HPA051349" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB034070: AB_2094867, HPA051349: AB_2681450" "unprognostic (1.11e-1)" "unprognostic (2.34e-2)" "unprognostic (3.49e-3)" "unprognostic (4.88e-3)" "unprognostic (1.88e-1)" "unprognostic (9.12e-2)" "unprognostic (3.77e-4)" "unprognostic (1.83e-1)" "unprognostic (1.61e-1)" "unprognostic (3.53e-2)" "unprognostic (9.62e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-3)" "unprognostic (6.55e-2)" "unprognostic (1.97e-1)" "unprognostic (4.56e-2)" "unprognostic (1.02e-1)" 5.2 3.9 10.1 7.1 9.7 4.9 5.3 4.1 8.3 5.6 10.1 11.4 4.6 7.8 6.1 8.4 7.5 18.5 8.0 3.8 8.7 7.8 5.5 2.3 9.9 7.2 8.4 3.9 4.4 6.6 5.2 19.5 3.6 9.5 4.6 11.5 4.7 6.1 4.3 2.0 7.9 11.0 6.4 9.0 6.9 8.3 30.8 10.2 8.0 5.8 3.4 7.6 6.0 6.1 6.4 11.2 21.7 13.9 4.3 8.1 4.7 5.3 5.8 2.6 6.5 6.6 13.1 2.5 5.1 5.9 5.2 5.6 3.1 5.7 3.5 3.6 6.4 6.6 4.0 1.6 4.1 5.8 10.0 6.4 1.8 2.0 2.0 2.8 7.5 5.9 3.7 5.8 8.6 3.1 5.8 15.9 4.3 1.8 3.2 5.6 4.6 4.1 1.8 1.0 6.6 3.5 3.0 1.7 1.3 6.3 3.7 6.7 3.8 5.3 2.1 3.7 3.6 4.7 2.1 11.4 10.7 5.8 2.7 2.9 2.3 2.7 1.8 12.1 1.3 5.4 18.3 10.4 19.4 5.9 12.5 4.6 6.4 6.8 5.4 11.2 6.2 4.6 5.5 21.7 4.3 13.9 6.4 8.1 4.7 10.1 9.7 4.1 8.3 8.7 7.8 8.4 3.9 9.5 10.2 17.9 4.8 6.0 10.2 19.1 2.6 1.9 7.6 64.3 11.4 5.2 43.2 1.0 3.3 7.4 103.5 9.0 14.8 0.0 8.2 3.0 9.3 7.5 6.9 0.9 7.3 1.6 34.1 9.8 12.7 252.1 7.8 16.2 8.5 6.4 18.0 9.2 7.0 14.0 6.3 3.0 16.3 6.5 7.2 68.7 18.8 18.6 0.8 8.6 18.5 6.4 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100005 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 20.1;Early spermatids: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 2.8 4.6 9.2 2.0 16.3 1.0 3.0 2.9 9.6 3.4 4.7 2.2 3.8 3.5 6.8 9.2 4.2 8.4 3.5 7.4 17.4 3.4 4.7 3.0 3.4 2.3 3.3 6.8 4.4 4.3 7.7 10.6 2.7 3.7 4.2 3.0 3.0 2.8 5.4 3.8 3.4 3.0 8.6 2.9 4.0 9.1 10.4 4.7 6.2 4.6 1.1 1.9 4.0 2.7 4.1 1.5 2.0 0.8 2.2 3.2 1.3 0.1 2.4 2.9 1.4 3.9 2.2 0.0 1.1 1.8 4.6 1.6 2.3 3.0 1.0 6.0 1.2 3.3 0.3 5.7 0.8 3.5 5.8 3.2 10.6 1.8 1.6 1.7 2.6 6.5 1.7 0.5 2.3 1.1 2.9 2.6 0.0 3.1 1.6 2.7 1.0 5.0 2.5 2.4 1.0 2.0 4.9 4.5 0.3 1.0 1.1 3.6 1.5 4.0 1.7 2.9 0.2 0.8 1.0 2.0 2.5 2.1 1.7 0.9 2.0 2.4 0.1 3.1 0.4 3.7 2.0 0.5 1.9 2.3 0.8 2.3 4.1 2.1 3.1 0.6 2.2 2.7 2.7 1.3 2.2 0.4 1.5 3.2 1.3 9.2 16.3 2.9 9.6 17.4 3.4 3.3 6.8 3.7 4.7 0.0 2.7 1.7 1.2 0.9 1.7 6.5 2.5 20.1 2.3 1.8 2.0 2.0 5.0 0.6 10.4 1.0 1.6 0.0 0.6 1.2 1.3 0.9 1.1 1.0 0.6 1.6 2.4 1.8 0.6 4.6 1.7 0.1 0.0 1.8 2.0 4.5 0.5 2.5 2.5 2.3 1.0 0.0 1.4 4.7 3.1 1.4 0.6 0.0 2.1 1.3 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155388-184173610 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" Yes No "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: AB_2683658" "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.77e-5)" "prognostic unfavorable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 22.8 18.5 18.0 16.8 19.4 15.3 25.1 18.3 23.2 22.6 27.6 24.7 23.9 16.2 32.1 16.4 20.0 22.2 22.2 27.9 19.9 12.3 16.8 13.1 20.6 12.1 21.4 16.0 30.0 22.7 17.2 17.8 56.0 17.4 19.7 15.8 31.1 18.7 26.2 26.3 27.6 19.1 30.3 16.4 17.8 19.4 15.6 20.1 7.3 20.9 13.3 14.6 24.5 26.3 2.5 2.7 4.1 4.0 1.5 3.1 1.2 20.1 6.6 16.0 18.1 16.6 16.7 41.3 11.9 12.3 14.5 12.1 19.3 8.1 14.1 32.1 15.6 15.7 17.2 13.1 9.5 10.1 22.2 13.7 15.8 9.9 11.7 24.9 8.8 12.3 16.8 17.1 10.5 12.1 24.4 10.6 9.5 15.7 19.6 15.2 19.2 12.9 10.4 14.1 14.8 9.5 20.6 18.6 12.3 13.5 16.6 17.4 22.0 15.0 17.3 29.2 16.3 43.1 11.2 10.4 13.2 12.8 13.8 18.6 21.0 15.5 15.8 13.1 9.4 10.1 0.2 2.4 4.1 2.3 4.0 3.1 2.5 1.5 2.4 2.3 2.0 2.0 1.3 3.6 1.5 2.8 2.7 1.1 1.2 18.0 19.4 18.3 23.2 19.9 12.3 21.4 16.0 17.4 20.1 23.8 16.0 9.3 11.7 16.7 18.7 25.7 5.1 8.1 17.0 21.0 25.5 27.9 19.9 11.6 10.5 12.8 27.8 0.0 14.3 16.8 18.6 17.6 16.2 17.8 17.3 58.8 33.0 22.1 17.5 35.6 31.1 13.3 11.8 4.6 20.2 18.5 17.1 17.3 35.0 14.9 17.2 19.4 22.1 8.8 10.2 19.1 43.6 9.6 19.0 22.2 DYRK1B MIRK ENSG00000105204 "Dual specificity tyrosine phosphorylation regulated kinase 1B" Q9Y463 19 39825350-39834201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.1" "Group enriched" "Detected in many" 14 "Early spermatids: 145.5;Late spermatids: 469.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028522, HPA028786" Uncertain Supported "Nucleoplasm,Mitotic chromosome" Yes No Nucleoplasm "Mitotic chromosome" "HPA028522: AB_2672656, HPA028786: AB_10670831" "unprognostic (2.22e-2)" "unprognostic (9.86e-2)" "unprognostic (4.55e-2)" "unprognostic (3.45e-3)" "unprognostic (1.96e-1)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (2.39e-1)" "unprognostic (6.02e-2)" "unprognostic (3.67e-2)" "unprognostic (8.93e-2)" "unprognostic (4.22e-2)" "prognostic favorable (8.83e-4)" "unprognostic (9.73e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-2)" "unprognostic (3.88e-2)" 4.8 7.9 7.4 3.7 10.2 5.0 4.0 10.1 13.1 4.5 4.2 7.4 6.1 6.2 6.4 12.3 6.7 8.0 4.6 9.0 6.6 6.1 6.1 3.2 5.4 5.1 4.4 6.7 6.1 5.2 7.1 12.3 3.8 6.4 5.5 3.4 6.7 5.5 5.8 89.1 6.3 5.1 3.9 3.4 5.9 5.2 28.8 4.6 11.2 6.4 25.3 5.3 5.6 4.1 4.7 8.3 4.8 3.2 6.2 7.0 2.6 0.4 8.6 8.4 5.9 4.8 4.5 0.7 2.7 1.7 2.5 2.3 0.8 3.3 1.3 10.6 3.2 0.1 2.9 1.2 1.9 2.2 4.9 7.3 0.6 5.4 0.8 4.0 0.3 1.8 6.1 1.2 0.8 2.8 8.2 0.6 3.3 1.4 1.9 0.4 4.3 1.9 0.8 2.0 2.5 2.0 0.9 0.1 0.6 5.4 2.1 12.2 13.8 4.2 4.2 0.2 4.7 4.1 0.5 4.2 1.1 1.9 0.9 0.8 3.1 1.0 0.9 7.1 0.8 0.4 1.2 3.1 3.2 5.9 3.2 7.0 4.7 4.0 5.9 3.5 3.5 2.2 3.5 4.8 6.2 2.9 8.3 4.2 2.6 7.4 10.2 10.1 13.1 6.6 6.1 4.4 6.7 6.4 4.6 0.0 1.1 13.7 3.6 3.1 14.9 5.3 5.1 1.4 0.0 15.7 19.6 1.8 8.3 11.7 145.5 5.7 9.1 0.0 3.7 1.5 4.0 5.4 1.1 3.0 4.9 9.5 19.5 6.2 9.2 469.8 6.6 2.7 5.0 3.6 9.4 8.1 8.6 8.6 4.9 11.2 13.0 0.0 2.3 22.4 14.0 2.5 1.1 6.9 8.5 3.2 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 17 "dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 5.3 2.0 2.2 6.1 2.5 10.9 5.5 12.1 3.3 17.4 5.1 5.3 3.1 2.9 14.8 6.5 4.3 15.2 7.9 3.8 2.4 2.1 5.1 1.2 6.4 2.0 2.6 1.6 12.4 8.3 6.2 5.6 2.7 6.1 9.3 2.1 10.9 2.5 5.0 1.7 10.4 2.3 11.3 3.4 3.1 10.0 4.2 3.4 0.1 4.2 4.2 2.5 8.0 17.8 0.0 1.5 1.7 1.8 0.0 0.0 0.4 5.2 3.1 6.2 5.2 4.0 5.3 1.4 8.6 5.2 5.1 6.5 2.1 0.4 0.0 4.4 7.9 7.1 1.7 4.5 2.0 2.5 1.1 4.4 2.3 6.4 0.3 3.2 1.7 4.0 5.6 2.1 5.6 2.7 5.2 2.8 1.4 1.7 0.0 6.9 0.3 0.0 0.7 7.5 0.0 1.1 0.0 7.2 0.0 2.3 8.4 2.2 4.9 8.8 0.0 4.4 3.6 2.3 3.6 2.1 12.7 5.8 6.1 4.4 0.0 0.0 0.1 5.0 2.5 4.9 0.0 1.8 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.2 2.5 12.1 3.3 2.4 2.1 2.6 1.6 6.1 3.4 3.0 1.3 0.0 0.6 3.2 6.5 2.7 2.5 93.7 11.4 1.8 7.9 0.0 5.0 3.1 15.6 1.8 0.0 0.0 1.1 0.1 3.5 0.5 0.0 0.0 1.4 3.2 0.0 0.0 1.0 1.0 5.8 2.7 0.0 1.0 0.0 2.3 3.7 0.0 3.9 0.5 17.8 0.0 4.7 0.4 1.5 3.8 0.0 0.0 0.0 0.1 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Group enriched" "Detected in many" 6 "Early spermatids: 229.6;Late spermatids: 321.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 4.0 6.6 7.0 7.1 4.1 3.5 56.2 5.9 4.2 6.8 6.7 9.0 4.5 11.3 3.8 4.3 4.5 3.4 9.0 5.2 7.9 9.2 6.5 9.7 6.0 8.1 9.2 9.1 7.9 4.6 9.3 9.9 6.7 5.2 6.8 9.3 10.3 8.3 5.6 8.3 9.0 5.1 12.4 7.6 6.8 8.3 5.8 6.2 5.9 7.1 7.2 12.6 7.2 6.8 6.9 9.4 10.1 7.3 6.6 7.2 5.3 6.3 8.5 11.0 22.1 11.9 7.0 10.9 8.5 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 8.9 12.9 2.9 7.7 41.7 6.8 4.5 7.6 6.7 10.3 12.2 5.9 7.2 8.3 7.8 229.6 11.7 13.6 0.0 7.0 11.7 16.0 15.1 10.3 27.0 14.1 20.6 33.0 11.6 21.8 321.2 10.6 14.6 21.9 5.4 11.2 4.8 11.8 10.5 11.3 18.9 6.0 25.8 11.3 18.6 11.5 47.4 30.0 20.4 10.9 14.5 EBNA1BP2 "EBP2, NOBP, P40" ENSG00000117395 "EBNA1 binding protein 2" Q99848 1 43164175-43270936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026512, HPA028277" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA026512: AB_1847954, HPA028277: AB_10603664" "unprognostic (9.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.05e-3)" "unprognostic (2.03e-2)" "unprognostic (8.59e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (7.64e-3)" "unprognostic (2.89e-2)" "unprognostic (1.24e-3)" "unprognostic (7.11e-2)" "unprognostic (1.64e-3)" "unprognostic (4.10e-3)" "unprognostic (3.04e-3)" "unprognostic (1.69e-1)" "unprognostic (3.22e-2)" "unprognostic (1.33e-2)" 18.9 24.8 30.2 22.8 41.1 19.3 27.6 17.7 35.7 18.1 23.6 19.0 15.6 15.4 22.4 40.6 27.8 30.4 15.6 24.9 26.3 25.2 34.0 66.0 18.5 21.9 25.1 29.8 21.8 30.7 24.5 30.0 26.0 29.2 20.3 26.0 16.6 22.3 22.3 28.4 22.8 16.9 24.3 21.6 18.4 19.7 24.8 27.4 18.2 28.8 31.3 25.8 21.5 19.8 26.9 29.6 10.2 22.8 24.1 25.1 17.8 61.7 36.1 13.5 39.1 10.9 12.3 28.0 43.1 21.6 68.9 43.4 40.3 38.6 41.1 34.2 31.3 32.5 44.0 29.2 39.9 75.4 19.4 28.8 28.0 32.5 35.4 19.8 48.5 21.6 9.8 40.4 50.6 41.0 13.2 37.7 28.3 42.3 13.9 33.5 34.0 36.8 29.0 58.7 41.5 33.5 27.0 30.7 46.3 25.3 27.0 26.9 28.9 24.9 46.6 43.2 22.9 19.1 26.5 29.0 26.7 50.3 42.6 70.0 20.6 40.6 50.8 22.1 50.3 53.6 7.5 20.1 10.2 24.0 22.8 25.1 26.9 24.5 24.9 29.6 26.7 22.8 22.8 1.8 24.1 21.6 28.3 24.6 17.8 30.2 41.1 17.7 35.7 26.3 25.2 25.1 29.8 29.2 27.4 32.8 33.2 26.8 68.9 109.3 25.1 28.5 56.0 87.0 48.9 29.6 5.9 95.0 76.3 100.0 109.6 36.8 23.0 70.0 107.4 112.0 52.9 58.1 49.7 127.1 57.6 14.3 23.2 32.5 23.4 70.9 30.8 30.6 52.3 54.1 37.8 44.2 101.2 11.5 36.0 100.9 22.3 38.8 54.7 79.6 103.6 86.9 70.5 23.5 59.7 77.3 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 23.2 22.3 22.2 22.4 23.8 34.8 23.2 34.7 27.0 20.4 18.6 21.8 20.0 15.6 23.7 20.9 21.2 17.0 20.6 18.8 17.9 16.9 22.4 23.6 17.7 21.4 23.4 16.7 24.1 21.1 32.5 32.1 23.4 25.5 21.8 18.1 16.7 21.4 21.3 19.9 23.3 16.8 19.9 19.4 20.5 18.5 25.4 23.1 32.7 24.2 18.7 22.4 22.1 20.7 20.4 16.8 23.3 26.3 25.4 27.2 15.7 18.9 13.7 15.6 23.6 14.3 14.2 12.8 14.8 23.3 24.2 28.4 24.8 20.0 14.9 14.6 14.5 18.1 15.9 16.6 17.6 24.9 12.1 16.2 18.8 11.2 17.7 21.7 22.4 12.6 15.9 14.7 20.3 25.6 18.7 25.8 13.6 19.4 10.5 22.8 16.0 20.1 12.4 15.9 17.7 39.7 14.9 17.3 8.1 19.4 14.1 6.9 12.9 13.4 30.5 19.0 16.8 17.5 10.8 15.8 10.6 21.4 11.3 17.0 12.2 8.2 25.4 19.7 18.8 9.0 15.0 19.3 20.9 21.8 20.5 23.2 20.4 20.6 21.4 16.8 18.6 27.2 19.4 23.3 25.4 26.3 11.5 19.7 15.7 22.2 23.8 34.7 27.0 17.9 16.9 23.4 16.7 25.5 23.1 26.8 8.9 6.1 23.3 9.7 13.9 10.5 10.2 6.7 23.9 7.0 23.6 20.2 6.6 13.1 32.2 15.5 8.9 23.3 10.7 12.7 11.4 10.9 18.5 8.1 14.5 19.1 10.4 18.4 16.5 7.8 14.7 9.4 13.5 8.2 9.7 9.9 12.3 3.5 12.4 10.3 12.4 6.5 12.7 27.0 12.6 9.5 27.8 13.1 7.3 23.3 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 92.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 21.0 17.2 16.4 12.9 29.0 13.2 19.4 18.4 18.1 16.6 16.6 14.1 20.8 17.1 18.9 17.2 13.6 14.3 13.2 19.9 27.4 13.7 16.0 16.6 12.7 13.8 15.1 12.8 17.9 19.2 28.5 20.8 12.8 15.7 19.2 16.4 13.7 14.9 23.3 92.6 15.3 17.8 19.5 11.5 13.9 15.7 18.3 11.5 8.7 17.7 23.7 14.5 17.8 18.5 5.6 11.6 4.0 8.6 6.6 8.2 3.6 20.7 19.2 12.9 13.8 30.8 30.9 21.2 25.6 22.0 21.1 14.6 17.8 12.9 21.0 12.1 22.4 17.3 30.3 16.4 17.1 19.7 23.1 10.3 12.9 23.2 25.5 22.9 24.1 14.2 28.0 18.0 21.1 31.5 24.0 21.4 5.3 29.7 29.8 17.2 17.6 0.1 14.1 25.2 26.6 16.1 11.8 39.6 12.6 17.9 18.7 24.7 11.8 21.9 23.6 16.0 14.6 18.5 12.9 23.3 14.2 16.3 21.2 23.4 26.4 49.2 25.8 20.8 10.0 13.1 4.0 8.2 2.7 6.9 8.6 8.2 5.6 7.4 8.0 11.6 5.3 4.5 7.6 2.6 6.6 6.2 5.3 5.8 3.6 16.4 29.0 18.4 18.1 27.4 13.7 15.1 12.8 15.7 11.5 53.6 52.8 0.0 0.0 0.0 0.0 0.0 0.0 44.2 60.3 12.2 0.0 13.8 8.3 18.8 0.0 0.0 0.0 0.0 18.6 9.6 0.0 0.0 22.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 19.0 0.0 0.0 20.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 EIF3A "EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 36.7 27.4 19.6 29.4 20.2 41.4 42.4 22.4 22.3 27.8 29.2 21.7 32.3 26.0 33.4 26.0 35.7 22.7 25.0 36.7 19.9 18.6 28.2 41.5 24.6 39.0 24.2 20.1 29.2 61.9 35.8 33.2 33.7 25.5 26.9 26.4 14.4 31.4 31.6 92.3 36.0 29.2 49.3 29.8 29.8 34.1 18.6 22.6 45.8 28.6 33.6 28.7 40.5 38.9 15.0 20.2 21.6 29.7 14.2 27.6 13.9 50.9 38.6 31.8 43.5 34.6 50.2 24.7 46.4 48.3 29.9 30.1 36.3 33.7 59.8 17.3 38.3 23.6 51.3 41.4 35.6 42.7 32.8 34.0 51.4 29.8 40.3 39.6 75.1 38.2 43.4 40.1 44.1 76.0 50.3 33.9 24.4 52.6 39.5 38.6 30.2 31.1 35.5 30.5 19.8 19.7 32.1 68.8 28.5 28.7 43.1 14.9 31.5 36.5 34.4 48.1 28.7 22.0 48.1 49.7 29.1 26.9 30.3 67.1 34.2 37.5 58.9 30.8 74.2 19.9 21.6 21.2 12.6 16.5 23.9 19.1 15.0 19.9 14.9 20.2 13.3 13.9 15.0 5.7 14.2 29.7 11.6 27.6 13.9 19.6 20.2 22.4 22.3 19.9 18.6 24.2 20.1 25.5 22.6 217.4 278.3 92.9 185.7 270.3 56.3 294.1 114.7 196.7 246.9 61.1 58.9 145.7 23.2 129.2 164.6 122.4 96.0 93.5 158.7 131.5 136.7 213.5 137.9 165.4 112.9 41.3 135.5 80.4 187.8 87.8 100.7 140.0 140.0 160.5 137.9 70.1 165.5 84.2 110.7 43.0 50.4 58.2 140.5 137.2 105.1 318.1 211.0 121.1 152.2 227.0 EMG1 ENSG00000126749 "EMG1, N1-specific pseudouridine methyltransferase" Q92979 12 6970893-6979941 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA039304: AB_2676432, HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 8.1 10.1 4.9 12.4 6.6 7.3 8.8 3.6 6.3 5.8 7.5 4.8 11.5 7.5 6.9 9.9 8.1 5.8 7.4 11.6 5.0 7.2 8.3 6.4 8.8 6.4 4.2 8.9 9.4 2.7 5.6 12.6 6.2 7.2 6.8 5.1 8.6 11.4 14.9 5.6 6.7 6.3 5.5 7.7 6.0 4.8 6.1 9.0 8.7 9.5 10.8 7.5 8.7 33.3 20.5 7.7 29.6 20.8 30.1 28.5 17.1 17.1 6.6 8.1 5.2 3.8 27.5 12.8 5.7 10.2 7.0 33.6 18.4 17.3 4.8 7.9 18.6 12.6 6.0 14.6 11.5 12.5 9.8 24.0 16.9 30.9 6.7 24.3 15.6 6.1 8.8 14.8 16.9 5.3 4.4 12.3 11.8 3.9 9.5 20.3 12.6 15.0 54.8 14.2 9.0 17.5 13.4 13.8 6.4 21.8 3.9 11.6 13.5 14.2 12.3 19.7 3.9 18.1 9.2 10.6 13.9 8.7 29.0 4.7 5.3 30.1 11.4 10.6 16.9 4.4 16.6 7.7 24.0 23.8 24.8 30.7 25.5 26.3 18.8 33.3 30.1 27.7 2.3 20.8 29.6 20.5 24.1 28.5 14.9 42.4 35.6 63.8 32.4 13.1 0.0 20.4 42.8 40.9 40.1 7.9 97.4 41.4 64.5 5.3 31.5 18.7 23.3 58.0 98.9 31.9 43.5 60.0 31.0 57.4 15.9 9.2 21.5 24.6 11.1 35.1 40.5 27.0 54.1 22.4 15.6 60.5 17.5 24.4 66.2 13.8 38.8 20.2 28.2 53.8 34.9 62.1 32.8 31.6 55.2 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Group enriched" "Detected in some" 8 "Collecting duct cells: 52.4;Proximal tubular cells: 31.6" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.8 0.0 0.0 1.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 52.4 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 ENKD1 "C16orf48, DKFZP434A1319" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Supported "Plasma membrane,Centrosome,Cytosol" Yes No "Plasma membrane" "Centrosome, Cytosol" "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favorable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 8.5 7.7 4.9 5.9 7.0 3.8 6.6 5.0 6.9 10.4 11.7 6.1 18.6 4.7 11.2 14.2 8.2 14.5 11.0 6.1 5.4 5.2 10.9 4.7 8.9 2.9 4.5 4.4 10.9 38.8 23.7 12.0 4.8 8.3 12.7 3.6 7.9 11.7 12.6 6.0 7.2 5.1 12.9 4.3 6.1 7.3 19.6 6.4 7.1 20.4 5.2 4.9 12.9 6.4 0.6 4.2 3.0 1.3 0.7 1.5 0.5 6.9 4.8 11.4 5.3 3.8 3.9 5.6 5.5 3.4 4.4 5.4 3.5 10.7 2.6 9.4 3.4 0.0 8.2 2.9 6.6 5.5 4.0 6.6 2.6 14.5 8.2 6.1 4.6 3.6 3.4 4.7 6.0 5.5 10.3 3.5 8.7 4.3 1.7 2.2 3.5 5.0 19.3 5.4 7.3 1.9 17.9 1.2 19.3 4.6 0.7 11.5 12.5 11.7 1.1 6.0 2.7 10.3 6.6 9.3 5.4 7.6 10.1 0.1 12.6 5.6 2.8 8.1 6.9 1.6 0.0 1.3 0.0 0.3 0.5 1.5 0.6 1.2 0.7 0.5 0.0 0.8 1.1 3.0 0.7 0.7 4.2 0.0 0.5 4.9 7.0 5.0 6.9 5.4 5.2 4.5 4.4 8.3 6.4 20.8 15.6 0.8 6.2 6.2 3.6 5.0 17.8 36.1 2.3 8.7 3.9 2.8 1.7 11.9 28.8 9.0 2.0 0.0 9.2 2.1 7.0 5.2 1.1 14.7 4.2 3.2 12.7 11.1 3.8 14.5 12.0 2.9 5.0 2.8 5.9 9.5 8.2 0.0 13.4 5.9 10.8 6.5 6.6 20.2 7.3 4.5 2.9 1.9 4.4 2.4 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 638.2;tongue: 320.3" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 511.6;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 100000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.6 0.3 0.2 0.6 0.2 0.7 0.5 0.6 0.2 0.2 0.4 0.0 0.1 0.8 0.4 8.5 8.6 0.4 0.1 38.3 0.2 0.1 0.5 5.0 0.4 0.5 0.2 0.0 0.4 0.3 0.3 0.5 0.2 0.1 2.1 0.1 1.2 11.8 0.1 638.2 0.3 0.7 0.4 0.2 0.8 0.4 0.5 0.0 0.6 4.8 320.3 10.5 0.3 0.3 13.3 21.0 27.1 24.8 18.5 23.3 36.0 2.9 6.3 2.9 2.7 2.5 0.7 6.9 5.1 0.7 0.3 0.3 3.0 2.0 5.4 7.0 0.4 0.9 3.7 1.0 0.4 0.3 71.7 5.8 5.2 30.7 4.5 0.9 1.6 30.3 4.2 1.0 0.5 1.0 2.6 0.3 6.2 2.4 9.9 1.5 1.6 1.9 6.3 3.7 0.8 2.6 8.5 49.3 25.8 0.7 1.9 1.8 6.9 3.3 2.8 3.7 2.0 2.6 1.7 1.6 3.0 5.7 1.3 3.8 7.0 3.9 4.4 1.7 5.1 3.0 13.5 15.6 27.1 21.8 22.5 14.7 13.3 18.7 20.3 21.0 11.1 12.3 19.7 19.7 18.5 24.8 16.6 23.3 36.0 0.2 0.2 0.6 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.0 2.6 2.9 1.0 1.8 3.2 511.6 0.0 0.0 2.3 5.2 3.9 4.3 0.0 1.4 1.3 2.2 4.3 0.0 0.7 3.1 3.6 1.0 8.1 38.1 4.4 3.2 0.0 3.1 3.8 2.7 0.3 4.5 1.7 134.3 2.3 1.5 1.3 1.7 0.4 5.4 2.4 6.5 0.9 8.6 3.9 1.6 2.7 4.3 2.1 0.6 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 11 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.4 1.8 18.6 8.8 1.5 0.2 6.2 1.9 2.8 2.3 2.9 4.9 9.0 13.8 5.0 2.5 3.8 3.4 23.2 1.8 2.5 24.8 7.1 39.5 5.6 8.0 2.9 13.4 26.4 0.5 5.4 2.2 4.0 5.7 4.1 22.1 37.2 11.0 0.0 2.5 21.7 8.8 19.5 12.3 2.9 33.4 8.2 19.8 2.2 9.5 25.1 18.6 5.8 5.5 12.6 6.6 4.2 5.2 0.4 0.1 3.9 3.6 3.8 16.5 21.4 24.7 3.5 13.8 2.1 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 17.9 64.9 30.6 6.3 9.3 105.3 20.1 30.6 22.7 21.6 15.7 129.6 2.3 14.9 15.8 13.9 14.5 25.2 116.8 16.1 3.2 3.3 11.2 23.1 28.8 6.5 20.6 40.0 20.3 22.1 13.3 2.0 11.5 0.0 11.8 25.9 13.2 25.6 22.4 2.1 10.5 166.4 12.9 4.7 8.6 53.0 14.6 3.4 42.8 28.3 11.5 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "Q03468, P0DP91, Q8N328" 10 49455368-49539538 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 25.1;hTERT-RPE1: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 7.9 6.9 11.5 6.0 12.3 13.9 11.1 21.0 13.9 9.8 7.0 8.9 10.6 6.4 9.3 8.6 13.5 8.1 7.7 9.1 12.7 6.5 10.1 10.0 8.0 7.9 9.2 11.4 12.5 13.1 20.3 14.2 9.7 10.1 10.5 8.8 9.2 10.5 13.7 9.6 14.4 9.1 7.9 11.8 9.2 7.6 7.8 12.4 7.8 13.6 8.2 9.6 9.9 11.6 7.9 5.1 10.9 8.1 1.6 5.3 2.1 4.8 2.5 1.9 1.2 3.3 5.5 1.5 8.7 12.1 6.0 4.2 2.6 3.0 2.1 1.6 7.8 2.9 4.6 2.7 6.9 6.1 3.4 1.7 1.6 9.6 1.4 1.9 2.2 1.7 1.9 9.4 5.8 25.1 57.2 8.7 1.5 3.2 0.6 7.7 3.5 1.5 1.3 1.7 1.9 4.5 1.4 2.8 1.2 2.0 3.5 2.5 2.7 6.4 2.3 3.9 4.4 4.2 1.2 16.7 3.3 2.7 4.0 2.2 2.3 2.2 2.0 4.1 2.4 2.4 10.9 4.1 9.7 5.3 3.7 4.2 7.9 3.1 2.9 5.1 6.3 3.8 1.8 9.8 1.6 8.1 2.8 4.0 2.1 11.5 12.3 21.0 13.9 12.7 6.5 9.2 11.4 10.1 12.4 14.9 10.4 2.4 1.3 3.2 0.0 4.9 7.6 13.4 12.5 8.7 0.0 1.9 5.0 4.6 8.2 2.0 3.8 0.0 5.3 1.5 3.5 2.3 7.0 4.0 2.3 0.0 1.2 3.7 3.8 10.6 2.6 3.9 1.7 14.4 4.5 0.0 4.8 3.5 2.1 2.8 0.0 6.5 1.9 5.4 4.2 3.6 1.5 5.0 2.4 1.6 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 823.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: AB_2673239" "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 12.6 15.4 30.7 8.3 32.0 12.4 15.2 19.7 43.7 15.1 13.4 23.2 10.8 12.3 14.7 22.2 13.4 23.4 12.7 21.1 28.9 25.1 25.3 15.5 11.7 10.0 23.9 26.8 18.6 15.7 24.0 17.2 13.5 22.9 16.7 14.1 14.8 14.7 16.9 35.7 13.3 8.6 17.7 17.9 9.5 10.6 24.4 21.9 9.7 17.6 11.9 11.0 12.5 12.1 18.8 25.3 9.6 22.2 14.8 18.2 15.2 28.6 22.2 28.2 31.2 18.5 23.3 17.7 18.8 25.0 33.4 31.2 14.3 30.7 20.5 31.8 23.1 17.1 16.6 25.2 32.0 23.6 22.9 48.6 22.9 37.5 20.2 27.1 23.1 13.2 23.7 30.1 25.3 34.8 24.8 22.9 22.9 22.3 16.7 21.9 19.3 25.6 21.6 33.4 25.5 35.2 24.7 25.9 30.0 25.9 15.1 48.1 22.7 20.5 28.1 33.2 23.3 18.4 19.1 13.9 22.1 23.1 24.0 28.4 15.9 18.5 22.0 27.4 20.1 27.8 9.4 16.3 9.6 16.7 22.2 18.2 18.8 14.0 16.2 25.3 18.3 16.7 17.2 1.5 14.8 21.3 18.9 18.1 15.2 30.7 32.0 19.7 43.7 28.9 25.1 23.9 26.8 22.9 21.9 23.8 16.8 23.4 29.6 28.0 20.9 13.7 10.2 10.7 9.1 27.9 2.0 80.0 82.9 48.6 192.5 20.2 20.0 0.0 54.5 67.1 42.9 35.8 15.0 21.3 39.5 23.8 113.7 19.6 24.3 823.2 33.6 22.4 45.5 35.1 48.9 30.3 33.0 25.9 34.3 131.8 13.5 6.5 31.1 46.2 48.7 30.2 51.5 15.4 35.1 23.5 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305572-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 8.2 9.6 6.0 8.9 7.7 7.9 17.8 9.8 9.4 4.3 32.4 4.9 18.3 43.1 4.6 6.2 17.1 4.1 15.7 45.2 6.8 5.0 21.4 26.9 8.7 9.2 10.4 5.2 2.5 20.5 10.1 4.6 11.0 8.0 7.5 12.6 6.0 28.7 14.9 78.3 10.5 46.4 7.1 7.4 9.3 14.1 2.2 6.0 6.0 8.2 27.1 10.0 8.5 12.0 4.1 4.2 8.5 8.4 2.6 5.4 2.4 9.8 15.8 3.9 9.5 5.3 5.2 21.5 9.7 4.7 3.6 3.6 14.5 12.0 13.5 18.2 5.1 9.6 25.4 6.6 13.1 1.4 9.1 8.5 8.7 18.7 11.4 7.4 14.8 22.0 7.2 20.0 8.2 10.8 5.1 5.1 7.2 14.7 7.5 6.0 22.2 7.2 21.0 10.9 11.9 30.1 7.7 7.7 30.3 12.1 20.8 8.3 10.2 4.9 33.0 31.2 2.3 10.2 14.7 11.0 6.7 8.0 18.7 9.8 11.6 9.5 8.9 10.9 14.5 5.2 0.3 4.7 7.1 4.4 8.4 4.4 2.9 3.8 3.1 4.2 4.1 4.1 5.4 8.5 2.6 7.5 3.2 5.1 2.4 6.0 7.7 9.8 9.4 6.8 5.0 10.4 5.2 8.0 6.0 8.9 27.2 29.9 28.0 16.6 29.0 7.9 132.5 5.3 12.5 19.2 31.4 79.6 46.4 50.0 2.6 9.0 143.7 46.7 68.6 49.1 11.9 19.0 7.0 154.8 29.6 31.8 36.4 44.2 93.5 0.2 6.1 20.2 16.9 19.8 71.8 17.3 67.0 94.7 11.3 48.1 19.0 12.9 10.3 2.8 8.0 16.2 112.2 15.3 83.1 49.8 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Yes NA Nucleoplasm "HPA044546: AB_10962867, HPA072938: AB_2686560" "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favorable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.1 11.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.6 1.0 1.3 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ETV4 "E1A-F, E1AF, PEA3" ENSG00000175832 "ETS variant 4" P43268 17 43527844-43579620 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 10.2;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.2;Intestinal endocrine cells: 14.3;Syncytiotrophoblasts: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 45.2;Hep G2: 42.4;SK-MEL-30: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005768 Approved Supported "Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA005768: AB_1848294" "unprognostic (2.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.14e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.58e-2)" "unprognostic (5.34e-2)" "unprognostic (8.13e-2)" "unprognostic (7.05e-2)" "unprognostic (3.01e-1)" "unprognostic (7.79e-2)" "unprognostic (2.03e-1)" "unprognostic (7.08e-2)" "prognostic favorable (7.60e-4)" "unprognostic (1.69e-1)" 0.6 2.4 1.4 0.9 1.4 0.0 6.8 1.6 8.3 3.6 3.3 0.4 1.3 5.7 3.4 2.2 9.9 2.4 38.4 2.6 1.8 1.3 7.8 1.4 2.5 0.4 2.3 1.1 1.2 23.8 19.3 19.7 11.6 2.7 4.7 1.6 1.7 4.9 4.5 1.3 6.7 3.8 1.2 1.8 0.5 3.6 1.3 0.5 0.3 6.6 15.0 12.1 3.1 5.3 0.2 0.0 1.3 0.2 0.0 0.6 0.1 5.9 16.8 20.6 45.2 0.8 5.3 4.6 1.9 5.3 3.8 3.9 9.4 8.6 0.0 1.1 1.0 9.4 10.9 0.7 10.1 3.4 0.2 0.1 0.5 2.7 42.4 1.1 11.4 5.4 0.9 0.3 14.6 9.1 4.3 8.1 0.0 11.8 0.0 7.8 2.4 0.0 20.3 29.8 30.4 28.2 24.5 2.5 14.4 8.5 4.3 0.0 18.4 0.5 1.1 48.9 11.8 0.2 3.4 3.7 2.7 13.5 4.0 5.4 1.8 11.3 0.0 4.9 2.2 15.9 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.0 0.0 0.1 1.4 1.4 1.6 3.6 1.8 1.3 2.3 1.1 2.7 0.5 0.0 0.0 0.0 2.1 1.6 1.1 0.6 10.2 1.4 3.4 0.0 0.0 2.2 14.9 6.8 2.8 0.6 0.9 0.0 0.9 11.2 1.7 0.4 0.0 0.0 0.7 0.0 14.3 0.6 0.0 3.9 0.3 0.0 3.3 0.0 0.8 7.7 2.7 2.3 0.4 0.0 0.3 0.0 0.8 0.0 0.0 1.0 12.5 0.0 2.5 3.1 EYA3 DKFZp686C132 ENSG00000158161 "EYA transcriptional coactivator and phosphatase 3" Q99504 1 27970344-28088696 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052432, HPA062889" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "HPA052432: AB_2681831, HPA062889: AB_2684895" "unprognostic (3.57e-1)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.11e-4)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (9.13e-2)" "unprognostic (8.98e-2)" "prognostic favorable (3.15e-6)" "unprognostic (5.17e-2)" "unprognostic (2.79e-1)" "unprognostic (7.60e-2)" "unprognostic (6.11e-2)" 12.8 10.0 14.9 24.0 12.9 8.6 13.3 21.9 13.8 14.7 10.2 14.4 12.8 10.7 14.4 12.4 19.4 11.8 8.1 11.7 10.6 11.8 21.6 11.3 12.5 15.6 11.1 8.8 12.4 12.9 20.9 29.2 13.8 12.9 11.8 11.7 16.4 11.8 13.1 14.5 16.3 12.2 10.5 10.1 14.2 10.0 20.6 13.7 17.4 17.3 12.2 25.0 10.7 13.8 8.6 12.4 10.5 11.2 10.4 12.1 2.6 10.5 4.4 9.0 6.7 10.6 8.2 5.1 7.7 7.4 9.1 9.0 4.3 6.5 16.7 8.6 5.2 3.4 10.4 16.6 6.4 10.8 8.8 9.3 19.0 9.0 7.7 6.3 18.3 17.5 5.0 5.8 10.0 6.8 7.9 11.6 6.2 17.4 6.5 8.1 4.6 11.7 12.3 18.9 8.4 5.9 8.9 16.6 10.6 10.7 5.9 10.4 5.7 8.3 5.2 7.4 7.6 4.3 4.9 11.1 11.0 5.9 10.1 6.3 9.7 9.7 15.5 7.9 17.9 4.8 7.5 11.2 10.5 12.1 10.4 10.8 8.6 9.5 8.7 12.4 7.6 8.3 9.4 9.7 10.4 8.3 7.7 8.2 2.6 14.9 12.9 21.9 13.8 10.6 11.8 11.1 8.8 12.9 13.7 8.9 9.6 18.4 9.6 15.9 17.4 7.5 2.5 1.4 5.7 24.4 15.7 11.8 13.3 9.9 72.6 10.8 8.6 0.0 7.9 11.4 10.4 8.5 11.5 6.8 8.8 17.5 19.7 15.4 12.3 29.7 9.5 14.3 11.8 10.0 9.2 9.1 11.2 10.2 5.6 11.6 18.9 12.9 8.5 40.6 26.0 19.9 9.2 25.4 8.9 9.9 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202635188-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 5.8 12.5 10.1 11.1 10.3 4.3 10.0 20.8 18.1 5.5 7.9 3.2 7.1 7.0 5.0 7.5 9.6 6.6 6.2 4.3 8.6 10.8 8.3 3.6 6.2 13.0 5.9 9.1 8.8 11.6 24.7 7.5 11.0 4.7 8.6 7.9 3.7 8.6 9.3 5.8 9.0 6.0 7.3 5.7 8.2 6.6 12.6 5.8 22.4 5.5 4.8 11.7 7.2 12.7 9.0 4.8 2.3 8.9 4.5 9.9 3.3 1.6 2.0 8.9 6.1 3.0 1.7 8.6 0.5 0.8 0.5 1.0 2.5 3.5 6.7 5.5 1.0 1.3 1.6 7.5 3.8 1.5 0.1 6.1 5.6 3.8 9.4 2.4 4.7 2.5 2.3 5.3 1.1 1.7 4.0 2.4 8.9 8.0 1.4 0.5 3.2 12.7 9.9 9.0 4.7 3.8 10.1 1.8 7.8 4.7 4.3 15.1 13.1 6.6 4.4 3.2 7.8 1.9 6.6 1.4 1.1 2.1 1.5 0.9 4.9 2.8 8.9 2.0 3.7 1.1 0.3 4.5 1.6 1.6 8.9 4.0 9.0 3.6 3.1 4.8 8.5 9.9 6.8 2.3 4.5 8.8 1.7 1.3 3.3 10.1 10.3 20.8 18.1 8.6 10.8 5.9 9.1 4.7 5.8 3.0 6.9 14.1 1.9 15.2 4.7 3.9 10.2 2.7 2.3 17.4 3.9 6.1 0.0 6.7 1.7 3.3 5.2 0.0 5.5 4.9 8.4 7.0 5.7 1.7 2.5 6.4 24.8 5.5 22.9 0.9 12.0 9.9 3.3 1.0 12.9 1.9 5.7 7.0 22.3 4.9 2.7 6.5 3.1 4.4 16.3 17.3 2.3 6.4 11.9 5.4 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 8.1 14.9 18.8 4.6 26.4 2.5 5.0 21.9 54.7 5.4 6.4 8.0 4.8 6.3 7.5 4.9 7.5 7.7 8.4 11.9 28.1 13.0 4.1 3.0 6.0 3.4 9.1 25.9 8.8 11.3 9.2 16.4 5.0 7.8 6.7 3.5 3.3 7.1 11.7 9.3 10.5 5.8 8.7 5.9 5.3 5.5 7.0 7.0 0.8 3.5 3.9 2.7 5.5 4.1 2.1 5.5 11.1 6.5 1.6 2.2 2.5 8.2 3.4 5.5 9.7 7.5 6.2 5.2 3.7 8.4 5.9 4.6 2.6 2.9 1.2 15.5 3.6 12.6 7.8 0.0 6.7 3.8 8.8 9.3 0.0 5.2 5.6 7.6 0.1 6.5 4.6 1.1 5.0 11.6 5.5 11.8 5.7 1.8 1.3 2.2 6.4 3.2 0.2 9.4 5.1 6.9 5.8 2.2 7.9 5.9 0.2 16.9 17.6 2.3 6.5 8.6 3.7 19.1 2.1 11.9 7.2 5.6 5.8 11.6 14.0 8.4 0.8 23.2 1.2 5.1 2.0 4.8 6.0 1.5 6.5 1.6 2.0 1.2 1.6 5.5 2.1 1.2 1.5 11.1 1.6 3.4 2.3 2.2 2.5 18.8 26.4 21.9 54.7 28.1 13.0 9.1 25.9 7.8 7.0 6.0 5.3 6.7 16.9 9.8 21.2 5.1 10.2 16.0 1.2 14.0 13.7 8.2 1.7 5.6 3.9 8.8 13.1 23.3 2.9 2.7 5.4 12.7 6.9 1.5 6.8 22.3 9.2 15.4 5.4 0.7 17.3 8.3 1.7 9.0 6.4 14.1 7.4 8.6 19.4 3.0 16.3 6.5 10.3 11.6 6.8 12.8 27.8 4.4 8.1 13.1 FAM206A "C9orf6, CG-8, FLJ20457, Simiate" ENSG00000119328 "Family with sequence similarity 206 member A" Q9NX38 9 108934181-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Cytosol" "Cytokinetic bridge" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 12.0 11.4 16.8 9.0 28.8 12.9 17.8 12.3 19.2 11.6 13.3 12.8 10.3 13.8 12.6 22.9 16.0 18.9 9.9 13.3 16.2 16.0 14.1 12.6 12.0 9.9 16.7 20.0 13.7 13.7 23.3 28.5 10.6 16.0 11.9 15.1 7.6 16.9 13.5 12.2 22.9 15.1 14.4 16.6 7.5 13.0 16.7 14.8 8.4 20.9 10.2 10.6 10.5 11.7 10.6 23.6 24.4 20.7 12.4 16.1 11.9 8.7 9.4 10.3 11.3 18.3 25.5 13.8 8.9 9.6 8.3 6.9 13.9 4.8 8.5 4.9 7.9 11.4 21.2 8.2 8.7 8.3 5.2 8.6 5.2 12.8 13.1 15.3 18.6 7.3 13.4 16.4 10.1 23.3 10.7 11.3 12.6 18.2 8.9 9.8 24.5 13.3 7.5 11.6 26.4 13.8 6.6 16.7 8.9 10.8 9.7 13.2 7.2 12.8 11.2 14.0 10.2 15.2 10.1 7.4 4.6 8.5 20.6 10.5 7.2 18.7 6.3 14.9 7.4 6.8 19.9 20.6 19.0 9.9 20.6 15.2 10.6 15.8 13.1 22.6 6.9 16.1 12.1 24.4 12.4 20.7 23.6 13.0 11.9 16.8 28.8 12.3 19.2 16.2 16.0 16.7 20.0 16.0 14.8 3.0 11.8 0.0 6.0 13.5 3.6 17.7 15.3 56.2 18.2 0.0 9.8 4.9 8.3 4.9 5.5 7.1 6.5 0.0 7.9 8.4 9.1 3.9 2.3 2.9 6.9 6.4 4.1 3.7 2.7 5.5 15.8 5.9 10.1 1.8 7.2 6.0 6.4 8.4 17.3 6.5 6.9 19.4 8.5 29.5 8.8 12.2 6.1 2.2 6.3 4.8 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.6 16.0 4.0 13.5 12.2 6.2 11.4 8.5 5.9 5.9 7.0 7.3 10.1 10.8 43.4 14.2 11.5 12.1 6.3 7.5 1.4 8.8 8.6 4.2 14.0 5.1 19.1 2.8 6.8 7.7 6.8 12.1 8.5 7.0 4.1 7.0 8.0 8.0 6.7 17.4 5.2 12.3 1.7 18.1 20.1 6.5 4.0 29.7 6.4 6.9 8.0 6.1 3.9 9.5 14.0 3.1 7.2 4.4 4.5 7.9 4.8 21.4 11.5 30.8 16.8 13.2 14.6 7.4 8.1 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 11.9 14.7 8.0 19.3 14.4 23.0 20.5 25.5 8.1 6.8 21.0 13.7 39.7 23.2 22.8 0.6 17.7 66.7 23.3 37.0 40.6 24.2 23.6 5.7 27.2 26.3 20.6 16.8 20.3 14.9 1.6 31.1 13.9 32.1 19.0 45.1 25.5 24.3 49.1 27.6 26.2 15.2 6.5 16.0 3.7 8.6 18.4 59.6 19.3 33.2 20.3 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;MCF7: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.3 0.0 0.0 2.6 2.4 0.2 3.8 1.8 2.6 3.3 0.0 5.9 3.4 4.1 2.7 1.0 2.4 0.0 1.5 1.9 42.6 2.3 0.0 10.2 0.0 2.7 0.0 0.0 2.7 3.0 2.0 0.6 0.8 2.6 0.0 0.0 0.0 2.3 13.4 0.0 4.7 0.9 2.0 2.0 0.0 0.0 0.0 1.2 0.0 6.0 5.3 6.2 3.9 0.2 0.0 4.2 3.8 3.5 0.0 0.4 5.1 0.0 0.0 9.2 0.0 1.4 0.3 7.1 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 14.9 6.5 6.5 5.9 5.7 17.4 15.7 5.1 4.0 7.9 12.2 3.9 3.3 28.2 10.7 24.9 4.1 2.2 0.0 9.9 4.8 5.8 2.7 3.5 18.8 8.7 14.3 1.2 8.6 4.1 25.0 7.8 4.0 11.8 10.0 3.3 19.1 7.9 3.6 10.3 32.6 12.6 0.0 7.9 34.4 39.6 5.8 0.8 4.5 3.3 1.6 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.5 19.5 15.4 12.9 1.7 2.0 27.7 14.2 8.9 28.2 17.3 29.8 14.5 8.0 14.1 9.3 21.9 27.2 21.1 24.4 26.5 2.6 8.3 9.3 15.0 21.4 1.4 4.1 4.9 1.0 1.2 16.2 9.4 3.4 15.4 3.6 8.2 11.6 16.0 17.0 6.3 6.0 12.8 18.4 24.9 6.1 28.5 4.4 8.1 8.1 7.1 11.9 41.5 34.7 6.1 15.0 21.7 4.2 7.3 18.7 23.0 21.2 31.3 3.5 5.4 8.3 8.4 6.1 13.7 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 0.0 2.2 0.0 5.2 2.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 2.6 0.0 0.0 0.4 0.5 2.6 23.3 0.0 36.2 0.9 0.7 0.0 5.4 4.0 0.0 1.7 1.8 2.1 0.6 0.3 0.4 0.0 0.0 2.2 0.0 0.1 3.7 0.0 4.3 0.0 19.4 2.1 11.1 14.5 1.6 127.6 2.2 2.5 4.3 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 2.0 5.4 2.2 5.4 0.9 7.1 3.2 7.9 1.5 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 1.0 3.4 6.0 3.7 6.0 1.5 14.1 5.2 1.9 2.6 8.6 8.0 6.3 2.2 12.5 5.3 2.6 3.0 2.9 4.7 7.2 7.0 1.1 11.9 3.3 2.9 2.0 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 6.0 1.3 10.8 5.1 5.0 9.1 1.2 5.1 1.4 5.7 0.0 13.7 7.4 5.0 3.8 1.7 3.8 31.6 0.0 5.3 8.6 4.5 5.9 1.1 5.9 6.2 1.6 2.4 6.7 4.1 1.0 4.9 7.3 5.0 1.0 13.3 7.3 6.4 9.5 1.8 6.3 8.1 0.0 4.2 2.3 8.0 5.8 3.2 5.9 13.5 5.1 FBXO38 "Fbx38, FLJ13962, MOKA, SP329" ENSG00000145868 "F-box protein 38" Q6PIJ6 5 148383935-148442836 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034821, HPA041444" Approved Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA034821: AB_10669897, HPA041444: AB_2677484" "unprognostic (7.72e-2)" "unprognostic (5.75e-3)" "unprognostic (1.95e-2)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-2)" "unprognostic (7.06e-2)" "unprognostic (5.43e-3)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (2.03e-1)" "unprognostic (6.29e-2)" "unprognostic (2.21e-3)" "unprognostic (1.31e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (4.70e-3)" 23.2 19.3 13.8 17.7 21.2 12.6 20.6 20.8 21.1 22.3 18.4 20.0 20.4 13.8 25.2 18.2 17.6 16.7 16.9 24.1 18.8 13.8 19.2 25.7 20.7 19.0 16.3 18.8 19.2 16.9 29.2 34.1 19.7 24.6 22.2 19.3 16.4 19.4 18.7 28.5 19.3 18.4 18.2 17.8 24.8 18.8 20.0 18.9 26.9 18.1 17.1 21.7 21.7 18.0 5.5 8.1 13.7 14.8 8.0 7.9 4.9 8.6 9.2 14.3 10.4 16.1 18.2 7.5 11.3 21.6 16.1 22.1 13.5 10.6 12.5 11.1 18.2 17.0 12.1 14.9 14.2 19.4 13.7 9.6 7.4 13.5 9.1 16.1 20.0 12.2 17.5 12.2 15.4 15.2 17.2 21.6 11.7 8.2 13.6 15.7 3.5 12.6 9.5 6.7 9.6 14.0 11.3 20.9 12.5 15.6 10.1 12.8 12.5 15.0 10.1 14.5 12.8 10.6 14.6 14.0 14.7 5.3 7.7 12.5 16.7 16.8 10.7 14.6 11.5 11.1 13.7 6.3 9.0 5.9 8.6 6.3 5.5 5.5 5.7 8.1 4.8 5.7 7.2 12.0 8.0 14.8 3.9 7.9 4.9 13.8 21.2 20.8 21.1 18.8 13.8 16.3 18.8 24.6 18.9 14.9 40.8 7.0 5.2 3.0 9.8 16.2 7.6 16.0 10.3 10.4 9.8 6.2 5.0 7.4 7.9 6.7 8.0 0.0 5.8 5.5 6.0 8.8 15.1 17.3 11.1 12.7 9.2 13.5 25.7 2.1 8.3 15.0 3.3 4.6 9.8 5.6 8.7 8.6 17.3 7.5 9.2 0.0 4.7 22.1 7.5 3.3 10.3 6.9 9.1 7.1 FCHSD2 "KIAA0769, SH3MD3" ENSG00000137478 "FCH and double SH3 domains 2" O94868 11 72836745-73142261 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Ito cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038545, HPA038546" Uncertain Supported "Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites" Yes No "Plasma membrane" "Nuclear speckles, Actin filaments, Focal adhesion sites" "HPA038545: AB_2676074, HPA038546: AB_10673013" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.62e-3)" "unprognostic (1.41e-2)" "unprognostic (2.62e-1)" "unprognostic (1.27e-2)" "unprognostic (2.56e-1)" "unprognostic (3.69e-2)" "unprognostic (6.16e-2)" "unprognostic (2.89e-3)" "unprognostic (2.02e-1)" "unprognostic (4.70e-1)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" 18.5 15.1 28.4 41.5 27.8 19.0 26.5 16.9 25.2 13.2 11.4 17.0 6.8 7.0 12.7 10.2 9.7 11.5 18.1 19.2 24.8 21.4 10.6 13.3 26.2 31.7 19.7 12.1 26.3 9.2 10.2 7.6 24.1 17.6 11.2 11.2 12.5 11.1 11.7 7.4 7.0 14.4 16.4 15.6 30.8 10.1 17.4 26.3 19.2 11.9 4.8 33.0 17.9 11.3 16.8 19.0 11.6 4.8 1.1 2.4 2.0 5.2 4.5 9.3 12.2 3.8 9.5 8.7 9.3 19.9 5.7 4.8 3.5 7.7 28.5 11.5 11.9 5.5 7.5 5.4 5.4 7.6 9.8 2.8 22.9 5.1 11.5 9.8 11.2 2.9 5.7 6.0 5.6 6.8 12.5 13.6 9.9 5.0 18.5 7.3 5.6 13.5 19.3 2.0 5.6 5.5 20.7 14.5 54.2 9.0 7.0 4.7 6.6 3.4 6.4 12.1 4.4 4.6 8.2 17.6 18.3 7.1 12.7 2.9 17.8 9.9 25.3 3.1 18.7 5.3 11.0 4.8 10.5 1.7 3.1 1.2 13.0 1.8 2.0 4.8 16.8 2.1 2.4 11.6 1.1 1.6 19.0 1.8 2.0 28.4 27.8 16.9 20.2 24.8 21.4 19.7 12.1 17.6 26.3 8.9 12.3 31.6 4.7 7.6 11.3 15.3 10.2 2.7 5.7 3.5 23.6 9.4 1.7 4.1 5.8 26.5 1.1 23.3 5.3 7.7 6.1 3.0 2.3 10.0 15.9 9.5 4.6 45.4 25.4 8.2 10.0 19.2 5.0 15.4 6.2 8.3 4.0 5.1 15.6 3.3 16.1 6.5 21.5 7.5 10.9 5.1 10.1 7.5 4.2 3.8 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FK506 binding protein like" Q9UIM3 6 32128707-32130291 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA043478: AB_2678500, HPA060158: AB_2684213" "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.6 5.6 4.1 2.7 4.7 4.6 7.1 12.1 6.2 4.4 4.5 3.9 8.9 6.0 4.1 8.7 12.7 7.0 4.5 6.0 4.1 3.5 5.9 6.7 4.5 7.7 7.1 2.4 7.0 13.2 6.2 5.0 6.9 5.8 3.8 4.9 3.7 8.0 3.6 5.1 11.5 4.4 5.1 3.6 7.8 6.6 7.6 6.8 10.5 11.6 2.8 6.8 4.7 6.3 3.4 3.7 8.3 4.8 3.3 4.6 1.5 0.0 2.0 4.4 11.9 6.6 4.7 3.8 2.9 3.3 5.5 5.3 9.5 4.0 3.3 3.4 5.1 7.4 2.2 6.2 5.7 3.8 5.9 7.6 0.0 6.6 5.3 3.7 0.0 3.6 4.6 5.8 10.7 6.7 4.1 5.8 8.7 11.1 8.3 5.6 3.2 3.6 4.1 3.3 8.6 1.7 3.0 5.8 7.3 5.7 0.7 8.5 2.0 2.9 5.3 6.4 2.3 9.2 6.4 2.5 8.0 6.6 4.1 7.0 4.4 7.7 3.0 3.1 5.4 4.9 4.9 3.4 2.3 4.6 4.8 4.4 2.8 2.6 3.3 3.7 3.4 3.0 2.9 8.3 3.3 2.5 2.9 1.1 1.5 4.1 4.7 12.1 6.2 4.1 3.5 7.1 2.4 5.8 6.8 6.0 5.1 4.7 3.2 10.0 2.9 2.0 5.1 0.0 4.5 1.8 0.0 8.3 5.0 6.7 2.2 4.5 8.1 0.0 5.9 10.6 7.4 3.3 2.3 2.8 4.5 9.5 5.8 3.7 3.2 4.0 2.6 4.4 6.8 4.6 4.9 6.4 5.4 3.7 3.2 7.7 4.0 0.0 6.2 8.9 8.3 8.9 11.8 6.5 5.0 4.1 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.2" "Group enriched" "Detected in many" 6 "B-cells: 32.3;Endothelial cells: 76.4;granulocytes: 22.0;Hofbauer cells: 36.1;Ito cells: 49.7;Kupffer cells: 85.1;Macrophages: 24.6;T-cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 41.0;HUVEC TERT2: 22.8;REH: 19.2;TIME: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 14.7 2.5 3.5 15.8 4.4 10.6 9.9 1.4 3.2 6.7 5.1 3.8 2.1 3.3 7.8 6.5 4.8 5.3 6.0 7.5 3.8 3.1 4.2 3.6 17.4 24.4 6.2 1.6 4.0 3.2 2.5 2.0 11.4 3.8 4.3 3.1 4.8 4.2 3.3 5.2 3.2 6.9 5.7 6.6 40.2 4.1 2.7 4.6 26.8 5.7 2.8 17.9 6.2 6.7 4.5 13.1 20.1 12.0 7.8 8.8 11.6 0.0 0.0 2.1 0.0 0.2 0.4 0.0 1.2 3.4 1.4 1.2 0.0 0.0 7.0 12.5 4.1 0.4 0.0 0.3 5.1 1.6 3.2 0.1 41.0 0.2 0.0 2.4 4.9 5.8 0.3 0.4 3.0 6.9 4.3 22.8 9.8 0.0 9.0 0.3 0.0 4.9 2.8 0.6 0.0 1.2 19.2 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 7.9 23.6 0.2 0.0 0.1 1.3 2.9 6.0 6.0 0.0 11.9 1.9 20.1 9.5 16.1 7.2 10.3 8.8 4.5 6.2 5.8 13.1 3.6 2.6 5.6 7.8 7.8 12.0 2.2 7.4 11.6 3.5 4.4 1.4 3.2 3.8 3.1 6.2 1.6 3.8 4.6 6.0 7.7 32.3 0.2 4.5 0.0 5.0 5.1 1.4 0.0 1.8 0.0 0.3 0.0 0.0 0.5 76.4 0.0 0.0 0.0 0.2 5.6 0.3 22.0 1.0 36.1 0.0 0.0 49.7 85.1 0.0 1.7 24.6 6.8 6.4 0.0 0.1 0.0 0.0 0.7 0.3 0.0 6.5 2.8 0.3 0.1 3.6 0.2 47.8 0.0 0.4 FOS "AP-1, c-fos" ENSG00000170345 "Fos proto-oncogene, AP-1 transcription factor subunit" P01100 14 75278774-75282230 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 84.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 84.5" "Cell line enhanced" "Detected in many" "hTCEpi: 98.8;OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018531 Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA018531: AB_1846576" "unprognostic (1.18e-2)" "unprognostic (8.70e-2)" "unprognostic (1.61e-1)" "unprognostic (3.80e-1)" "unprognostic (3.08e-2)" "unprognostic (4.82e-2)" "unprognostic (2.09e-1)" "unprognostic (3.30e-1)" "unprognostic (9.55e-3)" "unprognostic (4.20e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.81e-4)" "unprognostic (3.20e-2)" "unprognostic (1.52e-2)" "unprognostic (3.22e-1)" "unprognostic (1.43e-1)" "unprognostic (2.66e-2)" 104.8 58.4 17.0 143.7 30.0 157.6 40.7 24.0 21.3 132.3 48.7 52.3 22.1 17.4 79.7 50.5 93.6 239.5 271.8 56.8 17.5 21.4 22.7 47.9 70.7 31.0 23.9 10.6 94.5 32.7 40.9 52.9 130.2 44.6 60.6 49.3 64.4 42.8 255.8 37.5 156.2 44.1 98.1 43.7 18.5 60.7 33.2 26.8 10.1 77.5 226.7 28.1 60.8 54.0 0.0 11.6 84.5 12.3 0.7 0.1 3.3 0.4 0.3 1.5 2.2 13.2 4.0 9.1 1.3 0.5 0.9 0.7 0.9 2.6 0.1 0.4 9.2 9.2 0.6 0.7 15.9 0.2 0.2 0.2 0.2 3.8 0.3 6.1 0.5 9.3 9.9 98.8 0.8 6.0 1.3 0.5 1.9 0.4 4.2 0.2 5.4 0.1 2.6 1.6 35.5 0.5 0.4 0.3 4.8 4.1 4.3 11.4 0.7 2.0 18.3 7.8 4.9 0.3 1.9 1.3 0.1 1.2 0.8 0.4 11.4 11.9 2.0 0.6 1.6 1.2 6.0 12.3 14.6 0.0 3.5 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 84.5 0.7 0.4 0.2 0.0 3.3 17.0 30.0 24.0 21.3 17.5 21.4 23.9 10.6 44.6 26.8 1024.3 2295.6 355.2 364.1 763.7 85.4 943.0 545.2 294.5 662.0 181.5 121.7 1104.1 14.9 389.9 11.8 1089.3 1251.6 70.0 471.9 2288.8 1942.6 1138.8 1518.7 136.0 1546.5 33.4 1566.3 439.5 1852.6 21.7 873.9 1719.6 811.4 159.7 1650.2 515.9 381.7 1444.9 167.6 15.8 410.8 1190.0 1600.6 4.1 8.0 954.8 1909.4 705.6 1252.5 275.6 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312440-1314748 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 65.5;vagina: 39.9" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.6 0.5 2.3 0.6 4.0 0.5 1.4 1.6 5.9 7.1 1.9 3.2 0.0 6.9 1.1 0.7 7.2 3.2 31.8 0.5 2.2 1.9 7.1 3.6 5.8 0.5 2.7 1.5 0.5 10.1 0.5 1.8 1.2 3.8 18.2 0.8 7.5 35.8 1.3 0.6 16.8 0.8 6.6 1.9 0.5 65.5 0.6 0.8 0.8 3.1 7.8 11.7 26.3 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 14.0 8.5 0.0 0.2 0.0 0.0 16.4 0.0 0.7 0.0 0.0 0.4 0.0 3.0 34.5 0.0 0.0 0.9 0.0 6.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.2 0.0 0.0 0.0 0.1 14.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.0 1.6 5.9 2.2 1.9 2.7 1.5 3.8 0.8 14.9 8.8 0.0 2.1 53.7 0.0 0.8 0.0 2.7 13.6 38.4 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 6.9 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 39.6 0.0 0.0 0.0 3.1 FRYL "AF4p12, DKFZp686E205, KIAA0826, MOR2" ENSG00000075539 "FRY like transcription coactivator" O94915 4 48497361-48780322 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Mucus-secreting cells: 166.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031106, HPA031107" Supported Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA031106: AB_10600660, HPA031107: AB_10600536" "unprognostic (7.50e-2)" "unprognostic (9.72e-3)" "unprognostic (6.68e-3)" "unprognostic (3.22e-2)" "unprognostic (5.37e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (4.80e-2)" "unprognostic (4.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.62e-2)" "unprognostic (3.32e-2)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" 9.6 7.5 13.4 13.1 27.4 12.4 8.3 10.1 20.2 7.3 30.5 23.4 7.1 8.6 8.5 3.7 6.3 6.5 7.1 7.7 13.8 8.6 7.6 4.8 9.0 10.6 30.2 7.9 7.1 5.8 28.4 12.5 9.0 17.6 5.9 30.8 5.5 6.1 6.2 9.1 8.8 13.4 8.1 25.8 8.8 9.1 5.2 30.1 11.8 6.9 3.9 10.9 8.8 6.0 2.1 2.2 12.6 2.0 3.3 2.8 0.9 10.3 6.3 14.9 9.5 6.2 8.8 8.1 9.4 9.7 10.1 12.0 4.9 8.3 13.0 8.0 10.2 18.4 6.6 9.7 16.1 21.4 7.4 3.3 24.3 6.4 2.3 4.2 16.7 9.7 6.7 6.2 13.8 14.4 9.2 14.5 11.9 7.5 5.2 12.6 5.3 17.0 5.9 2.5 4.7 5.8 13.6 18.9 2.6 9.2 11.3 13.2 5.9 9.8 2.6 5.3 7.6 3.9 10.9 21.6 10.9 14.6 5.8 19.0 7.1 9.2 11.8 9.1 11.1 10.8 12.6 1.2 2.3 2.8 2.0 2.2 2.1 2.5 2.2 1.1 1.8 2.8 2.7 3.7 3.3 1.2 2.2 1.8 0.9 13.4 27.4 10.1 20.2 13.8 8.6 30.2 7.9 17.6 30.1 35.7 34.5 32.0 20.8 42.0 41.5 31.3 17.8 5.3 21.6 15.7 127.6 19.2 3.3 11.5 8.8 48.5 86.6 23.3 10.2 16.6 20.2 32.9 45.1 11.1 16.4 44.5 76.3 41.7 29.4 2.6 15.8 27.0 25.3 21.6 166.5 39.2 21.6 80.1 17.3 6.5 111.4 19.4 27.8 9.0 6.9 43.2 9.0 24.5 66.0 48.0 FTSJ3 SPB1 ENSG00000108592 "FtsJ RNA methyltransferase homolog 3" Q8IY81 17 63819433-63830012 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055544, HPA062628" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA055544: AB_2682843, HPA062628: AB_2684813" "unprognostic (1.33e-1)" "unprognostic (1.41e-1)" "unprognostic (6.60e-2)" "unprognostic (7.82e-2)" "unprognostic (6.45e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.85e-1)" "unprognostic (1.12e-1)" "unprognostic (4.99e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-1)" "unprognostic (3.43e-1)" 20.1 19.9 14.2 15.8 18.2 12.5 16.4 13.6 15.2 17.5 17.4 22.4 25.0 12.9 22.7 19.4 17.6 17.3 16.8 19.2 14.8 9.2 24.4 24.9 13.9 17.5 18.9 9.5 22.3 14.6 30.6 13.3 15.4 16.2 19.3 17.1 17.4 16.5 18.1 25.1 21.2 16.2 21.5 17.7 19.8 16.5 13.0 17.8 31.1 22.4 19.7 26.0 18.0 16.8 9.8 13.3 6.5 12.8 12.3 15.1 9.0 20.6 32.6 12.6 17.9 20.4 17.6 19.6 20.7 15.2 23.7 18.9 27.1 13.9 27.6 8.5 12.1 12.5 14.3 23.5 19.7 30.6 4.7 23.5 24.8 23.2 25.2 14.9 31.3 18.1 12.4 15.6 36.8 17.8 12.1 19.7 17.0 24.6 11.3 15.8 34.8 27.5 10.2 34.0 23.3 33.3 24.6 34.7 19.4 15.5 18.9 11.7 45.9 24.4 20.8 14.1 26.3 19.8 10.5 17.7 17.7 24.9 19.7 38.2 27.4 38.5 27.5 15.8 20.9 17.1 4.5 10.8 6.5 11.4 12.8 15.1 9.8 12.2 14.9 13.3 9.8 9.8 12.0 2.4 12.3 9.2 10.1 14.2 9.0 14.2 18.2 13.6 15.2 14.8 9.2 18.9 9.5 16.2 17.8 29.8 23.8 10.4 12.4 12.2 6.9 26.9 20.4 29.4 30.7 14.0 9.8 13.8 11.6 21.2 6.1 18.5 13.1 0.0 29.2 13.7 11.6 9.0 24.2 17.1 12.5 3.2 12.2 9.2 15.2 11.9 22.5 14.0 8.5 20.8 11.2 13.8 23.1 13.6 18.0 21.6 8.6 45.3 17.9 10.4 12.8 11.2 13.6 10.0 16.4 9.1 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 6 "Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5" "Not detected" "Not detected" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Yes No "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 26.1 0.0 0.0 0.2 0.1 9.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 11.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 6.0 0.3 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.3 0.0 0.0 88.4 1.4 0.0 0.0 0.0 32.6 0.1 0.3 0.0 2.5 1.0 0.3 6.5 0.0 11.6 3.6 0.0 0.0 0.0 1.8 0.0 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GATA6 ENSG00000141448 "GATA binding protein 6" Q92908 18 22169443-22202528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 77.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 78.9;Mucus-secreting cells: 48.1;Undifferentiated cells: 48.1" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 5.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "BEWO: 26.8;CACO-2: 32.6;hTERT-RPE1: 12.5;OE19: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011581, HPA066629" Approved Supported Nucleoplasm Yes No Nucleoplasm "CAB011581: AB_732529, HPA066629: AB_2685695" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (4.36e-2)" "unprognostic (3.47e-1)" "unprognostic (2.61e-1)" "unprognostic (8.45e-3)" "prognostic unfavorable (1.92e-9)" "unprognostic (8.75e-3)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-2)" 9.7 26.6 0.2 8.4 0.2 0.0 9.4 0.2 0.2 9.8 24.7 0.9 1.5 12.5 19.5 10.3 3.3 15.3 51.3 40.4 0.2 0.2 3.9 15.5 14.9 11.1 0.2 0.1 77.2 52.2 0.1 0.5 5.2 0.7 24.3 6.0 0.4 1.5 1.1 1.5 0.9 43.5 32.2 0.4 18.9 26.9 9.7 0.0 0.1 6.3 0.7 0.6 30.3 16.5 0.0 0.0 5.7 0.0 0.0 0.4 0.0 4.7 0.7 0.0 0.0 1.0 0.5 26.8 0.1 0.1 0.4 0.4 32.6 1.8 0.0 1.6 0.5 1.7 5.2 0.2 2.1 0.7 0.0 6.5 0.0 2.0 2.8 7.1 0.2 0.3 0.2 4.2 5.9 4.4 12.5 4.5 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 17.4 4.6 0.0 0.5 0.1 0.2 1.3 0.4 0.0 5.0 2.9 1.3 1.4 0.8 0.0 0.3 0.7 0.8 5.5 0.8 0.0 0.0 0.0 3.0 0.1 4.7 5.7 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.0 41.7 27.5 0.0 3.5 0.8 0.0 78.9 25.5 2.7 7.9 0.0 0.0 0.5 0.0 22.6 47.7 6.2 29.3 0.0 16.9 9.5 20.0 2.8 4.7 8.3 1.4 0.0 25.0 17.8 0.3 5.9 3.1 0.8 0.0 0.0 48.1 0.0 30.5 17.5 9.6 0.0 0.0 32.3 5.5 0.9 1.0 0.6 1.6 0.0 48.1 2.1 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447448-92459432 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 20.1 20.9 14.7 13.7 32.1 8.7 21.1 19.5 23.5 23.1 18.2 32.9 20.8 17.6 23.2 29.8 13.7 21.7 20.0 14.9 18.3 13.4 21.5 17.5 22.5 12.4 37.7 21.4 32.9 27.3 19.7 22.5 19.3 22.1 21.7 18.3 19.5 17.0 21.2 10.4 15.3 16.9 22.2 28.9 18.9 21.1 11.5 31.8 6.5 28.1 8.0 11.3 21.4 18.7 4.5 3.8 7.3 3.8 3.1 3.0 1.1 8.6 5.5 11.3 11.8 14.7 17.0 9.1 8.7 13.0 9.2 12.7 6.0 13.5 6.5 12.1 6.4 21.6 10.4 7.7 5.9 9.8 11.3 8.4 8.3 5.5 8.3 20.5 9.9 22.5 12.8 14.2 7.0 20.6 16.6 10.3 4.8 16.8 14.0 10.0 12.5 3.8 14.1 15.2 14.0 10.6 5.1 13.4 8.5 9.9 9.8 10.1 16.0 11.4 12.1 16.3 14.7 6.8 13.4 9.4 14.8 11.3 22.3 11.1 11.3 3.9 7.2 12.4 6.5 20.2 7.3 3.8 3.4 2.6 2.3 2.5 2.8 2.0 1.6 2.0 4.5 2.1 3.0 3.9 3.1 2.5 3.8 2.0 1.1 14.7 32.1 19.5 23.5 18.3 13.4 37.7 21.4 22.1 31.8 44.7 54.7 23.8 32.5 11.7 77.4 13.2 20.4 45.5 33.0 45.4 66.8 21.8 3.3 18.5 3.3 25.3 24.9 0.0 19.1 19.7 20.3 33.0 50.9 19.5 21.7 58.8 16.1 30.1 26.3 3.4 42.0 29.9 20.3 10.8 35.4 86.9 22.4 33.6 32.9 13.5 125.5 19.4 26.7 10.7 7.0 15.6 17.3 18.5 29.9 26.0 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in many" 8 "Hepatocytes: 1105.8;Proximal tubular cells: 2889.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Group enriched" "Detected in some" 4 "RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria Yes NA 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.8 9.0 0.3 0.0 1.5 0.6 4.5 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.2 5.2 0.7 0.2 0.2 0.0 0.1 0.0 0.1 2.1 0.1 0.2 0.0 0.1 0.6 0.1 3.2 7.9 0.0 0.1 57.1 0.4 0.9 15.0 6.6 1.1 1.8 0.1 0.3 0.6 0.8 5.9 0.0 0.0 0.1 0.0 1.7 35.3 44.6 0.2 0.5 0.1 0.4 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 3.0 0.6 33.0 12.7 48.2 8.6 29.5 191.1 2.7 5.7 68.0 0.0 1.0 250.4 36.2 7.4 7.8 4.2 23.3 255.7 0.9 9.9 3.9 3.5 1105.8 69.7 7.9 0.0 20.9 55.8 11.0 4.0 39.6 21.9 5.4 0.2 18.7 151.7 0.3 3.2 2889.0 4.0 6.5 11.3 22.9 7.4 116.9 1.5 6.9 0.4 15.5 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 1.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 32.5 1.2 0.0 0.0 5.6 0.4 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 1.0 0.0 0.2 0.1 0.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 2.1 0.0 0.4 0.8 0.0 0.2 0.8 0.0 9.6 0.0 3.5 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.3 1.0 0.0 0.0 5.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GDAP2 "dJ776P7.1, FLJ20142, MACROD3" ENSG00000196505 "Ganglioside induced differentiation associated protein 2" Q9NXN4 1 117863485-117929630 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046185 Approved Approved "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA046185: AB_10960897" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-2)" "unprognostic (4.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (4.26e-3)" "unprognostic (2.26e-3)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (3.28e-2)" "unprognostic (8.68e-2)" "unprognostic (1.68e-1)" 12.1 9.7 9.3 10.2 10.8 18.9 11.3 12.9 12.7 10.7 10.5 10.7 13.1 11.1 10.4 12.9 12.7 7.6 9.2 9.5 8.6 7.3 13.5 14.5 15.3 13.9 11.7 8.8 10.6 15.2 17.1 12.3 11.8 11.5 10.3 12.6 9.7 12.8 10.5 7.8 11.0 13.3 12.0 8.8 12.7 11.8 12.6 10.7 13.0 13.1 6.2 11.9 12.3 12.9 2.7 7.0 13.1 7.8 4.2 4.4 3.3 8.6 4.9 6.0 5.0 6.5 3.1 8.9 5.1 6.6 10.2 9.9 5.2 6.0 3.4 6.2 6.8 7.8 5.2 7.9 6.6 12.6 6.8 4.6 5.1 6.8 5.6 7.9 6.3 6.6 2.5 8.4 12.8 9.9 4.6 6.7 7.8 5.3 7.5 8.4 9.0 5.6 5.2 10.4 6.6 8.6 3.0 16.5 5.0 5.8 8.8 4.5 5.0 6.1 10.5 8.0 19.0 3.6 6.5 4.1 7.3 8.6 8.4 6.8 7.8 5.6 4.8 9.4 4.6 8.9 9.6 7.4 13.1 2.8 7.8 4.4 2.7 3.1 3.3 7.0 2.7 2.9 2.8 7.1 4.2 7.6 1.6 4.0 3.3 9.3 10.8 12.9 12.7 8.6 7.3 11.7 8.8 11.5 10.7 8.9 7.5 8.2 5.5 11.9 13.4 6.3 5.1 6.7 9.1 3.5 17.7 10.7 6.6 9.4 13.4 7.3 13.1 0.0 5.5 9.5 6.2 9.8 0.0 7.8 11.8 14.3 4.1 6.2 16.1 2.2 5.5 13.5 10.1 5.4 9.9 9.7 9.0 7.2 6.7 8.8 13.2 0.0 8.3 30.5 10.4 12.0 17.6 6.9 7.0 8.2 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.3 13.0 9.1 13.4 4.7 3.3 28.9 7.3 5.2 9.4 9.4 35.3 33.0 9.7 7.7 4.2 26.2 16.8 10.2 8.0 4.1 3.9 17.5 5.3 10.2 19.9 10.4 9.1 9.9 4.9 9.7 8.2 5.4 7.1 7.4 11.3 34.5 9.0 5.2 20.0 6.9 21.9 32.7 15.6 19.5 14.5 1.6 10.4 8.3 15.6 16.5 17.8 6.7 24.9 10.6 11.6 18.9 16.2 7.4 6.9 15.6 16.0 10.0 13.6 8.5 12.5 7.1 15.7 17.5 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 0.0 1.9 0.0 0.2 0.9 0.8 0.4 0.0 2.7 3.4 0.0 3.9 0.9 0.0 0.6 3.6 0.1 1.6 0.0 0.6 0.6 0.3 0.4 1.1 0.0 0.6 7.9 0.0 0.0 0.3 1.5 0.0 2.5 0.0 0.0 1.9 0.2 0.8 0.0 0.0 0.6 1.1 0.0 0.2 0.5 1.0 0.9 1.4 0.9 1.7 0.8 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA023131: AB_2671080" "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 13.5 5.7 14.9 15.7 17.6 11.6 10.6 12.8 12.0 10.0 12.0 13.7 13.7 14.2 10.0 6.9 10.7 8.3 8.9 8.5 16.4 12.4 9.6 11.2 9.6 13.9 10.3 11.6 11.0 18.4 8.0 7.4 5.0 8.5 9.7 8.6 13.5 20.0 14.0 10.3 13.8 13.4 11.8 9.7 13.4 11.6 11.6 6.9 12.0 10.6 12.8 17.1 9.0 8.2 1.5 3.5 0.9 1.1 3.4 2.2 0.6 4.9 10.2 4.8 7.5 7.9 3.2 5.3 2.9 1.8 2.2 2.7 2.9 14.5 6.4 5.6 4.8 3.2 6.5 2.6 3.3 1.5 11.3 7.7 9.9 4.7 3.3 5.6 3.0 3.3 10.1 1.7 3.0 6.6 5.2 4.8 10.0 5.2 10.8 6.1 13.4 14.2 2.5 4.4 9.4 14.3 8.7 2.2 6.4 5.3 11.2 4.6 5.4 8.9 3.8 6.0 4.6 16.9 1.4 2.7 3.4 9.4 4.8 3.0 14.4 6.7 5.1 5.5 5.9 5.5 0.0 1.1 0.0 1.4 1.0 2.2 1.5 1.6 0.9 0.6 1.4 2.0 1.0 0.9 3.4 0.0 3.5 2.1 0.6 14.9 17.6 12.8 12.0 16.4 12.4 10.3 11.6 8.5 6.9 0.0 0.0 12.9 14.5 6.5 14.5 1.4 17.8 0.0 0.0 12.2 19.6 4.5 21.6 2.4 5.2 4.0 13.1 0.0 3.4 3.6 7.8 6.9 4.6 8.1 6.0 6.4 11.1 7.4 9.1 3.1 15.0 5.6 8.5 2.8 7.4 11.3 3.5 17.3 15.6 14.0 11.5 6.5 11.3 13.3 13.3 9.4 2.4 13.8 13.0 5.5 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 272.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.9 14.8 37.6 15.5 5.3 5.7 25.1 24.5 13.0 29.5 32.4 28.7 9.0 25.1 31.3 7.9 21.7 14.7 32.5 18.1 31.8 9.3 34.0 34.4 26.4 47.0 5.0 26.7 12.6 4.6 5.9 17.9 7.0 6.1 14.5 19.6 43.2 13.4 20.8 19.5 50.1 28.9 20.5 20.4 11.7 29.2 29.4 32.2 12.4 21.8 30.2 18.6 11.0 18.2 21.6 22.1 19.1 16.4 7.1 18.1 18.3 20.8 41.5 14.9 45.7 47.1 5.5 50.4 25.9 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 6.0 14.1 15.7 25.3 29.3 8.9 9.4 15.3 33.5 52.4 41.8 2.0 52.0 8.3 78.3 58.9 14.3 21.2 0.0 100.1 110.5 15.8 27.7 12.7 15.3 45.0 11.1 24.9 9.8 9.2 17.5 8.9 12.4 21.9 19.8 24.9 29.4 43.9 272.7 10.3 14.6 12.1 19.4 12.3 132.2 59.4 55.6 40.7 17.5 87.0 19.7 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim" "Nuclear bodies, Mitotic chromosome" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavorable (6.11e-4)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 27.7 28.0 14.8 21.8 17.5 13.0 40.5 17.2 25.4 25.0 27.0 10.0 22.8 21.6 22.2 17.5 41.8 17.4 16.1 20.5 21.6 15.9 19.3 50.4 19.5 26.6 18.4 15.7 27.2 45.1 14.1 43.3 24.7 23.4 28.3 27.0 8.8 30.3 27.3 52.2 24.1 21.2 19.5 19.6 32.0 22.7 15.0 16.9 18.3 18.1 34.3 35.8 44.3 24.9 16.2 21.6 1.8 8.9 13.6 19.4 10.0 21.6 16.2 23.7 25.4 22.6 23.1 36.4 26.7 21.2 28.6 21.5 24.4 15.9 50.6 8.9 20.5 22.0 15.7 39.1 25.5 38.4 31.6 27.8 38.7 27.6 37.4 47.2 55.0 28.7 20.5 45.5 30.9 48.3 19.1 22.4 20.5 42.5 27.1 19.4 15.4 33.0 30.7 40.9 31.2 31.8 19.6 19.3 62.6 22.5 30.3 16.9 21.7 16.7 38.4 37.4 22.2 15.1 31.2 17.3 19.2 20.4 27.9 55.8 29.9 48.3 76.7 20.4 40.1 30.2 0.6 8.0 1.8 11.3 8.9 19.4 16.2 15.3 13.4 13.9 13.5 17.7 16.6 1.0 13.6 6.4 21.6 9.7 10.0 14.8 17.5 17.2 25.4 21.6 15.9 18.4 15.7 23.4 16.9 20.8 41.6 75.9 90.4 145.4 17.9 47.2 20.4 58.9 134.2 12.2 9.8 64.5 34.9 72.1 42.3 45.7 17.0 23.3 90.4 94.6 60.7 74.6 59.2 40.2 36.4 20.6 45.8 21.5 21.0 20.0 48.1 42.7 74.2 74.9 51.9 16.5 84.9 24.6 32.2 31.0 12.2 6.5 94.8 32.6 58.9 134.4 75.5 45.9 64.1 112.5 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452484-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA039764: AB_2676669, HPA047793: AB_2680157" "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavorable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favorable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 17.8 15.1 14.1 11.2 17.3 9.6 26.7 18.4 14.2 13.0 12.5 11.9 10.1 5.9 14.9 11.8 15.6 15.1 10.2 24.8 11.4 10.9 23.3 23.2 13.6 14.8 26.6 11.4 19.4 14.5 19.6 12.2 15.4 18.6 17.0 10.0 11.0 16.6 14.3 35.1 9.6 8.7 17.5 20.0 16.0 13.6 28.3 19.4 11.8 20.1 22.0 12.6 16.5 13.1 20.2 28.0 34.4 31.4 11.8 18.9 16.8 15.4 24.0 16.7 16.3 18.8 11.9 22.1 21.3 13.0 24.1 19.6 22.3 9.3 29.8 14.9 11.6 17.9 14.3 20.6 19.1 32.8 17.0 19.2 17.6 12.9 18.4 13.1 27.4 16.3 12.7 12.1 23.6 15.3 13.5 17.3 25.4 29.6 6.8 16.8 10.5 25.1 52.4 20.4 21.8 24.6 8.6 23.1 22.9 15.1 13.9 12.8 13.3 21.7 14.9 18.0 22.3 25.4 32.5 9.5 20.1 14.7 19.5 24.6 9.4 24.3 31.0 14.7 25.4 22.8 15.3 24.5 34.4 14.0 31.4 15.5 20.2 15.0 15.8 22.6 19.9 18.9 12.6 12.6 11.8 31.1 28.0 12.3 16.8 14.1 17.3 18.4 14.2 11.4 10.9 26.6 11.4 18.6 19.4 23.8 28.0 25.6 41.8 26.6 16.7 38.6 20.4 36.1 26.1 31.4 13.7 52.1 91.2 21.8 68.6 20.5 3.3 0.0 18.6 61.2 26.5 33.4 30.1 31.6 80.2 20.6 7.9 13.5 18.3 13.4 18.4 30.1 15.1 46.9 8.4 17.2 19.9 10.4 22.3 56.6 24.3 25.8 27.8 166.3 65.2 22.2 39.0 16.7 11.8 35.7 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.4 2.4 3.0 8.0 19.2 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.4 33.4 0.1 0.3 7.1 19.2 5.4 22.6 18.3 4.0 4.7 6.8 0.0 8.7 11.8 1.2 8.2 10.3 11.3 6.1 12.6 7.5 8.7 14.8 6.5 10.6 14.5 9.8 17.8 8.7 6.8 10.6 9.3 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 8.9 8.0 0.0 9.4 7.0 29.7 7.2 7.6 10.7 4.5 8.7 31.4 0.9 10.0 6.4 0.5 2.7 3.3 0.0 8.1 1.4 4.6 16.3 2.3 2.6 2.2 20.6 4.1 1.8 2.4 0.0 3.7 4.0 6.8 1.0 4.0 5.6 8.5 2.9 5.3 12.4 38.9 0.0 4.6 0.0 5.1 5.8 2.4 0.0 6.8 14.2 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.1 0.0 7.2 6.6 13.0 1.1 1.1 2.7 2.6 6.4 0.3 0.8 0.0 2.0 3.0 14.6 0.1 0.7 1.4 2.5 0.0 0.8 0.0 4.8 7.7 8.4 3.0 0.0 12.5 0.7 6.3 1.0 3.9 0.0 14.1 3.5 0.1 1.5 1.6 22.3 0.1 4.3 0.1 1.4 0.1 6.1 0.0 0.8 1.1 0.7 3.3 6.2 0.3 0.8 1.4 2.4 0.9 0.0 2.8 9.0 8.7 4.1 0.6 0.1 0.1 7.3 1.4 4.9 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 3.0 1.6 0.0 1.5 1.6 0.6 9.8 2.5 1.4 1.2 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.9 0.0 1.0 0.2 14.2 1.3 0.0 0.0 0.3 0.0 3.4 1.3 0.0 17.8 7.5 0.3 0.0 0.0 2.3 2.5 1.2 0.0 6.7 0.4 0.4 0.0 1.0 2.9 3.2 0.4 0.7 0.0 1.5 0.4 H1F0 "H10, H1FV" ENSG00000189060 "H1 histone family member 0" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 158.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 85.2;U-2 OS: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 21.7 13.6 27.5 14.7 24.9 158.1 32.3 35.7 41.7 48.2 37.9 20.4 11.3 35.8 42.7 18.5 66.0 31.7 38.5 30.3 23.5 17.6 33.2 90.6 22.8 15.0 16.0 23.8 48.5 43.5 20.2 25.6 33.6 23.5 43.7 34.0 28.3 43.2 12.4 53.5 53.2 59.2 28.0 18.6 16.3 34.6 15.2 18.8 56.3 36.1 33.4 32.0 24.9 45.2 0.1 6.3 12.5 9.0 0.1 2.4 4.7 20.2 8.8 27.4 12.1 7.2 6.6 38.9 16.5 34.6 48.5 69.2 35.9 32.5 0.0 4.1 13.7 11.3 39.8 0.0 11.4 34.6 0.1 2.0 34.3 3.2 23.8 25.4 0.0 0.1 6.2 20.3 24.3 27.4 0.5 12.8 7.9 0.0 0.0 3.7 33.6 5.7 3.3 10.6 85.2 43.5 9.5 16.3 7.0 7.6 5.5 6.3 35.4 45.7 31.2 60.2 12.8 24.3 21.5 8.5 3.7 110.7 16.3 3.3 0.0 2.3 0.1 4.5 12.4 10.5 12.5 7.6 11.3 0.1 9.0 0.1 0.0 0.8 0.2 6.3 0.1 2.4 0.3 4.2 0.1 7.7 5.7 0.2 4.7 27.5 24.9 35.7 41.7 23.5 17.6 16.0 23.8 23.5 18.8 26.8 114.5 10.0 163.5 62.0 29.8 40.3 107.0 97.7 135.4 97.7 3.9 33.1 106.1 132.1 1.8 71.9 117.5 280.4 159.3 112.5 82.5 175.2 22.0 68.2 59.5 42.9 119.1 63.3 67.8 3.7 85.4 44.3 81.0 92.8 180.5 46.0 119.5 160.1 57.0 42.8 5.6 109.9 96.7 55.8 24.9 78.3 183.8 7.0 103.1 138.2 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes No Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.4 16.0 25.3 15.1 2.3 1.7 26.7 30.1 9.2 17.0 15.0 25.3 11.4 18.2 18.2 6.9 12.8 27.5 11.9 8.6 4.6 26.8 33.5 36.9 4.4 26.0 2.4 18.1 23.0 1.4 1.9 7.2 4.4 2.7 8.5 24.0 29.8 30.0 8.1 67.5 41.4 54.2 18.4 12.1 33.9 40.5 29.8 8.5 7.7 11.5 27.0 32.1 23.9 13.9 4.2 4.5 20.8 13.8 10.4 16.5 43.6 13.4 22.3 8.2 8.0 18.4 3.8 29.5 32.1 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 6.0 12.6 41.6 30.9 27.4 17.4 16.3 15.3 2.7 9.1 7.0 19.6 39.1 10.0 14.6 7.0 21.1 36.5 46.7 9.9 93.2 26.6 29.8 32.3 3.6 37.9 9.5 33.3 25.8 20.0 2.5 13.3 24.5 18.6 37.9 33.9 37.9 14.1 24.5 10.3 7.5 43.2 12.9 36.5 72.1 17.9 24.7 53.7 30.5 50.3 20.8 HAUS3 "C4orf15, dgt3, IT1, MGC4701" ENSG00000214367 "HAUS augmin like complex subunit 3" Q68CZ6 4 2227464-2242164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040649, HPA048190" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria" Yes No "Microtubules, Mitochondria" "Cytokinetic bridge, Mitotic spindle" "HPA040649: AB_2677060, HPA048190: AB_2680308" "unprognostic (4.22e-2)" "unprognostic (1.50e-1)" "unprognostic (6.30e-2)" "unprognostic (2.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.57e-3)" "unprognostic (7.63e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.79e-2)" "unprognostic (2.15e-2)" "unprognostic (2.79e-1)" "unprognostic (4.40e-2)" "prognostic favorable (4.78e-5)" 11.7 10.8 15.5 10.9 14.7 44.4 11.5 26.3 14.3 8.6 9.5 10.0 8.6 9.6 11.0 9.1 10.3 8.8 6.9 6.3 11.8 5.9 7.8 8.8 11.1 15.0 11.7 11.0 10.8 13.6 7.3 18.9 10.3 10.5 10.7 8.8 6.0 10.8 8.5 9.0 10.4 11.2 9.6 14.5 15.2 10.5 12.5 13.7 20.7 9.8 4.3 13.0 9.3 9.6 11.0 8.6 14.9 7.8 12.2 15.6 7.6 9.8 5.0 14.5 14.2 6.9 9.6 14.2 15.7 6.9 14.3 13.2 8.7 12.7 18.5 6.7 6.0 17.8 9.1 11.6 7.9 18.3 7.0 7.7 11.0 11.7 7.1 5.5 11.5 12.5 5.5 10.6 12.9 6.5 7.5 11.6 8.8 21.0 22.4 14.4 5.1 16.7 20.0 12.3 9.0 12.0 13.3 12.9 11.1 7.2 7.0 17.9 9.9 9.7 7.1 9.0 12.3 15.4 7.6 8.1 17.8 9.6 10.8 16.6 11.3 11.3 17.2 9.5 17.3 13.4 10.1 5.5 14.9 10.9 7.4 14.4 7.7 11.5 12.2 5.0 11.0 13.4 12.1 6.4 12.2 7.8 8.6 15.6 7.6 15.5 14.7 26.3 14.3 11.8 5.9 11.7 11.0 10.5 13.7 3.0 4.5 4.2 4.8 11.2 11.1 4.6 10.2 4.0 12.5 3.5 11.8 6.4 1.7 6.3 9.9 6.7 3.0 0.0 4.9 9.5 7.8 4.5 12.7 3.0 6.2 23.8 6.9 6.2 4.1 4.9 9.2 8.7 11.8 8.2 5.3 6.9 4.4 0.0 8.1 2.6 11.6 0.0 6.7 20.1 15.1 6.8 4.2 20.2 5.2 2.6 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: AB_2683762" "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavorable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.8 11.1 10.3 16.3 6.4 8.6 11.1 13.2 8.8 13.3 5.3 13.6 8.3 20.5 9.6 12.6 5.0 13.0 12.4 9.9 15.5 5.2 13.3 10.1 7.8 17.2 9.2 17.5 20.6 6.7 6.8 9.4 5.7 5.8 10.7 10.9 12.8 3.6 13.0 6.7 13.4 22.0 12.1 13.2 11.6 14.9 14.0 16.6 7.4 8.9 13.4 7.1 12.8 16.6 8.3 8.3 7.5 12.8 13.9 10.7 7.2 8.2 10.1 8.7 6.9 18.4 10.6 17.7 10.5 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 3.0 4.3 2.7 0.7 2.9 7.2 5.2 5.1 2.7 1.2 1.8 15.7 3.0 6.6 2.2 9.3 3.6 3.8 0.0 2.6 2.9 2.6 1.9 1.1 6.7 8.3 1.6 3.4 2.5 25.3 13.3 3.1 7.0 1.7 3.6 3.3 1.9 2.6 2.9 2.1 3.4 7.3 0.0 2.1 4.8 4.5 1.5 0.8 4.4 4.9 1.4 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 43.3" "Cell type enriched" "Detected in some" 10 "Muller glia cells: 23.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 240 "Hep G2: 34.3" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 8.4 0.5 22.0 0.4 20.4 0.3 0.3 4.2 43.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.5 17.9 11.0 0.4 4.5 0.3 0.5 19.3 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.5 0.3 19.4 0.3 0.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.6 0.0 0.4 0.6 0.0 0.0 0.0 0.0 23.5 0.0 0.0 1.1 0.0 1.4 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890394-29064764 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 10.8 23.1 16.4 10.5 15.5 21.2 10.4 18.6 15.8 9.2 8.4 13.9 8.5 6.7 14.9 8.6 9.6 8.7 9.4 12.7 14.6 8.2 10.1 10.0 15.9 11.0 16.6 10.1 13.9 10.9 13.5 13.6 14.6 15.9 7.6 8.8 9.9 11.7 12.5 9.7 12.1 10.2 11.6 20.0 11.8 9.3 16.8 18.2 13.0 13.7 5.6 12.6 10.4 14.3 6.6 4.8 5.0 9.0 2.2 5.5 2.6 5.1 5.6 6.2 7.1 5.8 6.1 5.2 2.2 2.9 3.5 4.0 2.5 3.3 12.6 5.5 3.8 5.1 4.4 12.1 4.5 4.9 4.6 2.1 13.1 10.5 3.4 4.6 4.4 8.8 2.9 6.5 4.6 8.7 4.3 7.8 7.6 18.5 12.5 4.9 2.9 8.0 2.2 4.3 5.5 1.4 6.6 6.1 2.9 2.5 9.5 2.7 8.0 4.3 3.3 4.7 5.3 3.3 4.0 11.1 3.2 14.9 3.3 3.1 3.8 3.9 4.9 4.3 5.4 4.6 5.0 4.8 2.0 4.0 4.9 5.5 6.6 3.9 3.5 4.8 5.7 5.0 4.8 2.7 2.2 9.0 3.8 1.7 2.6 16.4 15.5 18.6 15.8 14.6 8.2 16.6 10.1 15.9 18.2 14.9 18.6 25.2 14.5 14.8 25.2 15.7 17.8 10.7 7.9 27.9 37.3 10.8 13.3 6.7 69.0 38.3 15.5 0.0 12.5 9.2 16.2 17.3 16.2 11.9 9.1 28.6 16.7 55.9 16.7 24.1 33.1 25.5 15.1 5.4 12.9 28.7 10.4 14.0 29.7 6.9 30.0 19.4 16.5 36.7 13.2 17.2 16.0 21.8 12.1 16.0 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.2 14.5 1.4 2.7 20.3 20.1 9.8 25.2 22.9 27.0 40.9 35.2 19.2 6.2 34.4 24.5 31.4 19.1 43.1 31.9 9.7 21.0 9.5 13.2 0.4 18.6 19.4 0.7 1.1 23.7 18.6 4.2 14.3 24.2 19.9 28.8 26.2 7.7 19.6 10.6 23.4 14.2 14.6 21.4 36.4 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 13.5 27.7 15.0 9.3 18.1 15.4 14.5 26.9 15.5 25.9 28.4 12.0 28.9 17.4 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 0.0 0.6 15.5 0.8 2.3 0.6 1.7 7.6 4.0 4.5 0.0 0.0 5.1 0.0 0.6 60.3 0.1 1.3 256.9 0.2 50.4 2.4 0.8 0.0 1.7 17.7 0.0 1.2 3.1 3.5 44.1 2.0 4.3 0.0 3.6 1.6 0.0 0.1 0.0 0.7 2.4 0.7 6.5 0.0 80.6 18.5 1.3 3.8 1.0 4.2 0.9 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA069659: AB_2686165" "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.6 5.1 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 18.3 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 709.1" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 6.8 0.0 11.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 54.2 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 22.1 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 32.3 0.1 709.1 118.4 8.2 1.8 0.0 0.0 0.0 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell type enhanced" "Detected in some" 17 "Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.8 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.2 4.1 0.2 1.9 0.2 2.3 6.9 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.4 1.9 0.1 0.3 1.0 0.0 3.6 3.4 0.0 2.8 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.1 1.0 0.7 0.0 5.5 0.7 1.2 0.0 0.2 0.0 1.1 0.3 0.0 0.0 2.8 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.7 3.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.6 6.2 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.4 0.3 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729465-169757953 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 58.5;Distal tubular cells: 77.9;Extravillous trophoblasts: 50.1;Hofbauer cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (5.63e-4)" "prognostic favorable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 16.5 18.6 27.3 14.9 26.3 13.7 20.9 22.9 31.7 17.6 17.5 17.6 10.0 11.5 23.2 25.2 17.2 16.9 12.7 20.9 27.3 24.0 17.5 20.8 13.5 18.0 24.9 22.6 23.1 13.1 13.9 22.9 16.0 33.4 17.4 17.6 15.1 12.2 16.0 17.4 18.6 11.3 24.2 23.8 16.4 14.0 12.9 19.8 20.8 18.5 14.9 19.3 19.0 14.8 13.6 15.6 12.8 14.1 14.9 22.2 13.3 12.6 8.0 28.0 14.7 17.1 21.3 11.9 23.1 22.9 28.8 30.6 5.4 13.7 6.6 6.2 15.0 21.1 5.7 19.2 16.8 30.6 20.7 13.1 21.6 11.8 7.7 12.1 18.2 7.9 13.7 17.1 18.5 5.7 17.5 24.9 22.9 16.2 26.0 25.0 10.2 38.1 15.9 11.4 12.2 10.5 16.8 13.3 7.9 16.4 8.4 6.7 25.0 15.3 6.7 20.8 20.3 13.3 16.4 12.0 9.8 15.6 23.0 20.5 12.4 18.4 19.7 27.2 17.8 15.6 8.9 12.3 12.8 18.5 14.1 21.9 13.6 21.5 22.2 15.6 11.1 21.2 21.7 3.3 14.9 13.1 10.7 22.0 13.3 27.3 26.3 22.9 31.7 27.3 24.0 24.9 22.6 33.4 19.8 41.7 23.7 0.0 0.0 0.0 0.0 0.0 0.0 28.1 31.8 26.2 0.0 58.5 77.9 38.2 0.0 0.0 0.0 0.0 40.0 50.1 0.0 0.0 16.3 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 6.4 0.0 0.0 27.9 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 163.1" "Cell type enhanced" "Detected in many" 8 "Ito cells: 1636.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 28.6 12.3 8.2 15.2 9.1 4.4 33.2 5.6 13.8 36.3 33.3 15.4 38.5 36.4 25.9 11.6 78.0 25.1 19.0 33.5 8.7 8.4 22.3 23.4 57.4 17.9 10.0 7.9 12.3 5.8 4.0 25.7 22.1 14.3 56.4 13.1 34.9 10.5 163.1 23.0 16.5 40.6 16.9 8.1 15.3 48.6 7.8 4.0 2.4 78.8 36.2 21.0 80.0 26.4 0.4 0.7 3.9 0.7 0.3 0.5 0.5 10.7 35.5 0.4 7.2 4.7 2.1 27.7 45.5 1.8 8.4 0.9 18.7 16.2 0.0 75.9 12.1 9.9 72.3 5.9 2.5 1.3 0.8 3.7 5.9 30.8 60.2 6.4 0.1 0.3 8.7 10.4 0.0 0.6 14.0 5.1 4.0 13.0 0.3 16.1 14.0 1.6 0.2 25.5 48.0 75.7 0.1 29.7 0.5 1.6 29.7 13.8 12.9 37.8 13.6 0.3 20.1 8.3 1.0 27.1 22.6 44.0 7.2 30.5 0.8 0.8 0.6 26.3 5.6 3.0 0.0 0.6 0.9 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.4 0.0 0.5 3.9 0.3 0.7 0.0 0.0 0.5 8.2 9.1 5.6 13.8 8.7 8.4 10.0 7.9 14.3 4.0 220.3 143.7 26.8 631.9 90.9 1.0 20.7 76.5 89.7 271.8 216.3 3.9 104.2 31.5 429.0 5.6 483.5 528.2 0.0 472.2 442.0 137.2 501.4 21.9 90.9 22.4 0.0 550.7 1636.4 76.9 5.9 26.4 25.7 86.0 13.6 450.7 80.6 190.0 770.0 0.4 2.7 4.0 12.9 193.3 1.9 2.2 76.9 74.5 24.9 241.9 477.9 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 29.1 26.9 15.9 22.3 24.9 20.7 19.5 15.2 21.4 27.0 28.7 22.2 22.2 37.1 26.3 24.4 22.1 21.8 24.0 20.7 9.9 12.2 30.7 13.9 36.5 17.8 28.3 19.4 29.4 23.2 15.0 20.8 22.7 17.4 20.6 15.5 7.7 20.4 21.7 40.8 22.0 22.8 7.1 27.1 35.6 19.4 13.6 32.3 30.1 18.2 20.3 13.9 9.5 32.2 15.1 6.8 13.3 16.7 18.2 17.1 10.7 25.1 35.9 28.1 7.0 47.3 28.0 24.0 18.9 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 32.8 32.7 56.5 52.5 71.9 33.9 48.4 43.3 30.8 7.9 48.8 27.5 80.9 175.8 81.7 113.6 44.1 164.4 46.7 79.1 82.6 56.8 36.9 91.2 33.0 116.8 17.5 59.8 43.6 88.9 226.7 49.5 66.0 64.1 101.0 81.8 37.0 65.2 122.8 55.2 192.8 37.1 51.8 69.3 14.0 17.0 67.8 92.7 54.5 93.0 43.8 IGFN1 "DKFZp434B1231, EEF1A2BP1" ENSG00000163395 "Immunoglobulin-like and fibronectin type III domain containing 1" Q86VF2 1 201190825-201228952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skeletal muscle: 118.8" "Group enriched" "Detected in some" 8 "Leydig cells: 20.4;Peritubular cells: 8.5" "Group enriched" "Detected in some" 11 "renal cancer: 1.8;thyroid cancer: 8.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HeLa: 37.7" HPA050415 Enhanced Approved "Midbody ring" Yes NA "Midbody ring" "HPA050415: AB_2681120" "unprognostic (2.09e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-2)" "unprognostic (3.25e-1)" "unprognostic (1.02e-2)" "unprognostic (2.00e-2)" "unprognostic (9.80e-3)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.27e-8)" "unprognostic (3.55e-4)" "unprognostic (6.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" 0.5 0.0 0.6 0.1 0.4 0.0 0.1 0.4 1.4 0.3 0.2 0.3 0.1 0.0 4.3 6.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.3 0.2 0.3 4.6 0.0 0.7 0.1 1.7 0.2 0.0 1.6 0.1 0.1 118.8 0.0 0.1 0.3 0.1 0.1 0.0 1.1 0.2 0.1 11.3 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.3 0.3 0.2 0.3 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 20.4 0.0 1.7 0.0 0.0 0.0 0.4 0.0 8.5 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell type enhanced" "Detected in many" 14 "B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 37 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" Yes NA 208000 14000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.4 9.3 23.8 0.4 0.0 0.0 0.2 0.0 0.2 1.6 1.4 5.0 0.0 0.0 0.7 9.9 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.1 0.1 0.1 0.1 0.4 0.0 28.3 2.4 11.7 0.8 15.8 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 3.0 10.0 169.7 0.1 7.2 0.0 1.2 10.2 8.1 3.4 1.8 0.0 0.2 0.0 0.1 1.3 4.9 0.0 70.0 0.2 0.2 6.6 0.1 25.5 2.4 16.6 0.0 0.0 36.2 59.0 0.7 10.0 30.8 27.0 0.0 0.3 0.4 0.0 0.3 17.0 0.3 0.6 6.5 3.7 2.1 4.7 3.1 0.3 92.0 0.0 0.0 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favorable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.2 9.7 2.6 4.6 3.4 2.5 60.5 1.6 4.3 0.7 1.0 7.8 5.0 1.3 3.8 2.3 5.7 4.3 3.1 1.6 0.2 7.4 3.8 0.0 12.7 6.7 2.0 10.7 0.5 5.8 8.7 2.3 1.2 2.0 0.9 7.0 1.5 0.0 2.5 6.2 4.3 5.6 9.1 67.8 7.3 7.3 7.3 6.4 29.2 3.5 3.5 0.0 36.5 8.3 3.5 3.4 7.8 13.4 0.0 1.3 2.5 17.9 1.6 5.0 13.3 3.7 5.8 7.2 2.2 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 17.9 25.4 6.9 15.2 93.8 0.2 10.6 45.9 9.4 9.1 21.0 0.0 35.5 373.0 57.8 2.3 5.8 44.1 0.0 96.5 196.1 13.1 33.2 2.3 62.3 36.5 0.0 16.8 8.6 39.4 4.7 4.4 16.7 13.5 4.6 70.8 21.8 73.4 51.8 3.5 383.7 0.9 103.5 9.5 0.4 11.7 123.6 88.9 4.4 78.2 45.7 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" 4 "monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 27.0 25.9 19.7 16.8 2.6 3.2 10.5 17.0 7.4 15.9 10.2 13.6 18.4 25.1 14.1 5.8 17.6 26.6 19.5 10.3 12.5 22.3 13.5 16.4 25.5 11.1 1.0 18.8 23.4 1.6 2.3 15.3 8.9 2.6 9.5 18.3 17.3 21.0 8.7 22.0 30.3 15.4 21.2 10.5 12.7 28.4 24.8 18.9 4.5 13.6 15.0 16.3 17.1 11.1 10.5 8.2 17.4 6.8 10.6 15.7 20.1 22.4 18.1 11.2 17.2 28.2 8.7 12.4 18.8 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 3.0 2.9 2.2 0.8 4.9 1.9 0.9 0.0 4.0 5.7 0.0 0.0 1.6 0.0 1.7 0.8 0.8 1.3 0.0 2.1 6.0 0.8 1.0 3.5 0.9 3.5 0.0 0.0 0.0 0.8 0.2 2.6 2.5 3.3 8.2 2.0 2.3 1.7 1.5 1.4 0.3 2.2 0.0 0.4 6.9 5.8 2.9 1.8 2.5 1.7 1.0 ING4 "my036, p29ING4" ENSG00000111653 "Inhibitor of growth family member 4" Q9UNL4 12 6650280-6663148 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Chromatin regulator" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031817, HPA057338" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA031817: AB_2674056, HPA057338: AB_2683412" "unprognostic (2.95e-1)" "unprognostic (1.92e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (9.44e-2)" "unprognostic (5.76e-3)" "unprognostic (1.65e-2)" "prognostic favorable (5.16e-4)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (7.66e-3)" "unprognostic (1.52e-1)" "unprognostic (4.32e-2)" "unprognostic (1.31e-1)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (1.42e-2)" 15.0 17.7 30.7 13.0 27.6 9.3 25.9 36.7 34.3 20.0 20.2 22.3 18.9 16.2 23.8 29.5 17.1 25.5 16.3 18.9 27.9 21.0 19.0 20.7 16.6 22.2 30.2 24.8 26.7 17.9 21.1 18.7 19.5 29.9 21.1 20.3 15.5 20.2 22.5 15.6 26.2 16.9 21.4 25.0 24.9 17.6 13.3 29.0 29.5 24.2 10.2 21.3 20.0 18.3 29.4 23.9 19.4 33.1 25.1 29.1 25.2 4.3 5.9 17.6 8.3 13.7 13.7 11.3 5.8 9.4 9.7 11.7 2.6 19.9 7.6 3.8 8.1 7.7 6.9 8.6 6.8 10.8 14.6 12.7 10.8 10.8 5.4 8.0 4.2 5.1 13.7 15.8 5.1 6.6 31.5 14.5 14.8 5.0 4.3 9.2 3.1 15.4 6.5 25.9 9.6 5.7 14.6 9.2 7.9 12.0 5.0 7.3 19.0 9.0 3.0 10.7 26.6 4.0 11.8 10.9 4.0 8.1 4.5 3.7 5.3 7.2 10.0 10.7 6.6 4.0 19.4 22.0 17.7 25.0 29.3 22.7 21.9 20.8 21.0 23.9 29.4 29.1 24.8 14.1 25.1 33.1 18.5 20.7 25.2 30.7 27.6 36.7 34.3 27.9 21.0 30.2 24.8 29.9 29.0 20.8 14.7 22.9 10.7 7.2 29.6 9.0 10.2 14.7 18.2 17.4 17.7 33.6 24.9 19.0 1.7 21.5 11.8 0.0 7.1 11.0 15.1 13.3 27.6 6.0 21.9 33.4 24.2 18.4 14.5 4.2 31.9 20.8 10.1 36.1 19.7 32.7 10.9 18.6 35.3 17.9 26.3 32.3 19.8 20.0 16.4 8.8 25.6 32.4 17.1 7.0 INTS8 "C8orf52, FLJ20530, INT8, MGC131633" ENSG00000164941 "Integrator complex subunit 8" Q75QN2 8 94813311-94881746 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057299 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA057299: AB_2683403" "unprognostic (1.08e-2)" "unprognostic (3.12e-2)" "unprognostic (1.28e-1)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.07e-2)" "unprognostic (6.87e-2)" "unprognostic (9.77e-3)" "unprognostic (4.84e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.24e-1)" "unprognostic (5.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.96e-2)" 10.5 10.0 12.7 19.3 16.1 16.6 14.3 17.1 16.0 19.2 15.4 9.1 12.5 9.4 14.4 8.3 15.9 10.6 9.2 15.2 11.6 12.6 10.2 10.8 11.5 19.3 12.4 9.5 15.0 20.1 14.7 22.9 11.4 11.1 14.0 18.2 9.7 12.9 13.7 15.6 12.5 15.1 16.7 12.5 17.0 14.6 35.1 10.7 31.9 13.3 7.6 16.1 17.1 13.2 13.0 9.7 14.4 9.8 10.9 13.0 4.5 22.1 14.1 21.5 18.8 7.8 18.8 11.5 12.4 11.1 15.6 14.5 9.4 16.2 22.4 11.5 8.7 19.5 14.0 26.3 12.4 20.9 25.1 14.0 19.8 8.5 9.2 9.5 10.5 14.6 7.5 5.9 15.0 12.9 17.9 17.1 15.1 18.9 16.9 9.4 14.3 22.4 8.7 12.7 48.5 24.5 18.8 8.7 12.7 13.0 11.4 16.1 8.9 11.7 3.2 10.6 18.4 16.1 13.4 11.9 7.3 8.5 13.6 10.7 10.5 18.1 19.2 9.4 21.1 13.9 2.1 9.8 14.4 5.2 6.8 8.4 13.0 12.2 13.0 9.7 10.4 12.2 7.2 9.9 10.9 6.6 5.7 9.9 4.5 12.7 16.1 17.1 16.0 11.6 12.6 12.4 9.5 11.1 10.7 14.9 7.5 11.3 9.5 5.3 13.4 7.3 5.1 18.7 10.3 7.0 31.4 8.3 3.3 7.1 14.4 9.0 7.4 0.0 11.7 10.7 9.0 7.2 12.7 5.3 8.6 27.0 17.2 9.8 13.5 3.4 15.0 12.4 6.8 16.2 11.4 7.0 10.0 11.5 15.2 3.5 19.6 6.5 8.9 48.8 29.4 6.0 7.1 10.1 9.9 6.7 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 10.8 28.8 10.5 14.1 13.4 8.1 11.0 14.2 16.5 11.3 11.7 15.5 7.7 9.3 16.4 16.1 14.1 13.7 9.1 13.0 9.5 7.6 12.8 9.3 11.4 17.9 15.2 8.1 11.4 12.5 13.4 24.0 11.4 12.1 11.6 12.9 17.9 15.5 10.6 14.1 12.4 11.9 12.8 13.5 20.4 11.7 15.2 13.3 28.4 17.2 8.5 23.1 13.2 11.2 17.6 24.3 15.5 19.3 19.9 17.0 9.3 13.2 9.4 11.3 12.0 14.0 6.6 5.0 6.1 8.4 10.7 11.9 6.5 7.5 13.2 8.6 6.2 9.6 11.1 21.8 12.5 15.0 5.5 8.9 13.2 5.3 11.3 10.2 6.6 10.3 7.5 9.0 12.9 9.3 5.8 13.2 19.1 27.8 7.7 7.1 7.3 30.5 12.0 15.3 15.6 6.1 19.7 13.1 6.9 7.5 9.2 8.2 15.0 6.3 8.3 11.1 9.5 8.0 7.5 7.7 6.2 16.0 10.5 7.7 4.0 2.7 16.4 9.6 11.1 8.8 12.1 17.7 15.5 15.4 19.3 14.3 15.4 13.7 17.0 24.3 17.6 12.5 13.1 7.2 19.9 13.7 12.8 16.3 9.3 10.5 13.4 14.2 16.5 9.5 7.6 15.2 8.1 12.1 13.3 6.0 3.4 4.7 2.4 2.1 2.1 4.6 7.6 1.4 2.3 3.5 5.9 6.7 1.7 3.0 6.1 2.9 2.3 0.0 4.5 3.8 3.8 1.4 0.0 1.6 6.7 1.6 5.8 2.5 4.1 3.3 7.2 2.9 3.3 4.6 4.0 2.0 4.7 0.0 4.2 3.3 5.5 0.0 2.8 3.0 3.3 2.6 4.0 3.2 3.3 1.4 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA053644, HPA062531" Approved Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA053644: AB_2682214, HPA062531: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 16.2 0.0 0.0 5.8 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 4.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 0.0 0.0 0.0 0.0 0.0 2.2 10.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 5.8 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.1 6.5 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 360.6;Late spermatids: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 5.5 7.6 15.1 6.8 17.0 7.0 7.4 11.1 18.7 6.9 10.2 12.8 6.7 13.1 9.6 12.3 6.6 17.1 11.2 7.1 14.3 15.6 7.1 3.6 9.1 4.7 12.0 12.1 9.7 8.4 12.9 15.4 4.1 11.3 8.1 9.9 7.3 9.8 11.2 4.5 8.1 10.9 7.9 11.1 5.1 10.6 35.3 9.6 2.8 11.9 3.0 3.9 6.0 7.4 0.7 4.3 8.3 2.1 0.3 1.3 0.3 20.0 10.5 4.5 13.8 5.6 8.5 7.8 4.2 7.1 5.6 6.1 5.4 11.6 1.4 4.9 9.8 12.2 10.4 3.1 4.9 5.9 3.5 6.5 2.7 12.7 1.7 4.1 7.2 4.0 3.5 8.1 5.4 5.7 6.5 6.0 5.8 8.6 2.6 7.4 20.4 3.2 5.5 3.9 9.0 7.7 3.1 5.2 5.2 6.0 9.4 9.5 11.2 4.7 20.0 4.4 3.3 24.6 9.8 5.9 4.7 9.5 17.8 7.1 2.9 4.9 0.3 9.2 5.2 13.1 1.1 1.4 3.6 1.3 2.1 0.5 0.5 0.7 0.6 0.6 0.7 0.5 1.1 8.3 0.3 0.7 4.3 0.3 0.3 15.1 17.0 11.1 18.7 14.3 15.6 12.0 12.1 11.3 9.6 11.9 11.0 0.0 5.0 4.8 7.8 7.7 22.9 60.2 14.8 12.2 56.9 3.7 14.9 16.6 360.6 3.6 15.8 0.0 17.4 6.9 6.4 7.3 1.1 2.8 8.7 19.1 8.1 7.4 6.4 290.7 13.0 5.9 0.0 10.8 10.7 14.1 17.5 11.8 14.5 8.1 38.1 19.4 3.6 43.3 53.7 3.8 1.6 4.4 10.0 3.3 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Late spermatids: 16.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes Yes "Nucleoli rim" Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.4 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.5 13.0 21.8 2.1 6.5 10.3 9.1 22.5 7.3 9.0 15.5 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.3 4.2 10.0 5.1 6.3 3.4 12.6 12.4 2.2 5.5 7.8 23.3 11.5 7.6 12.0 2.4 4.4 8.1 6.8 10.5 15.9 18.7 6.4 13.1 14.9 10.3 6.5 15.6 18.7 12.7 20.6 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 0.0 0.0 0.5 0.0 1.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 1.1 0.0 0.0 3.1 0.5 0.2 0.0 0.0 3.4 0.0 1.2 4.3 0.3 16.8 0.3 2.2 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 3.8 2.4 0.9 0.7 0.0 2.9 0.4 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge" Yes No "Nucleoplasm, Endoplasmic reticulum" "Cytokinetic bridge" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.2 16.1 11.1 15.4 14.0 12.0 14.3 17.8 17.2 16.2 13.2 23.2 21.3 11.8 19.6 16.6 13.2 17.2 14.7 12.0 8.7 9.8 15.0 11.4 14.4 14.0 13.3 9.9 29.0 28.4 22.7 23.0 13.8 13.3 13.8 14.7 22.1 23.0 19.5 7.8 10.9 13.9 13.5 10.6 20.3 14.8 10.6 15.2 25.4 26.2 9.3 23.0 14.4 15.3 17.7 12.9 5.4 21.2 13.8 14.4 10.0 4.8 7.1 8.3 6.6 7.2 8.3 7.7 10.8 6.1 13.1 9.7 15.3 12.0 11.1 3.0 10.1 6.6 6.2 12.7 10.7 9.8 9.8 7.6 15.7 8.1 6.1 13.3 14.2 8.5 11.1 12.8 11.9 18.4 10.8 8.9 10.7 8.4 12.1 7.4 14.6 20.5 8.3 16.9 11.0 5.5 10.4 9.2 6.4 7.8 8.2 4.0 12.7 13.4 11.8 4.8 11.7 7.3 6.6 9.1 8.7 5.4 8.3 20.6 1.6 0.9 16.9 5.7 8.3 8.6 2.8 10.9 5.4 13.7 14.3 12.8 17.7 10.5 13.4 12.9 17.1 14.4 13.5 1.3 13.8 21.2 9.8 8.5 10.0 11.1 14.0 17.8 17.2 8.7 9.8 13.3 9.9 13.3 15.2 11.9 19.9 25.1 8.5 3.0 34.9 15.1 15.3 9.4 13.6 12.2 60.9 23.3 10.0 7.9 42.6 6.0 13.5 0.0 6.3 8.5 9.4 7.3 5.8 10.2 11.3 30.2 9.1 13.5 7.2 9.0 15.5 9.8 1.7 9.0 12.6 14.7 6.1 16.1 12.4 4.4 52.4 6.5 8.4 12.6 17.9 3.4 14.5 25.9 16.4 4.6 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol Yes No 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.4 5.0 0.4 0.2 1.3 2.4 1.5 19.6 29.9 0.7 1.2 9.3 13.7 0.0 3.4 8.3 11.5 30.2 1.6 22.1 2.8 0.0 1.5 1.4 1.2 5.5 4.5 0.2 0.4 0.9 3.8 19.7 3.5 28.1 27.8 1.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 5.0 10.0 0.0 0.1 0.0 6.3 10.3 0.2 1.1 1.0 1.3 2.0 0.8 3.2 0.0 23.8 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.6 0.0 15.8 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 53.6 13.6 0.0 300.3 134.2 2.3 1.2 20.4 88.3 161.5 50.6 3.9 0.2 8.3 157.1 0.0 15.8 20.6 0.0 144.3 1.6 1.9 266.4 1.1 0.0 0.3 0.0 13.3 5.5 0.0 0.0 1.1 3.8 11.8 1.8 32.4 18.0 350.7 15.2 0.0 2.9 5.0 0.0 4.2 0.0 0.9 32.5 0.3 1.9 28.1 321.7 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 36.1;Early spermatids: 121.0;Late spermatids: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 11.5 7.8 10.4 10.2 12.3 1.4 10.3 11.1 9.8 12.5 10.1 6.2 7.9 8.2 13.0 9.1 9.7 12.3 8.7 8.4 9.2 6.8 9.1 5.9 8.0 9.7 10.0 7.8 16.4 7.0 13.4 15.6 12.0 10.0 13.5 10.7 6.0 9.7 11.7 9.9 8.9 12.4 12.8 17.9 10.4 9.9 17.9 13.1 11.6 14.0 6.3 10.3 12.4 14.8 5.3 9.0 6.0 5.7 3.9 7.6 3.4 6.8 4.3 9.0 6.6 18.2 20.2 6.5 11.6 8.0 8.4 11.0 7.3 16.6 9.4 17.0 10.7 10.7 10.7 4.4 7.9 9.8 10.1 4.1 8.7 11.1 5.5 14.6 4.9 5.6 9.6 12.6 12.1 15.2 15.6 7.5 10.9 4.6 4.1 13.5 1.4 6.3 14.1 1.3 12.3 5.9 6.5 8.7 7.6 10.3 7.2 3.6 6.5 6.7 4.7 5.1 8.8 5.7 6.7 9.2 16.2 7.2 14.1 4.6 3.5 7.7 5.5 7.5 7.9 6.9 6.0 5.7 5.5 3.8 4.5 5.3 5.3 6.0 4.7 5.7 4.1 7.6 6.8 2.1 3.9 5.2 9.0 2.8 3.4 10.4 12.3 11.1 9.8 9.2 6.8 10.0 7.8 10.0 13.1 8.9 4.3 5.0 9.5 4.1 7.1 5.5 12.7 36.1 15.9 0.0 3.9 5.3 1.7 9.6 121.0 5.5 5.7 0.0 4.5 4.6 7.1 6.7 3.5 2.1 4.3 7.9 5.8 7.4 4.1 37.3 7.8 5.2 1.7 4.6 8.8 4.5 6.4 5.5 8.9 5.4 11.5 0.0 9.0 9.5 4.3 5.3 3.3 3.8 7.3 6.4 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58780788-58784327 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 71.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 64.5 29.4 26.7 33.7 17.2 68.4 61.7 19.5 20.6 60.0 32.7 30.8 28.4 13.3 40.5 21.8 34.1 72.6 48.5 31.3 20.2 12.4 21.2 39.3 55.1 14.3 15.3 12.0 49.8 48.7 15.0 16.7 21.6 24.1 48.6 16.7 40.5 59.4 39.3 32.2 51.3 28.6 40.7 17.6 22.9 47.0 18.2 18.1 9.0 61.0 35.2 23.3 41.5 33.1 7.4 1.3 4.0 5.1 3.2 2.5 1.2 16.1 2.3 5.2 1.0 8.3 9.5 0.1 20.6 7.5 14.6 8.9 4.2 1.2 0.6 9.9 12.8 31.6 5.6 0.4 6.7 9.3 12.8 37.5 0.2 0.9 4.7 6.9 1.1 3.7 10.2 17.3 18.8 7.9 6.6 10.9 0.7 5.7 9.4 5.6 3.0 1.0 9.0 4.2 7.8 14.7 0.4 71.6 3.2 13.7 1.5 14.5 4.2 14.3 15.0 6.0 5.9 5.3 0.6 19.1 33.3 15.1 12.0 25.8 20.9 3.3 1.2 34.8 2.1 9.5 1.2 5.1 2.0 2.4 1.1 1.3 4.1 1.2 2.5 1.3 7.4 0.3 1.7 4.0 3.2 0.4 0.2 0.9 1.2 26.7 17.2 19.5 20.6 20.2 12.4 15.3 12.0 24.1 18.1 500.2 627.8 505.0 717.3 1097.5 107.5 1349.5 494.3 76.3 282.1 99.5 247.4 529.1 43.1 569.2 40.2 960.8 1411.6 46.7 449.9 86.5 867.7 1920.0 529.9 118.4 560.4 82.6 1440.1 352.4 430.2 18.1 1136.5 481.3 718.7 237.2 1907.1 688.6 543.7 1520.1 243.3 25.0 400.6 1513.4 1714.3 15.6 13.8 843.0 347.6 518.9 938.7 449.9 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.7 15.6 24.9 16.6 20.2 20.2 18.5 24.2 14.7 19.4 19.4 8.8 9.9 8.7 15.9 15.7 27.4 23.5 12.1 13.9 23.0 17.8 6.5 15.3 16.5 10.4 14.0 16.0 16.7 12.0 20.5 13.1 26.0 20.2 34.7 22.4 16.3 18.3 26.4 8.7 10.0 13.2 18.2 22.9 12.4 15.5 15.1 8.1 17.9 24.0 14.1 12.6 14.8 10.9 7.1 25.8 13.5 19.2 19.9 26.4 13.6 23.4 19.1 11.4 15.3 17.9 23.7 17.5 19.6 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 35.7 25.1 24.1 50.0 36.7 53.1 11.8 28.1 44.2 34.2 24.4 49.1 52.9 28.2 51.7 63.2 41.9 19.0 0.0 47.3 69.4 32.9 72.1 42.8 18.4 34.4 63.5 23.0 32.5 28.5 42.2 29.4 37.7 30.4 56.9 30.5 52.5 80.0 38.6 31.1 34.2 40.0 58.2 43.0 37.0 44.8 47.4 150.1 31.6 35.9 104.3 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell type enhanced" "Detected in some" 6 "Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 12 "REH: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 2.1 0.0 0.1 0.1 0.9 1.9 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 0.0 0.0 0.0 2.5 2.3 2.2 0.8 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 2.3 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.9 0.9 5.0 3.6 0.0 1.3 0.2 0.0 1.8 0.0 0.9 0.0 1.9 0.4 4.3 3.3 0.1 0.7 0.0 1.4 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140177035 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 20.1 3.2 6.6 15.2 4.7 18.7 10.4 8.7 6.1 13.2 12.0 4.7 4.6 10.3 8.9 5.8 13.0 5.8 6.0 8.0 5.7 3.5 4.9 8.5 9.7 10.1 4.8 2.8 5.0 6.4 7.0 6.7 15.5 6.7 6.9 12.2 3.7 11.4 4.5 24.6 15.0 16.3 9.3 6.0 6.7 11.9 9.4 5.9 10.8 6.4 10.3 15.2 13.1 9.1 2.8 3.0 6.1 2.3 1.8 1.6 0.8 0.9 0.4 2.9 3.1 2.7 2.3 5.9 1.3 1.9 0.5 0.6 0.3 0.4 2.0 2.0 1.3 1.6 1.1 4.1 2.5 0.9 11.3 2.5 0.1 0.4 5.3 2.7 1.9 2.1 2.7 5.6 1.6 8.8 1.4 2.8 5.4 6.4 8.9 0.5 0.8 3.5 3.1 4.7 6.5 1.6 4.0 0.2 4.0 1.0 1.2 5.2 6.3 3.0 7.0 3.0 4.9 9.6 0.7 4.9 0.6 1.1 1.9 0.8 3.1 0.4 6.6 1.6 5.2 1.1 1.6 2.3 0.9 1.1 1.3 0.9 1.5 1.6 1.5 3.0 2.8 1.5 1.0 6.1 1.8 0.5 1.2 1.3 0.8 6.6 4.7 8.7 6.1 5.7 3.5 4.8 2.8 6.7 5.9 14.9 27.5 13.2 37.9 44.3 12.4 12.1 10.2 26.8 25.0 15.7 25.5 7.1 1.7 6.4 4.1 20.3 28.2 23.3 8.2 2.5 15.4 28.1 8.1 16.9 9.7 6.4 50.6 24.5 36.3 3.4 7.2 33.7 3.3 3.6 38.6 3.7 10.2 26.8 3.9 2.6 9.5 6.5 17.6 24.7 10.0 40.7 31.7 13.1 21.9 43.9 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Enhanced "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favorable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favorable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.6 4.3 12.4 8.6 8.4 13.2 6.2 7.7 10.8 9.9 10.1 4.4 5.9 16.4 5.9 8.0 4.7 4.7 14.5 8.1 13.1 9.0 4.9 11.9 8.1 5.3 5.8 14.9 8.4 9.4 9.9 10.1 9.6 11.0 8.2 10.2 16.8 9.0 9.6 3.8 16.5 10.5 11.6 7.1 5.6 6.8 11.8 9.2 6.3 5.7 6.2 10.6 8.9 7.0 6.1 8.6 11.6 12.8 9.4 5.5 5.0 14.4 8.7 5.8 16.5 10.0 10.2 14.5 8.0 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 35.7 29.6 39.6 25.1 30.7 17.4 23.8 30.6 32.1 45.5 22.7 7.9 37.2 58.0 37.7 149.2 31.5 17.6 0.0 53.7 48.7 27.7 35.1 37.0 22.9 30.8 14.3 15.0 30.7 39.1 61.4 34.8 35.6 13.5 26.2 22.9 41.7 40.6 23.5 46.3 29.3 12.2 0.0 25.5 46.8 40.9 24.3 47.8 34.8 24.1 36.6 KIAA1211L "C2orf55, MGC42367" ENSG00000196872 "KIAA1211 like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;epididymis: 27.7" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 95.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 22.3;HDLM-2: 32.0;Karpas-707: 9.4;MCF7: 8.5;SiHa: 9.1;SK-BR-3: 12.2" "Group enriched" "Detected in many" 15 "amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 2.7 0.8 19.0 1.3 23.7 0.5 3.5 2.4 27.4 4.6 5.0 0.8 3.5 6.7 1.5 27.7 9.1 19.3 2.5 1.4 12.9 1.9 2.5 0.4 3.9 0.6 2.7 18.3 1.4 3.7 9.6 4.3 4.0 0.1 1.6 4.0 0.0 9.0 4.3 1.3 4.3 6.1 2.1 1.2 1.0 6.8 3.6 3.6 0.0 4.3 3.3 2.5 2.4 3.2 0.0 0.7 1.4 0.3 0.2 0.9 0.0 4.3 0.2 0.1 1.7 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.2 2.6 0.0 5.7 0.0 0.1 3.9 0.1 0.2 0.0 32.0 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.6 0.0 1.3 0.0 0.0 9.4 0.0 8.5 0.1 0.6 0.0 4.3 0.4 0.0 0.0 0.4 1.7 3.4 3.2 0.5 9.1 12.2 0.0 0.0 4.7 0.7 5.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.7 0.0 0.0 19.0 23.7 2.4 27.4 12.9 1.9 2.7 18.3 0.1 3.6 14.9 2.9 0.0 3.1 0.6 0.0 4.2 5.1 95.0 23.9 3.5 0.0 0.3 3.3 3.7 11.8 9.0 10.0 0.0 6.5 1.1 0.2 1.7 0.0 0.0 2.6 0.0 15.1 6.7 1.5 17.2 0.3 0.9 0.0 0.0 11.4 0.0 4.8 8.6 0.4 2.2 0.0 0.0 0.4 15.9 12.6 5.3 0.3 0.0 8.8 5.1 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Group enriched" "Detected in many" 4 "Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 31.0 13.9 31.4 29.2 2.3 3.5 7.8 22.4 19.6 24.9 24.8 12.1 20.6 34.4 11.5 10.4 10.6 22.5 22.4 11.4 29.3 20.5 12.9 21.5 13.3 12.7 0.4 34.6 20.1 1.1 1.0 19.2 18.0 5.8 15.4 14.4 15.2 40.2 18.8 12.4 29.4 19.5 12.5 12.6 9.6 31.7 31.1 12.1 6.5 9.1 9.6 13.8 17.5 7.9 9.1 11.2 21.5 11.1 8.7 11.4 16.4 11.6 29.4 11.2 17.3 35.4 9.2 25.0 15.4 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 0.0 1.3 0.8 0.8 2.6 1.3 1.4 0.0 4.0 3.4 1.8 0.0 1.5 1.7 0.4 9.6 0.3 0.4 23.3 0.6 11.2 1.6 0.8 0.0 0.0 6.7 0.0 0.0 2.5 2.5 3.9 0.9 2.6 0.0 1.0 1.9 0.8 0.3 0.0 0.7 0.5 0.4 0.0 1.2 24.7 25.8 2.9 1.3 3.8 2.9 0.9 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020620-28108308 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3;testis: 16.9" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 22.1;Erythroid cells: 23.3;Spermatocytes: 76.3;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.9 0.5 0.6 3.9 0.8 7.9 0.6 0.9 0.9 0.8 2.1 0.3 0.0 1.5 0.5 0.8 3.1 0.5 0.4 0.5 0.7 0.5 1.8 0.5 1.5 4.8 0.5 0.0 0.6 0.5 0.0 0.6 3.4 0.8 0.5 2.2 1.3 0.9 1.6 0.8 1.3 1.9 0.6 0.9 2.7 1.0 16.9 0.2 31.3 2.8 2.0 4.9 1.0 1.2 2.3 0.7 6.4 0.4 2.8 2.2 0.4 12.5 12.6 12.8 8.9 0.4 1.8 4.3 13.1 6.1 20.9 22.0 4.2 5.1 10.6 4.7 6.7 11.4 12.7 10.9 5.1 29.4 10.5 6.6 6.9 8.6 5.3 1.0 10.1 6.3 3.3 0.6 7.3 8.6 3.7 8.0 8.8 10.9 9.3 11.8 6.6 10.2 7.5 6.3 8.2 5.2 8.0 30.6 5.2 5.9 3.7 7.7 5.9 10.9 5.2 3.6 8.2 11.1 3.1 4.6 16.7 13.0 15.6 17.0 3.7 8.7 10.7 10.0 7.5 11.7 6.4 0.0 0.8 0.2 0.4 0.8 2.3 0.9 0.5 0.7 1.0 0.8 0.3 0.0 2.8 0.1 0.6 2.2 0.4 0.6 0.8 0.9 0.9 0.7 0.5 0.5 0.0 0.8 0.2 3.0 0.0 6.0 1.0 2.1 0.2 0.4 0.0 2.7 3.4 0.0 5.9 2.6 0.0 0.5 22.1 0.3 0.5 23.3 0.8 6.4 0.4 0.2 4.6 0.0 1.9 0.0 1.7 1.3 1.0 4.0 0.6 1.1 0.0 1.8 0.9 0.3 0.4 0.0 0.4 0.5 1.6 0.0 0.3 76.3 16.2 0.9 1.4 3.2 1.4 0.1 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.4 18.8 16.2 15.1 0.4 1.4 13.6 12.4 4.6 15.6 12.3 15.6 12.5 12.8 5.3 4.7 10.0 15.9 11.1 5.0 7.9 26.3 16.6 16.5 21.2 9.6 0.0 13.6 14.5 0.3 0.2 13.5 5.4 2.1 7.9 13.3 12.4 21.8 8.0 11.2 25.3 13.4 11.9 13.1 13.0 19.4 24.7 8.5 2.5 7.9 12.2 11.8 8.3 7.5 4.6 7.8 14.1 9.7 5.2 23.3 23.1 13.7 26.0 7.0 6.9 15.7 7.5 10.4 15.0 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.5 0.4 0.7 0.5 0.6 0.1 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.5 4.7 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 15.7 0.2 0.0 1.4 0.1 0.4 0.1 0.1 0.7 0.1 3.7 0.1 0.0 0.4 11.4 16.8 0.3 1.6 0.1 0.3 0.0 0.6 31.6 1.7 19.8 0.0 0.0 9.1 4.1 2.0 1.5 0.0 3.2 0.0 16.8 0.1 0.0 3.2 0.4 0.2 0.2 0.2 0.8 0.0 3.4 1.1 0.0 1.4 0.0 0.1 36.2 16.7 7.8 1.6 4.9 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 0.0 6.7 6.1 0.2 0.9 21.3 1.2 0.0 0.0 0.0 1.8 55.0 0.0 0.0 0.6 20.0 1.8 0.0 0.0 1.4 0.1 0.9 0.3 5.8 0.0 1.4 1.6 0.0 0.6 3.8 57.7 0.9 2.5 0.0 2.8 1.1 22.6 1.7 0.0 0.0 0.0 23.6 6.5 1.2 1.4 2.5 0.9 0.0 11.7 0.7 1.8 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Group enriched" "Detected in some" 82 "Early spermatids: 638.1;Late spermatids: 419.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 638.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.5 15.8 23.9 11.7 1.1 2.0 9.4 17.2 9.2 23.5 20.5 17.7 13.3 13.9 10.8 8.4 18.2 13.6 25.8 9.3 26.6 15.9 13.0 15.7 19.3 12.5 0.2 17.4 10.9 0.7 0.5 19.5 11.2 2.8 14.3 10.7 19.9 30.9 22.1 14.5 15.9 8.6 24.1 24.1 16.8 17.7 32.3 13.0 5.6 8.9 15.8 13.2 28.0 11.9 7.3 12.6 9.5 6.8 9.9 15.6 20.3 16.7 20.4 8.9 15.3 20.1 8.2 19.1 23.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 0.0 0.3 0.0 0.2 1.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 46.7 0.0 10.3 1.0 0.1 0.0 0.0 4.3 0.0 1.2 1.8 0.6 0.5 0.0 0.9 0.0 0.0 1.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.2 5.8 0.3 1.5 0.5 2.1 0.3 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 120.7;Suprabasal keratinocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 28.7 9.1 2.5 7.0 3.5 11.8 33.1 8.2 4.4 12.9 13.0 5.1 10.8 3.5 12.8 11.7 8.3 11.2 11.6 19.4 2.9 2.3 12.7 27.9 14.6 15.9 5.5 2.4 13.7 38.3 7.3 2.4 9.9 3.4 13.9 4.7 9.2 11.3 10.9 14.0 19.1 7.7 30.4 3.5 16.1 10.2 16.7 2.7 1.5 9.1 8.5 5.6 11.1 42.7 2.9 6.6 1.7 12.7 5.4 2.7 3.8 3.7 1.8 4.4 0.4 3.1 5.5 10.7 4.4 4.5 2.5 2.6 4.3 8.8 0.0 8.0 5.3 10.2 0.9 3.8 3.4 1.7 25.9 2.9 1.9 5.4 0.8 3.0 7.9 12.6 8.6 12.7 4.8 1.3 6.5 2.2 0.7 5.2 17.5 2.5 4.4 0.0 1.4 7.1 3.0 3.8 4.2 0.1 7.3 6.1 4.7 5.7 3.5 6.7 13.9 12.9 7.3 3.2 10.8 6.2 11.1 9.3 8.3 1.4 15.9 18.9 10.2 2.9 2.1 5.9 0.0 6.9 1.7 2.6 11.0 0.8 2.8 1.7 1.8 6.6 2.9 0.5 1.0 0.2 5.4 12.7 0.3 2.7 3.8 2.5 3.5 8.2 4.4 2.9 2.3 5.5 2.4 3.4 2.7 6.0 5.8 3.2 13.5 53.8 5.2 2.8 7.6 5.3 7.9 7.0 5.9 2.4 24.9 7.7 120.7 16.6 3.1 0.0 7.4 3.3 9.7 13.1 8.1 34.1 11.6 3.2 6.8 43.0 29.9 21.5 13.6 21.1 28.7 3.6 6.8 2.3 8.2 0.0 15.6 5.3 4.7 32.3 44.3 14.1 35.0 75.4 6.9 5.7 7.4 9.5 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved Nucleoli Yes No Nucleoli "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favorable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favorable (1.69e-4)" 12.7 12.1 13.5 23.1 15.5 17.0 12.7 15.5 15.8 9.9 13.8 14.6 16.1 13.1 17.5 14.4 12.8 13.1 17.7 10.2 14.7 12.9 11.4 16.1 12.5 21.0 14.7 13.6 12.1 20.6 15.6 14.2 8.7 12.9 11.0 15.8 10.7 16.6 16.3 30.7 15.9 12.0 12.7 15.5 14.9 14.5 26.6 12.9 22.7 14.0 14.5 19.5 12.7 11.8 6.1 6.1 4.4 11.1 17.6 14.4 6.4 6.7 12.4 6.3 9.5 2.5 3.4 9.8 6.4 6.0 10.6 5.0 18.3 9.7 10.7 8.6 5.0 3.7 11.1 9.6 8.5 7.6 1.6 10.7 6.1 7.8 12.0 6.5 5.6 6.4 1.5 4.5 9.5 10.7 5.2 8.8 18.1 19.5 5.6 7.0 29.0 13.1 16.6 10.6 7.6 9.3 12.7 7.3 6.1 6.3 7.9 9.7 9.3 13.4 6.9 3.1 5.4 10.9 9.0 5.5 5.9 10.1 3.0 12.1 27.3 9.3 46.5 5.7 14.5 4.0 0.0 6.0 4.4 14.4 7.8 12.6 6.1 6.0 11.6 4.4 5.5 6.1 9.2 0.4 17.6 11.1 6.1 5.0 6.4 13.5 15.5 15.5 15.8 14.7 12.9 14.7 13.6 12.9 12.9 0.0 15.6 9.0 8.9 4.0 14.4 8.5 12.7 9.4 15.9 8.7 25.5 12.5 10.0 9.5 50.2 6.7 11.1 23.3 14.4 7.3 5.9 11.1 3.5 11.3 11.7 11.1 23.1 9.8 16.5 59.9 6.1 6.8 8.5 9.0 12.0 6.2 11.7 11.5 7.1 19.2 17.7 0.0 6.2 19.4 11.7 5.8 10.0 30.2 18.5 15.3 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 6 "Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.3 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 5.0 0.0 0.0 1.6 0.0 0.0 0.0 3.5 3.7 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.5 0.0 1.5 0.5 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.1 0.0 1.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 0.0 4.1 0.0 11.1 0.8 13.0 8.5 7.6 53.5 9.1 27.9 2.0 2.3 48.0 6.8 336.6 3.3 3.2 0.0 4.9 2.8 3.5 10.5 1.1 7.3 0.5 3.2 5.2 1.8 0.3 352.6 7.5 0.3 6.8 1.0 12.5 27.9 4.2 7.0 7.8 29.8 16.9 12.9 1.9 259.8 11.1 0.6 0.7 0.0 7.6 5.6 KLHL22 "FLJ14360, KELCHL" ENSG00000099910 "Kelch like family member 22" Q53GT1 22 20441519-20495883 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040766 Supported "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No "Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA040766: AB_2732488" "unprognostic (4.15e-1)" "unprognostic (9.34e-3)" "unprognostic (5.37e-2)" "prognostic favorable (4.88e-6)" "unprognostic (1.17e-1)" "unprognostic (2.30e-3)" "unprognostic (1.00e-2)" "unprognostic (1.19e-3)" "unprognostic (2.20e-1)" "unprognostic (8.99e-2)" "prognostic favorable (3.85e-6)" "unprognostic (3.94e-2)" "prognostic favorable (1.34e-8)" "unprognostic (3.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.64e-2)" "unprognostic (1.08e-2)" 10.8 12.4 15.2 11.2 17.8 8.6 9.6 26.9 24.0 15.4 10.7 11.8 13.1 6.5 17.8 15.7 8.5 15.1 15.9 11.2 14.2 14.9 13.7 9.0 11.1 13.1 11.5 16.3 19.8 16.3 20.7 14.7 13.2 10.9 16.6 9.2 17.0 11.3 16.2 16.3 9.9 8.0 19.0 7.8 12.5 9.9 8.3 9.6 5.0 18.5 6.8 17.1 11.1 12.3 7.1 12.9 15.1 6.6 13.7 16.0 5.1 9.0 8.9 20.1 16.7 17.2 19.8 5.0 11.6 19.2 11.9 13.1 4.6 3.4 6.0 3.9 20.4 9.2 11.6 13.9 5.2 10.6 12.3 7.5 5.7 8.7 4.5 15.8 1.4 6.7 15.3 7.9 10.3 7.3 14.7 16.5 4.9 16.7 6.4 11.5 14.2 1.2 8.5 3.5 7.1 6.4 12.5 7.4 0.3 6.9 11.0 10.9 11.3 12.0 9.3 8.4 7.3 8.2 5.0 7.3 14.4 6.9 9.7 4.8 3.6 3.7 4.5 7.6 5.6 9.3 5.4 3.6 15.1 7.3 5.1 5.7 7.1 9.3 6.6 12.9 6.1 7.3 7.3 8.7 13.7 6.6 4.9 16.0 5.1 15.2 17.8 26.9 24.0 14.2 14.9 11.5 16.3 10.9 9.6 0.0 3.0 3.7 2.7 1.4 10.8 4.1 10.2 4.0 3.4 8.7 3.9 13.9 3.3 7.6 0.2 3.0 2.1 0.0 2.2 5.8 5.5 3.4 4.7 5.0 6.9 12.7 2.9 4.3 4.3 1.3 11.2 3.4 1.7 1.8 4.8 12.8 5.3 3.2 18.7 7.3 5.9 6.5 4.7 6.2 7.7 1.3 11.2 6.9 3.5 1.3 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.7 0.0 1.0 0.0 0.0 0.0 0.2 9.7 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487531-183555689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.2" "Cell type enhanced" "Detected in many" 12 "B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 4.4 1.2 1.4 43.2 3.3 2.9 2.2 0.5 1.8 1.7 4.1 2.4 0.5 2.3 1.1 0.3 1.7 4.2 2.3 1.9 1.8 1.3 1.4 1.4 8.0 23.8 4.4 0.0 0.7 0.8 0.2 1.0 1.8 2.8 1.4 2.2 0.8 4.6 0.6 0.7 0.8 9.9 0.7 8.8 15.1 3.5 0.7 2.3 21.4 1.6 0.5 34.5 2.8 2.7 4.4 5.2 13.3 3.3 2.8 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 9.8 0.0 0.0 0.0 2.6 10.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.1 7.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 5.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.0 31.6 16.4 46.4 0.0 2.9 0.0 7.1 3.3 13.3 0.8 2.7 0.9 4.4 3.0 1.3 2.3 3.3 3.6 2.2 3.1 2.8 3.0 5.2 4.8 2.7 1.4 3.3 0.5 1.8 1.8 1.3 4.4 0.0 2.8 2.3 6.0 9.2 16.2 1.5 1.0 0.6 3.2 0.0 18.7 9.1 0.0 2.0 0.2 0.0 0.0 1.5 2.9 0.0 0.0 0.0 0.2 1.1 1.1 47.6 0.0 22.0 0.0 0.0 1.8 16.7 0.0 0.3 17.0 8.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.5 0.5 10.8 0.0 1.0 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.1 16.3 16.5 13.3 17.1 11.5 17.7 9.1 9.5 11.8 6.3 28.6 7.3 17.8 11.8 12.7 8.5 11.6 21.7 10.0 9.8 10.4 17.4 22.6 17.1 15.3 11.7 26.8 22.7 9.7 14.4 16.5 17.1 14.1 17.5 18.5 28.3 9.9 13.3 18.9 13.3 25.0 15.6 23.7 14.1 20.0 10.2 6.4 9.9 19.0 13.8 11.7 14.0 13.8 9.5 15.0 13.7 23.5 23.3 9.3 16.6 8.1 15.2 14.1 9.1 17.3 10.7 13.9 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 8.9 18.4 11.1 6.5 12.5 25.2 4.7 12.7 5.3 9.1 17.4 49.1 6.6 1.7 5.8 2.5 12.6 11.1 0.0 5.2 4.6 8.5 8.3 8.1 12.3 8.3 20.6 12.6 17.2 19.7 1.1 8.9 9.6 10.1 4.6 10.5 5.2 7.2 8.6 10.3 4.3 38.9 6.5 3.3 3.7 3.2 15.4 9.5 10.4 10.1 8.4 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Cell type enhanced" "Detected in some" 12 "Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.9 5.6 11.5 8.3 0.3 1.7 5.1 12.8 5.2 10.0 8.5 6.9 4.4 7.3 4.1 5.5 7.6 13.7 10.8 6.0 10.6 12.6 3.0 21.4 9.6 2.0 0.0 16.3 10.8 0.3 0.2 6.7 4.2 1.3 8.5 13.0 13.7 12.2 11.7 3.7 13.9 3.3 5.6 6.6 6.0 12.7 16.5 3.6 1.5 9.7 9.9 4.6 11.1 6.3 1.3 3.8 6.8 5.0 7.9 11.7 10.4 13.4 7.1 4.7 15.9 14.2 4.7 11.1 11.1 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 1.8 0.0 2.4 1.7 0.2 0.0 0.0 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Group enriched" "Detected in many" 4 "Early spermatids: 321.9;Late spermatids: 423.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.2 14.7 29.4 19.2 6.5 10.1 15.3 21.7 16.9 44.9 39.7 31.5 13.8 12.1 11.1 14.6 35.8 36.2 31.3 20.1 40.7 21.5 15.3 35.9 33.0 19.8 6.1 19.2 18.8 5.2 11.6 22.6 22.7 11.0 25.1 30.5 25.8 21.0 37.7 15.8 16.6 15.5 18.5 26.8 22.4 17.1 22.1 14.0 15.6 13.0 28.7 19.9 18.1 20.0 4.8 18.6 20.9 13.8 12.9 21.7 22.2 22.1 30.0 18.0 29.1 21.8 13.4 25.8 17.7 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 8.9 0.6 0.8 3.1 1.9 7.8 4.7 2.5 9.4 5.7 0.0 7.9 14.3 3.3 9.5 321.9 1.7 1.6 46.7 8.1 35.4 6.2 3.8 1.1 5.7 18.4 4.8 2.4 3.1 7.5 423.6 8.3 7.6 3.3 8.2 3.6 7.0 8.7 0.0 6.7 4.4 7.4 0.0 2.7 83.7 18.1 1.3 17.6 3.2 3.0 2.8 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KRI1 FLJ12949 ENSG00000129347 "KRI1 homolog" Q8N9T8 19 10553078-10566037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043110, HPA043574" Approved Enhanced Nucleoli Yes No Nucleoli "HPA043110: AB_2678321, HPA043574: AB_2678561" "unprognostic (6.38e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (9.37e-4)" "unprognostic (6.70e-2)" "unprognostic (2.35e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (4.89e-10)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.02e-1)" 14.7 12.5 10.4 23.6 20.6 19.1 14.3 27.8 19.6 14.5 13.4 16.6 12.4 12.7 15.9 17.6 17.2 14.3 15.0 12.1 13.1 10.3 11.9 13.3 12.4 25.2 16.7 9.8 17.2 19.5 21.0 18.3 10.9 14.9 15.6 9.8 20.3 14.7 18.2 23.0 25.3 16.8 15.0 17.2 23.0 12.7 14.6 18.6 46.8 15.6 10.9 21.3 15.8 15.9 8.5 14.1 2.5 4.9 8.5 11.2 3.9 12.3 6.3 8.1 11.7 4.4 4.9 5.6 11.4 5.4 7.2 6.7 9.1 4.5 18.2 13.5 4.6 6.3 9.7 9.9 8.9 8.2 19.8 22.5 57.8 12.2 5.9 8.1 22.6 21.0 6.0 7.3 10.4 10.7 6.3 4.6 11.1 16.1 18.6 6.2 11.0 23.2 33.7 13.0 10.0 15.1 9.8 10.6 9.0 6.1 11.0 13.4 6.3 13.4 7.9 8.4 7.5 9.9 16.6 5.5 9.4 7.9 25.2 23.8 13.2 15.3 13.1 7.9 18.4 14.0 1.3 4.5 2.5 11.2 4.9 10.3 7.1 7.5 9.0 5.8 8.5 8.4 9.0 0.8 8.5 2.5 14.1 5.4 3.9 10.4 20.6 27.8 19.6 13.1 10.3 16.7 9.8 14.9 18.6 14.9 23.8 9.3 12.1 11.9 14.0 6.1 7.6 22.7 22.7 14.0 37.3 9.8 1.7 6.5 3.2 7.3 6.7 0.0 6.4 7.3 8.2 6.6 18.5 7.4 6.8 11.1 9.2 9.8 10.2 5.0 7.8 8.2 8.5 1.8 7.8 8.9 5.0 7.0 8.5 3.9 51.4 0.0 7.3 28.7 15.0 12.0 3.8 15.3 9.5 5.9 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1, small subunit processome component homolog" Q13601 12 75490861-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA043433: AB_10960988, HPA051690: AB_2681574" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 22.5 18.4 14.2 15.1 22.0 38.0 17.8 29.1 23.3 21.2 14.3 6.7 14.6 12.6 18.3 15.2 24.2 14.7 10.5 12.5 12.6 10.8 23.7 25.0 13.5 18.2 12.8 16.4 21.7 15.0 17.8 33.5 21.4 19.8 20.9 11.8 6.3 20.7 14.2 28.8 16.6 15.2 15.7 16.1 19.8 15.1 12.3 17.3 24.3 20.5 22.4 18.1 19.6 16.4 15.8 10.8 8.9 4.6 8.6 14.7 5.6 25.4 21.1 13.3 11.8 10.5 9.6 24.3 22.3 14.2 17.6 11.3 15.4 13.4 27.1 18.2 11.0 17.6 13.4 17.8 19.6 19.9 22.3 18.1 26.2 11.7 17.9 12.7 46.1 16.6 9.9 16.8 20.2 19.3 17.8 12.0 25.9 28.9 8.7 17.2 16.8 26.8 13.1 19.6 14.1 19.3 21.3 25.6 16.3 19.6 32.2 16.0 13.3 21.1 15.0 26.3 13.3 24.9 18.8 14.9 16.3 10.8 16.8 23.1 17.4 21.8 17.0 8.8 16.3 29.3 7.7 2.4 8.9 10.1 4.6 12.4 15.8 14.1 11.4 3.9 14.4 14.7 13.8 1.1 8.6 3.7 10.8 12.5 5.6 14.2 22.0 29.1 23.3 12.6 10.8 12.8 16.4 19.8 17.3 65.5 42.2 31.8 91.0 43.6 53.3 22.4 15.3 48.2 54.6 38.4 31.4 56.6 49.7 37.5 4.0 32.2 15.1 0.0 42.7 45.8 41.4 40.8 36.9 36.7 26.1 69.9 17.2 22.1 18.8 5.3 48.6 29.3 11.8 32.5 23.2 65.0 33.7 27.9 50.2 37.3 53.6 12.9 36.3 55.6 54.8 38.8 58.9 48.4 29.3 62.9 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619437-41624842 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 109.0;tongue: 144.0" "Group enriched" "Detected in many" 8 "Basal glandular cells: 10709.5;Urothelial cells: 6883.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTCEpi: 653.9;SiHa: 272.2" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" Yes No 750000000 "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204" "prognostic favorable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 0.7 0.0 0.7 0.7 0.7 0.1 52.3 0.7 0.8 12.6 0.8 0.7 1.2 0.0 1.0 3.1 38.6 0.9 0.9 0.7 0.7 0.0 0.8 0.7 3.7 0.7 0.7 1.0 0.8 0.7 0.0 0.9 4.1 0.8 15.0 0.0 0.7 26.8 33.4 0.7 109.0 0.7 1.2 0.7 0.7 0.0 0.8 0.7 5.1 0.8 144.0 19.7 55.6 25.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 6.5 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 66.1 0.0 67.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 653.9 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 24.8 0.0 0.0 272.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.8 0.7 0.0 0.7 1.0 0.8 0.7 20.8 7.4 0.0 10709.5 124.0 0.0 0.0 0.0 112.4 563.0 34.9 0.0 2.0 0.0 285.1 0.3 2.9 0.0 0.0 180.6 118.1 9.3 924.1 3.5 0.0 3.5 19.1 1.7 0.0 0.0 1.3 2.0 7.9 10.1 11.8 0.1 0.0 1050.1 0.0 199.8 0.0 0.0 0.0 5.7 0.4 0.2 108.7 4.8 0.5 0.6 6883.0 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" Yes No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.2 7.4 1.1 5.1 6.9 1.5 3.7 7.7 1.5 2.7 3.8 4.0 1.3 5.4 4.8 4.6 3.2 4.2 6.6 2.3 2.9 4.3 8.6 1.6 1.0 2.6 5.1 31.5 4.3 4.8 1.7 5.1 7.6 30.6 4.1 6.2 3.5 3.8 0.3 10.8 0.9 3.5 0.7 1.6 4.0 2.1 0.0 4.9 1.2 0.2 1.0 1.4 0.3 3.0 9.5 7.8 4.5 20.9 2.5 3.5 0.4 2.4 0.6 0.0 2.3 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 3.0 9.2 7.5 4.8 4.5 2.9 2.9 2.5 5.3 3.4 8.7 2.0 10.2 1.7 4.3 18.5 5.6 0.7 0.0 4.9 6.0 6.7 4.2 38.3 4.9 3.3 0.0 3.5 7.4 8.2 1.6 8.9 3.6 1.7 4.6 7.2 5.6 7.5 3.5 5.6 4.3 0.7 6.5 5.1 5.4 6.1 3.9 5.1 10.0 4.1 5.2 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.9 9.6 9.2 8.7 18.3 22.3 0.1 17.3 19.5 62.9 76.5 17.5 20.9 43.2 11.5 13.3 37.5 6.8 34.5 12.2 24.0 16.4 9.9 23.9 10.6 22.8 21.3 21.5 15.4 22.7 7.8 20.6 10.9 7.2 21.8 11.4 23.1 30.9 14.8 11.8 19.1 29.5 19.2 20.6 18.4 29.7 8.8 21.8 16.4 12.9 13.6 11.2 15.8 9.8 33.8 13.3 8.3 8.3 14.1 16.0 10.8 16.8 30.0 28.4 43.4 37.3 21.6 35.9 15.4 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 26.8 44.7 44.2 21.0 19.6 8.0 43.2 10.2 46.8 26.1 26.2 2.0 31.2 99.5 46.8 71.4 104.1 38.5 0.0 96.6 44.5 25.9 23.1 63.4 92.3 227.4 6.4 15.6 68.2 96.6 22.8 21.3 135.7 40.5 251.5 30.0 93.7 42.5 30.2 32.9 217.2 12.6 32.3 24.7 46.4 13.2 19.9 46.6 30.5 39.9 21.7 LARP6 "acheron, FLJ11196" ENSG00000166173 "La ribonucleoprotein domain family member 6" Q9BRS8 15 70829130-70854159 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 324.8;Late spermatids: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enhanced" "Detected in many" "U-2197: 58.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020338, HPA049029" Approved Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "HPA020338: AB_1844500, HPA049029: AB_2680604" "unprognostic (1.35e-3)" "unprognostic (1.95e-1)" "unprognostic (7.43e-2)" "unprognostic (2.63e-3)" "unprognostic (2.96e-2)" "unprognostic (4.70e-2)" "unprognostic (2.44e-2)" "unprognostic (2.80e-3)" "unprognostic (4.27e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (9.90e-5)" "unprognostic (4.51e-3)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" "unprognostic (3.43e-1)" 28.3 10.1 25.5 7.7 36.9 1.3 27.4 10.8 57.2 24.1 6.2 44.7 3.4 3.4 17.6 32.6 9.4 13.4 12.6 27.9 33.1 20.9 17.1 4.6 6.3 3.4 36.0 19.3 24.7 8.6 11.4 8.8 9.1 25.1 16.6 5.6 4.3 12.3 17.1 10.8 4.9 4.1 14.1 43.1 2.5 9.3 9.7 31.7 0.7 27.0 4.0 2.7 10.3 16.9 0.3 0.3 2.6 0.3 0.5 0.4 0.1 10.1 10.8 3.5 7.0 18.0 20.2 0.0 31.4 24.5 17.0 18.1 3.1 2.9 0.0 12.9 17.0 16.5 5.5 7.9 2.7 16.9 0.1 19.4 0.0 9.0 2.8 32.7 0.0 0.0 12.6 11.5 17.0 27.3 17.9 5.5 3.8 0.0 0.1 7.5 1.7 0.0 0.0 3.7 0.0 28.3 0.0 12.7 0.0 5.5 8.7 2.1 4.6 10.4 0.1 21.5 5.7 0.5 0.5 7.2 6.9 27.8 58.3 25.9 0.0 0.0 0.0 29.7 0.0 3.5 1.1 0.3 0.3 0.4 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.3 2.6 0.5 0.2 0.3 0.2 0.1 25.5 36.9 10.8 34.8 33.1 20.9 36.0 19.3 25.1 31.7 0.0 1.4 0.0 40.1 16.1 28.7 16.9 25.5 12.0 6.8 12.2 2.0 0.4 46.4 51.0 324.8 12.8 0.0 0.0 21.7 0.7 58.7 51.8 0.0 13.1 1.1 23.8 11.5 11.6 0.3 173.4 67.9 2.6 18.6 0.0 0.2 21.0 44.8 0.0 43.2 62.8 4.8 19.4 22.7 17.4 8.0 7.9 0.3 0.5 0.4 22.5 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell type enhanced" "Detected in some" 11 "Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA044257: AB_2678880" "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.8 1.4 0.0 0.1 1.7 1.4 6.5 0.3 0.2 0.4 0.4 9.3 5.7 0.2 1.6 0.7 0.6 1.5 0.0 0.3 0.0 8.0 1.7 4.1 0.5 19.3 1.3 0.2 2.6 1.8 1.4 1.4 0.3 0.2 1.6 0.1 2.7 2.0 0.3 2.0 0.1 0.8 0.4 1.6 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.1 2.3 0.3 8.4 0.1 0.2 0.3 3.6 1.4 6.1 7.4 0.1 2.6 2.0 0.2 1.4 0.7 4.3 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.4 0.3 0.0 0.0 2.8 0.9 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 6.3 0.0 6.5 0.2 0.0 0.0 0.1 0.5 0.0 0.8 0.1 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39458587-39485109 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 82.3;Late spermatids: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favorable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 9.8 12.9 9.9 7.0 12.7 10.2 11.3 10.2 13.3 7.0 10.7 12.9 8.1 10.4 9.1 10.7 11.6 11.9 7.4 14.0 10.6 10.6 15.7 15.5 5.7 9.0 12.3 10.5 19.2 12.4 10.0 11.5 6.8 15.7 8.2 12.4 9.0 7.8 7.0 42.7 8.8 9.9 13.6 12.4 8.9 9.9 20.1 13.2 8.7 8.8 13.5 8.3 10.0 7.9 9.6 5.8 3.7 7.1 6.9 16.7 4.3 4.0 3.1 4.0 3.8 8.4 8.2 3.4 4.6 2.6 4.3 2.9 5.0 5.5 14.6 5.3 1.7 10.9 3.6 11.3 6.3 5.8 1.6 2.8 6.1 1.6 5.0 7.7 13.2 4.0 7.9 10.5 5.1 16.2 9.6 4.9 9.1 14.4 3.6 5.2 2.5 7.4 17.0 5.3 10.6 10.1 6.5 10.8 8.8 5.1 2.1 4.4 3.8 2.7 3.6 14.9 5.8 4.0 6.1 1.8 3.5 7.7 4.5 10.7 7.1 10.8 10.2 5.4 15.4 3.0 2.0 6.2 3.7 6.1 7.1 12.6 9.6 8.3 8.0 5.8 8.5 16.7 11.5 3.3 6.9 5.1 5.4 5.2 4.3 9.9 12.7 10.2 13.3 10.6 10.6 12.3 10.5 15.7 13.2 8.9 9.3 13.4 11.9 8.7 24.0 16.5 10.2 20.1 13.6 17.4 9.8 21.5 18.3 10.7 82.3 7.1 13.1 0.0 5.5 12.9 8.0 5.2 17.3 17.0 15.4 9.5 17.4 5.5 11.7 80.7 9.5 10.9 1.7 17.2 12.1 15.2 9.0 10.5 11.7 23.2 23.3 0.0 9.5 47.0 20.9 8.2 8.0 12.9 18.1 8.4 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 4.1 5.6 8.1 25.2 10.4 37.8 6.4 17.2 10.6 6.5 9.2 6.5 8.7 12.0 6.8 6.1 11.0 7.8 6.9 2.6 6.3 5.3 6.0 6.2 5.9 18.6 7.7 7.4 10.8 10.3 9.1 9.7 11.7 8.1 7.5 6.0 4.6 7.2 7.9 6.1 12.5 12.8 3.6 7.1 11.2 6.7 15.1 11.5 34.7 10.7 12.1 16.9 6.6 8.6 10.4 1.3 2.0 5.6 10.9 11.5 4.8 15.8 20.4 21.9 14.1 0.9 1.1 15.8 9.2 6.8 14.8 16.4 11.5 15.6 28.7 5.7 3.9 4.1 10.7 9.0 9.0 6.4 15.4 15.5 17.7 14.4 14.9 0.3 22.0 14.7 2.0 0.7 7.9 1.2 1.9 7.9 17.5 15.0 10.8 7.5 12.7 35.1 32.7 12.4 17.1 4.7 30.3 17.1 14.1 4.6 24.2 13.8 13.8 11.1 13.0 3.1 5.2 8.4 16.9 7.8 11.8 20.0 9.9 14.3 10.7 16.8 29.2 4.8 12.4 13.1 0.0 1.4 2.0 7.6 5.6 6.8 10.3 8.4 7.6 1.3 10.4 11.5 8.0 1.1 10.9 2.7 1.2 8.9 4.8 8.1 10.4 17.2 10.6 6.3 5.3 7.7 7.4 8.1 11.5 3.0 9.9 14.6 6.7 7.3 17.6 3.9 2.5 25.4 12.5 3.5 9.8 16.2 6.6 5.1 17.7 5.5 4.5 0.0 4.5 29.3 5.0 2.8 5.8 3.9 13.9 7.9 0.0 4.3 5.2 6.4 2.0 5.8 3.3 10.8 6.8 11.9 3.5 5.8 1.8 3.7 11.6 12.9 4.9 9.8 28.5 8.0 8.4 11.4 8.1 5.5 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell type enriched" "Detected in some" 16 "Muller glia cells: 199.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Group enriched" "Detected in some" 11 "RPTEC TERT1: 24.5;SuSa: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: AB_2683715" "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.8 0.0 0.0 0.0 1.4 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LLPH "C12orf31, hLLP, MGC14817" ENSG00000139233 "LLP homolog, long-term synaptic facilitation" Q9BRT6 12 66116555-66130768 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048920, HPA058786" Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA048920: AB_2680556, HPA058786: AB_2683820" "unprognostic (3.60e-3)" "unprognostic (4.94e-2)" "unprognostic (4.07e-2)" "unprognostic (3.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.31e-2)" "prognostic unfavorable (6.44e-7)" "unprognostic (7.15e-2)" "unprognostic (1.30e-2)" "unprognostic (8.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.07e-2)" "unprognostic (3.87e-2)" "unprognostic (9.65e-3)" "unprognostic (2.49e-2)" "unprognostic (3.37e-1)" "unprognostic (2.94e-2)" 20.4 38.1 16.4 20.4 16.9 40.9 17.9 10.9 20.0 16.4 20.2 11.2 19.7 16.4 17.2 17.1 21.3 14.4 13.4 19.9 15.7 13.9 27.8 31.3 14.5 21.4 20.6 16.7 18.2 16.2 11.1 18.0 24.3 17.3 18.1 18.6 9.9 15.9 14.5 47.3 13.9 27.9 21.0 26.7 29.7 18.6 20.0 17.6 23.8 22.9 23.5 21.6 23.6 22.4 23.6 24.6 34.9 34.7 20.0 29.4 21.1 27.2 22.1 13.6 16.8 15.9 15.7 16.8 32.0 20.7 23.8 20.2 19.1 11.6 31.7 26.4 21.2 18.8 23.4 21.2 19.4 32.3 27.7 18.2 33.5 16.0 17.0 19.2 58.2 23.6 15.8 20.1 20.2 21.8 18.7 20.5 16.1 28.9 22.8 27.8 29.3 26.0 39.2 29.2 22.3 23.5 22.1 25.1 22.8 23.3 33.0 13.7 16.9 20.7 22.1 33.7 15.0 28.4 31.8 22.1 18.7 26.8 22.7 29.0 17.7 27.4 46.9 24.4 27.4 28.3 22.2 25.6 26.4 23.7 29.0 27.0 23.6 27.6 25.5 24.6 21.7 23.9 25.2 34.9 20.0 34.7 21.2 29.4 21.1 16.4 16.9 10.9 20.0 15.7 13.9 20.6 16.7 17.3 17.6 11.9 36.4 61.0 44.6 24.2 16.2 20.7 50.9 30.8 53.4 29.6 3.9 54.4 56.3 64.5 29.5 27.6 32.9 0.0 61.6 55.9 32.7 30.8 87.7 53.9 56.6 20.6 13.3 33.2 50.4 10.0 40.6 51.5 33.7 79.4 24.4 25.7 76.7 34.5 28.3 61.5 14.5 25.8 23.6 77.7 46.2 26.7 60.8 41.5 28.5 46.2 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328468-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 105.3;T-47d: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Yes No Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572" "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favorable (1.42e-4)" "unprognostic (1.70e-1)" 19.3 7.5 39.8 11.7 36.4 8.0 13.9 10.3 102.4 22.7 16.2 9.8 10.9 11.5 19.4 18.1 22.2 13.7 21.0 17.2 62.3 18.0 12.8 14.5 16.6 11.5 21.0 50.9 18.4 10.4 11.6 13.3 27.5 13.0 26.0 14.3 11.2 36.2 37.9 18.4 17.1 21.1 15.3 16.5 15.8 38.6 12.0 11.0 4.4 14.2 12.5 36.3 15.4 21.4 7.8 7.2 18.9 8.2 15.3 6.9 3.6 9.4 7.4 5.8 105.3 17.9 21.3 14.8 8.6 6.8 8.1 9.1 18.2 6.0 22.2 11.0 10.0 13.2 7.9 2.3 6.0 8.1 11.8 5.8 20.2 16.2 5.6 17.2 10.9 27.5 11.1 13.9 12.6 7.2 14.7 5.5 8.6 4.5 19.7 4.3 3.8 0.3 7.1 21.3 10.2 7.0 12.6 8.1 4.8 10.0 36.4 4.8 0.3 34.6 5.1 25.5 11.6 67.0 30.0 3.5 38.2 7.2 9.1 28.1 18.1 11.9 5.0 4.7 2.4 5.4 18.9 6.8 13.0 6.0 8.2 6.9 7.8 5.4 6.1 5.0 4.4 1.4 3.5 10.9 15.3 7.7 7.2 1.4 3.6 39.8 36.4 10.3 102.4 62.3 18.0 21.0 50.9 13.0 11.0 41.7 27.4 50.6 46.8 87.3 192.0 49.2 163.1 29.4 48.9 34.9 68.7 270.0 53.0 48.7 1.6 54.7 57.7 23.3 112.7 251.2 186.2 38.4 292.9 75.1 64.5 104.9 29.9 81.6 115.9 4.5 88.1 61.6 62.4 25.2 66.7 78.4 77.9 34.8 221.3 42.6 34.0 32.3 148.3 3.9 34.7 81.2 214.1 67.1 38.3 32.9 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in all" 5 "Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 12.0 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 18.6 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.2 17.2 2.5 11.8 10.3 17.3 14.8 8.8 8.3 1.9 16.7 3.7 9.1 6.3 3.4 7.4 9.6 16.1 9.2 13.4 9.5 11.1 9.0 6.2 11.2 5.3 3.8 6.4 0.0 10.1 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 62.5 38.2 16.9 8.2 4.9 31.9 10.4 140.1 21.4 35.2 36.6 13.7 17.4 14.9 9.7 2.1 17.5 52.0 46.7 16.6 9.6 15.9 14.5 11.6 111.5 19.6 109.7 14.3 20.3 21.0 6.9 21.0 19.9 8.5 24.4 30.3 16.0 18.6 10.5 29.4 40.8 14.8 6.5 9.9 28.8 59.6 1.8 41.4 39.9 11.9 3.4 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 144.2;Late spermatids: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 12.1 13.0 12.1 9.6 32.9 26.2 4.0 10.1 16.9 5.8 8.8 14.6 15.2 8.5 39.5 12.1 8.5 8.5 5.3 10.6 9.5 15.9 8.3 3.9 3.6 37.6 24.5 12.7 7.7 19.0 9.4 16.3 46.8 16.5 24.1 12.7 8.5 15.1 25.2 16.1 12.5 8.6 12.6 18.1 6.9 17.2 6.7 10.2 21.0 7.1 11.9 11.4 6.3 10.5 16.8 7.0 10.8 7.4 6.4 8.4 6.1 13.2 6.9 14.9 20.9 13.3 21.9 13.7 7.3 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 17.9 13.9 29.7 49.4 18.7 29.4 53.1 25.5 24.1 10.3 22.7 13.7 23.9 64.6 36.2 144.2 28.7 7.0 0.0 38.2 7.9 24.2 36.6 15.1 41.4 13.8 14.3 28.8 11.1 11.6 327.6 26.7 12.7 16.9 55.9 15.3 26.4 29.5 14.0 35.7 98.2 27.2 12.9 22.0 66.8 24.3 18.2 12.5 26.1 25.2 44.5 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MAEA "EMP, GID9" ENSG00000090316 "Macrophage erythroblast attacher" Q7L5Y9 4 1289851-1340147 "Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 23.6 35.4 25.5 26.3 28.4 19.5 20.9 34.0 35.8 24.4 33.3 21.7 26.8 39.9 27.3 23.8 34.7 26.0 29.2 36.6 23.7 33.1 33.2 27.9 19.1 26.1 23.3 32.0 33.4 32.0 21.9 30.3 27.6 34.0 23.6 17.2 22.3 36.7 28.0 27.3 29.0 38.2 20.9 17.7 31.0 30.3 23.3 26.7 26.5 26.1 28.5 26.5 26.3 25.4 19.7 18.9 48.2 28.0 17.0 35.8 21.9 22.7 27.0 19.2 19.0 12.8 12.8 25.0 23.3 12.2 18.8 17.3 28.0 29.3 20.7 18.2 16.7 34.9 16.9 18.4 28.5 7.8 16.6 20.5 19.5 29.8 26.7 15.3 21.9 21.0 15.9 15.6 15.2 9.6 13.1 15.2 20.0 27.1 16.6 16.5 24.1 32.5 33.6 25.3 24.7 29.1 31.7 15.4 18.7 20.1 27.5 34.5 24.1 20.8 15.7 15.8 11.2 29.0 19.1 21.3 35.1 15.1 16.0 38.5 20.9 32.0 22.8 24.5 20.2 19.3 23.9 20.2 27.2 25.5 20.7 35.8 19.7 20.5 24.1 18.9 16.5 18.3 18.8 48.2 17.0 28.0 13.3 23.1 21.9 25.5 28.4 34.0 35.8 23.7 33.1 23.3 32.0 34.0 26.7 17.9 23.5 19.1 12.9 16.7 25.9 30.8 12.7 14.7 21.6 15.7 19.6 42.4 39.7 39.2 5.8 20.4 33.8 0.0 26.5 43.0 21.1 18.9 10.4 15.3 34.2 20.6 19.5 18.4 22.3 8.2 32.8 16.9 27.0 55.9 30.8 20.6 33.1 32.0 35.0 28.1 18.6 12.9 16.5 25.9 41.2 17.3 79.6 27.4 32.9 18.6 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Cell line enhanced" "Detected in some" "HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 16.2 34.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 3.9 1.4 3.3 0.0 0.0 0.0 0.0 0.3 0.2 9.3 0.7 8.4 0.8 2.0 3.1 0.8 0.1 0.2 9.2 0.1 13.4 0.0 0.0 0.0 0.0 8.9 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 20.8 32.3 6.7 25.3 60.9 14.6 153.6 7.6 0.0 13.6 48.8 23.6 7.5 1.7 2.0 0.6 19.9 50.9 0.0 3.0 2.1 61.9 37.1 10.4 32.6 322.7 3.2 55.5 34.4 488.8 0.7 27.3 252.1 20.3 0.0 13.7 25.8 5.4 24.6 23.0 0.8 8.2 12.9 44.3 0.5 0.9 77.0 10.4 4.4 8.1 17.7 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 9 "Spermatocytes: 30.7;Spermatogonia: 86.6" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 35.8;U-266/84: 40.4" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA062230: AB_2684718" "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.5 0.0 0.0 0.0 0.1 2.5 0.4 4.9 0.0 0.0 40.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 30.7 86.6 0.0 0.0 0.0 0.0 0.0 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427724-76431353 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 9.4;Horizontal cells: 27.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in many" "GAMG: 9.4" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favorable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favorable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 2.6 5.8 13.8 3.0 23.5 1.1 3.3 18.7 33.9 4.7 1.9 3.2 0.5 1.5 5.4 3.5 2.3 4.8 2.3 3.9 18.9 20.3 4.1 1.1 2.6 4.1 10.2 22.0 8.4 4.1 15.1 5.1 0.8 19.8 5.9 2.1 2.3 3.4 7.4 2.2 3.3 2.0 4.8 5.4 4.5 2.6 1.3 4.9 1.1 4.0 0.1 3.6 2.4 1.8 1.0 0.0 0.0 0.0 1.5 2.4 0.4 0.2 4.5 4.7 8.9 3.3 1.9 4.1 3.4 3.4 2.9 1.6 1.0 0.7 0.9 1.7 3.0 9.4 3.4 6.9 6.4 2.4 2.2 0.1 0.0 0.0 2.9 0.7 1.8 0.6 1.4 2.9 0.8 0.8 0.1 1.1 4.9 0.3 0.0 4.4 0.6 4.9 0.2 5.6 0.0 6.9 3.9 3.5 0.0 3.7 0.0 0.0 2.4 0.0 0.4 0.6 5.0 2.1 0.1 0.6 4.4 5.6 4.6 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.8 1.1 2.3 0.0 1.0 1.4 1.3 0.0 1.5 0.0 0.0 0.0 0.4 13.8 23.5 18.7 33.9 18.9 20.3 10.2 22.0 19.8 4.9 3.0 1.6 0.0 0.6 0.5 9.4 1.6 0.0 0.0 1.2 1.8 3.9 0.1 1.7 1.5 0.0 1.0 0.0 0.0 1.3 0.4 0.7 0.2 1.1 0.0 0.1 27.0 0.0 0.6 0.3 0.0 1.4 0.0 0.0 0.0 0.2 4.3 0.8 0.0 4.2 0.9 5.1 19.4 1.4 0.2 0.2 0.1 0.1 4.3 0.0 0.1 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 335.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Yes No Mitochondria "CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 10.0 5.2 9.7 5.8 19.6 20.6 13.2 12.3 12.7 13.0 10.5 6.4 8.3 12.8 7.3 8.8 7.0 13.5 7.3 14.8 13.1 10.5 5.0 5.2 8.3 7.4 15.4 8.8 11.9 11.3 17.0 12.7 24.8 12.1 14.3 3.9 11.7 18.6 17.0 11.1 4.3 6.7 17.8 8.6 9.1 6.6 7.8 6.7 14.3 7.3 7.5 10.1 8.8 12.0 15.9 15.3 7.6 13.6 17.5 8.3 8.7 5.2 15.5 23.8 27.9 335.8 14.2 7.0 10.8 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 184.6 337.7 161.5 413.1 434.6 37.7 75.0 170.7 65.6 141.0 31.4 56.9 80.9 34.9 139.8 191.3 189.6 281.5 23.3 149.6 178.6 195.3 286.6 340.1 210.0 235.2 11.1 249.0 192.8 356.1 271.6 67.3 381.9 259.8 113.6 185.2 58.8 165.7 122.2 57.3 57.2 70.9 77.6 218.3 33.9 33.0 500.0 226.1 179.7 132.6 219.4 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.7 15.5 18.4 13.9 0.6 1.1 8.0 14.4 2.2 16.2 16.9 15.1 9.8 20.7 6.5 3.6 6.0 16.1 25.8 8.5 15.0 10.8 12.3 25.8 6.9 10.0 0.0 13.2 11.7 0.2 0.3 16.4 1.5 1.3 5.2 16.8 30.4 14.2 8.8 12.3 31.3 5.7 10.9 13.2 3.8 24.8 16.3 12.8 3.7 5.0 3.7 14.0 11.6 8.3 2.2 10.0 10.4 9.1 3.2 10.3 19.4 15.5 15.5 4.4 17.1 27.2 6.6 14.6 8.0 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 0.0 0.0 1.5 0.2 1.4 0.0 1.2 0.0 0.0 1.2 0.0 0.0 4.1 0.0 0.4 1.1 0.1 0.0 23.3 0.2 17.2 1.0 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.9 5.9 14.0 0.4 2.9 1.0 1.8 0.0 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 45.5;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.6 3.3 7.1 4.3 3.4 9.7 5.4 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 1.9 6.9 5.1 5.4 4.0 10.8 10.5 5.8 3.3 4.2 4.2 6.5 5.5 4.1 5.3 4.9 5.2 3.5 3.1 7.8 9.4 17.8 3.6 9.1 6.9 6.2 7.8 4.4 11.5 7.2 5.0 16.0 3.4 3.6 8.8 4.6 4.7 4.6 5.3 2.4 3.4 8.6 3.7 7.4 5.9 9.0 7.1 12.4 10.0 11.8 5.2 8.7 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 3.0 10.1 12.7 3.9 12.6 3.9 0.7 2.5 1.4 1.2 5.2 9.8 5.8 3.3 3.7 45.5 4.7 4.3 0.0 3.4 8.8 6.2 4.9 1.1 4.0 4.3 4.8 2.4 3.7 9.4 52.0 6.1 4.7 1.7 2.8 4.3 5.2 5.1 3.5 3.5 1.9 5.7 0.0 6.4 21.0 16.9 9.4 14.1 4.9 5.0 7.6 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476986-17493226 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA056415: AB_2683120" "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favorable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favorable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 10.2 12.7 16.0 6.5 23.5 12.3 14.1 16.3 29.1 13.0 11.2 9.2 10.9 11.2 11.7 17.3 8.2 11.7 6.6 30.0 14.3 13.6 13.9 19.1 8.2 11.5 13.6 14.5 12.4 10.2 20.3 11.3 7.9 12.6 11.4 10.5 8.9 15.8 14.9 34.4 11.3 10.5 8.6 10.3 9.5 10.1 12.9 8.6 14.9 13.4 15.2 9.1 7.5 7.8 11.4 12.8 11.8 11.4 10.3 13.4 7.4 7.3 9.4 8.1 8.7 6.6 5.9 7.0 6.0 7.4 9.3 8.4 13.7 3.7 9.1 6.9 6.2 5.6 9.6 10.3 8.3 8.8 5.7 16.4 5.5 6.2 9.8 7.0 4.4 4.8 9.6 7.9 7.8 8.1 7.0 6.3 13.3 6.5 4.2 6.2 6.2 19.7 9.1 7.5 15.3 9.7 15.3 18.4 5.9 8.1 5.2 5.3 8.4 7.9 6.3 13.3 32.1 7.4 5.8 4.3 6.9 8.0 11.8 9.4 8.0 5.6 5.0 8.6 7.8 7.2 2.7 7.0 11.8 10.3 9.6 13.4 11.4 10.7 10.6 7.8 10.4 11.6 12.8 2.4 10.3 11.4 12.8 10.3 7.4 16.0 23.5 16.3 29.1 14.3 13.6 13.6 14.5 12.6 8.6 3.0 4.1 0.9 8.0 4.0 14.2 17.7 7.6 5.3 4.5 8.7 13.7 7.7 10.0 5.6 5.3 3.7 6.6 0.0 4.0 4.5 5.5 7.3 0.0 4.5 5.3 15.9 15.1 5.5 2.4 5.2 5.2 3.8 1.7 3.6 9.3 22.1 2.9 5.8 8.9 4.5 22.8 0.0 6.1 8.8 25.4 4.3 8.0 5.0 7.3 7.4 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3489920-3611495 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted - unknown location" Yes No 580000 Microtubules "Cytokinetic bridge" "HPA052129: AB_2681739" "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 15.0 2.3 0.5 8.5 1.0 9.2 13.4 0.8 2.0 8.1 5.9 1.8 7.5 2.3 5.1 13.1 6.6 14.6 21.0 6.1 1.4 0.5 2.7 1.9 12.6 12.6 0.7 1.9 8.8 4.8 0.8 1.5 2.8 2.3 12.0 0.9 11.0 8.7 5.5 6.1 37.8 4.2 3.0 0.8 5.7 4.2 4.6 1.4 5.0 5.2 12.0 12.0 6.7 10.1 0.8 0.3 4.8 0.1 0.0 1.9 0.2 4.5 7.2 1.6 3.1 0.1 0.1 0.5 22.5 6.3 1.9 0.6 1.5 5.3 0.0 7.2 7.7 1.3 2.8 0.0 0.2 0.2 0.0 0.1 0.0 20.3 1.3 0.0 0.1 0.4 0.0 0.2 0.1 0.2 26.6 2.4 0.0 0.0 0.0 0.0 2.5 0.0 4.1 1.0 1.0 0.4 0.9 0.9 2.7 0.4 1.4 1.6 1.5 8.1 0.5 2.8 2.3 2.2 0.4 1.0 8.2 0.8 20.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 4.8 0.1 0.0 0.4 0.0 0.4 0.4 0.3 0.8 0.8 0.1 2.2 0.0 0.0 0.0 1.9 0.2 0.5 1.0 0.8 2.0 1.4 0.5 0.7 1.9 2.3 1.4 20.8 19.4 0.0 7.5 16.4 0.8 3.0 5.1 0.0 6.8 1.8 0.0 0.1 0.0 3.0 0.2 8.7 0.3 0.0 1.2 1.0 6.4 3.4 1.1 0.9 1.0 0.0 0.0 16.5 0.8 0.0 10.6 2.8 18.6 0.0 1.3 9.5 3.6 0.0 3.2 1.7 1.0 0.0 2.1 0.5 0.6 9.9 0.3 0.0 0.7 3.0 METTL14 KIAA1627 ENSG00000145388 "Methyltransferase like 14" Q9HCE5 4 118685368-118715433 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038002 Supported Supported Nucleoplasm Yes No Nucleoplasm "HPA038002: AB_10672401" "unprognostic (4.48e-1)" "unprognostic (5.13e-2)" "unprognostic (5.98e-3)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.83e-1)" "unprognostic (3.75e-2)" "unprognostic (4.40e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (1.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-3)" "unprognostic (7.76e-3)" 17.3 16.4 15.5 12.4 19.2 25.8 18.0 25.9 19.4 21.8 16.1 12.8 11.7 13.4 19.1 17.2 16.4 15.9 12.0 12.3 13.3 11.3 17.4 22.0 13.9 15.9 16.4 16.0 22.6 14.6 17.1 34.5 13.6 16.0 20.0 13.0 12.3 13.7 14.9 13.5 16.4 15.4 14.5 17.3 17.3 14.2 26.6 18.4 24.1 18.7 10.6 16.2 23.0 16.1 18.9 12.3 24.1 17.5 17.1 18.4 10.7 14.7 6.8 14.9 14.0 9.4 11.9 10.9 13.2 10.1 10.0 11.5 9.8 17.7 16.8 7.9 9.2 10.0 7.3 12.6 10.9 12.8 13.2 7.7 14.0 8.6 10.9 10.8 22.6 16.8 10.5 12.6 11.5 7.7 13.1 9.0 13.5 14.9 14.3 13.6 9.9 22.1 19.0 12.8 12.7 6.0 12.7 18.7 8.4 10.8 9.8 12.3 13.8 9.3 17.3 12.5 14.3 7.8 21.6 12.1 14.5 13.3 12.9 10.4 12.0 12.5 19.1 10.3 12.7 11.7 24.1 10.6 22.3 14.7 15.6 16.6 18.9 15.4 15.1 12.3 18.1 18.4 16.6 8.5 17.1 17.5 9.8 16.2 10.7 15.5 19.2 25.9 19.4 13.3 11.3 16.4 16.0 16.0 18.4 23.8 23.4 4.8 15.3 9.6 15.8 13.7 15.3 13.4 27.3 22.7 21.6 15.0 10.0 9.5 64.5 14.8 10.9 0.0 13.6 8.9 10.1 14.5 20.9 29.7 10.5 7.9 11.6 14.7 15.5 9.0 17.3 12.0 6.8 7.2 14.1 12.0 12.0 15.0 13.1 18.2 24.7 12.9 11.7 18.9 16.8 10.5 12.8 17.5 13.0 13.2 METTL22 "C16orf68, FLJ12433, MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 86.1;Late spermatids: 289.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672" "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 8.4 10.6 5.4 10.5 8.8 12.5 8.0 17.1 10.2 9.6 10.9 10.9 13.6 9.2 13.0 12.2 7.6 8.6 9.8 15.0 7.0 7.3 7.1 9.5 6.5 10.8 7.9 6.8 10.8 10.6 7.3 7.6 9.4 9.3 10.5 7.9 10.2 9.5 15.6 45.2 15.7 6.4 11.4 6.3 8.1 9.8 27.8 9.3 10.4 10.1 10.0 9.1 9.7 9.9 1.1 2.8 12.6 3.0 1.8 1.6 1.4 3.7 7.7 8.8 8.3 3.3 8.5 7.6 6.4 3.4 7.7 8.7 7.5 8.7 5.8 5.8 5.6 2.8 7.1 5.5 10.2 5.1 8.5 7.5 6.0 13.4 21.2 10.0 6.1 4.6 8.5 7.4 8.4 9.2 4.7 6.1 8.1 8.0 6.0 5.8 13.2 6.3 14.8 4.7 1.7 7.6 9.6 6.6 12.1 3.7 4.0 10.8 7.2 5.6 6.6 4.2 5.0 7.2 5.1 4.7 9.1 7.9 7.4 2.9 8.1 4.3 9.1 3.3 8.2 4.2 1.4 3.0 2.4 1.3 2.3 1.2 1.1 1.1 1.3 2.8 1.1 1.5 0.7 12.6 1.8 2.5 1.6 1.6 1.4 5.4 8.8 17.1 10.2 7.0 7.3 7.9 6.8 9.3 9.3 8.9 6.4 9.7 6.4 3.0 13.1 16.7 5.1 2.7 5.7 0.0 3.9 10.3 10.0 8.1 86.1 6.7 5.6 0.0 8.3 8.2 4.3 8.9 8.1 6.2 26.1 1.6 6.9 5.5 27.8 289.3 10.0 22.9 1.7 2.8 5.1 5.4 7.7 8.2 13.1 6.8 12.2 0.0 4.7 22.1 12.9 2.4 11.1 5.7 5.9 6.5 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 231.7;Early spermatids: 185.4;Late spermatids: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" Yes No "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.8 7.9 9.3 8.8 20.0 12.2 10.9 12.3 11.5 11.9 10.6 15.8 25.4 11.2 10.5 12.5 13.1 13.6 6.5 6.4 12.4 5.1 13.1 11.3 14.9 10.9 9.6 6.0 11.2 14.4 10.5 15.2 6.9 17.3 22.6 15.1 13.5 16.8 15.1 10.6 13.5 9.8 3.9 15.8 4.6 10.7 12.1 23.3 9.2 10.3 9.0 15.2 11.8 16.8 10.5 14.3 29.5 9.2 15.9 21.7 10.7 13.6 10.2 18.7 7.4 17.0 16.8 5.3 14.3 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 11.9 12.3 7.5 17.8 14.9 36.0 15.1 10.2 4.0 14.8 14.0 231.7 33.6 5.0 13.3 185.4 14.8 23.9 0.0 15.9 60.6 17.0 13.3 26.5 15.6 29.3 38.1 16.1 17.2 21.9 141.7 17.0 18.6 18.6 21.6 14.2 18.8 16.6 10.5 13.1 8.7 96.6 6.5 12.8 33.4 10.4 15.1 34.6 17.5 14.3 12.5 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Cell line enhanced" "Detected in many" "WM-115: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.9 15.4 8.2 13.2 6.1 7.9 9.8 12.3 13.4 17.5 13.8 14.6 2.0 15.6 6.3 16.8 20.1 16.2 12.0 14.2 17.0 15.1 11.4 16.2 16.3 6.1 4.1 7.2 8.7 6.3 11.4 18.3 19.5 11.1 10.1 4.5 17.8 10.1 6.4 12.5 6.8 4.5 5.5 10.3 10.0 9.5 12.2 0.7 14.0 9.9 21.5 8.4 17.4 11.0 26.2 13.0 4.4 3.1 17.8 18.0 11.6 12.3 25.6 6.6 11.7 20.9 15.6 3.2 51.4 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 3.0 15.1 14.3 10.9 10.0 13.4 13.4 12.7 20.1 15.9 12.2 49.1 11.8 0.0 19.8 9.4 14.0 21.9 23.3 8.4 29.4 9.6 10.5 18.5 33.0 2.7 1.6 9.8 6.2 2.7 10.5 3.7 3.7 8.5 8.2 18.5 59.7 22.3 20.1 6.0 3.9 11.6 0.0 9.2 19.3 12.6 10.3 9.4 7.7 15.7 6.7 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 28.0 32.6 9.7 22.7 16.1 59.4 16.6 8.9 19.5 19.5 24.7 17.6 12.6 19.0 14.1 14.2 38.7 28.3 40.8 27.8 10.4 9.8 17.9 19.3 28.7 19.9 10.2 6.5 36.7 20.0 8.2 32.7 19.7 22.3 20.1 11.1 19.5 18.8 22.2 48.2 26.6 31.6 14.6 14.6 30.7 21.9 10.5 9.2 28.6 14.0 31.3 34.5 19.4 20.1 0.4 0.5 13.5 1.2 1.4 1.2 0.6 5.2 11.6 19.9 9.2 4.2 7.3 14.6 9.1 5.5 4.7 3.3 15.1 5.9 8.4 10.0 6.8 2.5 10.8 6.0 9.7 1.8 11.7 11.0 11.7 7.6 11.8 8.7 11.8 17.5 11.2 9.1 5.6 5.4 7.3 7.7 10.0 15.0 8.8 4.9 21.0 15.7 4.8 43.7 10.3 7.7 24.5 5.6 3.8 8.8 6.2 16.0 20.9 19.3 18.6 12.0 10.8 7.4 13.5 9.5 8.6 9.6 39.5 9.8 8.4 4.5 11.4 16.5 5.3 29.2 1.1 1.2 1.2 1.2 1.2 0.8 0.3 0.4 0.8 0.5 0.4 0.2 0.6 13.5 1.4 1.2 0.5 0.1 0.6 9.7 16.1 8.9 15.5 10.4 9.8 10.2 6.5 22.3 9.2 35.7 74.9 43.3 105.5 87.8 56.5 71.4 104.4 30.8 33.0 127.4 29.5 12.3 16.6 100.6 27.2 122.8 266.9 0.0 134.4 37.6 65.2 167.2 60.0 71.2 67.2 20.6 157.9 183.5 91.3 20.0 46.1 71.9 40.5 13.6 163.9 48.5 185.5 221.8 31.1 33.6 32.7 38.8 178.2 2.7 14.0 129.5 68.0 56.7 123.5 150.3 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130314-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947" "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 20.5 17.6 21.8 20.2 28.0 21.2 23.7 26.7 25.7 23.5 17.6 12.6 22.0 16.5 22.3 26.7 30.6 19.4 17.1 20.4 21.6 20.3 22.2 27.5 15.5 21.9 30.4 22.7 25.4 20.7 20.0 36.7 18.5 26.3 24.0 18.4 8.1 21.8 28.8 48.4 24.4 16.8 25.0 25.0 22.0 17.6 13.7 29.8 22.3 20.4 26.3 24.4 22.2 22.2 13.5 12.8 8.7 17.3 12.4 17.4 8.4 15.0 11.4 14.7 17.5 13.7 13.0 20.1 16.8 13.4 13.9 10.3 20.4 11.1 21.2 10.6 11.7 10.8 14.1 18.4 11.9 18.6 14.6 14.7 25.4 9.0 46.4 12.0 32.8 20.4 11.1 15.3 11.4 15.3 9.5 11.7 13.3 36.7 16.9 13.8 16.1 26.4 33.3 24.4 21.0 13.0 22.0 23.0 25.0 11.2 16.4 17.9 13.8 11.2 26.1 16.1 13.0 13.2 14.6 12.2 16.5 17.7 15.7 21.2 14.4 16.2 34.7 14.2 27.5 16.5 8.7 9.9 7.2 12.4 13.6 16.0 13.5 15.7 14.8 11.7 12.3 17.4 15.3 1.4 12.4 17.3 12.8 13.2 8.4 21.8 28.0 26.7 25.7 21.6 20.3 30.4 22.7 26.3 29.8 32.8 49.8 36.5 30.0 29.8 35.6 38.2 17.8 38.8 66.0 17.4 3.9 41.6 21.6 35.8 4.3 33.7 11.5 23.3 36.1 40.3 37.1 24.7 46.2 28.1 23.8 17.5 17.2 20.3 16.4 5.3 45.1 24.7 11.8 28.9 19.6 22.1 29.5 10.5 41.1 21.9 47.2 38.8 34.8 57.9 88.6 29.4 27.1 34.8 22.9 28.6 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.9 34.6 18.9 23.4 11.8 13.9 46.1 30.7 22.2 27.5 26.2 42.4 61.7 33.5 33.9 21.1 28.0 40.1 15.5 42.5 20.7 35.4 25.5 24.9 13.8 96.1 35.9 39.1 35.9 20.8 29.4 35.6 30.4 21.8 43.6 42.7 25.5 33.4 20.1 61.7 31.6 59.5 34.8 54.8 76.5 39.2 23.6 39.5 28.7 26.3 18.9 24.4 23.8 23.3 32.6 14.1 22.4 37.5 33.5 28.8 33.7 36.0 46.5 33.1 39.0 40.8 26.2 26.9 45.9 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 68.5 78.6 124.3 65.2 107.6 20.6 96.4 201.2 95.0 89.9 129.1 17.7 163.2 235.4 222.3 47.9 83.9 246.5 93.5 272.5 246.5 72.7 86.6 121.1 226.4 208.7 19.1 132.6 105.6 152.4 44.5 51.8 104.0 118.1 247.9 188.7 49.5 303.7 207.0 46.3 360.5 27.7 64.7 84.5 124.7 106.0 130.4 105.4 86.1 183.5 87.8 MRRF RRF ENSG00000148187 "Mitochondrial ribosome recycling factor" Q96E11 9 122264603-122331343 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 205.6;Late spermatids: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047177, HPA049987" Supported Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA047177: AB_2679970, HPA049987: AB_2680984" "unprognostic (8.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.40e-2)" "unprognostic (6.06e-3)" "unprognostic (3.64e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.71e-2)" "unprognostic (1.89e-2)" "unprognostic (4.44e-2)" "unprognostic (2.98e-1)" "unprognostic (9.01e-2)" "prognostic favorable (2.14e-8)" "unprognostic (3.89e-2)" "unprognostic (4.05e-1)" "unprognostic (8.02e-2)" "unprognostic (8.88e-3)" 20.1 17.0 10.1 12.6 14.8 13.4 21.0 15.0 14.5 13.0 26.3 14.0 20.3 25.3 23.3 17.8 21.6 10.4 9.9 18.8 10.5 11.2 23.3 21.7 12.5 14.8 17.1 11.7 12.1 17.6 24.3 20.1 12.7 15.9 14.3 31.6 14.8 15.8 14.7 31.1 19.1 19.4 15.7 15.4 15.7 13.5 17.1 15.1 10.6 16.1 23.3 20.9 15.2 14.3 10.3 19.6 3.8 18.7 13.7 11.6 7.1 13.1 17.7 10.1 16.9 14.5 13.3 19.3 13.1 16.8 17.7 10.4 21.1 15.8 28.6 6.6 10.4 14.1 38.6 28.9 30.6 14.5 9.5 11.8 9.7 21.7 11.5 9.6 27.2 13.0 12.4 20.9 15.8 28.4 9.0 19.7 11.5 16.5 11.0 17.7 20.9 13.5 8.9 11.8 32.9 17.9 10.2 19.3 30.3 30.1 13.4 12.0 7.9 14.1 22.9 10.4 10.1 24.7 7.0 10.5 7.8 11.9 20.2 16.0 7.6 18.4 12.9 14.8 16.3 8.9 2.7 11.5 3.8 9.3 18.7 10.0 10.3 9.4 8.7 19.6 9.2 9.8 11.6 1.4 13.7 18.7 8.4 10.4 7.1 10.1 14.8 15.0 14.5 10.5 11.2 17.1 11.7 15.9 15.1 3.0 7.8 16.1 18.7 13.7 10.7 17.9 22.9 18.7 12.5 14.0 11.8 24.2 29.9 32.2 205.6 19.9 25.2 0.0 25.7 44.0 10.8 12.9 24.3 16.3 27.3 4.8 7.5 11.6 10.5 142.3 8.9 17.2 13.5 22.6 21.2 6.1 23.3 21.0 7.1 29.2 23.1 19.4 12.2 33.2 15.7 19.6 31.0 10.2 32.9 16.3 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Erythroid cells: 23.3;Spermatocytes: 9.2;Spermatogonia: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 30.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 3.7 2.4 4.9 8.3 6.9 7.1 5.4 16.8 7.3 3.8 3.4 4.1 3.2 3.0 5.8 5.2 4.2 3.6 2.5 2.2 3.6 3.2 2.3 1.8 2.6 8.2 4.8 3.3 5.3 2.7 2.6 3.9 4.2 5.1 3.2 5.5 3.2 3.6 2.3 2.0 6.0 3.2 4.2 4.6 4.6 2.7 11.0 4.8 12.6 2.3 3.4 8.0 2.9 3.5 2.7 0.6 0.6 2.0 1.7 3.2 1.1 9.8 2.9 9.8 4.0 1.4 2.4 4.8 7.5 4.3 11.1 14.4 3.1 5.5 9.0 7.7 2.5 3.3 8.5 9.2 4.5 13.7 7.4 7.0 7.5 4.2 3.7 0.7 7.9 5.8 0.9 2.0 8.5 5.5 1.7 4.9 8.3 4.8 6.8 6.4 4.4 12.6 4.9 4.4 7.8 5.9 7.3 10.1 6.4 2.6 3.5 5.1 5.9 5.1 30.1 4.5 5.6 5.6 5.8 2.9 4.8 8.7 6.1 12.1 2.7 5.6 5.2 4.5 9.9 5.4 0.0 0.4 0.6 1.3 2.0 2.0 2.7 1.9 2.3 0.6 1.9 3.2 2.7 0.2 1.7 1.0 0.0 2.2 1.1 4.9 6.9 16.8 7.3 3.6 3.2 4.8 3.3 5.1 4.8 0.0 1.0 0.0 1.3 0.7 0.0 1.1 0.0 2.7 1.2 1.8 0.0 1.6 0.0 0.7 0.6 0.0 0.0 23.3 1.5 2.6 1.1 0.9 2.3 0.8 1.4 0.0 0.0 1.3 0.8 0.0 1.4 1.6 1.7 1.0 1.3 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 9.2 7.0 0.5 0.6 2.2 1.0 0.8 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favorable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.7 8.3 16.5 9.5 22.5 10.1 12.3 14.9 16.6 14.5 20.7 5.7 13.2 13.6 5.4 17.3 16.5 9.9 22.5 21.3 19.7 18.4 16.3 17.4 15.9 25.1 14.8 20.7 13.3 17.2 20.9 17.0 19.7 18.9 16.5 18.6 15.5 6.0 17.4 12.4 15.1 14.3 18.9 18.1 14.3 14.8 18.8 7.7 13.8 17.6 15.2 13.2 12.2 15.2 11.3 11.7 11.2 10.7 22.8 13.4 13.1 15.7 13.3 16.1 4.1 33.2 11.3 13.2 12.3 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 11.9 23.0 29.4 17.6 0.0 0.0 17.5 25.5 32.1 23.9 19.2 0.0 24.9 34.9 21.1 40.5 13.6 19.2 23.3 21.3 22.9 13.5 15.6 10.5 27.2 22.0 0.0 10.5 14.7 21.8 48.5 21.6 18.0 0.0 19.8 26.7 0.0 20.5 25.8 24.8 32.1 0.0 38.8 15.9 42.6 38.1 0.0 19.8 30.5 22.5 14.8 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820348-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 46.8;pituitary gland: 19.3" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 122.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.9;intermediate monocyte: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7" "Group enriched" "Detected in some" 4 "HaCaT: 16.7;HeLa: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" Yes NA "Microtubules, Cytokinetic bridge" "HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.6 0.8 2.3 0.7 6.1 0.7 0.6 12.2 8.8 1.1 0.8 0.1 0.0 0.7 2.1 0.6 0.8 1.4 0.7 46.8 3.4 1.9 0.6 1.1 0.7 1.0 1.2 4.6 8.2 4.7 0.5 19.3 0.5 2.3 0.8 0.8 2.0 1.0 0.7 0.6 0.7 0.9 1.7 0.7 1.0 1.5 1.6 0.9 0.0 1.1 0.0 0.6 2.6 0.7 0.0 1.3 1.9 1.7 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 16.7 0.5 0.0 0.0 0.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.2 0.0 2.9 2.1 0.1 0.6 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.3 0.1 0.4 0.0 0.0 0.0 0.2 1.9 0.0 1.7 0.1 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 2.3 6.1 12.2 8.8 3.4 1.9 1.2 4.6 2.3 0.9 0.0 0.3 0.0 0.5 0.5 0.0 122.0 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 1.0 0.2 0.0 0.6 0.1 0.0 0.0 0.6 0.0 2.5 0.9 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.1 0.2 0.0 0.0 0.9 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.0;SK-MEL-30: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.4 2.2 5.6 11.2 8.8 6.7 2.4 3.2 10.8 2.1 6.6 0.9 9.8 7.2 5.2 5.5 3.5 7.1 6.7 7.6 5.6 3.6 9.0 1.9 4.4 4.1 5.8 3.8 4.3 7.1 29.0 3.7 14.8 32.0 2.0 5.7 7.1 15.6 3.5 3.5 2.5 7.8 2.4 8.9 6.7 1.6 7.3 11.4 7.3 0.5 9.5 15.7 3.1 2.3 52.2 7.3 2.6 12.5 2.0 3.7 6.4 4.0 1.6 12.9 6.8 2.6 10.0 14.2 3.9 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 14.9 15.6 8.3 48.3 51.5 37.3 78.1 28.1 21.4 31.8 31.4 45.2 3.4 39.7 15.1 4.1 38.3 50.6 116.8 12.7 13.2 31.9 46.8 3.5 46.4 10.1 49.3 16.3 19.6 18.4 7.0 41.7 19.0 99.5 18.0 20.8 127.5 14.4 35.1 52.3 53.0 43.0 45.3 88.6 8.6 26.0 58.8 8.1 21.3 15.6 33.1 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Cell line enhanced" "Detected in many" "MCF7: 103.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 26.3 16.8 14.9 15.4 0.1 0.5 19.3 11.9 4.0 37.8 27.9 82.4 16.6 53.3 6.9 5.2 7.9 16.1 26.9 8.2 14.2 9.9 17.2 24.9 16.8 22.2 0.0 22.7 17.3 0.3 0.7 14.4 3.2 0.8 10.1 26.5 24.8 66.3 3.3 103.7 46.1 32.0 17.1 21.2 14.7 32.1 30.6 30.5 7.0 5.4 13.7 20.0 35.5 35.7 3.6 16.4 23.5 24.9 4.7 2.3 38.0 16.7 20.5 23.0 47.4 83.8 4.9 19.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.0 13.4 0.2 3.8 0.0 1.7 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.5 93.5 0.8 28.3 0.4 0.1 0.0 0.0 11.2 0.0 0.0 1.3 1.6 10.0 0.0 0.5 1.7 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.4 25.7 2.0 3.1 2.1 2.2 0.9 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 168.2" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 5.2;Hep G2: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" Yes No 680000 Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 6.3 2.7 0.2 0.0 59.5 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.7 0.0 104.6 0.4 1.5 0.0 0.0 0.0 0.0 1.9 0.1 0.0 2.7 39.7 2.8 0.2 0.1 0.8 0.4 2.3 0.4 0.2 0.4 0.0 0.1 5.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 1.5 0.0 2.2 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 19.8 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.1 1.1 0.2 0.6 0.7 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.3 0.4 0.1 0.4 0.2 0.2 0.0 0.8 0.3 0.4 2.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 168.2 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.1 15.5 0.1 4.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.6 0.6 0.0 0.0 0.0 0.0 0.0 1.4 2.9 0.0 25.9 2.8 6.5 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.3 N6AMT1 "C21orf127, HEMK2, MTQ2, N6AMT, PRED28" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Yes No Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957" "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 5.4 10.9 10.1 6.0 18.6 2.0 10.5 7.4 14.8 9.9 7.0 17.0 6.0 6.7 13.8 13.7 5.6 9.3 6.2 10.8 10.8 9.2 9.0 6.3 5.5 6.7 21.3 8.4 18.3 6.6 14.6 15.6 13.1 14.1 10.1 7.4 8.4 6.5 9.0 11.3 8.0 6.2 7.8 14.5 7.9 6.7 7.6 19.3 3.9 12.1 4.0 6.9 8.7 9.2 2.2 2.0 1.6 2.1 4.1 4.8 1.8 3.4 3.1 7.8 10.8 6.5 7.2 6.0 7.4 3.1 4.4 2.6 3.8 6.2 3.8 3.8 4.0 7.8 4.1 6.6 3.7 5.4 4.8 5.1 8.0 4.7 4.8 5.8 4.8 3.1 3.7 8.0 4.4 3.1 8.2 3.2 4.7 9.9 6.8 9.0 3.4 2.3 3.9 9.8 7.2 4.3 3.4 7.4 2.9 8.0 5.0 5.9 8.3 6.7 2.4 2.7 7.3 3.3 4.2 7.5 3.7 6.6 6.7 4.5 4.1 4.6 2.1 5.8 12.6 6.8 1.1 1.5 1.6 1.8 2.1 2.0 2.2 3.4 2.3 2.0 2.2 4.8 3.4 0.5 4.1 1.6 1.7 1.4 1.8 10.1 18.6 7.4 14.8 10.8 9.2 21.3 8.4 14.1 19.3 3.0 4.8 1.4 5.3 1.6 11.1 14.0 7.6 21.4 6.8 12.2 7.9 15.0 6.6 9.7 2.5 4.9 0.9 23.3 5.5 9.8 6.1 3.4 1.1 2.8 6.2 9.5 0.0 4.9 1.2 3.4 8.9 2.6 1.7 2.8 2.6 10.3 6.4 4.8 9.6 7.3 10.0 0.0 8.2 2.6 8.1 3.1 12.5 2.5 3.3 4.8 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105602-34147670 "Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 18.5 22.8 20.5 21.9 27.5 23.6 20.8 21.9 29.9 18.1 17.6 24.3 16.4 13.7 30.6 19.8 25.2 21.7 14.7 16.4 17.2 18.6 15.9 21.8 15.1 28.7 16.9 19.8 26.4 24.9 31.5 23.1 20.1 23.4 19.5 21.7 23.0 22.5 17.8 23.4 31.0 16.6 21.5 15.1 23.6 18.0 30.9 16.9 31.2 18.3 19.4 35.3 17.8 19.7 10.4 12.8 2.2 11.1 11.8 13.7 6.9 12.4 17.6 9.4 20.0 11.4 10.1 10.9 12.4 9.1 15.8 12.6 19.7 7.2 40.0 9.2 10.4 13.6 18.9 35.4 18.9 20.2 11.1 22.7 18.1 14.4 18.4 10.3 45.3 13.2 10.3 13.0 10.3 29.0 7.4 12.0 19.3 39.5 14.0 13.1 23.6 36.9 20.6 13.5 21.6 21.2 27.8 31.9 16.7 9.1 21.8 14.0 10.6 16.7 17.7 7.4 9.5 17.7 12.5 9.6 14.1 11.2 20.6 22.9 15.3 18.3 38.1 14.2 18.8 13.9 0.5 6.6 2.2 10.3 11.1 13.7 10.4 11.1 11.7 12.8 9.6 11.5 11.2 0.8 11.8 9.7 9.7 9.6 6.9 20.5 27.5 21.9 29.9 17.2 18.6 16.9 19.8 23.4 16.9 6.0 16.5 12.0 9.6 10.9 11.2 9.8 10.2 14.7 22.7 14.0 11.8 15.4 5.0 6.8 3.8 7.8 3.5 23.3 8.3 9.9 7.4 6.4 4.7 7.2 10.5 11.1 6.9 6.7 4.0 2.1 8.6 6.0 1.7 11.8 8.5 7.7 6.9 2.9 12.4 5.0 10.1 12.9 8.1 17.9 25.4 12.0 12.0 10.2 12.4 6.3 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Cell type enhanced" "Detected in many" 22 "Spermatocytes: 77.0;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 31.2 11.9 30.2 15.6 1.1 1.6 20.0 14.8 10.4 28.7 30.3 21.9 17.5 29.2 10.5 6.5 26.2 14.1 25.8 10.1 30.8 25.6 17.1 30.1 12.4 19.8 0.2 27.8 25.7 0.5 1.1 22.2 9.4 2.7 11.3 23.4 20.8 21.6 13.6 14.7 40.7 29.0 21.6 13.8 15.1 31.7 27.5 23.7 5.7 12.1 17.9 13.7 8.6 12.1 5.2 11.9 8.9 20.6 6.5 21.2 32.4 19.8 23.9 11.6 16.5 31.0 9.1 27.9 23.9 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 0.0 0.0 0.8 0.2 0.6 0.4 0.4 0.0 2.7 2.3 0.0 7.9 1.1 0.0 0.4 3.9 0.5 0.0 0.0 0.0 14.1 0.4 0.5 1.1 0.5 6.8 0.0 0.0 0.6 3.2 4.0 0.9 3.0 1.7 0.0 1.0 4.7 0.2 0.0 0.4 0.0 2.3 0.0 0.9 77.0 26.2 0.6 1.6 5.4 1.2 0.6 NCAPH2 "384D8-2, CAP-H2, hCAP-H2" ENSG00000025770 "Non-SMC condensin II complex subunit H2" Q6IBW4 22 50508216-50523472 "Predicted intracellular proteins" "DNA condensation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067932, HPA069056" Enhanced Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA067932: AB_2685926, HPA069056: AB_2686076" "unprognostic (2.01e-1)" "prognostic favorable (2.24e-8)" "unprognostic (3.65e-2)" "unprognostic (2.81e-1)" "unprognostic (5.04e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.92e-2)" "unprognostic (8.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-2)" "unprognostic (6.31e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" 15.7 12.4 24.5 17.8 18.8 57.4 14.7 33.5 29.4 14.5 14.2 17.4 14.6 15.6 17.5 15.7 18.0 17.2 11.4 18.2 20.0 19.6 14.5 13.8 17.0 22.2 17.8 19.2 22.8 22.6 16.3 22.0 20.0 19.0 15.2 10.8 16.8 22.4 16.6 20.2 23.2 15.7 20.5 15.7 18.4 15.7 26.1 20.4 25.2 16.3 16.8 21.0 12.0 14.5 13.7 10.1 14.5 11.6 11.3 20.9 12.8 19.9 10.8 18.9 19.3 5.6 6.5 24.5 15.8 11.0 28.6 31.2 22.0 13.8 23.1 8.7 11.3 16.0 15.9 17.2 15.1 8.3 13.2 28.5 13.3 27.4 19.7 6.9 29.4 24.0 5.9 9.5 22.6 7.6 4.3 9.2 20.2 16.7 45.0 11.5 27.5 20.1 33.6 13.4 12.0 13.0 33.8 24.6 25.4 8.3 13.1 12.3 16.1 12.4 18.5 14.8 6.3 12.7 29.0 5.9 22.4 27.0 18.3 23.4 23.5 13.1 34.2 16.8 15.1 21.0 10.6 8.4 14.5 17.1 10.4 20.9 13.7 17.7 17.4 7.0 13.2 18.7 15.5 10.2 11.3 11.6 10.1 16.8 12.8 24.5 18.8 33.5 29.4 20.0 19.6 17.8 19.2 19.0 20.4 20.8 26.9 14.1 20.2 16.8 17.5 17.1 15.3 4.0 6.8 8.7 3.9 24.7 13.3 11.3 30.7 11.3 15.5 0.0 20.2 48.4 17.3 13.7 16.2 9.5 16.9 7.9 12.6 11.1 7.2 86.8 16.1 10.9 11.8 19.8 15.5 14.5 14.9 11.5 16.3 7.0 12.9 19.4 21.2 29.6 36.4 16.2 26.3 15.8 15.6 17.6 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes 600000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 63.3 59.3 71.9 52.7 42.5 46.2 74.0 71.7 48.7 67.7 60.0 97.9 45.6 84.2 61.8 55.3 90.9 62.2 143.9 96.3 116.1 49.2 60.3 140.5 56.3 131.9 46.6 160.1 53.3 43.8 55.9 84.5 89.0 38.9 71.0 76.8 125.1 28.9 59.5 86.2 140.1 99.4 107.1 66.9 42.6 104.6 129.7 73.9 49.7 84.2 62.3 44.4 48.0 55.1 63.3 61.3 41.4 81.1 60.3 54.3 56.2 63.4 94.2 54.8 53.8 181.3 39.5 104.5 56.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 271.0 357.6 280.1 370.4 408.5 137.1 290.7 137.6 385.4 589.2 184.9 45.2 333.3 195.6 173.5 15.4 228.8 106.1 210.2 218.7 336.0 249.6 218.4 431.8 217.9 213.5 76.3 191.8 122.8 135.8 18.9 201.0 194.7 156.9 238.1 192.5 194.0 213.8 138.2 150.3 209.2 125.5 148.8 282.2 390.1 563.8 385.9 316.9 226.1 268.8 321.5 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 26.9;Early spermatids: 68.8;Late spermatids: 86.3;Rod photoreceptor cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enriched" "Detected in some" 23 "HEK 293: 292.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" Yes NA "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 292.9 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 0.0 0.0 0.0 0.1 1.1 26.9 2.0 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 68.8 0.6 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 19.1 3.4 0.0 0.0 86.3 0.9 0.0 1.7 0.0 0.0 20.8 0.0 0.0 4.2 0.4 46.9 0.0 1.3 2.2 1.3 0.3 0.0 0.0 0.0 0.3 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156963-198322420 "Enzymes, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 85.5;fHDF/TERT166: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 31.7 31.4 24.9 15.2 23.0 5.6 23.7 7.8 15.6 19.3 20.6 25.5 13.7 11.3 24.5 11.4 18.7 12.8 15.1 74.7 23.9 20.4 16.1 16.0 22.3 14.9 26.8 13.4 17.2 11.1 14.6 17.6 40.5 18.0 20.0 13.2 11.8 13.5 21.3 29.9 10.6 15.8 30.9 34.9 16.4 11.7 9.5 22.6 18.0 14.9 12.8 12.5 27.4 20.7 1.6 2.1 6.1 2.2 3.8 14.7 1.4 7.1 1.9 2.3 0.9 6.0 6.9 2.7 85.5 35.8 34.8 16.5 3.5 7.1 2.6 6.2 115.4 2.0 4.4 3.5 4.6 35.2 8.1 5.0 3.5 8.2 1.4 7.2 5.9 7.3 4.3 4.0 22.9 6.9 13.0 6.6 21.6 2.7 6.4 15.9 2.2 5.1 3.5 1.2 5.7 1.4 2.7 5.7 4.5 5.9 3.7 1.4 2.7 14.2 8.2 9.5 3.4 6.0 5.4 14.5 9.8 8.3 28.0 8.9 4.5 4.1 1.7 4.2 5.4 7.5 1.9 2.2 3.0 3.2 1.9 14.7 1.3 3.6 4.6 2.1 1.6 2.9 3.6 6.1 3.8 1.7 1.4 6.0 1.4 24.9 23.0 7.8 15.6 23.9 20.4 26.8 13.4 18.0 22.6 26.8 24.2 12.3 15.3 45.6 9.4 150.0 10.2 25.4 21.6 17.4 13.7 11.6 10.0 8.8 2.1 26.3 19.8 46.7 16.9 13.3 24.9 20.4 8.1 19.2 15.2 3.2 19.0 35.0 42.5 1.7 27.0 23.7 28.7 16.2 19.6 10.0 34.6 17.3 36.0 11.6 25.0 19.4 44.2 7.5 5.7 43.0 53.8 20.1 14.9 22.4 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002440-113019861 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 15.1 12.3 12.6 12.9 19.8 15.9 15.5 22.8 21.3 14.4 12.8 15.3 11.6 12.3 15.4 19.0 12.7 12.8 13.0 14.0 13.2 12.5 12.4 10.3 11.3 19.3 14.2 13.7 14.8 16.5 13.4 18.2 12.4 15.6 12.4 9.8 11.5 13.5 15.1 28.1 18.2 13.6 16.0 17.5 17.5 14.2 19.1 12.8 21.9 20.0 16.4 15.5 17.5 10.9 3.8 3.4 2.9 3.0 7.9 6.4 2.7 10.0 8.4 13.4 10.0 4.4 8.0 7.2 9.7 6.1 5.4 3.6 7.6 6.6 13.3 5.3 3.1 7.6 10.6 9.8 4.3 7.5 2.6 6.2 20.4 7.4 5.6 8.0 12.9 7.5 12.6 7.8 4.4 11.2 14.7 4.7 13.2 6.9 10.7 3.9 6.4 11.1 7.6 13.9 8.9 10.8 9.1 10.6 6.9 6.1 8.9 9.3 13.6 5.5 7.0 15.9 10.4 8.0 11.1 9.4 7.5 7.5 2.7 6.8 10.6 8.2 15.7 12.0 10.3 5.3 2.9 2.3 2.7 4.4 3.0 4.5 3.8 5.1 3.7 3.4 3.1 6.4 6.3 1.5 7.9 1.2 2.4 2.2 2.7 12.6 19.8 22.8 21.3 13.2 12.5 14.2 13.7 15.6 12.8 8.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 17.4 0.0 15.4 14.9 12.5 0.0 0.0 0.0 0.0 11.1 12.4 0.0 0.0 16.3 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 16.2 0.0 0.0 12.4 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 186.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA020068: AB_2670348" "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.7 11.6 12.9 6.8 3.1 63.7 17.0 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 3.0 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 12.0 7.9 10.8 32.8 16.3 7.5 13.3 17.9 7.4 15.6 38.6 12.7 11.3 21.4 8.0 8.4 14.1 10.0 5.5 14.9 27.7 5.0 20.2 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 29.8 38.9 8.2 74.8 35.7 7.7 10.1 45.9 77.6 83.0 12.2 3.9 84.2 5.0 11.3 2.0 33.2 153.4 0.0 21.4 96.0 33.1 71.1 15.0 45.0 12.6 3.2 77.6 14.1 12.4 1.7 20.1 13.0 33.7 83.0 146.5 3.4 41.8 114.6 82.4 21.2 3.1 109.9 58.2 24.9 18.6 28.2 98.2 7.0 102.0 186.5 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NFAT5 "KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP" ENSG00000102908 "Nuclear factor of activated T cells 5" O94916 16 69565094-69704666 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057304, HPA069711" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057304: AB_2683407, HPA069711: AB_2686180" "unprognostic (2.71e-1)" "unprognostic (1.50e-2)" "unprognostic (1.77e-1)" "unprognostic (3.57e-2)" "unprognostic (5.65e-3)" "unprognostic (2.08e-1)" "unprognostic (2.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (3.56e-2)" "unprognostic (4.05e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.08e-4)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (6.32e-2)" "unprognostic (9.42e-2)" 15.4 19.1 19.0 17.0 17.1 25.1 15.8 22.4 18.0 19.3 11.9 11.9 12.5 7.7 18.7 19.5 15.7 15.0 11.7 11.6 15.6 8.2 15.7 10.2 15.6 10.5 13.0 12.7 15.6 13.8 35.6 24.2 30.8 13.1 14.7 12.8 13.9 20.1 15.6 12.1 26.5 14.0 12.5 10.5 11.6 12.0 10.1 14.4 10.3 21.9 7.7 10.8 19.6 30.4 2.1 2.9 5.5 4.6 1.1 2.6 0.5 11.1 14.6 7.2 8.9 10.8 13.1 7.9 11.6 13.9 12.3 9.0 11.0 9.2 5.1 6.9 14.0 4.9 9.7 6.4 6.6 13.0 2.9 2.5 4.0 5.3 13.5 8.8 3.9 7.6 9.1 4.5 9.3 11.4 10.2 12.0 3.0 7.8 2.7 11.4 4.9 3.0 5.7 4.2 2.3 1.7 5.3 3.2 2.8 11.8 19.2 3.9 2.4 25.0 2.7 6.9 9.2 5.5 3.1 14.9 10.8 6.6 5.8 3.9 5.9 4.5 8.9 7.2 3.4 6.4 3.5 1.3 1.4 2.2 0.8 1.6 2.1 1.1 2.6 0.6 1.9 0.9 0.8 5.5 1.1 4.6 2.9 1.6 0.5 19.0 17.1 22.4 18.0 15.6 8.2 13.0 12.7 13.1 14.4 44.7 38.8 29.6 89.1 131.5 50.5 7.8 35.7 17.4 37.5 137.9 80.5 49.6 5.0 15.7 6.5 62.4 23.8 0.0 11.1 13.9 39.1 74.1 19.6 23.1 15.6 57.2 23.5 47.3 21.8 4.7 55.0 41.6 55.6 38.7 30.3 54.8 18.7 24.6 51.6 7.0 64.7 25.8 65.5 64.9 26.2 122.5 42.6 32.0 18.1 90.9 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 5.8 7.8 10.1 7.8 13.7 13.4 7.3 17.0 11.2 7.8 9.2 7.6 7.0 8.5 12.7 12.4 8.7 12.5 6.3 4.5 8.4 5.2 7.4 6.6 7.1 8.8 7.5 9.1 14.6 11.4 10.3 10.2 8.4 7.4 9.6 6.7 9.2 9.9 9.6 10.4 14.6 9.0 11.8 5.5 7.0 8.3 27.0 7.0 13.6 18.8 6.6 10.6 10.5 9.5 7.8 8.5 11.1 9.8 3.7 11.5 6.9 7.8 7.5 17.1 9.2 7.3 7.3 10.8 5.4 5.0 6.5 6.4 23.4 13.6 18.8 15.0 4.2 9.6 20.2 16.5 10.7 6.1 7.4 14.4 37.1 13.6 9.7 5.3 9.4 12.6 4.6 11.9 10.7 11.3 7.5 11.2 12.7 21.6 14.4 6.5 7.1 8.0 16.3 8.7 11.6 17.8 11.9 7.4 8.6 8.2 24.8 8.8 9.2 12.3 12.2 3.4 13.3 28.4 8.8 8.8 9.8 9.7 7.2 6.8 4.6 5.6 17.3 4.1 18.7 8.4 11.1 8.4 10.0 10.9 9.8 11.5 5.9 11.1 9.1 8.5 7.8 9.3 7.5 10.0 3.7 8.5 7.7 7.4 6.9 10.1 13.7 17.0 11.2 8.4 5.2 7.5 9.1 7.4 7.0 8.9 15.9 5.2 15.5 26.1 9.3 7.3 7.6 12.0 13.6 7.0 9.8 16.8 6.6 9.6 8.2 7.0 9.7 0.0 8.8 13.2 10.4 9.4 10.4 10.4 9.0 7.9 8.2 8.6 8.1 5.8 13.6 7.3 13.5 10.0 8.8 9.7 8.9 7.0 9.9 6.9 10.6 32.3 8.4 39.3 45.3 30.7 19.5 10.0 10.6 15.4 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.4 9.8 15.4 8.6 3.7 1.2 4.2 3.3 4.0 2.9 3.5 1.7 4.7 2.8 5.0 3.4 4.9 9.5 2.4 5.8 1.9 8.8 4.5 4.5 5.4 5.5 5.2 3.4 5.1 8.7 3.7 4.8 3.8 3.6 4.8 5.6 5.8 2.4 3.5 4.9 2.2 4.6 3.6 4.4 7.5 5.5 2.3 4.2 13.1 9.8 12.3 8.1 6.5 3.5 7.0 2.6 7.4 5.8 9.6 4.1 6.2 7.5 3.8 20.0 5.0 4.2 5.4 7.8 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 17.9 20.6 6.7 10.6 6.4 10.7 7.8 2.5 103.1 36.4 5.2 9.8 5.1 5.0 27.1 1.5 8.4 7.3 0.0 20.6 3.7 5.0 7.7 19.7 3.4 3.7 15.9 25.4 5.5 4.0 2.2 8.3 5.9 8.5 17.2 15.6 13.3 25.7 17.5 8.1 6.7 10.4 12.9 8.6 4.8 3.6 4.4 5.6 8.5 15.7 6.4 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Group enriched" "Detected in some" 7 "Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 0.0 0.0 0.0 2.1 2.5 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 4.9 1.5 1.9 0.0 0.0 0.0 0.3 NIFK "hNIFK, MKI67IP, Nopp34" ENSG00000155438 "Nucleolar protein interacting with the FHA domain of MKI67" Q9BYG3 2 121726945-121736923 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015382, HPA035735, HPA035736, CAB075728, CAB075729" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.21e-1)" "unprognostic (4.15e-3)" "prognostic unfavorable (2.92e-6)" "unprognostic (7.74e-3)" "unprognostic (4.63e-2)" "unprognostic (3.21e-2)" "unprognostic (6.02e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (5.01e-11)" "unprognostic (1.72e-1)" "unprognostic (1.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" 25.1 18.7 18.4 22.1 19.0 19.9 28.1 14.3 20.8 24.0 17.3 14.8 9.8 16.5 21.4 17.4 28.2 20.3 16.6 15.4 16.1 15.1 24.2 40.1 14.7 30.8 15.8 15.2 32.8 33.7 12.9 28.9 19.8 18.5 21.2 19.7 10.2 16.5 14.2 35.5 22.8 17.9 20.9 18.3 28.1 19.2 18.7 18.0 31.3 23.6 21.3 29.5 26.1 21.0 28.1 25.9 12.5 23.5 27.1 32.9 24.6 28.8 8.7 18.9 18.5 16.6 23.0 22.7 22.7 20.4 28.6 31.3 25.5 14.7 39.7 28.4 17.7 24.8 18.7 40.6 30.7 42.9 24.1 21.5 39.0 12.3 23.8 23.3 35.9 21.6 23.1 35.4 37.8 50.7 13.3 20.5 15.8 43.8 19.8 24.7 14.2 27.5 35.7 46.3 34.5 31.5 26.4 21.2 48.6 25.4 18.1 23.6 24.4 14.3 28.6 49.6 17.9 13.7 30.9 11.8 19.7 32.2 22.2 32.3 23.2 34.9 44.1 15.3 35.5 27.4 12.5 19.8 9.3 22.9 23.5 32.1 27.0 28.2 26.2 25.9 28.1 32.9 30.8 1.3 27.1 20.9 22.6 23.5 24.6 18.4 19.0 14.3 20.8 16.1 15.1 15.8 15.2 18.5 18.0 41.7 23.4 49.1 90.7 87.3 25.6 18.3 15.3 44.2 64.8 14.0 11.8 63.5 39.7 65.3 10.4 41.8 15.2 23.3 39.1 70.0 52.4 39.8 53.1 31.1 49.2 12.7 27.0 22.7 32.3 3.8 53.2 41.0 21.9 45.1 37.8 44.7 45.9 21.0 42.5 40.0 38.4 38.8 44.3 54.8 72.2 88.7 40.8 39.4 44.3 93.5 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452705-25585517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 20.1;Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 10 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "AF22: 14.6;Hep G2: 22.9" "Low region specificity" "Detected in many" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 3.8 7.5 5.9 7.6 10.7 0.8 4.2 17.2 4.2 10.3 6.7 5.5 3.9 4.1 13.0 9.7 4.7 4.1 7.5 4.0 5.8 6.3 17.1 5.9 5.3 2.7 4.5 4.2 18.5 5.0 14.8 12.1 2.0 7.5 8.8 2.8 13.8 4.7 5.2 5.2 2.7 3.6 9.7 5.5 5.3 6.5 10.5 2.0 17.2 8.2 2.6 3.9 2.8 6.6 0.2 0.0 0.0 0.0 0.0 2.2 0.2 0.6 6.7 14.6 9.6 1.6 4.9 4.5 2.2 1.9 2.0 2.8 1.7 4.7 0.3 3.2 3.5 4.8 0.5 2.1 0.4 1.7 0.3 3.0 1.0 3.0 22.9 3.5 0.3 0.0 6.0 0.4 2.3 0.0 5.6 4.2 11.2 1.1 0.1 2.4 5.9 13.0 0.4 4.1 0.1 0.7 0.3 11.4 0.5 1.0 0.8 14.5 10.3 5.1 1.9 5.5 12.3 3.1 3.9 0.2 0.1 5.6 0.0 0.1 1.5 2.6 0.0 0.1 0.3 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.2 5.9 10.7 17.2 4.2 5.8 6.3 4.5 4.2 7.5 2.0 0.0 10.5 0.0 3.6 1.8 2.4 4.5 15.3 20.1 5.7 7.0 23.6 2.5 0.0 4.7 0.4 1.8 0.3 0.0 1.1 1.1 6.2 3.9 0.0 6.0 1.8 7.9 5.8 6.7 0.8 1.8 12.0 0.7 0.0 0.0 1.6 2.4 2.5 0.8 11.7 6.9 1.9 6.5 2.1 2.4 4.1 0.6 1.3 0.0 1.5 1.6 NLN "AGTBP, KIAA1226" ENSG00000123213 Neurolysin Q9BYT8 5 65722196-65871725 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;monocytes: 5.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031862 Approved Approved Mitochondria Yes No 53000 Mitochondria "HPA031862: AB_10600827" "unprognostic (5.91e-3)" "unprognostic (4.52e-2)" "unprognostic (1.34e-3)" "unprognostic (4.37e-2)" "unprognostic (3.85e-1)" "unprognostic (1.45e-2)" "unprognostic (7.29e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.27e-1)" "prognostic favorable (5.58e-7)" "unprognostic (1.52e-2)" "unprognostic (1.98e-1)" "unprognostic (1.29e-1)" "unprognostic (6.18e-3)" 4.5 2.4 7.6 4.7 10.5 2.9 7.3 2.8 11.9 4.1 6.8 5.8 1.0 2.4 5.8 5.0 5.2 3.3 2.7 5.1 7.2 7.6 7.5 18.9 3.4 5.1 8.7 8.5 4.0 11.0 3.6 2.4 4.9 9.8 5.4 6.5 2.0 4.3 2.6 15.0 5.7 5.3 5.5 10.9 5.8 7.5 2.4 6.2 1.8 5.5 7.9 4.0 4.3 3.3 0.9 4.1 0.6 5.9 0.9 0.7 1.8 9.2 8.9 5.3 8.7 6.7 11.5 10.6 9.4 4.0 5.5 6.0 5.1 5.5 13.2 11.9 11.2 11.1 7.4 6.8 14.4 9.7 3.9 4.6 3.6 6.7 12.8 5.8 8.3 2.2 8.7 7.9 7.6 9.1 4.7 15.5 5.9 7.8 2.8 11.9 7.1 5.7 7.5 16.1 4.7 2.6 6.7 11.2 20.9 9.1 4.1 16.4 8.5 7.6 7.8 7.7 14.9 9.3 9.9 8.9 3.7 4.4 5.4 7.0 2.4 4.8 5.8 5.7 16.4 5.5 0.2 4.7 0.2 0.2 5.9 0.3 0.9 0.4 0.3 4.1 0.9 0.7 0.5 0.6 0.9 4.1 0.2 0.1 1.8 7.6 10.5 2.8 11.9 7.2 7.6 8.7 8.5 9.8 6.2 6.0 3.2 1.5 5.1 5.0 0.6 13.2 10.2 2.7 11.4 12.2 3.9 5.2 5.0 15.3 0.2 5.0 20.6 0.0 12.3 12.1 5.2 8.8 15.0 26.4 24.7 4.8 1.7 5.5 23.4 0.0 4.0 8.4 1.7 2.8 7.1 13.2 23.5 10.7 2.1 17.4 3.5 0.0 3.1 1.4 4.3 4.5 2.4 0.9 7.1 5.5 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Yes No Mitochondria "CAB045997: AB_11126630, HPA072588: AB_2686538" "unprognostic (3.27e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavorable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 34.5 34.4 21.5 13.9 17.6 46.8 34.6 10.4 13.6 25.6 44.6 12.8 40.7 9.7 21.7 33.7 25.1 20.0 39.9 26.9 16.6 16.5 20.2 61.2 13.5 27.5 16.9 11.3 31.9 19.2 22.0 17.3 19.4 11.7 46.9 10.6 32.2 44.4 44.0 13.7 7.5 15.3 83.9 12.4 17.8 27.1 13.3 10.9 19.6 21.0 14.2 14.5 64.1 27.5 13.1 28.6 18.2 6.3 1.2 13.7 5.2 0.1 50.4 44.8 61.6 18.0 31.6 10.0 23.7 28.6 35.9 30.9 33.6 29.3 0.5 17.9 37.8 13.0 0.6 24.2 25.5 10.6 20.3 36.2 24.4 6.9 44.9 34.0 17.8 9.0 40.6 13.4 22.0 2.1 25.9 23.0 35.1 25.3 4.3 26.7 41.3 15.5 22.4 45.7 12.3 11.2 78.4 10.0 12.7 24.9 0.2 13.1 71.0 6.0 0.4 22.1 17.2 30.0 41.8 28.7 25.7 37.4 17.1 5.9 0.5 0.3 13.3 11.2 3.2 29.6 4.1 6.3 18.2 7.5 5.6 6.5 12.3 7.7 8.3 8.7 13.1 13.7 7.1 2.2 1.2 4.8 28.6 0.4 5.2 21.5 17.6 10.4 13.6 16.6 16.5 16.9 11.3 11.7 10.9 0.0 11.5 29.0 48.4 28.6 13.9 34.0 35.7 4.0 4.5 55.8 2.0 59.9 212.2 109.2 3.5 43.9 11.0 186.9 35.0 20.4 74.3 109.3 29.9 119.9 107.7 7.9 43.4 47.9 41.0 14.6 82.6 23.2 59.1 66.7 34.5 18.6 75.4 17.3 89.1 59.0 5.4 51.8 95.1 1.4 43.5 21.5 18.2 14.9 56.3 48.5 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115172-138139443 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.1;testis: 36.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.3 5.2 12.3 0.6 18.4 0.3 3.7 3.5 13.9 7.1 1.2 3.9 4.7 0.5 4.1 18.2 1.0 28.1 6.8 2.9 12.0 10.7 15.4 0.6 3.6 0.6 9.4 9.9 4.5 3.5 12.1 8.9 0.4 13.1 4.2 1.1 4.8 3.1 3.9 0.4 0.4 0.5 2.6 4.2 0.4 2.2 36.2 4.8 0.0 9.6 0.3 0.4 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 0.0 0.6 0.4 0.6 0.2 0.1 1.5 0.0 0.9 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 1.9 0.0 0.8 0.0 3.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 25.6 0.0 5.9 2.2 0.0 0.7 3.8 1.5 0.5 1.3 0.0 0.6 0.0 0.0 0.8 0.4 0.6 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 18.4 3.5 13.9 12.0 10.7 9.4 9.9 13.1 4.8 6.0 6.9 0.0 9.1 0.6 11.4 2.8 2.5 327.9 26.1 31.4 13.7 0.4 72.9 18.8 516.0 3.4 0.0 0.0 3.6 0.0 3.2 7.9 0.0 0.5 0.1 6.4 5.2 1.3 0.0 184.0 8.3 0.7 10.1 1.0 2.5 15.8 5.2 0.0 13.1 66.5 21.6 0.0 1.0 142.0 20.4 0.3 0.0 0.0 1.1 5.6 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944204-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 420000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044258: AB_10961284, HPA062195: AB_2684707" "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 17.7 15.6 13.4 20.5 17.8 23.8 18.2 23.7 27.4 15.0 15.3 15.6 13.5 16.8 19.0 13.5 27.7 18.3 21.8 23.0 15.3 15.3 15.2 36.6 14.0 19.3 18.7 19.0 16.9 26.8 20.8 15.3 15.9 16.7 16.6 11.1 14.0 22.0 16.5 40.0 32.4 14.6 14.7 13.6 17.5 16.4 21.1 18.0 22.7 19.8 29.5 21.8 17.5 18.0 14.3 20.2 11.3 29.0 18.8 18.4 16.0 27.6 27.6 4.9 32.1 9.0 8.0 18.1 20.7 9.7 29.0 15.9 36.6 27.2 31.2 29.4 13.7 24.1 25.4 36.7 30.9 12.3 19.6 41.8 16.5 35.7 31.7 20.3 36.3 16.3 13.1 8.8 31.8 21.3 9.0 14.0 11.1 46.6 14.4 12.8 43.8 23.3 22.0 28.3 20.0 32.8 29.3 20.6 37.8 13.3 11.7 34.7 34.1 27.4 41.5 25.3 7.8 18.5 19.9 16.0 17.3 24.7 18.9 35.3 24.8 26.7 56.4 21.5 51.6 14.4 7.2 17.0 11.3 14.2 25.7 18.4 14.3 13.8 13.6 20.2 11.9 14.3 11.1 1.6 18.8 29.0 13.0 10.9 16.0 13.4 17.8 23.7 27.4 15.3 15.3 18.7 19.0 16.7 18.0 14.9 23.9 46.0 71.4 61.6 53.0 2.8 20.4 20.1 13.6 34.9 58.9 54.4 14.9 44.4 5.6 27.4 17.0 0.0 39.8 56.2 34.7 37.8 12.8 19.8 34.6 42.9 28.8 17.8 23.1 8.1 27.3 24.1 23.6 30.7 23.4 21.7 31.2 17.5 20.1 15.2 68.2 32.3 49.2 36.7 73.9 71.6 49.2 39.9 41.2 60.5 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003547 Uncertain Approved "Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles" Yes No "Nucleoli, Mitotic chromosome" "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favorable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favorable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favorable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 16.9 15.7 11.7 13.4 3.8 4.0 14.8 8.5 3.9 3.8 4.1 8.8 7.1 14.5 5.1 3.8 4.0 18.5 6.7 22.4 1.3 15.2 24.5 12.3 12.6 20.1 10.3 29.1 18.1 5.9 7.3 15.2 5.9 5.3 7.3 8.6 9.1 13.1 3.3 14.8 15.9 21.7 13.4 7.6 21.2 21.8 7.6 10.9 8.5 6.0 9.5 18.7 9.9 9.1 13.5 1.8 13.0 13.8 10.2 16.2 16.4 11.8 15.6 11.0 13.4 18.7 15.4 21.6 18.9 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 3.0 11.7 16.1 10.3 34.7 11.5 3.1 7.6 9.4 7.9 14.0 5.9 16.5 3.3 23.3 77.4 12.6 26.9 0.0 25.4 13.3 12.5 7.3 15.0 4.9 12.1 27.0 12.1 9.8 8.7 31.6 9.2 16.0 20.3 19.0 18.9 9.1 18.7 31.6 10.6 6.4 8.1 12.9 8.2 14.4 24.4 34.8 16.6 16.7 18.4 13.2 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 15.8 11.5 11.6 14.6 20.0 8.5 13.6 15.9 15.9 15.1 13.2 7.3 12.1 6.4 16.4 11.1 14.1 13.0 9.4 9.4 13.7 8.2 10.6 8.9 9.5 13.6 17.9 8.4 17.5 11.1 25.3 23.6 11.8 13.4 14.0 11.0 5.2 11.0 13.2 15.0 12.9 10.7 14.6 19.5 15.7 10.6 7.7 17.8 18.7 15.2 11.2 15.1 16.3 16.2 13.6 12.2 13.6 14.7 12.6 17.5 6.6 8.1 13.2 6.1 12.3 13.9 11.8 8.4 9.3 7.3 10.0 9.6 4.7 8.5 25.6 8.2 9.8 16.6 16.9 21.8 13.0 11.1 16.0 9.9 18.2 13.2 10.5 9.4 30.3 13.9 12.4 9.6 11.2 15.7 8.2 12.3 7.6 27.6 7.9 11.5 13.1 21.1 10.6 10.3 11.6 12.6 12.8 18.0 10.4 5.2 5.5 11.4 5.6 12.8 11.2 7.8 8.3 4.5 9.6 11.9 9.3 6.0 13.1 9.7 8.0 17.9 13.9 8.6 17.5 11.9 13.6 8.3 11.3 12.5 11.1 17.5 13.6 11.9 12.0 12.2 12.6 14.6 12.5 3.2 12.6 14.7 10.3 13.2 6.6 11.6 20.0 15.9 15.9 13.7 8.2 17.9 8.4 13.4 17.8 17.9 33.1 27.4 15.8 11.6 18.5 25.6 12.7 32.1 23.9 10.4 9.8 16.1 13.3 20.5 9.0 20.2 8.8 23.3 11.2 17.4 13.2 11.2 48.8 9.6 23.0 27.0 8.6 20.3 16.1 6.8 29.7 19.8 10.1 27.1 14.3 13.7 15.3 7.0 22.3 12.4 16.8 6.5 13.4 46.1 37.9 13.9 12.2 15.2 17.9 9.6 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411137 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced "Nucleoplasm,Nucleoli rim" Yes No 810000 "Nucleoli rim" Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (7.48e-4)" "prognostic unfavorable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 56.8 44.7 29.9 61.1 33.6 76.0 67.0 37.7 34.6 113.5 57.8 24.8 39.3 36.7 78.2 50.5 81.6 65.0 44.0 48.5 28.8 31.6 64.9 78.8 59.5 128.1 36.1 27.9 177.4 102.0 27.1 57.9 65.2 36.1 87.2 49.3 29.5 47.3 48.2 67.9 42.7 52.8 92.4 43.2 85.9 54.0 56.7 31.3 111.3 112.6 66.5 82.1 116.8 65.7 85.3 54.1 12.3 29.1 59.0 126.6 91.4 119.9 81.3 98.8 139.9 60.4 110.3 147.3 109.2 99.8 148.0 133.3 193.9 84.8 321.2 86.8 63.1 99.7 70.4 137.0 248.2 192.8 100.0 108.7 113.3 79.7 142.8 89.5 228.2 94.0 97.3 87.5 100.4 198.1 116.7 110.3 74.8 137.8 73.9 107.4 149.0 148.9 162.3 123.6 64.0 99.9 133.7 109.0 164.6 126.2 84.6 77.9 62.6 65.2 106.8 197.6 72.0 131.0 101.3 68.9 49.5 109.2 56.9 183.8 59.2 107.6 193.2 74.9 185.8 98.7 12.3 26.9 8.4 45.7 29.1 84.6 85.3 85.1 66.2 54.1 62.8 126.6 99.0 4.0 59.0 23.1 48.7 73.2 91.4 29.9 33.6 37.7 34.6 28.8 31.6 36.1 27.9 36.1 31.3 321.6 347.3 775.5 994.0 1243.7 166.1 228.8 387.3 346.6 597.1 307.1 41.2 1400.5 630.0 839.1 64.3 646.8 150.8 116.8 796.2 1641.6 855.4 473.8 427.8 235.7 952.5 120.8 347.6 298.3 500.7 53.0 902.7 605.7 578.6 960.4 654.2 214.7 840.7 333.1 610.9 657.5 112.2 426.9 861.0 695.1 635.2 890.7 1286.9 674.9 783.2 797.7 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.6 2.1 0.0 0.0 0.0 4.3 2.1 2.3 0.6 0.0 0.7 1.6 0.0 0.0 0.0 1.6 2.5 3.6 4.5 0.5 0.0 4.4 2.7 0.1 0.0 0.0 0.0 4.4 0.0 2.5 2.0 5.3 0.0 1.8 2.7 2.3 2.9 1.7 0.8 1.7 3.1 1.4 0.0 2.9 2.3 3.3 1.6 2.4 0.5 5.4 1.6 0.8 2.3 1.2 1.5 1.7 3.0 0.9 0.2 3.4 2.9 2.1 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 0.0 0.6 0.0 0.5 0.1 4.0 1.4 0.0 0.0 0.0 1.8 5.9 0.2 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.0 9.2 25.8 17.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 23.1;EFO-21: 23.1;RH-30: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.0 3.4 23.1 0.2 9.3 1.0 10.7 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.1 10.4 1.9 4.8 4.8 4.6 2.1 0.0 1.3 0.0 3.7 1.8 1.9 0.0 0.0 4.8 3.1 2.5 0.8 7.6 8.4 0.0 0.0 16.8 3.1 0.5 0.1 0.2 4.5 0.0 1.4 0.0 33.2 4.0 2.5 5.9 2.7 0.1 2.6 0.8 0.2 15.9 1.2 0.1 6.2 3.8 12.9 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 0.0 3.7 0.0 32.0 11.9 30.8 46.0 2.5 0.0 5.7 7.0 0.0 0.4 3.3 5.0 0.3 46.6 0.0 23.3 8.3 4.1 9.2 4.4 0.0 10.5 6.1 38.1 0.0 119.1 9.7 1.7 3.7 1.3 10.1 1.0 2.0 1.7 11.7 0.0 2.8 1.4 2.6 0.0 14.4 0.7 5.5 13.9 0.2 0.9 0.9 3.7 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 4.3 7.4 3.7 9.9 8.9 5.0 6.3 3.5 5.1 3.4 8.1 7.2 9.5 7.0 6.5 13.8 3.8 4.5 7.0 7.0 5.9 3.0 7.1 12.8 5.1 5.3 7.3 4.5 4.4 7.8 7.4 4.1 3.6 5.8 5.2 4.7 3.7 5.0 8.8 8.6 7.2 5.8 5.2 11.8 5.8 6.0 5.6 7.2 2.4 4.6 2.8 4.8 6.8 3.7 6.2 1.9 2.5 3.4 4.9 3.7 1.1 5.1 3.7 6.0 7.5 3.8 3.2 1.3 4.6 4.1 2.4 2.7 9.7 10.8 2.5 2.3 2.8 3.9 6.1 0.6 4.3 2.4 1.9 10.5 7.0 6.0 5.3 0.3 3.9 2.9 2.3 4.7 3.1 1.7 6.4 1.8 4.6 5.9 4.0 2.4 2.4 2.3 5.6 2.3 3.3 11.9 5.1 1.0 0.2 3.3 2.4 2.7 3.9 2.5 6.2 2.0 2.7 3.4 2.5 3.4 2.1 8.2 0.8 1.7 2.9 3.3 3.4 5.9 7.2 2.0 0.1 2.6 2.5 1.8 2.5 2.1 3.0 1.5 1.6 1.9 6.2 2.3 2.4 1.0 4.9 3.4 0.6 3.7 1.1 3.7 8.9 3.5 5.1 5.9 3.0 7.3 4.5 5.8 7.2 6.0 1.3 2.2 2.3 0.8 1.3 6.2 0.0 6.7 2.3 3.5 3.9 3.0 3.3 1.6 2.6 1.0 1.2 0.0 0.6 0.7 1.3 1.4 0.0 3.2 1.5 0.0 1.2 0.6 1.3 3.4 0.9 1.5 0.0 1.8 1.8 0.8 1.2 2.9 0.7 4.1 1.7 0.0 1.0 3.2 0.5 1.3 0.9 0.0 1.3 0.9 NUDT15 "FLJ10956, MTH2" ENSG00000136159 "Nudix hydrolase 15" Q9NV35 13 48037567-48047222 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038968, HPA038969" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA038968: AB_10697402, HPA038969: AB_2676295" "unprognostic (9.48e-2)" "unprognostic (5.91e-3)" "unprognostic (2.64e-2)" "unprognostic (9.00e-3)" "unprognostic (4.99e-2)" "unprognostic (2.50e-3)" "unprognostic (2.29e-2)" "unprognostic (7.47e-3)" "prognostic unfavorable (1.25e-5)" "unprognostic (1.04e-1)" "unprognostic (8.50e-2)" "unprognostic (3.69e-1)" "unprognostic (4.63e-2)" "unprognostic (1.84e-3)" "unprognostic (3.35e-1)" "unprognostic (9.58e-2)" "unprognostic (8.93e-3)" 15.0 15.2 11.4 16.6 14.6 16.5 18.0 14.1 17.7 14.8 21.1 9.5 14.3 22.1 11.1 15.5 23.8 12.8 13.5 13.3 10.5 15.7 20.3 21.3 11.1 7.4 12.8 11.1 13.0 13.8 6.1 18.6 14.2 15.8 16.9 24.1 8.2 14.1 12.6 15.9 10.8 20.5 11.3 11.9 9.6 13.9 22.2 10.6 11.6 22.3 24.1 12.0 12.1 14.2 4.7 7.0 4.6 9.9 3.8 9.2 4.1 19.6 11.9 22.4 9.9 9.2 13.4 16.5 16.0 15.1 17.7 17.2 17.6 19.1 14.6 9.1 12.6 15.9 23.2 21.7 23.5 27.4 7.6 18.7 14.2 11.7 19.1 8.6 21.2 13.6 9.2 15.1 14.3 20.2 8.0 19.1 14.7 12.5 5.8 28.4 9.6 16.7 20.1 35.9 30.1 14.2 11.5 14.5 9.5 19.7 15.0 13.6 14.5 10.9 18.8 12.4 20.1 9.6 16.1 9.8 12.5 15.2 15.6 22.0 3.1 5.1 18.3 6.5 16.7 20.1 2.1 7.3 4.6 4.6 9.9 4.5 4.7 7.4 5.8 7.0 4.7 8.8 9.2 1.6 3.8 6.7 5.6 5.0 4.1 11.4 14.6 14.1 17.7 10.5 15.7 12.8 11.1 15.8 10.6 11.9 11.2 7.5 29.2 14.7 7.3 10.8 15.3 12.0 20.5 7.0 2.0 29.2 41.4 15.1 13.5 11.7 22.0 0.0 15.4 67.2 13.0 26.5 9.2 14.7 14.6 36.5 8.1 8.0 6.7 7.2 15.5 9.6 10.1 10.8 19.4 7.7 12.6 11.5 11.7 33.4 7.1 0.0 21.2 5.8 30.2 17.9 31.8 5.7 29.5 30.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUFIP1 NUFIP ENSG00000083635 "NUFIP1, FMR1 interacting protein 1" Q9UHK0 13 44939249-44989483 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 8.9 9.8 10.4 10.7 16.4 17.4 11.6 11.0 17.2 9.8 7.8 10.8 4.8 7.1 11.7 14.4 9.2 9.2 6.3 6.4 12.7 9.6 10.2 13.7 11.2 8.5 8.9 12.6 13.7 11.5 9.3 9.6 7.7 7.9 9.1 7.9 6.3 8.6 8.8 17.0 10.1 6.4 10.3 10.0 8.4 8.6 14.1 8.8 11.4 10.1 6.8 9.3 8.9 8.3 6.6 6.3 1.1 3.7 8.3 6.9 2.5 5.4 4.3 7.3 6.1 5.0 5.3 8.8 6.5 5.6 12.1 7.8 11.6 8.8 16.0 5.5 6.0 7.3 8.6 13.6 9.2 15.8 4.9 10.7 12.2 2.9 10.4 8.4 15.7 5.0 5.5 8.6 8.1 12.4 4.7 6.0 8.3 9.7 2.7 8.5 6.2 12.9 9.9 17.3 14.6 7.1 12.8 7.0 9.8 7.3 4.7 4.0 9.0 5.6 7.6 7.0 7.2 5.8 8.8 4.5 6.2 5.3 7.9 8.9 3.7 5.7 20.2 7.0 11.1 8.7 0.0 3.7 1.1 3.9 3.7 6.9 5.9 4.3 4.1 4.7 6.6 6.8 5.1 0.2 8.3 2.3 6.3 2.4 2.5 10.4 16.4 11.0 17.2 12.7 9.6 8.9 12.6 7.9 8.8 6.0 9.8 6.7 10.1 13.7 7.2 4.0 5.1 5.3 18.2 5.2 11.8 13.3 14.9 11.0 34.3 7.7 2.4 23.3 14.4 12.0 9.3 4.8 17.3 8.1 9.3 7.9 5.2 8.0 4.3 47.9 10.0 7.9 8.5 6.4 4.7 8.2 8.9 0.0 10.6 12.2 6.6 6.5 8.5 26.7 28.3 14.4 7.3 6.2 8.1 7.1 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Yes Yes Nucleoplasm "Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.4 12.6 41.8 19.9 2.2 3.6 13.9 30.0 17.7 33.1 32.1 17.0 19.6 19.4 16.7 11.3 26.6 36.2 32.2 14.7 31.8 34.9 15.8 49.4 31.3 16.0 0.6 31.4 22.2 1.1 1.7 17.6 13.6 6.5 19.8 30.1 27.0 66.3 25.6 10.0 38.8 21.1 21.5 38.5 15.6 41.9 44.6 21.0 11.8 11.7 30.3 20.8 41.3 24.3 8.6 15.9 36.6 23.3 12.0 25.7 32.3 29.0 52.7 24.7 47.7 62.1 13.5 47.2 44.1 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 0.0 1.0 6.7 5.9 34.2 0.8 0.8 22.9 0.0 4.5 0.0 0.0 10.7 3.3 2.1 20.6 0.7 1.8 350.4 0.4 100.9 8.5 4.1 6.9 3.8 30.5 0.0 2.9 9.2 13.2 8.5 0.3 16.4 3.3 6.4 3.4 1.5 1.6 0.0 1.8 3.9 0.9 0.0 4.1 103.5 65.4 21.8 16.1 13.4 10.2 4.7 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.2 70.2 7.2 5.8 0.4 2.3 2.9 31.4 5.5 1.2 7.8 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 1.1 3.3 1.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 11.7 5.6 3.9 3.4 0.1 3.0 17.6 0.2 0.0 5.8 2.2 5.7 0.0 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.2 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 3.0 4.6 2.4 4.8 3.1 0.4 1.7 0.0 0.0 2.3 3.5 0.0 4.0 3.3 10.8 6.1 13.4 4.1 0.0 8.6 15.8 5.4 6.5 1.1 1.5 16.5 0.0 1.7 9.2 4.7 5.9 9.5 6.6 1.7 6.4 6.3 4.4 14.5 4.0 14.2 2.1 0.2 0.0 3.1 0.5 0.2 4.1 1.6 4.6 3.7 25.3 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533083-71575897 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595" "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favorable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavorable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.85e-7)" 26.1 24.0 33.3 39.7 36.6 38.7 33.7 75.7 43.8 25.0 23.0 22.0 31.1 22.5 36.7 48.3 24.3 33.4 21.2 25.1 29.3 15.4 27.4 20.3 31.0 47.9 30.2 25.6 42.8 46.1 26.5 34.5 19.5 26.6 34.2 30.3 29.9 35.9 30.9 35.0 45.4 38.4 31.1 32.3 56.7 28.2 11.8 36.6 35.7 34.1 27.6 41.4 24.9 31.0 9.7 7.6 3.2 7.2 12.5 9.9 6.0 14.2 13.3 17.3 15.2 18.7 17.3 11.7 10.9 19.8 11.9 18.3 14.0 16.4 17.0 7.7 13.4 12.4 17.8 18.9 10.7 14.7 14.5 19.4 10.7 31.9 10.0 14.2 22.0 17.8 16.5 21.8 13.0 24.6 20.6 11.1 36.5 10.8 59.1 11.3 12.1 16.9 26.5 11.5 12.7 18.3 16.8 19.5 21.7 18.4 16.5 8.9 7.8 17.0 11.3 10.5 13.7 8.3 15.0 12.8 12.9 10.5 13.4 6.3 16.1 11.6 20.4 9.1 23.2 7.8 3.2 5.3 2.3 9.9 7.2 9.0 9.7 8.3 8.0 7.5 8.5 9.7 9.5 2.4 12.5 6.5 7.6 7.6 6.0 33.3 36.6 75.7 43.8 29.3 15.4 30.2 25.6 26.6 36.6 32.8 80.7 38.6 31.8 78.3 24.7 38.6 20.4 20.1 31.8 47.1 7.9 11.8 8.3 11.5 1.7 42.7 29.0 46.7 12.1 7.0 45.0 42.9 26.6 24.9 14.0 38.1 33.6 45.4 64.9 1.8 49.5 36.1 33.7 15.4 36.2 13.8 15.0 31.6 28.0 12.2 23.2 32.3 32.5 1.8 6.0 73.5 9.2 59.0 30.2 38.6 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" Yes NA "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 21.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.3 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 149.7 0.1 0.0 0.4 0.0 0.0 0.0 132.6 0.0 0.0 1.7 216.4 0.2 0.0 104.8 0.0 804.6 0.0 0.0 16.5 0.0 0.0 0.1 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 18.0 135.9 3.2 1519.9 238.2 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 937.7 2045.0 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 84.9;Spermatogonia: 102.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: AB_2686537" "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavorable (3.53e-4)" "prognostic favorable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.8 1.4 4.1 8.9 7.0 14.2 1.1 3.8 6.1 1.3 2.8 1.2 1.4 2.7 1.5 1.9 6.7 0.9 1.2 2.3 4.4 3.5 0.8 1.6 1.5 10.6 3.1 4.5 0.9 0.6 0.3 1.2 5.2 2.4 0.8 3.1 0.5 1.4 0.6 0.4 1.9 2.7 1.7 2.9 4.1 1.5 23.1 1.4 12.8 0.9 4.2 10.7 2.6 2.0 4.1 3.4 1.0 2.6 2.8 4.1 2.5 10.9 10.1 16.2 12.6 2.0 2.5 12.0 19.6 7.3 21.7 11.4 14.2 6.7 12.7 10.3 3.7 11.0 11.2 20.8 5.4 18.4 6.5 16.8 10.5 5.4 14.3 2.5 17.2 11.1 0.7 1.0 11.8 6.2 3.5 7.1 11.1 12.7 6.5 13.1 9.6 23.1 21.6 17.9 7.6 27.9 27.9 29.8 12.9 5.3 3.8 19.4 11.5 10.0 11.1 6.8 13.5 5.9 13.7 4.3 20.0 13.6 12.6 18.4 5.0 6.7 44.4 8.5 11.3 15.4 0.0 1.1 1.0 3.5 2.6 1.4 2.7 2.0 2.0 2.2 4.1 2.9 1.4 0.5 2.8 2.5 3.4 4.1 2.5 4.1 7.0 3.8 6.1 4.4 3.5 3.1 4.5 2.4 1.4 3.0 16.4 15.2 2.4 6.0 6.1 3.3 2.5 17.4 9.1 5.2 3.9 22.0 1.7 2.6 9.4 3.0 2.1 0.0 0.6 30.9 9.9 1.7 1.1 8.3 13.2 11.1 1.7 0.0 3.3 6.2 2.6 6.1 32.1 0.0 5.6 2.5 1.6 0.0 3.2 0.7 8.4 0.0 2.2 84.9 102.2 5.3 9.2 4.4 10.3 1.7 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 94.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 15.2 3.9 11.4 22.1 35.2 27.1 9.5 44.7 40.5 17.3 41.6 6.5 11.9 5.2 17.1 44.2 10.5 17.3 7.1 16.3 37.9 6.6 2.7 4.4 3.7 7.7 14.7 8.1 3.1 16.4 9.5 14.7 19.5 94.8 8.1 4.4 6.8 2.7 14.9 4.0 3.2 7.8 4.1 7.1 17.3 2.9 7.6 9.3 9.7 6.6 1.0 6.4 9.1 27.0 10.6 26.9 4.1 7.6 7.7 21.2 8.7 5.9 10.4 15.6 5.6 2.5 38.0 11.8 10.3 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 6.0 27.9 18.6 25.1 32.3 12.9 37.9 2.5 56.2 31.8 22.7 25.5 25.0 0.0 26.6 10.0 23.3 10.7 0.0 17.0 76.6 76.1 22.0 39.3 25.1 39.6 11.1 9.9 19.0 44.8 4.7 48.1 41.1 42.2 36.1 7.6 33.4 37.2 18.2 44.2 22.8 17.6 38.8 31.1 35.7 35.8 20.8 27.8 13.8 6.5 17.3 PAICS "ADE2H1, AIRC, PAIS" ENSG00000128050 "Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase" P22234 4 56435741-56464579 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Decarboxylase, Ligase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035895, HPA041538" Approved Approved Cytosol Yes No 340000 Cytosol "HPA035895: AB_10669660, HPA041538: AB_2677540" "unprognostic (2.59e-3)" "unprognostic (7.90e-3)" "unprognostic (3.84e-3)" "unprognostic (2.88e-2)" "unprognostic (9.85e-2)" "unprognostic (2.82e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.07e-3)" "unprognostic (1.23e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.48e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.11e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.16e-1)" 15.5 27.1 21.6 20.4 17.4 21.4 29.3 15.8 20.6 17.5 22.5 18.5 18.4 17.2 19.6 12.6 29.0 19.6 11.4 13.4 16.7 22.6 26.5 63.7 11.3 25.6 26.4 19.2 23.3 27.7 26.2 17.9 24.3 29.8 17.5 30.5 13.1 15.7 16.8 23.8 20.0 16.1 19.4 23.5 19.8 12.8 18.3 15.9 44.9 17.8 26.8 33.1 18.7 18.9 13.7 12.8 3.2 6.4 10.9 14.4 6.7 34.3 25.8 53.3 33.0 11.4 25.9 45.9 29.8 21.6 42.8 42.2 40.9 40.9 79.6 34.7 19.9 23.3 21.3 84.1 43.3 73.4 15.9 29.6 43.2 39.5 45.3 21.9 76.8 19.3 21.9 31.4 45.4 34.3 23.7 35.0 45.7 74.5 29.7 36.8 22.9 88.1 38.5 61.1 66.2 32.3 71.6 22.8 52.3 40.5 24.1 57.3 34.3 29.3 41.0 18.0 45.5 27.1 24.6 18.8 33.9 44.4 33.3 60.8 21.0 18.0 83.7 35.7 56.3 37.3 3.2 3.7 0.3 4.1 6.4 11.8 13.7 11.5 7.3 11.4 8.9 14.4 12.1 0.9 10.9 4.8 12.8 8.3 6.7 21.6 17.4 15.8 20.6 16.7 22.6 26.4 19.2 29.8 15.9 20.8 19.3 31.8 57.8 50.4 26.0 20.9 56.0 21.4 31.8 31.4 5.9 117.2 31.5 30.5 45.8 21.6 14.2 46.7 22.8 137.4 35.6 28.6 20.7 68.6 45.7 27.0 23.8 11.6 15.8 6.6 27.6 17.1 16.9 22.6 34.9 13.2 23.3 7.0 21.9 41.1 22.9 0.0 17.9 39.4 47.7 44.2 45.7 16.0 65.0 44.1 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 113.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA049781: AB_2680879" "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favorable (9.14e-4)" "prognostic favorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.7 16.4 20.4 20.2 25.5 13.1 13.5 25.4 13.2 17.8 14.8 15.3 16.5 8.6 24.7 10.2 13.3 15.5 26.7 17.1 38.8 11.7 19.3 21.0 33.0 11.1 29.2 33.4 21.1 13.8 15.2 12.5 32.2 29.3 21.1 4.2 32.2 37.0 16.2 23.5 9.0 17.5 11.4 10.8 19.8 25.9 4.7 19.9 14.7 18.6 26.9 14.0 21.1 16.5 21.8 12.5 4.5 17.3 16.6 17.1 11.1 11.3 25.9 17.2 15.4 20.1 22.4 26.0 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 89.3 19.8 21.5 31.5 28.4 13.4 6.5 30.6 113.8 69.4 54.1 9.8 17.1 14.9 29.3 5.2 17.4 7.0 0.0 40.0 37.0 49.8 27.9 41.5 8.1 53.6 28.6 22.5 20.3 50.0 3.7 16.7 46.3 57.3 35.1 18.0 37.3 29.6 7.0 24.1 21.2 13.7 25.8 22.7 16.5 14.3 35.8 7.4 11.8 15.1 20.1 PARP3 "ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" Yes No "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: AB_2685881" "prognostic favorable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favorable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 15.2 29.2 11.2 14.6 17.1 2.8 13.6 5.7 18.8 7.5 17.3 10.6 14.3 26.9 10.3 14.1 10.8 12.1 16.2 12.4 11.6 12.3 17.3 22.3 13.3 9.7 12.0 14.2 8.2 3.9 34.2 9.8 6.2 12.2 12.1 10.7 13.2 14.0 18.1 14.6 6.1 26.3 18.9 8.7 12.8 15.8 4.5 10.2 2.9 17.0 9.6 10.3 15.1 8.9 9.0 2.9 1.7 4.1 6.6 4.9 2.3 5.9 3.3 0.9 9.0 8.7 16.5 2.5 9.8 15.8 12.1 13.6 1.9 15.8 8.1 2.6 16.1 7.0 0.9 2.5 8.8 5.9 19.9 0.6 4.1 6.7 6.3 9.4 2.5 5.7 13.0 5.5 7.7 5.2 18.6 6.0 5.1 1.7 7.7 9.3 1.5 2.2 6.3 1.2 2.0 9.5 3.5 1.5 7.0 7.4 6.5 1.0 3.4 9.9 2.8 5.2 0.7 3.4 2.8 13.6 24.4 5.1 3.6 5.9 11.8 14.3 3.5 15.7 7.4 7.6 0.0 2.6 1.7 3.6 4.1 3.4 9.0 4.2 2.8 2.9 4.3 4.9 4.9 0.1 6.6 2.0 1.2 4.3 2.3 11.2 17.1 5.7 18.8 11.6 12.3 12.0 14.2 12.2 10.2 6.0 10.6 10.1 10.0 2.4 1.7 5.9 12.7 9.4 7.9 0.0 0.0 0.4 6.6 8.8 5.9 3.0 15.8 0.0 5.7 0.3 4.5 3.4 4.6 8.5 3.4 0.0 2.9 1.8 2.2 8.4 4.4 2.9 6.8 6.4 11.0 4.0 7.9 3.5 1.4 16.1 2.1 6.5 6.2 3.2 1.8 1.3 0.5 5.3 11.2 6.4 PARP4 "ADPRTL1, p193, VAULT3, VPARP, VWA5C" ENSG00000102699 "Poly(ADP-ribose) polymerase family member 4" Q9UKK3 13 24420926-24512810 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Ribonucleoprotein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 83.0;granulocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011739 Approved Supported Cytosol Yes No Cytosol "HPA011739: AB_1854986" "unprognostic (1.61e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-2)" "unprognostic (4.35e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (2.52e-1)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (4.12e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.21e-5)" "unprognostic (3.23e-2)" "unprognostic (1.71e-1)" "unprognostic (3.80e-2)" "unprognostic (2.84e-3)" 25.3 24.7 6.6 16.7 12.9 11.6 14.6 2.3 7.0 17.8 39.4 16.7 21.6 22.9 19.1 11.2 22.2 14.9 23.8 11.3 7.9 5.6 28.8 17.3 17.8 16.5 14.6 4.4 15.9 15.5 11.2 12.6 14.8 12.5 16.1 24.1 14.0 17.7 30.9 6.5 10.2 49.9 15.5 20.5 28.4 20.4 7.0 12.1 28.8 18.2 11.3 26.2 23.3 13.2 9.0 16.4 26.1 18.6 11.8 12.9 10.6 14.6 13.1 6.4 11.6 17.8 25.4 5.4 17.1 22.4 15.0 13.4 5.3 38.2 11.0 17.1 15.5 16.6 17.1 9.6 17.3 12.3 25.1 6.7 15.7 12.2 12.3 10.2 20.1 15.6 14.6 5.8 12.4 6.6 29.4 24.6 8.6 4.4 4.9 17.7 6.8 12.6 9.7 7.3 34.7 16.2 12.0 12.1 15.4 27.9 30.2 5.9 7.5 12.5 5.0 11.8 8.8 2.5 16.6 34.8 6.8 7.1 8.7 17.4 5.6 6.4 14.5 12.4 10.6 14.8 25.2 12.4 26.1 12.9 15.3 12.9 9.0 10.8 12.8 16.4 5.1 8.1 9.6 14.3 11.8 18.6 6.2 12.7 10.6 6.6 12.9 2.3 7.0 7.9 5.6 14.6 4.4 12.5 12.1 47.6 43.8 12.3 5.6 2.5 6.0 15.5 20.4 83.0 64.8 24.4 2.0 4.6 5.0 20.5 3.5 18.8 54.7 0.0 19.4 7.7 6.9 8.6 92.8 12.9 15.7 1.6 4.7 36.2 23.1 3.1 10.9 25.1 8.5 31.5 26.9 7.0 25.8 48.9 7.8 15.6 6.9 6.5 6.2 2.8 7.2 3.3 1.6 15.2 26.0 14.8 PARP6 pART17 ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 137.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 13.7 16.6 28.0 12.8 32.4 25.1 26.5 46.6 41.2 15.5 16.2 16.9 18.2 14.1 23.3 23.8 14.0 17.0 20.2 18.4 26.1 22.4 14.3 9.0 15.7 16.8 19.9 21.8 26.3 20.9 20.6 30.8 17.0 19.4 19.3 14.3 14.5 21.3 18.8 23.9 20.3 14.4 19.6 14.2 18.2 18.2 25.1 15.8 9.6 21.7 12.5 15.8 16.3 15.8 4.1 4.0 12.1 5.3 4.3 4.3 2.9 7.3 13.2 13.9 18.1 15.0 12.5 11.3 6.3 9.5 10.4 15.4 8.7 13.3 10.0 3.9 9.5 15.3 9.6 15.3 8.5 6.0 11.9 13.8 14.6 23.1 0.1 12.5 7.5 14.0 16.0 21.0 9.7 26.8 16.4 6.9 16.8 7.4 11.6 8.3 13.3 6.4 13.2 6.4 6.1 0.0 11.9 9.9 7.9 9.6 14.5 39.4 20.9 10.5 8.6 17.1 19.3 10.9 8.7 6.5 13.1 12.0 17.0 9.5 13.1 12.0 10.9 9.4 14.7 9.0 1.7 5.3 12.1 3.8 4.4 2.7 3.3 2.7 4.0 4.0 4.1 4.3 3.2 5.7 4.3 4.9 3.1 4.2 2.9 28.0 32.4 46.6 41.2 26.1 22.4 19.9 21.8 19.4 15.8 20.8 20.5 4.7 8.4 12.8 14.0 14.6 0.0 2.7 15.9 8.7 19.6 5.9 6.6 7.3 49.1 9.8 9.2 0.0 11.2 4.3 9.3 7.6 15.1 4.2 8.1 17.5 16.7 7.4 12.4 137.7 11.5 8.2 15.1 6.4 5.3 7.4 8.1 5.8 9.2 10.3 15.1 6.5 9.5 39.0 8.3 13.8 5.4 7.5 5.6 8.3 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "T-cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.6 0.0 5.4 8.6 1.5 2.6 8.6 1.9 7.0 1.9 5.5 0.3 15.4 6.9 8.2 0.2 19.8 5.8 0.9 5.8 4.5 9.7 7.4 5.1 4.7 0.4 2.8 11.9 0.1 3.3 4.9 3.8 2.7 11.6 0.1 10.9 0.7 4.2 2.6 3.8 14.2 15.0 5.8 0.2 2.8 7.2 11.4 7.9 3.5 5.8 6.0 9.3 6.2 10.2 1.6 8.3 0.4 42.0 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.4 6.5 3.3 7.9 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 29.8 22.6 12.3 4.8 7.1 13.4 4.5 12.7 21.4 21.6 21.0 0.0 17.5 6.6 11.2 19.7 4.5 6.9 0.0 8.8 5.9 9.1 8.6 13.9 3.6 12.9 6.4 14.5 8.6 28.5 11.4 1.1 17.1 8.5 13.6 3.6 0.5 14.3 7.6 2.8 3.7 2.1 6.5 6.9 5.1 5.5 3.4 20.7 90.6 6.5 13.5 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria Yes No 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 9.1 3.4 8.3 13.9 5.5 3.5 1.9 7.9 3.6 3.5 4.5 3.3 0.0 3.8 2.9 4.8 3.9 3.8 21.0 1.1 1.8 5.3 4.5 28.3 17.3 10.9 0.0 5.9 21.0 5.4 2.9 6.6 2.3 2.9 7.9 8.5 0.0 1.2 19.4 5.1 2.4 6.4 7.7 7.6 3.8 7.0 1.8 3.3 0.9 7.4 10.5 17.6 9.4 7.2 2.6 7.7 1.2 3.2 4.0 3.7 4.7 2.1 2.0 2.3 0.0 4.1 2.9 3.4 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 0.0 4.8 2.2 1.1 1.1 4.7 3.7 10.2 0.0 1.2 3.5 2.0 15.6 1.7 3.1 15.2 1.4 18.6 0.0 1.6 3.5 1.9 2.4 9.2 192.6 11.2 0.0 8.6 4.3 6.9 39.9 0.6 1.6 5.0 32.5 4.2 9.2 2.3 7.0 3.9 37.8 4.7 0.0 1.4 6.0 4.2 0.5 21.3 1.3 6.0 1.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCIF1 "bA465L10.1, C20orf67, PPP1R121" ENSG00000100982 "PDX1 C-terminal inhibiting factor 1" Q9H4Z3 20 45934628-45948023 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: AB_2680801" "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavorable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 18.5 15.7 12.7 18.4 17.8 26.2 19.2 33.7 27.9 26.0 19.4 26.7 15.9 14.7 29.8 17.0 19.4 28.8 16.9 23.7 12.9 12.4 16.3 13.2 18.9 23.9 17.7 13.6 37.5 23.5 21.5 18.9 18.7 14.4 20.0 10.8 23.9 20.6 20.8 27.1 24.2 17.1 19.6 16.1 22.8 16.3 17.6 16.2 36.0 24.8 15.3 22.2 18.7 20.4 31.8 28.1 42.4 26.4 38.3 32.7 31.9 11.4 15.9 12.4 15.3 8.7 10.7 13.8 4.7 14.1 14.2 13.8 27.1 15.5 12.4 15.7 12.4 16.4 13.0 8.8 16.1 6.1 7.6 6.3 15.9 12.8 18.1 16.5 14.2 16.1 14.7 16.9 8.7 14.0 12.7 11.8 20.7 11.1 17.4 10.1 24.1 28.0 26.7 4.4 13.9 14.0 17.5 11.5 15.2 11.5 12.1 17.0 17.1 17.6 16.6 8.9 6.9 17.5 16.7 10.1 17.5 14.0 15.4 9.2 20.2 11.6 11.4 22.0 13.2 10.1 37.2 26.4 42.4 32.7 25.7 25.6 30.2 28.3 29.5 28.1 31.8 29.8 25.9 42.3 38.3 24.8 22.6 29.1 31.9 12.7 17.8 33.7 27.9 12.9 12.4 17.7 13.6 14.4 16.2 3.0 13.9 23.9 22.3 7.7 9.2 19.8 15.3 14.7 5.7 10.4 2.0 16.0 13.3 16.7 7.6 13.9 10.8 0.0 33.3 18.9 12.0 21.3 13.9 9.7 15.1 12.7 25.5 9.2 13.9 6.4 10.6 17.3 16.9 24.4 15.0 10.3 21.8 14.0 12.0 18.2 9.5 0.0 13.9 12.6 10.4 9.4 23.2 27.3 11.9 32.3 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3770.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in some" 18 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.7 0.8 1.2 0.0 0.0 1.4 0.0 0.2 0.0 0.8 0.6 2.8 2.5 0.1 0.0 0.3 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.6 0.0 0.3 0.4 18.4 0.4 0.3 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.5 1.6 0.0 0.4 4.0 3.4 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 0.0 2.9 0.0 0.8 0.7 166.8 0.0 0.0 0.0 2.3 5.2 21.6 0.2 8.3 0.6 765.5 0.0 0.6 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.4 22.3 0.0 0.0 1.2 3770.2 9.8 1.0 1.7 1.8 0.2 24.5 0.5 0.0 12.4 0.3 79.8 19.4 0.0 11.1 6.4 1.0 0.0 1.5 0.5 0.6 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Approved Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: AB_2686754" "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 22.8 24.2 18.1 25.4 16.7 20.0 73.3 14.2 20.2 19.6 25.6 12.0 26.6 21.6 23.1 28.5 29.8 23.3 28.3 32.0 17.0 15.6 28.5 33.4 27.5 52.9 16.5 12.8 24.3 53.4 19.9 16.4 21.2 15.4 21.6 26.8 18.0 27.0 32.0 30.8 19.1 26.1 20.7 20.8 30.3 26.3 17.2 10.5 44.3 31.9 28.5 32.9 25.2 22.3 13.8 15.3 9.6 12.3 16.4 17.5 10.6 13.4 9.9 15.0 35.2 21.7 23.9 16.6 16.1 18.5 19.1 21.4 17.7 11.9 24.5 13.1 17.7 25.6 19.4 32.2 26.7 28.1 20.0 35.2 34.7 12.8 32.0 26.4 43.0 23.4 21.7 26.3 24.2 39.3 20.1 26.5 34.1 68.8 16.0 23.3 29.4 29.8 31.1 21.6 43.7 15.2 21.3 11.6 31.7 28.8 8.0 27.7 28.9 18.3 30.0 18.8 17.1 15.2 44.1 20.0 9.4 20.3 22.4 28.4 21.6 25.1 26.6 17.6 42.1 24.0 3.7 11.0 9.6 13.4 10.6 15.7 13.3 15.3 14.1 15.3 13.8 15.2 14.1 4.7 16.4 12.3 14.2 17.5 10.6 18.1 16.7 14.2 20.2 17.0 15.6 16.5 12.8 15.4 10.5 11.9 11.7 52.0 64.7 44.0 33.6 21.0 35.7 14.7 10.3 27.9 11.8 52.7 66.3 54.2 13.5 31.8 31.0 23.3 64.2 59.4 32.4 48.8 16.1 24.6 43.9 15.9 45.3 38.6 37.4 12.9 45.5 39.8 33.7 35.1 39.8 22.3 51.7 35.1 38.2 65.4 32.9 19.4 39.1 28.4 93.3 40.3 39.0 65.7 63.8 68.2 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.3 39.2 14.5 30.8 16.7 16.4 22.3 22.9 18.8 39.1 30.5 45.4 14.8 46.6 20.5 26.0 30.2 24.0 44.5 40.8 28.8 19.9 42.8 22.6 22.5 39.1 41.7 54.5 23.8 23.1 25.7 40.6 40.9 18.7 25.1 16.7 37.2 19.0 23.6 43.3 26.4 55.3 28.1 33.8 28.8 33.8 25.3 45.6 21.4 23.8 25.1 26.0 22.6 25.8 30.3 12.1 18.1 28.0 19.8 45.9 34.8 23.3 38.2 24.2 20.7 47.6 32.2 25.1 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 3.0 17.6 13.7 18.1 20.0 6.4 3.4 25.5 26.8 19.4 24.4 7.9 30.6 21.6 36.3 38.4 21.1 24.6 0.0 38.0 33.3 14.9 13.1 17.4 20.7 33.9 3.2 22.5 28.8 29.7 10.4 18.4 20.8 20.3 31.5 19.9 13.1 33.1 14.0 19.1 39.6 8.1 19.4 18.4 23.5 19.3 19.9 23.8 15.0 24.7 12.2 PHF2 "CENP-35, JHDM1E, KDM7C, KIAA0662" ENSG00000197724 "PHD finger protein 2" O75151 9 93576407-93679587 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Early spermatids: 142.5;Late spermatids: 473.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010831 Approved Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA010831: AB_1855294" "unprognostic (9.42e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.30e-1)" "unprognostic (2.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.44e-1)" "unprognostic (8.48e-2)" "unprognostic (1.07e-1)" "unprognostic (5.89e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.17e-1)" "unprognostic (4.19e-2)" 16.8 14.6 17.4 17.7 22.2 16.7 23.2 33.1 19.0 19.8 18.1 27.8 18.6 11.3 22.0 15.9 14.5 18.4 16.7 19.1 15.3 14.5 10.8 9.3 17.8 20.7 23.1 15.6 27.1 18.5 22.6 21.7 17.6 16.6 18.6 10.6 16.9 19.0 21.9 27.8 21.4 13.3 24.9 18.5 21.4 15.9 9.6 18.2 19.8 18.8 12.0 12.1 16.4 32.5 2.5 3.8 5.0 2.6 1.0 4.0 2.2 9.3 7.8 16.4 13.4 10.5 8.2 8.5 7.4 9.9 10.7 7.7 3.6 5.5 6.7 5.5 9.5 9.6 18.3 10.3 7.1 5.7 17.9 6.8 5.4 8.9 5.6 9.4 10.6 18.6 8.2 12.3 5.0 8.5 10.5 8.5 10.3 7.8 11.5 7.4 20.6 20.2 11.8 4.3 16.3 6.8 22.8 12.7 2.6 6.8 11.8 21.6 10.7 7.7 12.7 6.7 5.0 8.5 18.7 9.9 10.2 8.8 11.1 10.5 9.3 1.5 5.0 5.6 6.5 11.4 1.1 2.6 2.5 3.3 1.4 3.1 1.8 3.3 2.1 2.7 2.5 3.6 4.0 5.0 1.0 2.0 3.8 1.9 2.2 17.4 22.2 33.1 19.0 15.3 14.5 23.1 15.6 16.6 18.2 14.9 13.6 5.1 5.8 6.8 13.9 13.8 5.1 18.7 20.5 5.2 7.9 6.2 0.0 5.3 142.5 12.0 4.9 23.3 4.9 3.1 8.5 7.5 16.2 6.8 4.9 9.5 15.6 8.0 11.1 473.2 18.4 7.6 3.3 1.8 7.9 9.9 5.2 2.9 19.1 3.0 7.5 19.4 10.3 1.4 2.5 6.9 5.0 7.0 7.0 7.2 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 39.2;ASC TERT1: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545" "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.5 5.1 39.2 39.8 3.7 7.8 9.6 4.6 2.7 3.9 11.4 0.0 14.7 15.6 6.2 6.6 2.3 16.0 0.7 0.2 1.5 3.0 1.9 1.9 10.1 0.0 5.7 20.7 3.5 6.4 4.4 10.4 13.1 0.2 2.6 0.1 5.9 1.2 0.0 0.1 3.7 0.1 1.3 0.4 2.7 0.2 4.6 2.4 2.4 5.2 19.9 1.7 5.5 4.2 7.3 0.9 16.0 9.5 8.6 4.8 6.2 0.0 0.0 0.0 2.7 0.5 10.7 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 6.0 13.6 0.9 8.3 16.4 3.5 3.9 0.0 0.0 10.3 29.6 0.0 0.9 0.0 9.1 68.1 25.1 16.5 0.0 3.9 1.3 32.9 5.0 1.1 0.6 5.0 3.2 8.1 31.3 3.5 60.6 62.2 7.0 11.8 3.6 21.4 6.7 15.4 28.1 41.8 5.7 1.8 38.8 45.5 7.4 5.8 8.0 1.3 2.2 13.5 2.1 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208497-178232791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria Yes No 190000 Mitochondria "HPA036461: AB_10670717, HPA063608: AB_2685059" "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavorable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 18.7 13.1 10.5 25.0 10.8 9.8 15.5 8.3 10.9 13.9 24.3 13.4 14.4 15.1 13.5 14.9 10.7 13.6 17.5 15.5 8.9 4.9 18.1 44.4 14.7 16.8 13.7 9.3 13.2 18.0 11.9 11.9 11.8 10.2 12.4 23.9 12.1 12.3 13.7 20.2 7.6 29.8 14.1 10.7 20.2 15.3 16.4 11.7 16.3 16.6 10.5 17.4 14.0 11.8 13.9 32.8 16.7 21.7 10.7 14.0 14.3 5.8 2.4 5.8 2.3 14.7 11.7 8.8 3.7 4.1 4.9 7.9 6.2 7.5 7.6 11.2 11.2 6.2 3.8 5.0 9.4 5.7 15.6 5.0 9.7 9.8 4.4 23.9 5.5 6.3 13.3 9.9 6.2 15.1 10.1 16.3 11.4 7.1 17.7 7.4 8.5 7.7 2.9 1.2 7.3 8.0 5.1 2.8 15.3 8.9 5.3 3.6 3.3 5.8 3.4 6.1 7.1 3.7 4.5 6.6 5.1 4.6 3.3 3.9 11.3 3.1 4.6 1.5 5.9 3.4 6.3 19.5 16.7 10.0 21.7 10.1 13.9 11.3 11.4 25.2 12.6 14.0 11.3 4.4 10.7 21.3 32.8 12.9 14.3 10.5 10.8 8.3 10.9 8.9 4.9 13.7 9.3 10.2 11.7 17.9 14.7 36.2 35.3 9.5 20.4 15.7 33.1 12.0 9.1 22.7 23.6 14.0 16.6 17.9 16.8 22.4 97.5 0.0 16.2 15.1 23.7 24.7 12.7 27.6 27.2 14.3 18.5 22.7 23.8 45.2 39.4 30.7 23.6 63.1 33.9 26.4 14.7 54.6 23.7 31.0 26.5 12.9 16.5 28.6 23.7 9.2 18.4 34.6 33.9 31.3 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803224-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.6" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 405.0;Late spermatids: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Yes No Nucleoplasm "HPA068792: AB_2686037" "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.71e-1)" 5.6 6.7 9.8 4.7 12.7 7.0 6.1 16.7 13.5 4.7 5.6 8.1 8.0 3.7 6.0 8.8 4.7 5.3 5.5 7.5 8.4 8.1 7.4 6.6 4.9 6.5 7.9 8.5 5.8 5.0 19.3 10.4 4.8 12.1 7.7 8.1 8.2 5.9 7.9 15.6 8.5 4.8 5.7 7.6 6.5 5.3 61.6 9.1 7.5 9.2 4.1 5.8 5.3 4.6 6.8 5.1 2.9 4.4 4.8 6.7 2.1 11.9 4.9 5.6 7.9 5.6 7.1 2.6 6.3 5.1 5.5 5.1 5.8 4.5 12.1 3.5 4.7 5.6 4.1 11.1 6.7 7.9 5.9 4.2 7.4 4.7 6.7 5.5 12.3 5.4 7.3 4.1 4.8 5.2 9.0 4.9 10.6 5.5 3.2 10.8 6.4 7.2 7.3 6.1 2.2 3.2 13.2 12.0 0.1 5.1 9.2 10.7 8.3 5.7 3.7 4.1 6.6 5.5 5.6 6.2 11.9 5.1 4.1 4.7 9.4 4.6 15.4 8.8 13.4 11.6 1.5 4.4 2.8 5.4 3.4 3.8 4.1 4.8 6.1 5.0 6.8 6.7 5.7 2.9 4.8 3.0 5.1 4.2 2.1 9.8 12.7 16.7 13.5 8.4 8.1 7.9 8.5 12.1 9.1 17.9 18.7 15.8 17.1 18.3 46.7 26.5 12.7 10.7 6.8 24.4 84.4 1.9 16.6 11.8 405.0 21.0 11.6 23.3 7.7 1.9 16.5 28.6 13.9 17.9 22.7 30.2 27.3 35.6 40.4 431.0 31.1 16.5 11.8 31.5 14.1 27.0 7.6 17.5 32.9 18.9 39.4 6.5 16.4 130.6 70.9 13.4 1.1 15.0 21.8 15.3 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37059170-37073170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Yes No Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 20.0 30.3 12.3 7.9 13.4 4.2 18.0 6.9 14.3 13.1 13.8 15.6 23.1 9.9 11.7 60.6 12.5 13.9 15.2 27.8 12.3 15.2 19.0 27.4 14.7 9.9 16.1 9.8 15.0 45.4 23.9 28.9 16.2 17.9 21.3 14.3 16.6 22.2 17.4 25.0 7.0 12.8 24.0 24.8 10.1 14.8 19.3 8.4 16.3 20.3 17.3 9.9 17.2 9.2 18.2 16.7 1.7 11.1 8.7 19.3 8.7 9.1 4.4 9.2 5.6 16.7 10.9 6.1 7.4 13.7 6.7 7.6 5.8 19.4 12.6 16.6 11.2 30.3 7.4 7.6 8.4 7.1 13.1 13.2 28.6 5.5 8.0 10.1 8.4 6.3 9.9 16.0 12.1 15.2 15.7 11.5 28.6 17.0 22.6 14.8 6.1 11.2 9.3 7.0 26.2 10.7 11.0 4.7 13.3 16.9 5.1 19.0 11.4 20.9 15.8 28.1 12.8 13.5 18.5 6.0 5.0 2.4 5.8 6.7 30.1 32.7 14.4 14.4 10.8 16.3 0.2 7.1 1.7 11.3 10.4 14.0 18.2 14.5 12.1 11.1 15.3 19.3 16.7 1.0 8.7 11.1 16.7 10.7 8.7 12.3 13.4 6.9 14.3 12.3 15.2 16.1 9.8 17.9 8.4 26.8 36.1 32.3 46.9 29.3 19.4 74.2 43.3 56.2 26.1 41.8 9.8 49.2 76.3 48.2 68.0 32.1 27.7 0.0 62.5 46.0 37.9 46.4 16.1 77.3 60.5 15.9 43.1 32.5 40.6 54.3 63.9 44.6 35.4 37.9 52.5 26.5 65.1 55.4 32.9 92.2 26.6 64.7 43.9 193.5 109.2 23.1 43.7 28.8 53.6 46.5 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.0;HMC-1: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 23.0 10.0 4.3 3.6 3.9 5.3 29.3 5.4 5.2 5.5 5.9 10.7 8.8 9.3 14.8 5.3 10.6 9.9 5.6 8.6 9.9 11.8 6.3 42.0 6.8 6.4 4.0 10.2 66.6 4.5 6.6 3.8 7.8 9.8 8.3 4.5 16.0 6.9 6.9 10.6 5.9 7.2 6.2 17.0 9.4 4.3 4.5 6.6 8.5 12.8 3.7 2.7 15.0 6.5 19.3 13.2 16.3 24.4 8.7 3.5 4.5 7.7 7.6 11.7 7.6 8.5 8.6 9.9 4.9 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 8.9 14.7 4.7 12.9 16.9 15.4 30.2 12.7 14.7 21.6 17.4 23.6 29.1 5.0 9.4 0.9 8.5 21.3 0.0 16.5 46.3 6.5 23.0 13.9 15.8 13.4 20.6 15.6 11.6 28.8 1.1 3.4 19.7 6.8 14.4 14.9 8.2 15.2 21.8 6.3 18.9 17.9 6.5 6.1 10.7 14.9 20.5 40.0 6.1 12.7 15.3 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651732-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: AB_2679153" "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 4.5 2.1 3.4 34.8 7.1 32.8 2.9 3.3 4.3 3.2 3.3 5.5 0.7 3.1 3.7 3.4 3.5 4.0 6.5 2.9 4.2 3.1 4.6 3.3 8.2 40.3 7.4 1.8 5.3 2.2 2.3 2.2 3.3 4.6 3.2 2.1 3.1 11.2 1.8 0.9 2.0 11.4 2.9 5.3 35.5 3.3 3.0 5.7 23.5 4.1 2.3 36.0 5.8 3.6 8.4 14.5 35.0 15.0 14.5 13.7 16.6 2.7 1.8 0.1 0.5 0.4 0.4 0.2 4.2 8.6 9.2 7.6 0.1 1.1 7.3 1.7 3.3 4.4 0.8 0.7 3.8 5.8 51.7 0.1 0.8 0.4 3.0 1.8 18.8 6.6 1.5 1.6 10.3 3.5 4.0 1.3 5.2 2.6 0.0 5.2 0.2 1.8 22.4 0.8 0.1 0.5 23.3 4.6 0.2 3.9 0.0 0.6 0.5 0.9 1.7 4.1 2.5 0.3 22.5 3.4 2.7 2.8 0.0 3.9 1.7 1.6 10.2 5.9 26.9 1.5 9.6 11.8 21.1 12.9 13.1 13.7 7.8 9.8 11.8 12.5 8.4 12.9 13.4 35.0 14.5 15.0 14.5 7.4 16.6 3.4 7.1 3.3 4.3 4.2 3.1 7.4 1.8 4.6 5.7 8.9 20.7 7.8 1.8 1.3 0.4 2.7 0.0 1.4 1.2 0.0 2.0 0.1 1.7 3.1 2.0 1.6 0.0 0.0 1.8 0.3 1.4 2.5 24.3 0.0 12.5 0.0 0.0 3.7 28.8 1.7 1.1 13.4 3.3 1.0 0.0 2.5 7.7 0.0 1.4 2.9 1.6 6.5 3.8 1.1 2.1 1.0 0.2 30.5 0.1 2.0 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027735-135034813 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8" "Cell type enhanced" "Detected in some" 27 "Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Yes No Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 0.3 0.3 0.0 4.7 0.0 0.3 0.2 0.0 0.2 14.8 2.8 0.0 0.0 5.6 0.5 1.2 119.4 0.3 1.9 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 32.9 1.3 1.0 8.8 1.1 10.8 33.0 0.2 8.6 0.5 3.2 18.6 0.0 0.2 7.4 0.4 0.0 0.0 0.4 58.8 60.8 18.2 28.9 0.3 0.3 1.4 0.4 0.4 1.1 0.2 17.2 10.6 0.0 14.2 0.6 0.2 4.4 3.4 5.0 1.7 0.6 40.4 10.2 19.4 5.5 0.2 4.2 5.9 2.3 8.3 0.1 0.2 15.0 4.8 33.0 11.1 5.2 1.7 0.0 0.4 6.0 0.0 1.9 0.1 0.0 3.0 32.2 0.0 0.5 5.3 0.1 3.8 0.0 1.5 9.5 5.7 0.3 0.3 0.2 5.4 6.6 0.0 15.1 8.2 0.0 0.1 48.1 1.1 0.6 1.9 4.8 1.0 5.3 0.0 0.0 12.7 2.5 0.1 0.0 1.4 0.3 0.1 0.9 0.3 0.5 0.3 0.6 1.1 0.2 0.3 0.3 1.0 0.7 0.4 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 84.7 1.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.4 0.0 0.3 0.0 0.4 2.0 0.9 52.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.0 0.3 0.0 9.9 0.3 0.0 0.0 2.0 0.0 1.4 1.4 4.1 5.9 6.4 0.0 0.6 214.7 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PLEKHA4 PEPP1 ENSG00000105559 "Pleckstrin homology domain containing A4" Q9H4M7 19 48837097-48868632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Peritubular cells: 50.2;Smooth muscle cells: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;ASC TERT1: 19.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.3;SK-MEL-30: 32.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA042978, HPA048473" Uncertain Approved "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes No "Plasma membrane, Cytosol" "Cytokinetic bridge, Centriolar satellite" "HPA042978: AB_2678249, HPA048473: AB_2680409" "prognostic favorable (1.97e-4)" "unprognostic (4.39e-1)" "unprognostic (8.16e-2)" "unprognostic (2.85e-2)" "unprognostic (3.98e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (5.09e-2)" "unprognostic (1.01e-2)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.84e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-3)" "unprognostic (6.38e-2)" 14.0 10.2 5.0 10.1 7.7 0.3 11.4 4.5 5.5 9.4 14.6 6.1 3.5 4.7 13.2 5.6 8.7 10.2 9.7 19.3 3.9 3.0 9.7 10.8 9.6 5.7 28.9 2.6 22.8 11.4 3.1 13.3 5.2 12.4 9.7 3.4 12.5 6.0 8.1 8.9 5.9 5.1 23.3 13.5 8.0 7.9 6.2 4.4 7.4 12.9 5.8 6.3 11.0 7.3 7.4 2.0 1.4 0.7 1.2 5.3 1.6 3.8 0.2 4.4 28.0 6.5 19.1 3.5 3.0 10.9 12.0 22.3 2.5 1.1 0.1 5.3 4.2 4.7 1.2 1.5 1.5 1.9 0.0 1.5 1.0 0.6 2.8 5.0 0.0 6.4 9.8 1.0 6.9 0.4 4.9 3.5 4.9 4.0 2.3 3.2 2.3 1.3 0.2 0.6 2.5 0.3 0.1 14.0 0.2 3.6 0.0 0.0 4.9 1.3 1.1 32.2 1.1 1.7 1.3 0.5 3.8 3.1 4.9 0.7 12.7 10.5 2.2 4.5 0.3 10.1 0.0 0.6 1.4 3.1 0.7 2.3 3.0 3.0 2.0 0.2 7.4 5.3 4.7 0.3 1.2 0.5 2.0 1.0 1.6 5.0 7.7 4.5 5.5 3.9 3.0 28.9 2.6 12.4 4.4 0.0 18.9 0.0 26.3 8.5 0.7 29.1 5.1 28.1 43.3 7.0 0.0 2.7 1.7 16.3 0.4 6.6 1.0 0.0 4.4 4.2 39.8 15.0 0.0 12.1 2.4 0.0 1.2 5.5 0.3 0.4 38.3 2.8 11.8 1.8 1.0 8.4 6.8 0.0 50.2 9.9 0.7 6.5 103.2 3.5 2.5 8.5 2.4 1.3 1.8 19.6 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 43.2;Ito cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 14.7;naive B-cell: 15.9" "Lineage enriched" "Detected in single" 29 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4" "Region enriched" "Detected in many" 5 "thalamus: 56.1" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 27.5 2.2 7.3 10.6 7.3 2.3 10.0 2.4 7.1 8.3 5.8 10.1 4.8 4.8 7.8 14.1 9.6 8.9 8.1 5.9 7.7 6.7 4.5 5.1 12.1 13.5 10.5 3.0 4.7 2.8 8.2 5.1 13.9 11.1 4.1 6.2 3.4 3.5 5.4 6.4 8.9 6.0 5.7 19.6 28.9 4.5 7.3 7.7 39.7 6.0 5.8 13.3 7.4 8.5 15.9 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 12.5 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 6.9 3.0 4.9 4.8 0.0 1.2 1.8 18.4 1.6 0.0 7.7 2.0 0.3 0.9 0.0 0.0 0.0 1.4 0.8 4.7 0.0 0.1 0.0 7.7 4.1 0.0 16.4 0.0 0.2 1.5 0.0 0.9 4.8 0.5 0.8 0.0 0.0 3.6 8.2 0.4 0.1 0.0 2.2 1.5 1.4 0.0 0.0 7.7 0.0 1.7 0.0 3.3 0.0 0.0 11.4 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.5 14.7 0.3 0.4 0.0 15.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 7.3 7.3 2.4 7.1 7.7 6.7 10.5 3.0 11.1 7.7 0.0 3.8 8.1 0.6 3.8 0.2 1.6 2.5 5.3 3.4 7.0 0.0 4.2 3.3 2.3 2.7 43.2 4.3 0.0 1.0 1.3 9.9 0.7 0.0 3.0 0.5 0.0 5.2 39.9 6.1 1.3 0.3 0.8 5.0 8.2 9.0 8.3 6.3 10.5 0.4 2.8 0.5 0.0 2.3 1.0 0.9 3.1 2.4 3.2 4.2 2.4 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2" "Cell line enhanced" "Detected in many" "A-431: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 12.8 2.9 17.2 7.8 36.9 11.4 19.8 7.3 29.4 15.2 15.9 67.3 9.3 10.2 31.6 9.9 26.4 19.8 17.5 12.5 24.2 12.8 19.5 16.5 8.4 4.0 40.7 21.6 16.8 22.7 17.9 3.7 22.3 19.5 12.3 12.1 13.6 19.6 31.6 5.9 19.6 10.0 20.7 24.5 16.0 11.5 5.1 40.9 1.2 14.5 6.4 5.3 16.6 17.1 0.0 0.7 16.7 1.9 6.4 12.2 2.9 29.0 13.5 11.3 17.1 1.2 0.0 19.7 3.3 3.9 5.2 4.2 14.2 12.9 0.0 5.9 3.1 1.8 28.1 7.6 25.9 1.8 0.0 6.6 12.9 16.7 3.4 1.5 0.4 6.2 1.5 15.0 1.1 9.4 8.7 3.4 0.1 0.0 0.1 1.7 13.7 0.0 11.8 3.8 7.7 14.5 0.1 5.6 2.0 14.3 21.3 3.9 6.9 6.7 10.1 9.7 10.9 11.0 2.9 6.5 2.3 23.4 0.1 4.5 0.0 0.0 0.0 0.2 1.3 4.0 4.5 1.9 11.7 12.2 1.1 8.6 0.0 3.7 5.2 0.7 0.0 0.4 2.7 16.7 6.4 0.7 0.0 1.1 2.9 17.2 36.9 7.3 29.4 24.2 12.8 40.7 21.6 19.5 40.9 3.0 3.8 0.8 15.7 17.2 3.6 6.9 17.8 2.7 3.4 45.4 0.0 6.9 10.0 25.0 0.7 3.0 14.7 0.0 17.7 8.6 8.4 13.8 1.1 9.6 4.4 0.0 33.4 1.8 6.0 0.9 6.9 3.3 5.0 0.0 22.8 11.7 28.1 20.1 24.1 7.0 0.8 25.8 16.5 0.0 1.1 18.7 2.2 5.7 15.0 33.4 POLR3E "FLJ10509, RPC5, SIN" ENSG00000058600 "RNA polymerase III subunit E" Q9NVU0 16 22297375-22335103 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041419, HPA041477" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA041419: AB_2677468, HPA041477: AB_10796345" "unprognostic (3.09e-2)" "unprognostic (8.59e-2)" "unprognostic (8.23e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (7.28e-2)" "unprognostic (2.42e-2)" "unprognostic (7.73e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (8.14e-2)" "unprognostic (1.91e-1)" "unprognostic (8.96e-2)" "unprognostic (8.19e-3)" "unprognostic (3.41e-2)" 10.8 15.8 8.9 10.4 11.1 9.8 15.5 11.7 12.9 11.7 10.7 12.0 13.0 9.7 12.4 9.3 13.1 11.1 8.5 13.9 10.9 7.0 9.5 14.0 9.5 12.7 11.1 9.8 11.0 21.2 15.7 15.8 8.9 10.7 12.7 6.6 11.8 15.0 15.2 50.7 12.7 8.9 9.2 10.0 9.5 12.4 9.6 10.7 10.4 12.3 9.1 14.0 11.4 10.4 5.9 5.7 1.9 3.8 5.3 7.2 4.8 6.6 9.3 2.7 6.7 5.3 4.0 9.2 5.4 2.8 3.6 2.5 11.7 4.7 13.8 7.1 3.8 2.5 6.4 13.3 7.5 2.9 9.1 19.0 7.0 10.1 22.3 6.5 10.9 7.8 3.9 8.3 7.7 9.4 1.7 9.1 5.8 19.9 5.6 4.1 10.8 10.9 4.5 13.7 7.4 7.9 14.3 6.0 17.7 3.7 4.0 9.9 7.4 5.1 9.5 5.2 2.3 5.5 6.3 5.7 3.6 4.1 3.1 5.9 7.6 13.5 12.7 4.1 8.4 6.7 0.0 3.3 1.9 6.5 3.8 7.2 5.9 7.2 6.8 5.7 5.1 7.0 5.8 0.3 5.3 3.1 3.3 7.2 4.8 8.9 11.1 11.7 12.9 10.9 7.0 11.1 9.8 10.7 10.7 3.0 14.3 16.6 20.1 28.8 22.8 16.2 7.6 16.0 11.4 17.4 29.5 19.3 5.0 10.9 31.0 13.1 10.9 0.0 11.0 16.4 14.4 22.7 27.6 11.1 11.5 19.1 14.5 5.5 12.3 13.9 11.5 9.4 13.5 7.2 16.4 10.6 13.0 11.5 8.5 9.1 38.3 12.9 16.5 18.4 16.2 34.6 23.7 19.2 15.0 23.8 PPAT "GPAT, PRAT" ENSG00000128059 "Phosphoribosyl pyrophosphate amidotransferase" Q06203 4 56393362-56435615 "Enzymes, Predicted intracellular proteins" "Purine biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036091, HPA036092" Approved Approved "Midbody ring" Yes No "Midbody ring" "HPA036091: AB_2674936, HPA036092: AB_10603132" "unprognostic (5.11e-2)" "unprognostic (5.13e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (1.38e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (1.14e-8)" "unprognostic (6.74e-3)" "unprognostic (2.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.88e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.34e-4)" "unprognostic (1.41e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.09e-1)" 5.6 10.1 10.8 9.5 11.7 7.3 11.1 11.7 13.7 7.3 6.0 6.9 7.6 6.1 7.4 5.6 8.1 7.1 5.3 4.4 8.9 9.7 9.7 10.3 3.9 12.0 9.7 12.1 12.5 10.8 5.6 6.8 10.3 9.5 6.2 7.7 3.8 9.2 7.6 7.0 6.7 5.1 5.6 9.7 6.3 5.5 13.0 8.9 15.2 9.4 6.4 12.0 7.0 6.6 8.2 3.7 3.3 3.9 11.2 9.5 4.3 8.7 7.3 15.1 7.3 4.9 6.4 12.3 9.8 4.3 8.1 8.7 14.6 10.7 30.8 13.3 4.6 7.5 6.5 29.0 9.8 16.3 8.0 12.9 12.4 9.2 16.1 7.5 24.4 7.8 5.5 7.7 11.5 13.0 5.0 8.5 12.7 31.2 17.1 9.1 7.9 30.1 18.6 20.0 19.9 8.8 25.5 9.9 21.6 13.6 6.2 25.5 12.4 7.8 14.3 8.8 14.8 9.6 5.2 5.9 8.5 14.7 8.5 17.2 12.8 12.8 32.0 9.5 15.6 7.9 3.3 2.0 1.0 4.6 3.1 6.9 8.2 6.3 6.2 2.8 6.3 9.5 8.6 0.5 11.2 3.9 3.7 4.7 4.3 10.8 11.7 11.7 13.7 8.9 9.7 9.7 12.1 9.5 8.9 0.0 5.6 6.7 8.0 27.5 8.3 3.6 5.1 8.1 11.4 3.5 2.0 24.8 8.3 3.7 2.1 7.1 0.5 0.0 2.3 21.1 10.4 5.9 6.9 6.6 6.9 36.5 4.1 8.0 1.8 2.0 7.2 3.4 8.5 1.0 3.7 4.9 2.7 0.0 5.3 9.5 4.5 0.0 10.4 7.7 28.6 27.9 6.4 9.6 8.9 5.3 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2540.0;Paneth cells: 2816.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.6 13.9 9.5 19.2 10.8 18.2 30.7 27.5 8.9 36.0 14.2 25.4 26.9 9.6 37.1 18.3 13.7 47.3 4.8 31.4 5.8 17.1 9.5 3.9 13.0 4.8 29.7 0.0 20.6 17.9 63.4 9.1 12.7 11.9 14.1 12.2 16.1 22.7 13.1 60.8 45.7 0.4 10.3 35.8 80.8 20.9 21.5 19.4 25.7 18.4 32.6 24.9 27.3 44.1 18.9 6.6 63.0 26.2 23.2 30.4 34.6 40.2 22.7 18.1 14.2 6.5 21.5 11.3 19.8 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 291.8 201.0 276.1 613.6 510.4 42.1 61.0 749.1 294.5 174.0 910.7 11.8 432.7 2540.0 793.9 185.5 235.8 2093.0 327.1 669.9 547.6 555.3 988.2 330.2 190.7 548.2 47.7 765.2 266.4 322.1 856.1 344.3 360.7 1130.3 1110.9 1414.5 95.8 744.2 2816.1 271.2 1340.7 49.4 194.1 670.9 133.9 288.9 814.8 346.3 385.8 996.5 1073.4 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Group enriched" "Detected in some" 11 "Early spermatids: 51.1;Late spermatids: 94.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.4 0.0 0.0 0.0 94.3 0.6 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.5 0.0 0.0 0.8 0.0 0.0 0.8 1.2 0.0 0.0 6.5 0.1 0.1 2.3 0.0 16.5 0.0 0.4 0.1 4.9 0.0 0.1 0.0 1.2 0.5 2.1 0.3 1.3 0.1 0.0 0.5 0.0 4.1 1.6 0.0 0.0 2.9 7.8 0.0 2.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 7.6 15.8 0.2 0.0 1.0 0.1 0.0 7.0 0.0 0.0 1.9 0.0 2.4 0.0 0.1 4.4 0.3 0.0 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 0.0 0.0 0.0 0.0 0.0 16.0 1.6 0.0 0.0 3.4 0.0 29.5 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.1 73.1 2.9 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 0.0 11.7 0.0 0.0 9.3 2.5 0.0 0.0 0.0 0.0 0.0 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295643-23302848 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 61.2;Early spermatids: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 4.2 7.6 14.5 8.2 22.5 5.5 6.8 27.3 22.9 6.5 5.8 17.5 8.4 9.7 8.2 16.6 4.3 6.5 5.4 4.7 12.4 12.6 9.3 6.9 5.1 13.6 27.0 20.7 11.8 7.1 11.7 14.3 4.4 20.8 9.3 9.6 7.4 6.3 10.4 13.6 16.9 8.8 5.8 21.6 11.0 7.8 11.5 25.9 5.9 13.8 4.9 12.3 5.2 7.0 3.0 1.1 1.6 4.7 0.9 1.7 1.0 0.8 2.2 2.7 1.9 5.2 2.3 1.3 0.9 1.6 1.5 1.3 1.2 4.2 8.0 0.6 1.1 1.6 5.6 1.6 0.8 1.8 2.9 1.6 1.4 4.2 2.8 1.4 1.6 3.3 1.9 3.3 0.9 4.6 2.5 0.7 4.4 1.3 7.3 1.2 1.9 1.5 2.6 0.6 2.6 2.0 2.4 1.8 5.1 0.8 1.8 3.3 0.9 1.3 1.1 0.8 1.4 1.4 0.6 1.2 1.8 1.0 3.1 0.6 30.7 3.2 3.7 1.4 2.9 1.1 0.5 1.3 0.5 1.5 3.9 1.7 3.0 0.5 0.7 1.1 2.3 1.7 1.0 1.6 0.9 4.7 1.0 1.0 1.0 14.5 22.5 27.3 22.9 12.4 12.6 27.0 20.7 20.8 25.9 3.0 3.7 10.8 7.8 4.9 61.2 7.7 2.5 2.7 4.5 19.2 35.3 6.1 5.0 1.8 92.4 6.0 10.7 0.0 2.9 1.6 3.9 5.5 3.5 6.4 6.2 30.2 8.1 8.6 7.8 50.4 25.3 8.2 10.1 1.0 6.4 22.9 2.8 4.8 24.4 5.9 38.7 12.9 2.8 24.7 9.1 8.0 4.3 10.1 8.3 7.8 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222365-170305981 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: AB_2676124" "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favorable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 10.3 7.5 11.4 5.9 15.5 2.1 9.5 14.8 16.6 12.5 11.1 7.0 6.0 10.4 13.1 8.4 20.6 15.1 10.5 10.1 9.5 7.7 13.0 6.7 14.8 3.9 5.6 9.4 15.2 7.7 12.4 14.7 9.8 11.0 16.3 12.2 7.3 25.8 12.6 12.7 11.0 11.6 12.5 6.8 6.1 30.2 15.0 5.3 12.6 23.1 8.4 9.9 16.3 13.0 1.9 1.8 1.0 1.3 5.8 4.8 1.4 34.3 8.7 8.8 9.4 7.8 10.9 14.2 8.8 13.0 11.7 12.7 12.7 16.8 10.5 29.1 12.3 16.1 16.1 16.5 17.3 20.1 7.6 10.2 9.7 11.0 7.0 12.4 8.7 4.4 9.8 12.1 10.0 15.7 19.0 9.1 5.8 10.7 8.7 11.7 11.8 12.6 3.4 18.4 36.7 9.7 9.2 13.5 17.3 18.4 10.5 14.0 11.4 19.0 25.0 8.6 13.6 27.5 6.0 9.6 12.2 9.4 11.4 14.5 15.0 14.4 15.0 8.8 6.9 4.7 0.1 1.3 1.0 2.6 1.2 4.0 1.8 3.6 4.8 1.8 1.9 3.9 2.2 0.7 5.8 1.1 1.8 2.3 1.4 11.4 15.5 14.8 16.6 9.5 7.7 5.6 9.4 11.0 5.3 68.5 56.0 2.2 46.0 50.7 15.9 14.9 25.5 22.7 46.6 47.1 13.7 23.8 21.6 13.9 5.5 18.0 21.2 0.0 19.5 22.1 25.6 78.7 8.1 17.8 8.9 14.3 28.2 16.5 20.8 3.6 21.6 10.0 16.9 6.4 28.1 8.1 36.5 17.5 26.9 15.1 9.3 19.4 11.4 12.9 15.1 55.7 17.3 5.7 27.7 69.1 PRR11 FLJ11029 ENSG00000068489 "Proline rich 11" Q96HE9 17 59155499-59204705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023923, HPA052376" Uncertain Approved "Endoplasmic reticulum" Yes Yes "Endoplasmic reticulum" "HPA023923: AB_1855783, HPA052376: AB_2681803" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.15e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.22e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.80e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.84e-1)" "unprognostic (1.55e-3)" 3.2 1.4 2.8 13.8 4.2 14.9 2.0 0.9 2.8 3.1 4.2 2.2 0.7 6.9 2.0 2.1 10.3 1.7 2.1 1.4 3.1 2.3 1.7 1.1 3.4 9.6 3.2 1.6 1.7 1.0 0.2 0.6 4.8 2.0 1.2 5.5 1.2 2.2 0.5 1.3 2.9 4.8 3.2 5.1 7.3 2.5 2.5 2.1 40.8 1.3 7.7 11.7 2.8 3.2 1.4 3.0 2.5 10.6 0.7 2.0 0.8 27.6 13.3 21.0 6.1 0.6 4.9 8.6 17.2 10.8 17.9 14.3 16.4 18.7 17.9 17.6 12.6 14.6 10.2 16.1 17.7 39.3 24.8 10.3 19.7 14.7 11.0 0.2 20.8 8.3 1.1 1.3 19.7 26.2 4.4 20.2 15.0 10.7 19.5 19.1 21.5 20.4 3.7 8.7 13.0 22.5 16.4 31.5 11.5 4.8 7.5 9.1 12.6 14.2 5.2 7.5 10.6 14.0 8.0 13.7 36.8 43.0 18.5 30.6 12.6 24.2 18.0 8.2 11.6 35.9 1.0 2.3 2.5 0.8 5.1 0.3 1.4 0.6 1.0 3.0 0.9 0.6 0.8 2.3 0.7 10.6 1.6 2.0 0.8 2.8 4.2 0.9 2.8 3.1 2.3 3.2 1.6 2.0 2.1 0.0 1.7 7.0 1.9 1.6 2.0 0.8 0.0 0.0 2.3 0.0 0.0 1.8 0.0 0.3 0.5 1.1 0.4 46.7 0.4 19.2 1.6 1.0 2.3 0.0 6.5 1.6 4.7 3.7 13.3 0.2 0.9 5.1 1.7 6.4 2.2 0.8 0.6 0.0 2.1 0.3 2.8 0.0 2.1 3.0 5.1 1.1 1.7 2.5 4.3 1.4 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.0 0.0 2.5 0.0 7.0 24.5 0.0 11.1 25.5 15.9 12.2 0.0 0.0 0.0 0.0 30.7 2.8 0.0 2.4 0.2 16.8 0.0 0.6 0.0 0.3 0.0 6.7 0.0 0.0 19.7 2.7 4.7 15.0 32.1 0.5 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.3 2.0 0.0 0.0 0.1 36.7 4.2 1.1 5.7 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 0.0 0.0 0.0 6.4 1.1 2.0 2.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.0 10.5 6.0 0.0 0.0 0.5 14.3 0.0 0.6 1.2 7.4 2.6 1.2 1.7 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.5 0.0 8.3 0.6 1.5 0.5 0.5 0.0 0.0 0.5 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Group enriched" "Detected in some" 8 "Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.1 3.3 4.5 0.2 0.3 3.5 2.3 1.8 5.4 5.1 2.5 3.8 0.7 7.0 1.9 4.0 1.3 1.6 1.7 1.2 2.6 1.5 4.2 3.6 1.5 1.2 1.1 2.6 1.8 2.4 3.5 0.7 1.1 0.9 4.4 2.2 2.0 2.4 9.3 3.9 2.0 3.5 3.7 0.0 1.6 0.6 0.4 1.8 3.4 7.6 3.0 3.2 2.3 0.9 1.1 3.0 1.5 1.2 3.6 5.3 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 0.0 0.3 0.0 0.7 0.6 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.7 1.7 0.9 22.2 0.5 0.4 0.0 1.0 0.6 0.4 0.4 0.0 0.2 0.7 1.6 0.0 0.0 0.0 45.8 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.1 0.5 0.1 0.0 0.6 32.9 25.6 0.6 0.5 0.0 0.5 0.4 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 12.4;Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 22.3;SCLC-21H: 6.5;SH-SY5Y: 14.6;T-47d: 7.3" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.7 5.3 4.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.3 0.0 1.5 0.0 0.5 0.1 4.1 0.0 0.0 0.0 5.2 0.0 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.3 0.4 22.3 0.0 0.2 3.0 4.3 6.5 14.6 0.0 0.2 0.0 0.4 7.3 0.0 0.0 0.0 2.7 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 12.4 0.8 2.5 0.0 0.0 5.2 11.8 0.2 5.0 2.7 5.2 0.0 0.0 0.0 0.8 0.2 0.0 1.8 0.0 0.2 0.1 9.5 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 4.2 0.7 0.0 0.0 1.0 4.3 0.0 0.3 0.2 0.7 0.0 0.2 0.0 0.4 1.0 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 30.1;Paneth cells: 31.7;T-cells: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 16.6;HMC-1: 27.5;hTERT-HME1: 28.6;SiHa: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge, Cytosol" "HPA070174: AB_2686231" "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.71e-8)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 2.9 1.5 4.2 8.1 15.5 3.1 2.4 1.7 9.5 9.5 25.7 34.1 1.1 2.5 2.6 1.6 1.4 4.9 5.3 1.6 7.2 5.1 3.8 2.3 10.4 6.2 24.9 3.8 11.4 2.0 1.0 2.7 2.8 16.6 2.3 21.4 3.3 6.3 1.6 0.7 1.6 9.3 4.8 22.8 26.1 2.6 1.2 19.7 1.1 3.0 0.2 2.6 3.6 3.6 1.1 4.2 16.9 12.3 4.6 20.1 7.2 0.0 2.8 5.0 0.1 0.7 0.0 0.0 6.0 4.7 12.8 13.2 0.0 0.0 0.0 2.0 7.5 2.9 0.2 1.0 3.1 6.2 2.3 1.7 0.6 16.6 0.0 1.6 0.0 27.5 2.0 4.3 1.2 28.6 12.0 5.3 0.0 0.0 0.0 6.5 1.5 0.3 0.0 0.3 0.0 1.1 1.7 0.5 0.5 13.0 3.1 0.0 0.2 18.9 0.0 1.2 3.3 0.0 0.2 3.7 10.8 3.4 0.0 7.5 0.1 0.0 0.0 4.6 0.6 3.3 16.9 1.1 13.3 20.1 11.8 4.6 0.0 7.2 16.8 1.3 1.1 1.6 10.8 6.5 4.6 12.3 4.2 0.0 7.2 4.2 15.5 1.7 9.5 7.2 5.1 24.9 3.8 16.6 19.7 17.9 6.2 0.0 0.2 0.3 0.0 0.8 2.5 10.7 6.8 7.0 0.0 0.1 1.7 1.2 12.4 4.7 18.8 0.0 2.1 0.1 1.3 0.2 4.7 0.5 7.3 0.0 1.7 14.1 9.5 30.1 0.6 1.5 0.0 3.6 17.0 1.0 2.3 31.7 0.4 0.3 0.3 6.5 1.2 0.4 0.5 0.5 0.2 21.3 13.3 0.3 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 598.4;Late spermatids: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 4.9 2.6 11.7 0.0 4.2 26.2 0.6 2.6 4.1 2.4 5.0 1.5 2.0 2.9 1.7 10.7 10.6 0.4 3.4 4.7 4.6 0.0 3.0 0.2 2.0 0.2 7.7 0.0 0.1 6.8 2.9 13.3 2.3 22.8 3.1 0.7 0.3 2.3 22.0 1.7 0.0 0.5 2.3 4.3 6.8 2.3 10.2 1.3 6.1 6.4 5.0 5.6 1.1 0.5 1.8 2.6 0.0 1.1 12.9 7.5 5.2 17.6 2.3 0.2 0.3 6.7 23.6 1.2 2.5 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 3.0 2.4 0.5 11.9 19.5 56.4 111.0 5.1 32.1 13.6 8.7 111.9 2.6 1.7 13.2 598.4 4.9 21.3 0.0 7.4 1.2 30.9 8.6 0.0 36.1 11.0 17.5 5.8 6.2 9.7 164.8 30.8 10.6 1.7 103.6 15.1 80.8 19.5 14.4 50.5 0.2 50.2 12.9 11.5 10.0 15.8 8.7 0.9 0.0 13.0 24.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase, non-receptor type 23" Q9H3S7 3 47381011-47413441 "Enzymes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 15.9 18.5 23.1 17.4 22.3 19.2 21.6 22.8 25.0 18.1 12.5 21.4 14.6 20.7 20.0 15.1 17.2 17.2 12.8 13.2 17.9 11.7 16.4 13.0 16.8 17.8 24.6 23.7 23.4 19.4 53.4 29.9 17.1 20.5 16.9 10.4 15.2 20.8 19.0 25.7 25.9 16.0 16.0 20.3 19.2 17.9 17.8 22.7 9.7 24.8 9.7 11.1 17.7 18.1 1.4 1.1 3.7 1.2 0.9 1.5 0.8 13.0 18.6 10.4 13.4 13.6 10.5 10.0 11.9 11.9 11.2 9.5 15.7 12.9 9.3 11.0 13.5 19.9 11.7 8.9 12.9 5.4 8.6 9.6 12.8 13.6 14.6 15.0 7.5 17.4 13.9 13.3 14.5 14.9 7.9 13.7 7.9 9.5 12.8 11.9 18.3 7.1 6.3 11.1 9.1 13.1 4.4 5.0 11.2 8.4 25.3 5.5 13.0 10.5 22.4 8.7 6.6 12.8 7.2 13.7 17.1 14.5 23.7 16.8 18.4 12.0 5.4 18.6 7.1 12.1 3.7 1.2 0.0 0.8 0.5 0.6 1.4 0.6 1.3 0.4 0.7 0.6 0.8 1.4 0.9 0.5 1.1 1.5 0.8 23.1 22.3 22.8 25.0 17.9 11.7 24.6 23.7 20.5 22.7 8.9 6.5 1.5 4.4 7.1 11.3 6.2 10.2 10.7 7.9 5.2 13.7 8.5 1.7 9.1 1.4 11.1 14.2 0.0 7.6 6.5 6.1 7.9 2.3 9.6 11.6 15.9 7.0 12.3 11.1 2.1 17.8 7.8 11.8 9.0 15.6 9.2 11.8 8.6 12.7 8.2 13.8 6.5 6.2 7.4 10.9 9.5 7.8 4.3 11.5 6.3 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685732-107713167 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli rim,Golgi apparatus" Yes No "Nucleoli rim" "Golgi apparatus" "HPA038708: AB_2676163" "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.65e-4)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 33.2 25.4 29.4 29.3 32.2 27.9 35.1 32.9 38.7 25.6 29.2 20.3 26.1 17.9 32.9 26.8 33.9 27.5 21.1 18.7 32.9 25.3 31.5 32.3 22.0 29.6 22.9 38.6 35.2 31.1 31.6 23.0 29.8 37.6 27.1 27.5 16.6 26.0 30.5 43.5 32.7 24.2 33.6 33.3 28.7 27.0 36.3 22.1 32.5 27.1 26.8 36.5 30.0 28.1 31.7 21.6 10.9 14.7 18.8 23.8 12.7 24.0 30.3 18.4 17.5 25.9 28.5 24.4 25.4 28.9 36.2 30.7 30.4 11.5 37.3 13.8 39.3 24.5 21.2 24.9 26.8 35.9 18.6 28.4 28.3 18.6 35.3 26.7 34.2 20.4 25.6 24.8 33.3 30.0 28.5 42.2 23.1 37.2 10.5 38.6 26.6 24.0 33.9 22.0 22.3 49.7 19.8 21.7 34.7 22.5 34.2 20.9 16.8 20.8 15.1 34.9 24.3 26.6 17.1 32.9 27.6 14.0 22.3 28.8 15.1 20.8 29.3 12.3 19.1 24.1 10.9 9.8 7.1 20.2 12.4 18.6 31.7 20.2 21.2 15.9 28.5 17.3 23.8 3.1 18.8 14.7 21.6 21.5 12.7 29.4 32.2 32.9 38.7 32.9 25.3 22.9 38.6 37.6 22.1 38.7 30.2 62.6 43.1 42.9 46.5 20.1 22.9 50.9 46.6 26.2 35.3 58.8 49.7 58.1 7.9 42.1 17.6 23.3 54.3 62.1 45.9 25.8 55.5 39.8 41.3 31.8 20.2 38.6 30.2 5.4 46.6 39.1 28.7 101.0 30.3 47.0 55.3 17.5 41.4 59.8 40.3 25.8 36.0 110.6 70.9 43.4 38.2 41.5 32.1 37.3 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol Yes No Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favorable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favorable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 14.8 14.2 21.4 14.8 20.9 18.4 24.6 16.5 36.3 13.9 18.4 26.0 14.8 14.5 16.4 18.2 12.5 17.9 16.4 23.8 21.5 16.9 13.2 16.6 18.8 15.9 30.1 16.3 22.1 50.3 16.0 14.7 10.4 20.7 14.8 12.0 15.3 24.8 20.7 36.6 16.3 14.4 18.3 33.7 13.0 16.9 17.4 21.4 15.8 13.6 14.7 13.9 12.9 12.6 28.5 29.7 41.6 27.1 29.7 36.5 25.7 21.2 26.7 21.5 20.8 9.2 12.5 14.6 14.0 13.6 24.1 17.6 18.5 10.0 21.5 15.0 17.3 16.5 16.0 22.6 26.2 16.3 13.7 22.2 20.0 18.4 15.5 21.8 13.6 15.0 14.8 20.8 20.6 9.7 17.8 18.4 24.4 23.1 18.2 14.1 17.4 30.7 22.8 17.1 23.0 19.5 21.0 26.2 12.8 11.5 23.4 27.5 23.7 16.0 19.1 22.9 15.4 17.4 16.4 15.6 22.2 18.5 18.4 28.6 13.4 11.9 22.1 17.2 19.1 27.4 17.8 27.1 41.6 36.5 22.6 31.5 28.5 29.6 30.4 29.7 21.0 23.2 26.6 16.6 29.7 24.2 27.7 30.5 25.7 21.4 20.9 16.5 36.3 21.5 16.9 30.1 16.3 20.7 21.4 23.8 14.3 5.2 14.0 13.3 22.4 21.3 17.8 24.1 10.3 5.2 25.5 16.1 48.0 25.7 28.8 17.9 24.9 0.0 43.9 18.7 27.2 9.6 22.0 17.3 25.7 17.5 18.4 12.9 13.7 72.6 16.4 14.0 20.3 15.4 21.3 35.2 32.4 19.2 20.5 24.7 93.2 12.9 29.3 43.5 32.0 14.2 6.4 20.0 22.8 9.9 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Cell type enriched" "Detected in many" 14 "Proximal tubular cells: 333.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Enhanced Enhanced "Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria" Yes No "Vesicles, Centriolar satellite" "Nucleoplasm, Cytokinetic bridge, Mitochondria" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favorable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favorable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favorable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.2 9.8 8.6 14.5 9.5 8.5 8.5 8.0 7.8 5.6 7.5 2.1 12.3 10.0 12.4 6.9 4.6 6.1 9.0 2.7 9.1 8.7 5.5 9.5 21.7 15.5 5.5 6.9 9.1 6.2 8.0 7.0 9.1 11.9 8.5 2.8 4.9 9.8 13.7 8.9 10.9 8.2 3.2 4.2 18.5 7.8 3.2 7.8 2.7 10.2 9.5 8.7 10.7 5.4 3.5 5.9 10.2 19.2 11.4 7.6 10.6 5.6 6.8 5.3 14.5 4.3 3.9 8.4 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 3.0 1.7 3.4 0.4 3.3 8.2 11.7 7.6 4.0 6.8 5.2 5.9 0.8 23.2 1.4 1.0 2.5 6.4 0.0 1.0 0.1 2.3 1.1 1.1 14.1 0.7 20.6 2.9 19.6 5.1 1.6 0.6 1.2 0.0 0.0 2.7 6.1 1.6 1.7 1.8 333.9 7.1 6.5 2.1 2.7 3.0 1.9 0.7 2.6 4.1 0.3 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 13.0 4.6 16.5 8.2 1.0 2.1 19.3 17.2 7.6 19.2 25.4 12.5 12.7 17.1 2.5 3.7 9.0 8.3 11.4 5.1 29.5 13.4 9.7 21.5 8.0 8.6 0.2 19.5 10.9 0.4 0.5 11.5 11.2 2.7 7.7 11.8 13.4 19.7 12.1 4.7 15.9 7.1 40.1 12.7 5.2 16.0 19.8 6.7 5.8 6.5 5.5 6.1 12.8 10.0 4.1 17.4 4.0 11.4 3.4 13.1 13.4 14.1 18.3 3.0 3.4 32.7 4.9 14.1 10.5 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 0.0 0.3 7.5 1.7 4.6 3.0 1.2 2.5 0.0 5.7 0.0 3.9 6.8 0.0 2.0 33.7 0.7 1.3 46.7 2.3 30.1 2.9 1.1 1.1 1.0 34.3 0.0 2.4 1.8 4.7 50.0 1.1 6.6 0.0 10.8 2.8 2.6 1.1 0.0 1.4 1.2 4.9 0.0 1.9 35.8 29.9 2.3 3.9 3.8 7.7 0.9 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.5 4.5 1.5 0.5 3.4 4.0 1.8 2.9 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 0.0 1.7 5.8 0.0 4.3 1.1 2.2 0.0 1.6 0.0 0.0 4.5 0.3 0.3 0.0 0.3 2.6 0.0 0.4 0.0 1.6 2.8 0.0 0.0 0.4 0.8 0.5 0.0 3.6 0.0 0.9 1.4 0.3 2.0 0.0 5.5 2.8 2.5 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 8.9 1.3 0.0 5.2 0.2 20.8 1.4 5.1 0.0 2.3 0.0 13.7 8.7 0.0 6.3 76.6 2.8 2.8 0.0 1.2 2.7 2.6 5.1 0.0 1.3 1.6 0.0 5.2 3.1 1.2 31.1 2.6 0.0 1.7 1.8 3.3 5.6 3.6 3.5 2.8 0.7 24.1 0.0 2.2 27.1 24.0 0.0 2.1 0.0 4.5 6.1 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.2 30.6 20.0 20.9 10.8 8.9 24.3 50.5 27.6 51.0 26.7 37.1 19.2 31.4 40.8 37.0 24.6 54.3 36.3 39.8 30.8 25.4 56.3 26.6 29.9 28.9 13.5 42.9 20.0 8.6 19.0 36.3 32.2 16.8 26.7 11.8 34.1 22.4 29.0 49.9 25.0 34.9 21.8 53.1 36.4 30.7 19.7 33.1 19.9 33.4 18.2 12.1 35.9 31.8 18.5 19.2 18.7 17.3 41.2 39.1 37.5 21.5 41.5 16.7 22.2 29.9 27.3 30.5 22.5 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 3.0 24.7 28.1 17.5 20.5 15.2 17.4 22.9 9.4 9.1 8.7 13.7 15.1 3.3 34.2 259.8 12.7 10.1 0.0 17.4 28.1 9.3 32.2 5.8 17.9 14.0 14.3 24.0 11.6 13.4 1320.8 13.8 17.1 11.8 10.0 13.9 7.8 29.0 6.5 11.3 11.2 24.4 0.0 9.0 18.0 19.2 27.0 19.8 23.8 10.9 19.2 RANGRF "HSPC165, HSPC236, MOG1, RANGNRF" ENSG00000108961 "RAN guanine nucleotide release factor" Q9HD47 17 8288497-8290092 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 361.7;Late spermatids: 822.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057280, HPA057888" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057280: AB_2683393, HPA057888: AB_2683549" "unprognostic (2.87e-2)" "unprognostic (2.93e-2)" "unprognostic (7.41e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.90e-3)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.01e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" 14.5 14.7 24.7 11.7 29.1 11.8 26.5 10.9 19.2 31.5 15.4 7.9 13.5 10.5 20.0 22.5 10.6 21.5 10.9 23.4 15.1 17.8 17.0 11.5 18.9 26.9 16.2 19.2 21.0 6.3 16.2 17.1 14.6 18.8 15.9 10.8 17.2 6.0 19.4 11.4 9.8 11.9 18.8 12.2 15.4 16.7 70.1 15.9 16.8 11.6 9.1 20.3 14.1 10.5 26.8 22.3 25.3 16.3 21.8 40.2 18.2 16.0 18.9 13.9 14.2 10.2 12.9 11.7 9.4 18.6 26.1 24.4 10.1 6.4 30.7 10.2 11.3 10.4 18.2 25.6 12.7 18.7 21.4 32.4 15.3 14.9 13.9 23.1 9.6 22.4 12.6 23.2 22.2 21.3 12.5 20.6 29.8 6.7 8.7 15.9 0.4 29.4 31.5 9.7 9.7 7.3 26.0 10.8 18.3 14.1 7.1 5.4 15.1 7.6 11.3 20.0 9.1 0.9 9.3 11.4 5.7 10.0 11.0 19.0 14.8 11.7 37.0 12.1 19.1 8.3 4.9 16.2 25.3 24.2 16.3 22.6 24.2 29.3 27.4 17.3 26.8 26.2 22.4 2.1 21.8 12.5 22.3 40.2 18.2 24.7 29.1 10.9 19.2 15.1 17.8 16.2 19.2 18.8 15.9 8.9 25.0 41.4 21.7 16.1 23.2 4.0 0.0 14.7 14.8 24.4 11.8 83.8 58.0 22.9 361.7 25.3 11.9 23.3 16.5 38.1 26.0 20.4 26.6 13.6 42.0 19.1 19.0 19.6 11.9 822.0 26.2 23.5 16.9 36.1 15.2 23.5 17.8 24.5 29.7 43.5 28.7 19.4 20.8 112.7 18.1 17.1 94.4 41.5 22.9 11.9 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.1 5.8 4.3 0.6 1.4 2.8 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 1.0 39.0 1.1 1.3 1.6 3.1 2.9 1.0 1.3 2.4 0.7 2.1 3.6 1.6 19.5 1.2 0.5 1.7 1.7 5.8 0.7 1.2 0.8 6.0 1.9 2.5 1.8 10.7 1.1 3.6 0.7 1.0 0.7 11.4 11.2 2.3 1.3 13.2 0.5 5.1 34.1 1.6 3.3 1.4 2.9 1.5 1.3 1.9 1.8 1.4 3.3 1.3 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 0.0 0.6 0.8 9.6 40.4 2.1 1.6 20.4 0.0 1.2 1.8 5.9 0.1 0.0 0.5 2.4 1.6 66.1 0.0 0.7 0.2 1.0 5.0 5.7 3.8 0.5 1.6 4.7 4.9 0.8 1.4 3.1 1.6 5.0 1.8 32.6 2.8 1.2 46.5 3.5 0.0 4.6 0.0 1.4 11.5 10.4 84.8 0.6 0.0 32.3 31.9 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270327-27273690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 18.7;Sertoli cells: 32.3;Smooth muscle cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.5" "Group enriched" "Detected in many" 5 "B-cells: 4.5;granulocytes: 3.3;monocytes: 2.9" "Cell line enriched" "Detected in many" 4 "ASC diff: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 18.9 5.0 2.3 8.1 9.8 3.3 36.4 5.9 5.8 11.6 15.7 7.3 4.3 13.1 14.1 10.4 9.7 14.1 6.5 9.4 4.7 2.1 17.1 30.0 11.6 26.7 3.3 1.2 13.7 3.2 1.4 7.2 5.2 3.6 15.9 20.7 8.1 6.6 10.4 4.9 6.1 24.4 28.5 3.3 17.7 8.9 8.7 5.3 0.9 7.6 3.9 16.4 16.8 27.5 4.5 0.6 3.3 2.9 0.4 0.7 0.2 0.3 1.2 0.3 0.6 43.1 4.4 0.2 1.8 1.9 0.1 0.1 7.8 0.8 0.4 0.6 1.4 1.0 0.2 2.2 0.8 0.1 1.7 8.9 1.7 0.2 0.5 7.0 0.5 0.7 4.7 0.7 0.1 0.1 1.7 0.6 0.7 0.2 0.0 0.0 0.8 0.0 2.3 1.2 7.7 10.0 0.5 0.0 0.2 1.5 5.8 0.8 0.2 0.7 3.2 0.2 1.1 0.2 0.7 0.3 0.1 0.4 2.9 0.3 0.1 0.0 0.0 0.3 1.9 0.1 1.2 2.0 0.8 0.0 0.4 0.0 0.1 0.0 0.1 0.6 4.5 0.2 0.7 3.3 0.4 2.9 0.1 0.0 0.2 2.3 9.8 5.9 5.8 4.7 2.1 3.3 1.2 3.6 5.3 14.9 9.1 0.0 2.4 4.0 0.0 1.1 0.0 18.7 14.8 7.0 0.0 0.6 3.3 1.0 0.0 1.2 6.3 0.0 2.0 0.1 1.9 1.0 0.0 0.0 1.1 0.0 0.0 1.8 0.6 0.0 0.3 3.5 1.7 1.0 5.2 0.0 0.6 11.5 1.4 1.1 0.0 32.3 45.0 0.0 0.0 3.9 0.7 0.0 6.0 0.9 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 410.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.6 10.7 30.3 29.3 5.4 9.3 13.3 11.7 4.0 5.6 16.0 18.6 14.2 15.8 11.0 16.0 8.7 14.5 18.6 6.6 12.0 8.3 8.8 10.4 13.1 11.6 26.2 18.6 17.8 7.9 11.4 23.5 18.0 20.6 6.8 11.7 13.0 3.7 23.0 15.6 4.7 14.4 7.9 16.8 21.1 21.3 11.4 13.0 9.4 7.9 21.2 9.3 9.1 10.1 12.1 15.2 14.9 14.5 7.7 11.9 6.9 17.9 10.6 21.8 18.0 14.5 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 38.7 83.1 23.6 26.7 20.5 27.2 10.1 40.8 42.8 43.3 26.2 19.6 4.5 14.9 10.6 410.5 23.6 18.8 0.0 8.9 12.0 22.6 37.9 53.2 40.8 10.1 33.4 19.0 33.2 46.3 128.8 38.9 26.4 10.1 23.4 31.9 37.2 10.2 10.5 40.3 21.4 22.5 38.8 24.7 118.2 42.4 24.1 3.4 79.1 23.7 30.9 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM28 FLJ10377 ENSG00000106344 "RNA binding motif protein 28" Q9NW13 7 128297685-128343908 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019058, HPA026672, HPA031519" Enhanced Supported Nucleoli Yes No Nucleoli "HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920" "unprognostic (2.34e-1)" "unprognostic (1.87e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.72e-11)" "unprognostic (6.83e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.20e-2)" "unprognostic (4.01e-2)" "unprognostic (3.97e-3)" "unprognostic (1.45e-3)" "unprognostic (7.15e-3)" "unprognostic (3.05e-1)" "unprognostic (2.18e-2)" "unprognostic (1.04e-1)" 22.1 17.7 16.3 18.4 25.1 14.2 17.5 26.5 25.3 12.8 13.7 19.7 9.6 13.2 17.1 9.9 15.1 12.5 10.9 24.4 18.1 8.6 12.0 18.8 13.2 17.9 26.5 16.2 19.7 15.7 16.5 18.4 14.5 17.3 13.1 12.7 12.3 13.0 13.0 33.5 17.3 11.2 14.2 25.4 13.8 14.1 18.4 24.4 11.7 16.1 12.2 15.6 13.8 18.9 14.5 14.3 9.8 11.5 12.3 13.7 5.5 18.6 20.6 12.5 35.7 8.9 5.7 17.1 17.2 7.1 15.6 17.0 17.1 16.4 24.8 9.4 7.8 22.8 12.7 18.3 14.6 20.3 12.4 17.6 24.9 14.4 15.7 7.9 31.3 22.4 6.4 9.6 20.7 12.5 5.9 14.4 13.8 46.5 14.5 12.1 15.1 22.4 17.9 23.8 12.9 16.2 17.8 15.0 23.8 7.6 12.7 14.0 17.0 22.2 37.2 11.8 15.6 9.5 9.6 13.8 22.7 11.8 20.1 20.8 15.0 12.8 43.0 14.9 26.5 24.4 3.5 11.5 4.4 13.7 8.9 9.4 12.8 11.6 12.2 11.5 14.5 10.5 12.0 9.8 12.3 7.8 14.3 7.1 5.5 16.3 25.1 26.5 25.3 18.1 8.6 26.5 16.2 17.3 24.4 14.9 32.7 12.7 12.1 14.3 55.3 21.5 5.1 21.4 38.7 12.2 88.4 17.7 21.6 15.9 2.1 18.8 6.2 0.0 19.6 22.7 16.4 9.7 34.8 12.8 16.8 38.1 10.9 7.4 14.3 1.3 25.6 14.5 5.0 13.6 13.8 23.3 15.5 7.0 19.4 12.9 52.9 6.5 21.7 41.1 51.3 12.7 15.6 16.0 14.8 10.9 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.1 7.2 13.0 23.6 12.8 8.9 11.5 11.1 12.3 13.8 20.8 13.9 7.7 9.2 18.1 11.3 11.7 11.1 18.8 18.4 15.6 6.5 8.5 14.4 24.6 15.3 11.4 13.5 10.7 7.4 10.6 9.2 20.8 22.1 10.7 14.5 6.9 21.4 21.2 27.6 16.6 6.5 20.1 10.5 24.0 11.9 9.2 11.8 21.5 17.7 11.3 28.9 6.9 24.6 26.8 9.6 11.7 10.2 16.1 25.6 13.0 21.0 22.0 13.7 16.5 18.2 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 17.9 10.9 5.1 5.4 2.9 3.3 2.6 5.1 16.0 11.4 3.5 9.8 5.2 5.0 5.6 5.6 3.5 3.6 0.0 5.4 3.7 3.5 4.5 22.0 3.0 2.9 0.0 7.5 5.5 6.8 4.4 3.7 4.3 3.3 9.0 2.6 4.1 7.1 2.9 5.3 7.9 4.9 0.0 5.2 6.1 5.3 3.3 5.1 11.4 3.7 5.7 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.1 1.2 0.3 1.5 5.4 0.1 0.3 0.2 0.6 0.7 0.1 0.1 0.2 0.4 0.3 0.2 7.9 0.0 0.2 0.2 1.0 0.2 0.1 5.8 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.0 0.1 2.4 0.9 0.0 0.0 1.6 1.6 6.4 23.4 2.3 0.0 5.8 1.0 0.5 0.0 0.0 36.7 24.4 0.1 1.6 0.9 4.6 1.3 2.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 0.0 0.0 0.0 0.0 0.0 15.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.7 0.5 0.0 0.0 0.0 0.2 3.2 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.9 0.3 0.0 0.4 0.0 2.1 0.0 0.2 0.7 2.6 0.3 0.7 0.0 1.1 0.0 RINT1 "FLJ11785, RINT-1" ENSG00000135249 "RAD50 interactor 1" Q6NUQ1 7 105532085-105567677 "Predicted intracellular proteins" "Cell cycle, ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019875, HPA031646" Approved Approved "Golgi apparatus" Yes No "Golgi apparatus" "HPA019875: AB_1856283, HPA031646: AB_2673975" "unprognostic (1.58e-2)" "unprognostic (3.94e-2)" "unprognostic (9.00e-2)" "unprognostic (1.80e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-2)" "unprognostic (4.68e-3)" "unprognostic (1.33e-2)" "unprognostic (4.96e-3)" "unprognostic (2.41e-1)" "unprognostic (8.72e-2)" "unprognostic (5.35e-2)" "unprognostic (8.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (1.76e-1)" 12.2 13.6 9.0 13.0 12.4 13.8 12.8 17.8 15.0 12.7 10.5 8.9 11.9 13.6 13.4 8.4 17.7 11.9 9.1 11.8 16.2 8.1 12.9 14.5 11.3 15.5 10.2 12.0 15.0 24.7 14.7 17.9 11.9 13.3 10.7 11.3 9.9 14.7 11.8 35.1 14.5 11.6 9.7 12.3 12.0 12.7 15.1 10.1 15.5 13.3 10.5 17.8 13.1 13.6 9.9 5.5 4.2 5.5 8.0 12.0 6.4 12.8 11.1 5.4 11.5 8.4 11.5 7.0 12.5 8.4 12.5 14.3 12.2 7.0 14.4 14.4 10.7 13.1 9.0 10.5 9.3 16.3 7.5 11.9 8.0 12.4 8.1 6.1 17.4 8.4 6.8 6.4 13.2 7.1 8.0 13.4 7.2 17.5 9.3 13.3 21.0 12.7 9.1 11.6 8.8 10.8 7.2 9.7 20.6 4.8 10.8 9.8 10.4 13.4 20.5 7.1 8.5 9.1 5.7 9.5 14.3 10.6 39.2 14.1 19.4 26.0 28.0 9.6 14.3 16.1 4.2 3.8 4.0 6.9 5.5 12.0 9.9 10.1 9.2 5.5 7.4 9.7 9.0 0.4 8.0 4.3 4.1 9.6 6.4 9.0 12.4 17.8 15.0 16.2 8.1 10.2 12.0 13.3 10.1 3.0 9.8 8.8 8.4 6.0 5.2 8.7 2.5 21.4 7.9 3.5 7.9 9.6 8.3 6.8 5.3 5.1 5.1 0.0 5.5 8.8 7.2 5.1 9.3 4.2 6.5 6.4 5.2 3.7 4.9 4.5 8.1 3.8 5.0 4.6 5.6 6.6 6.0 3.5 9.2 5.3 8.9 6.5 5.7 23.3 12.4 6.8 10.1 7.0 6.9 7.4 RLF "Zn-15L, ZNF292L" ENSG00000117000 "Rearranged L-myc fusion" Q13129 1 40161373-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA054653: AB_2682557, HPA057300: AB_2683404" "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 14.8 8.1 12.6 11.3 12.6 44.5 13.9 20.8 17.1 12.4 11.1 11.6 7.1 8.6 14.1 8.6 12.4 9.9 11.2 12.3 11.0 8.3 8.7 12.7 12.8 11.8 12.8 11.8 14.6 9.4 12.5 15.1 11.9 15.4 13.2 9.2 10.2 9.4 9.9 13.4 17.7 9.9 14.3 14.1 10.1 9.3 15.9 11.8 14.9 10.0 8.4 13.5 18.1 14.8 4.1 3.5 10.1 4.1 4.1 4.9 2.4 12.4 4.8 9.5 9.9 8.5 6.9 11.3 4.7 7.0 8.1 10.8 9.7 6.6 12.4 6.2 6.0 6.1 11.8 11.9 8.2 14.8 5.8 8.1 10.2 5.9 5.9 6.7 8.4 6.2 6.8 8.7 8.6 9.8 9.7 5.5 6.9 15.5 7.7 7.4 3.9 7.1 5.1 12.6 4.6 5.6 5.6 15.6 7.2 5.2 12.6 6.8 9.5 8.7 11.7 8.3 15.4 5.5 30.8 4.7 9.6 10.2 7.8 8.7 7.0 6.6 11.7 8.3 7.9 5.9 10.1 2.8 5.5 3.7 3.9 4.9 4.1 3.7 3.8 3.5 4.1 4.8 4.0 6.3 4.1 4.1 1.6 3.3 2.4 12.6 12.6 20.8 17.1 11.0 8.3 12.8 11.8 15.4 11.8 29.8 10.8 22.4 42.2 58.3 17.2 13.4 5.1 30.8 30.7 3.5 15.7 6.9 5.0 10.9 32.9 23.3 8.4 0.0 5.9 8.0 34.2 25.7 26.5 8.3 8.5 25.4 19.4 16.0 13.9 4.9 8.3 16.8 16.9 10.0 7.8 17.0 9.3 14.0 7.4 5.7 15.8 12.9 27.8 26.5 20.0 53.3 14.4 14.1 6.7 27.2 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Group enriched" "Detected in many" 6 "Early spermatids: 207.9;Late spermatids: 131.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.7" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.4 3.9 2.7 1.7 12.1 12.4 1.6 7.3 9.3 3.6 3.8 1.0 11.4 2.4 3.2 10.8 2.3 3.9 0.9 4.9 4.6 4.7 2.7 4.0 1.6 3.4 6.3 0.0 4.1 17.7 3.8 5.0 0.7 6.1 2.0 1.2 4.8 2.0 6.5 1.3 0.8 4.1 5.2 6.6 3.9 0.0 0.7 0.4 9.5 3.1 2.1 7.9 5.7 0.6 6.4 2.3 1.2 5.5 2.8 5.1 5.4 2.7 2.8 3.9 6.8 4.8 6.0 0.9 5.1 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 26.8 23.5 5.4 7.2 2.2 3.7 3.6 7.6 13.4 27.3 5.2 2.0 1.7 6.6 4.2 207.9 3.6 21.2 0.0 3.4 0.8 7.3 2.5 15.1 12.9 4.4 4.8 4.6 3.7 6.5 131.8 8.6 4.4 5.0 1.8 11.2 5.8 2.4 7.0 5.6 5.9 2.2 6.5 3.9 3.9 3.7 2.0 0.7 3.8 15.9 2.0 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favorable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.2 22.0 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.3 11.0 29.2 10.3 16.4 0.6 18.9 14.7 23.1 22.6 13.6 29.0 15.5 18.5 14.1 14.8 11.0 9.2 6.6 10.5 14.4 24.2 20.0 5.9 17.1 11.6 10.0 7.4 20.7 15.4 18.3 11.2 16.7 11.5 14.3 22.4 8.2 17.5 23.7 8.1 3.2 18.5 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.1 16.5 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 29.8 25.5 4.5 14.2 14.0 19.2 7.0 10.2 26.8 21.6 17.4 3.9 36.6 1.7 25.3 2.0 16.5 16.9 0.0 19.5 23.1 16.9 15.9 18.5 30.9 113.0 17.5 4.7 17.8 15.6 3.1 15.5 10.9 18.6 11.8 11.5 20.0 17.9 14.4 13.4 13.3 15.2 6.5 11.4 31.1 42.8 10.5 52.5 18.5 18.8 19.0 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487061-228495766 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 42.3;U-266/70: 76.8" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 15.7 30.3 25.6 12.5 28.1 12.3 10.3 33.2 54.7 11.4 10.7 15.5 12.5 14.7 12.9 12.2 18.0 14.2 14.5 17.7 25.2 24.9 16.2 20.4 11.5 9.8 20.2 29.3 20.2 19.4 22.3 16.4 8.8 22.7 15.0 6.6 12.3 30.3 12.6 55.5 15.5 13.2 8.6 16.3 19.0 14.2 9.5 11.4 11.1 27.9 19.4 11.2 10.0 13.1 2.0 1.7 8.7 2.1 1.0 2.3 0.6 9.4 7.1 5.0 10.5 5.5 3.6 9.7 7.9 4.9 5.0 3.8 3.6 6.6 21.6 16.6 9.0 4.1 7.6 6.3 6.7 1.9 9.8 8.1 6.5 5.3 4.7 15.0 7.4 12.8 6.3 12.1 3.8 5.2 6.1 4.4 16.5 10.4 42.3 3.6 5.3 11.8 6.6 11.2 6.7 7.3 10.1 4.6 20.3 3.6 6.0 11.1 11.2 8.1 16.8 21.4 1.7 11.8 17.8 10.1 6.2 6.4 6.7 7.5 76.8 23.0 11.8 16.7 7.8 10.4 0.0 1.1 8.7 1.3 2.1 1.5 1.2 1.5 2.3 1.4 2.0 1.4 1.2 0.3 1.0 1.4 1.7 1.3 0.6 25.6 28.1 33.2 47.3 25.2 24.9 20.2 29.3 22.7 11.4 23.8 13.3 36.1 41.5 32.2 84.0 56.1 38.2 8.1 18.2 38.4 17.7 14.3 96.2 13.8 0.5 22.6 33.3 0.0 20.8 20.1 31.6 30.3 44.9 56.2 24.8 52.4 38.4 29.4 29.7 2.5 22.7 23.8 37.1 6.4 26.7 103.2 20.8 20.4 24.4 99.3 37.8 19.4 38.1 4.4 22.0 48.3 14.8 41.5 27.6 24.7 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 21.1 17.1 13.9 14.1 19.2 15.4 20.7 16.7 17.3 14.5 13.8 9.0 10.3 10.3 15.4 12.1 19.2 15.8 14.4 19.6 16.5 11.0 18.8 30.7 12.2 15.3 16.8 11.3 20.9 25.9 13.7 21.6 15.5 19.3 15.5 14.1 9.5 14.0 11.5 46.3 16.7 10.6 19.8 17.4 16.3 14.2 18.1 18.7 10.0 20.4 29.3 15.8 22.1 15.1 10.3 9.3 0.8 7.7 11.1 12.4 6.1 8.0 3.9 4.4 17.4 7.7 12.1 11.6 11.6 6.9 10.3 10.3 15.7 5.9 19.0 11.1 5.8 15.3 9.2 14.6 11.0 23.4 8.0 13.4 12.4 4.9 9.1 9.3 18.8 6.0 7.3 8.8 14.3 29.3 6.9 8.2 8.8 33.0 10.5 12.9 7.8 13.9 19.8 12.8 13.1 7.1 13.3 8.4 13.5 9.9 8.1 7.5 9.7 5.1 6.8 19.1 6.6 6.2 16.1 5.3 8.5 7.5 83.2 31.0 4.5 7.0 23.7 11.3 23.8 17.1 0.3 6.9 0.8 5.9 7.7 12.4 10.3 8.4 7.7 8.1 7.8 11.1 10.5 0.2 11.1 4.9 9.3 7.3 6.1 13.9 19.2 16.7 17.3 16.5 11.0 16.8 11.3 19.3 18.7 17.9 26.9 21.2 94.7 69.6 12.6 61.4 45.9 61.6 63.7 17.4 0.0 40.8 58.0 40.9 72.5 33.0 12.0 0.0 41.1 44.2 40.8 42.1 44.0 66.6 48.0 17.5 10.9 22.7 27.3 20.4 31.9 26.8 35.4 18.0 26.8 18.6 37.2 21.0 25.5 70.4 8.2 12.9 35.4 37.2 27.3 58.0 28.9 17.9 32.7 65.4 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Supported "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 830000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 63.6 33.4 37.0 59.0 40.4 70.6 88.2 34.5 42.2 73.6 60.5 33.5 42.3 18.8 67.3 49.8 81.3 65.7 39.4 38.8 31.7 26.4 53.2 84.5 46.1 103.9 35.1 26.3 139.1 159.9 33.1 42.0 52.0 34.1 67.6 50.9 35.9 66.2 51.0 87.2 77.1 36.4 67.3 47.9 60.3 46.3 42.8 20.0 81.3 66.1 91.7 102.8 74.2 55.9 72.5 58.7 5.9 40.9 45.0 97.0 135.7 45.1 91.1 38.6 64.9 173.7 316.0 68.1 55.1 113.9 85.4 66.3 100.7 79.3 178.9 62.9 131.3 40.4 82.2 275.6 213.2 94.6 49.4 165.2 109.6 81.7 83.7 244.9 114.8 54.9 310.0 278.0 92.8 371.0 105.2 136.6 84.9 100.3 70.4 127.7 74.5 76.4 51.1 84.4 100.9 65.3 85.8 88.0 173.6 117.4 89.7 68.6 71.7 34.0 96.8 136.2 84.5 71.5 166.0 80.0 44.7 67.5 41.5 87.6 69.2 107.3 119.6 55.0 154.6 50.2 3.5 40.9 5.9 38.2 36.2 71.1 72.5 74.6 53.7 58.7 60.5 97.0 75.7 2.7 45.0 33.5 37.4 57.0 135.7 37.0 40.4 34.5 42.2 31.7 26.4 35.1 26.3 34.1 20.0 419.9 882.0 1803.2 2287.0 2152.7 118.6 357.6 588.5 738.8 1063.5 324.5 76.6 1844.2 1399.3 929.4 510.9 791.2 291.1 327.1 1855.6 3103.9 1180.5 1227.4 901.9 616.8 1082.4 38.1 731.3 578.2 1045.6 1022.7 1235.2 1320.8 1032.5 1779.1 995.5 130.7 1271.8 480.5 936.2 1212.4 111.6 452.7 1291.3 308.9 412.0 2258.1 2005.7 1400.6 1218.5 2270.0 RPL6 "L6, TAXREB107, TXREB1" ENSG00000089009 "Ribosomal protein L6" Q02878 12 112405190-112418838 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060903, HPA068418" Approved Approved "Microtubules,Cytokinetic bridge" Yes No 270000 "Microtubules, Cytokinetic bridge" "HPA060903: AB_2732653, HPA068418: AB_2685987" "unprognostic (5.95e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (5.49e-2)" "unprognostic (1.10e-2)" "unprognostic (2.50e-1)" "unprognostic (1.02e-2)" "unprognostic (3.74e-1)" "unprognostic (5.63e-2)" "unprognostic (1.07e-2)" "unprognostic (4.19e-3)" "unprognostic (2.52e-2)" "prognostic unfavorable (6.95e-4)" "unprognostic (2.45e-1)" "unprognostic (2.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.90e-2)" 63.6 60.2 58.0 55.5 72.9 102.2 94.0 42.0 87.8 63.8 65.1 39.4 50.5 39.8 68.9 83.2 86.5 64.9 38.9 45.8 50.0 38.7 78.8 111.9 45.2 84.5 45.3 72.6 149.8 113.7 39.3 78.7 69.2 91.1 56.9 63.5 32.9 81.5 51.8 73.6 80.0 50.9 52.5 46.0 68.0 67.6 60.0 42.3 71.2 62.9 122.7 106.4 61.9 68.1 164.0 158.0 28.3 98.8 125.5 191.9 287.6 96.8 91.9 112.6 115.3 141.0 233.0 150.7 95.4 133.0 125.3 72.1 143.4 61.2 210.8 81.1 99.0 48.9 95.1 120.0 163.7 125.6 83.0 152.8 113.7 81.5 127.5 148.3 202.3 88.5 215.9 228.2 95.4 219.9 232.6 140.2 137.2 149.1 57.7 143.8 129.3 145.9 325.6 159.2 204.3 106.7 134.6 123.8 202.3 155.2 159.0 105.8 137.1 66.2 175.7 159.0 106.3 184.6 206.9 84.3 63.1 77.5 80.8 104.6 79.9 124.0 169.1 81.6 146.2 94.3 28.3 98.8 20.9 114.5 84.1 189.8 164.0 174.1 147.8 136.0 145.4 191.9 162.2 12.7 125.5 73.3 158.0 137.8 287.6 58.0 72.9 42.0 87.8 50.0 38.7 45.3 72.6 91.1 42.3 741.5 1203.3 3176.6 3335.4 2794.0 249.2 237.4 1470.0 906.1 1552.6 603.7 129.6 2560.4 2967.7 1798.1 320.1 2016.2 774.2 724.2 2637.8 3961.8 1779.3 2297.0 1229.7 1338.0 1682.0 114.4 1334.9 1475.6 2186.3 568.6 2638.6 2337.5 1801.7 2647.6 1649.3 361.1 2447.2 1150.3 1494.6 2579.4 298.4 911.9 2153.7 404.1 478.4 3190.6 2566.3 2157.3 2203.0 3047.7 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" "Low cell line specificity" "Detected in many" HPA056994 Enhanced Supported Cytosol Yes Yes Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.5 17.9 25.4 17.4 2.2 4.1 25.1 48.3 24.0 34.5 37.6 29.9 14.1 27.1 6.7 15.1 35.0 14.5 41.0 24.9 42.3 60.8 15.8 52.3 17.2 26.3 0.1 38.7 25.1 1.5 0.5 42.2 3.6 5.7 27.9 21.0 21.9 80.5 42.9 22.3 42.7 20.8 20.5 30.4 21.0 32.2 55.4 18.6 17.0 22.5 25.1 20.7 39.7 28.2 4.9 11.0 15.2 6.9 9.7 26.5 38.5 19.8 67.7 52.3 41.0 55.4 18.8 32.9 38.0 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 3.0 1.0 2.2 1.0 9.3 0.0 1.2 2.5 5.3 1.2 0.0 0.0 5.4 1.7 0.5 3.0 0.3 2.6 93.5 0.0 192.1 3.6 1.1 5.7 1.7 40.1 0.0 0.0 5.5 5.9 5.7 0.3 3.5 0.0 0.0 7.9 0.0 0.5 0.0 0.4 1.6 0.0 0.0 0.3 5.2 44.5 1.4 40.7 7.2 13.0 2.0 RRN3 "DKFZp566E104, TIF-IA" ENSG00000085721 "RRN3 homolog, RNA polymerase I transcription factor" Q9NYV6 16 15060022-15094317 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049837 Supported Supported "Nucleoli rim" Yes No "Nucleoli rim" "HPA049837: AB_2680906" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" "unprognostic (5.74e-3)" "unprognostic (3.67e-2)" "unprognostic (4.50e-2)" "unprognostic (7.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.25e-3)" "unprognostic (1.17e-2)" "unprognostic (7.71e-2)" "unprognostic (2.76e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" 7.8 6.0 4.3 4.0 5.7 10.0 7.2 9.2 6.3 4.9 5.1 5.0 6.3 5.4 4.5 5.9 4.7 5.5 3.9 5.0 5.5 10.1 4.3 5.9 3.7 8.4 5.8 8.9 5.8 4.9 6.6 6.5 4.6 4.8 15.2 5.3 5.0 5.1 3.9 6.2 5.3 4.9 6.2 6.3 6.6 4.9 10.7 8.2 12.3 7.0 10.0 14.2 9.5 7.7 10.4 8.1 6.9 9.7 8.3 5.9 9.9 6.6 9.7 9.2 9.6 11.3 13.7 15.8 8.7 11.3 7.6 15.2 10.0 14.0 11.0 10.3 30.0 13.8 18.3 14.0 11.2 35.2 8.6 13.9 13.6 15.4 8.0 6.8 9.6 8.3 11.9 13.3 12.2 10.8 14.3 9.1 9.1 8.6 23.7 11.3 15.1 8.0 10.2 17.2 12.1 10.5 12.5 10.9 6.2 16.2 10.1 6.9 11.5 5.4 8.1 9.9 9.6 13.7 19.3 6.8 13.5 14.8 12.3 6.4 5.9 11.2 6.6 13.3 10.7 9.8 11.0 8.2 7.7 14.2 11.0 1.0 10.0 7.0 5.2 9.4 9.5 8.9 10.7 11.4 9.3 15.9 13.7 18.7 10.2 2.7 10.3 15.7 19.6 9.3 5.0 9.4 15.6 17.0 10.5 0.0 7.0 9.5 14.4 10.6 9.3 14.8 12.9 11.1 6.9 16.5 13.9 5.2 13.6 14.5 15.1 15.4 15.6 17.9 8.5 11.5 17.0 13.0 15.1 0.0 18.9 13.4 19.6 19.2 5.6 15.3 12.4 8.8 RRP1 "D21S2056E, NNP-1, Nop52, RRP1A" ENSG00000160214 "Ribosomal RNA processing 1" P56182 21 43789513-43805293 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016818, HPA018166" Approved Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA016818: AB_1854561, HPA018166: AB_1854562" "unprognostic (5.38e-2)" "unprognostic (3.48e-1)" "unprognostic (3.43e-1)" "unprognostic (2.53e-2)" "unprognostic (9.44e-2)" "unprognostic (1.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.26e-1)" "unprognostic (7.63e-3)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (6.29e-5)" "unprognostic (1.13e-1)" "unprognostic (9.21e-3)" "unprognostic (2.64e-1)" "unprognostic (1.88e-1)" 12.0 10.6 12.1 12.8 15.6 9.7 9.4 11.4 20.0 8.6 8.9 18.0 6.0 10.6 10.0 9.1 19.8 10.9 9.3 8.5 14.3 11.3 8.3 16.6 7.3 15.1 16.3 14.4 14.8 16.6 9.4 7.6 10.3 14.9 9.4 6.7 9.9 14.7 9.8 15.6 20.1 9.7 7.4 11.5 11.1 11.9 13.8 15.6 10.5 9.6 11.4 14.7 8.9 9.8 10.9 8.8 1.5 4.3 10.4 12.3 6.0 16.3 8.8 6.0 10.1 3.3 3.8 11.7 8.4 4.9 11.7 8.3 23.1 9.7 15.8 7.0 4.5 10.8 8.4 11.2 8.1 5.3 7.8 22.0 22.5 8.1 14.0 6.9 14.2 8.1 5.0 7.7 11.7 9.2 3.0 6.2 14.9 29.4 11.9 5.4 19.3 12.3 19.5 20.3 11.3 13.2 22.8 4.9 29.1 6.0 9.1 14.4 8.6 8.7 9.4 11.0 1.7 9.8 9.8 7.0 7.8 8.9 8.2 14.4 14.9 12.8 16.4 11.9 23.8 10.1 0.1 4.3 1.5 9.7 4.0 12.3 9.6 10.1 9.9 8.8 10.9 11.2 7.4 0.9 10.4 1.9 7.5 5.8 6.0 12.1 15.6 11.4 20.0 14.3 11.3 16.3 14.4 14.9 15.6 14.9 20.8 16.0 24.4 64.2 17.6 4.5 7.6 20.1 39.8 7.0 19.6 27.0 6.6 26.5 3.5 19.1 9.1 23.3 28.6 31.6 22.6 15.8 20.7 13.5 29.5 7.9 20.1 12.9 6.7 2.4 17.8 19.7 40.5 19.8 15.3 9.9 31.9 5.8 19.4 17.0 17.4 32.3 24.7 22.6 29.6 61.4 25.4 13.1 25.2 35.2 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285287-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 10.3 7.2 8.9 8.0 9.9 8.5 11.6 11.6 10.4 8.4 8.0 5.5 5.4 5.3 10.1 7.1 8.7 8.9 5.0 11.4 8.6 6.3 9.3 10.7 7.5 8.3 8.0 5.0 9.8 8.4 12.1 10.0 8.7 8.6 7.8 7.2 5.8 7.9 6.4 33.5 8.5 6.8 11.8 9.4 10.3 7.6 6.3 9.0 6.5 8.9 10.5 8.3 8.5 9.4 5.1 3.3 0.6 2.4 3.1 5.7 1.6 8.1 6.1 6.8 4.9 5.0 7.0 5.9 8.3 6.3 8.8 6.4 11.9 7.5 11.8 11.5 6.4 5.9 7.4 11.6 11.0 14.7 4.7 8.7 9.1 5.8 6.6 10.3 14.1 5.0 4.8 6.8 11.4 15.3 3.9 5.6 5.5 18.6 3.9 9.8 7.5 9.3 6.9 13.6 6.5 12.8 6.6 4.2 11.6 7.0 7.6 8.0 11.5 7.1 13.3 12.2 8.5 9.5 10.2 7.9 7.1 6.6 12.5 15.4 4.7 7.2 12.2 8.1 6.9 11.2 0.6 1.6 0.2 3.5 2.4 4.8 4.7 4.2 2.9 2.4 5.1 5.7 5.5 0.5 3.1 2.1 3.3 2.5 1.6 8.9 9.9 11.6 10.4 8.6 6.3 8.0 5.0 8.6 9.0 29.8 25.5 31.5 28.8 58.0 29.7 58.0 17.8 13.4 30.7 34.9 9.8 32.1 23.2 30.7 5.9 26.0 2.9 0.0 44.6 48.1 26.3 14.3 30.1 37.6 29.3 25.4 11.6 19.0 13.3 2.7 34.8 25.8 20.3 17.2 18.6 20.3 31.8 2.9 23.3 23.5 21.8 25.8 28.8 46.4 75.7 41.7 15.1 22.4 25.7 22.8 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659548-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 12.7 10.3 10.7 20.0 13.7 7.6 14.5 13.9 12.5 13.1 11.1 11.5 9.4 9.5 16.1 9.2 15.7 14.0 12.2 8.4 9.5 8.6 7.5 17.7 10.4 22.8 13.1 7.5 20.0 20.6 11.8 11.4 8.4 10.3 11.3 10.9 15.0 13.9 12.8 21.6 14.1 11.1 12.9 9.9 16.9 11.8 32.5 12.6 25.6 9.6 12.6 20.5 13.5 14.1 6.0 3.2 2.1 2.7 5.8 9.8 5.3 16.9 10.0 10.7 16.1 7.0 7.5 8.8 8.9 6.4 9.9 8.2 22.7 7.4 33.2 5.9 7.0 11.5 7.6 26.4 15.4 11.8 11.1 21.0 19.6 11.6 14.2 9.7 30.5 7.8 7.7 9.9 11.9 13.8 6.1 11.0 14.4 30.6 9.8 8.7 8.8 24.2 9.3 36.5 11.0 11.2 32.0 10.8 23.2 7.2 8.1 21.3 11.4 16.8 12.4 12.4 4.1 8.1 9.6 9.8 3.1 9.7 8.1 16.2 13.3 16.9 39.7 9.7 33.0 10.0 2.1 2.6 0.7 7.2 2.7 8.5 6.0 9.1 8.6 3.2 5.3 8.6 9.8 0.1 5.8 2.3 2.6 7.0 5.3 10.7 13.7 13.9 12.5 9.5 8.6 13.1 7.5 10.3 12.6 29.8 16.0 22.1 12.1 20.3 28.9 10.4 12.7 21.4 28.4 5.2 123.7 6.5 1.7 12.9 195.5 15.9 4.7 0.0 13.7 13.6 13.6 12.0 33.7 16.6 16.5 23.8 5.2 11.1 11.9 173.7 20.8 11.6 8.5 11.8 8.5 14.7 16.6 0.0 25.1 9.5 138.2 0.0 16.0 24.0 34.2 27.7 3.7 27.3 13.8 12.2 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 39.4 22.3 22.2 32.4 24.0 22.5 18.7 31.3 28.4 40.2 39.5 40.5 17.3 18.3 25.6 32.6 29.5 21.2 37.1 38.0 44.5 23.1 37.8 29.4 24.8 43.2 27.9 24.4 22.9 22.7 23.3 48.0 20.6 14.4 32.6 16.6 35.5 20.0 37.2 41.6 29.3 26.7 24.6 70.7 23.2 27.7 21.9 21.1 24.6 37.4 28.5 25.0 23.1 21.2 35.8 21.8 29.2 30.1 26.2 37.2 28.3 24.4 49.1 18.8 28.2 48.9 16.2 30.9 34.5 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 0.0 14.1 20.6 9.5 11.8 15.3 13.7 28.1 8.1 12.5 19.2 15.7 25.9 11.6 31.6 8.6 11.3 10.5 0.0 38.9 36.9 13.2 13.1 5.8 34.3 25.3 17.5 13.4 22.1 14.3 18.5 10.9 13.4 13.5 28.9 11.3 25.1 32.5 7.0 17.7 16.1 17.2 6.5 12.0 7.6 10.2 16.3 28.1 10.0 12.8 12.1 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator homolog" Q15050 8 66429028-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Supported Nucleoli Yes No Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 12.0 11.2 8.7 14.1 12.4 7.0 9.9 8.5 9.8 8.5 9.6 7.1 7.2 10.3 13.4 6.6 12.2 11.2 9.8 9.6 8.5 7.5 9.5 18.0 6.7 14.6 11.5 7.9 19.0 41.4 8.3 5.8 7.6 11.1 9.0 7.1 6.4 9.8 9.7 31.7 10.2 7.7 14.0 7.8 9.5 12.0 4.9 9.9 8.6 7.5 19.2 11.5 13.7 13.1 6.8 15.2 0.6 11.8 11.2 17.8 6.8 22.8 28.9 5.9 12.5 6.4 5.2 9.6 14.4 6.4 11.2 8.3 12.9 15.2 31.1 5.0 7.6 15.8 21.5 14.5 16.4 12.4 17.0 24.5 24.7 8.7 22.8 9.5 14.6 13.1 6.8 13.3 12.3 16.5 4.6 7.2 9.5 21.5 13.2 8.1 26.5 29.1 26.7 38.6 25.8 34.0 6.2 7.6 12.9 15.6 18.9 8.1 18.0 7.0 11.7 16.0 6.4 20.2 13.1 12.4 20.9 18.7 17.5 33.2 23.8 21.2 24.0 9.7 23.2 14.1 0.0 8.9 0.6 10.0 11.8 17.8 6.8 12.7 11.7 15.2 6.7 11.9 13.6 0.3 11.2 7.2 7.1 9.1 6.8 8.7 12.4 8.5 9.8 8.5 7.5 11.5 7.9 11.1 9.9 29.8 15.2 9.7 26.7 62.2 9.6 27.1 2.5 12.0 25.0 12.2 11.8 18.5 10.0 21.9 0.1 14.2 1.9 0.0 24.3 16.0 12.9 12.3 7.0 13.9 18.3 6.4 6.4 11.6 9.1 0.8 17.5 10.2 21.9 2.8 12.4 7.2 19.3 7.0 16.3 20.6 11.3 19.4 31.4 5.7 14.0 52.2 32.3 20.0 17.7 24.5 RSL1D1 "CSIG, DKFZP564M182, L12, PBK1, UTP30" ENSG00000171490 "Ribosomal L1 domain containing 1" O76021 16 11833850-11851585 "Predicted intracellular proteins, Ribosomal proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043483 Supported Enhanced "Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "HPA043483: AB_2678504" "unprognostic (4.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.23e-2)" "unprognostic (8.88e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.95e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.28e-1)" "unprognostic (2.24e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (4.72e-2)" "unprognostic (1.36e-1)" "unprognostic (2.02e-2)" "unprognostic (2.68e-2)" 31.5 16.8 11.6 15.8 15.0 18.6 36.1 16.3 16.2 26.6 21.5 11.5 12.6 14.9 20.6 14.0 28.6 21.8 14.2 17.3 11.2 11.4 17.9 24.0 15.9 29.4 14.2 11.7 58.1 32.7 14.9 20.7 22.0 15.0 30.2 18.1 14.7 18.1 17.0 66.9 21.2 23.2 25.6 15.7 25.2 17.8 19.9 12.6 25.2 27.8 19.8 28.7 37.8 20.8 32.2 31.0 3.0 30.2 28.5 49.0 53.4 21.3 20.4 17.1 21.4 22.5 40.7 20.4 19.9 22.4 25.9 26.6 19.7 20.3 53.8 33.1 16.6 18.0 15.3 45.8 30.3 42.2 21.0 24.7 26.5 20.1 44.9 42.1 37.5 17.7 29.6 43.1 26.7 62.3 19.5 25.1 21.2 46.4 25.0 31.8 23.7 29.3 21.8 43.8 25.9 21.2 30.6 31.5 57.0 23.3 18.8 24.0 19.7 37.6 28.7 26.7 18.5 24.7 29.2 15.3 17.3 19.4 16.3 28.7 20.1 28.9 62.8 18.8 39.6 23.0 3.0 30.2 2.9 18.2 28.6 33.2 32.2 33.6 23.4 31.0 27.0 49.0 35.0 1.6 28.5 26.1 19.1 23.4 53.4 11.6 15.0 16.3 16.2 11.2 11.4 14.2 11.7 15.0 12.6 131.0 127.1 161.6 243.1 293.9 41.6 166.3 68.8 107.1 230.9 47.1 21.6 166.1 114.4 110.6 14.1 113.7 58.6 0.0 160.3 244.9 140.4 116.0 146.9 67.2 131.5 36.5 90.6 47.9 127.0 11.5 184.6 158.8 87.7 275.1 126.0 46.3 134.3 73.7 118.5 126.3 23.5 58.2 198.5 98.4 131.5 253.7 134.3 149.8 155.6 181.7 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Cell line enhanced" "Detected in many" "OE19: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria Yes No 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.33e-4)" "prognostic unfavorable (1.00e-4)" "prognostic unfavorable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 63.5 65.2 0.2 13.5 73.8 98.4 48.6 36.0 48.7 32.3 32.8 117.1 88.5 0.0 35.0 62.8 38.3 111.1 18.5 140.1 30.1 11.4 5.3 7.7 29.7 27.4 26.4 2.9 6.7 25.5 118.1 35.2 40.5 29.0 71.4 4.2 0.1 0.1 42.9 55.1 0.5 18.6 8.8 273.2 72.5 0.0 12.6 1.2 136.1 18.9 0.5 0.5 58.8 21.1 27.4 77.4 46.6 7.4 75.8 15.5 38.8 73.4 25.1 1.7 0.3 10.9 91.1 2.6 54.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 2373.2 509.0 165.5 824.9 1416.6 10.1 91.6 634.4 507.3 913.4 902.0 3.9 1028.8 1291.5 1817.5 320.0 1052.4 1898.6 46.7 1882.2 473.9 2108.7 1493.1 280.8 168.1 1060.4 15.9 1037.0 742.7 952.8 225.8 599.2 1623.9 1548.8 1432.9 1679.7 14.1 2865.9 3115.1 60.8 287.0 25.8 142.3 345.1 12.6 80.7 1085.7 314.3 441.6 1750.5 1802.8 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 30 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.5 4.1 0.0 0.0 0.4 0.3 0.3 0.7 0.9 0.5 1.0 0.4 3.0 0.0 2.7 1.5 0.3 1.2 0.1 0.7 0.6 0.3 0.0 1.9 1.5 0.1 0.3 0.0 2.5 0.0 0.8 2.0 0.6 0.3 0.4 0.0 0.5 0.1 2.2 0.1 0.3 0.9 0.1 24.3 7.1 0.0 1.3 0.7 8.6 14.2 12.7 0.0 0.1 6.5 0.6 1.2 0.0 0.4 0.3 0.1 0.9 1.9 1.2 0.0 0.6 0.0 0.4 0.5 0.2 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 7.2 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.4 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802520 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "NK-cell: 6.3" "Lineage enriched" "Detected in single" 9 "NK-cells: 6.3" "Cell line enhanced" "Detected in some" "AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.3 0.4 0.3 0.3 0.9 1.2 0.3 0.8 0.9 0.4 0.7 0.3 2.2 0.1 0.3 0.8 0.3 0.2 0.3 0.3 0.3 0.1 0.5 1.9 0.3 0.3 0.3 0.3 0.3 4.6 8.8 0.6 0.3 0.9 3.1 0.2 4.5 2.2 0.4 0.3 0.3 0.7 0.3 0.3 0.8 0.3 11.7 0.3 0.3 8.6 0.3 0.3 0.9 0.3 0.1 0.1 0.6 0.1 6.3 0.2 0.0 0.0 0.8 13.1 9.1 0.0 0.0 17.5 0.0 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.2 0.0 0.0 3.0 0.2 0.1 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 31.5 0.1 0.2 1.2 0.0 0.0 0.0 0.2 3.0 1.6 8.0 0.0 0.7 22.0 0.0 0.5 0.0 0.5 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.6 6.3 0.1 0.1 0.0 0.0 0.3 0.9 0.8 0.9 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.3 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.0 0.0 0.2 25.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 1.0 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 52.5;WM-115: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256" "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favorable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.3 7.6 12.6 3.0 3.2 6.8 9.7 3.2 2.0 0.3 2.5 0.2 17.3 19.0 4.6 3.7 1.7 1.5 2.1 1.4 1.4 0.0 0.8 0.4 12.1 0.0 1.8 7.3 7.5 0.2 3.2 17.9 4.0 0.7 1.3 0.2 6.2 2.9 0.1 0.1 8.3 1.9 2.4 0.1 15.6 0.6 4.0 2.9 6.4 4.1 8.6 1.2 52.5 10.9 1.2 1.2 4.4 4.0 6.9 0.5 1.5 0.0 0.1 0.2 0.4 0.0 73.1 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 0.0 2.1 0.8 2.8 2.3 8.1 3.2 15.3 0.0 2.3 45.4 0.0 2.1 0.0 9.0 17.7 8.7 0.0 0.0 2.6 2.8 10.0 6.9 0.0 0.2 13.2 0.0 2.9 28.8 157.7 63.3 2.0 2.2 18.6 5.4 0.9 1.5 6.1 0.6 7.4 0.3 25.6 0.0 5.6 0.7 0.4 1.9 3.0 0.0 1.2 3.7 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO1/sentrin/SMT3 specific peptidase 3" Q9H4L4 17 7561875-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 16.3 16.0 22.3 20.9 23.4 16.6 18.0 29.2 38.4 15.9 22.5 18.4 16.8 16.2 18.6 22.7 18.6 19.9 17.0 26.1 21.0 19.2 17.5 15.1 18.7 18.8 20.0 23.3 19.6 17.8 29.5 17.3 23.6 17.2 16.0 20.5 17.3 18.6 21.9 22.0 20.8 17.6 23.1 15.3 18.9 17.2 28.8 16.4 18.9 19.0 14.2 23.4 16.8 32.8 0.8 0.7 1.1 0.7 1.1 1.7 0.3 26.5 32.2 19.1 29.6 21.7 15.9 20.0 19.5 20.0 34.0 32.0 19.2 11.6 31.8 19.4 25.6 23.5 25.6 41.1 30.5 28.6 22.4 37.5 16.5 27.3 19.7 29.3 15.1 21.0 20.3 31.2 38.8 38.1 19.6 27.3 36.3 21.1 9.0 26.2 17.8 36.8 11.5 23.7 24.8 19.6 33.7 17.9 18.3 22.7 15.6 19.1 24.7 19.5 18.9 20.7 25.5 15.9 9.9 14.3 19.6 17.0 18.6 41.8 13.2 13.7 20.2 19.7 16.1 28.9 0.1 0.7 0.2 0.4 0.4 0.1 0.4 0.2 1.3 0.1 0.8 1.7 0.5 1.1 1.1 0.1 0.7 0.3 0.3 22.3 23.4 29.2 38.4 21.0 19.2 20.0 23.3 17.2 16.4 3.0 4.8 2.7 5.7 7.6 5.8 5.9 7.6 1.4 4.5 1.8 21.6 2.6 0.0 1.9 1.1 4.5 2.3 0.0 2.1 1.9 3.9 4.1 1.1 2.6 1.3 6.4 6.3 9.8 6.9 0.4 3.7 4.1 3.3 1.8 2.5 5.0 1.9 0.0 2.1 0.7 8.0 0.0 3.6 2.8 3.5 10.2 3.4 4.9 3.4 5.6 SEPT2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" Yes No 8800000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favorable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 64.2 46.4 76.5 42.9 69.9 29.1 58.7 34.9 61.8 69.3 48.4 85.2 57.4 37.8 59.5 59.8 46.8 48.2 54.0 56.2 65.8 55.4 64.6 31.4 51.2 51.3 76.5 52.7 63.4 73.0 56.6 56.3 58.9 60.7 53.7 53.3 48.8 43.6 64.7 39.5 32.0 42.2 81.8 100.8 51.5 45.6 67.7 57.2 36.2 64.2 39.0 47.5 56.5 42.6 25.5 51.2 38.5 50.5 51.3 36.9 59.4 32.3 29.2 79.5 52.0 74.1 80.8 41.2 71.7 70.7 46.1 58.7 16.4 35.2 13.2 17.1 82.0 25.0 28.8 51.9 48.5 75.9 33.2 36.9 52.9 29.2 60.1 45.3 50.3 32.4 71.9 31.8 38.4 37.1 52.9 80.2 33.8 47.2 19.3 67.8 23.3 29.8 30.8 57.9 29.2 21.4 29.5 100.0 27.8 68.4 49.6 57.1 38.4 49.7 34.3 47.3 59.1 20.6 45.5 75.8 56.5 24.0 54.5 42.4 38.2 33.2 46.4 48.6 30.8 78.1 38.5 46.0 26.3 30.3 50.5 36.9 25.5 29.6 31.2 51.2 21.6 26.2 27.4 16.3 51.3 37.2 38.6 29.5 59.4 76.5 69.9 34.9 52.3 65.8 55.4 76.5 52.7 60.7 57.2 142.9 106.2 90.8 0.0 77.2 51.5 114.7 71.4 117.8 135.4 89.0 70.7 118.8 114.4 0.0 157.8 127.2 51.6 46.7 0.0 159.0 147.1 0.0 333.1 52.1 119.3 54.0 85.8 135.1 100.6 140.6 121.7 111.3 82.7 0.0 73.4 155.1 0.0 79.8 174.6 96.3 58.2 109.9 144.2 131.8 84.2 80.8 116.3 82.9 87.9 0.0 SEPT7 "CDC10, CDC3, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 1164.8;Sertoli cells: 802.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Enhanced "Nucleoli,Actin filaments,Midbody,Cytosol" Yes No 16000000 "Actin filaments" "Nucleoli, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 35.5 28.5 89.0 26.8 77.8 31.9 29.5 41.9 81.5 35.1 28.7 54.3 11.5 15.7 37.8 36.2 31.7 25.4 34.2 47.5 86.4 58.1 24.3 21.5 28.3 38.8 79.6 66.2 42.8 11.2 22.9 31.9 41.0 72.0 28.4 28.2 9.6 14.9 29.9 21.7 29.1 20.1 42.6 76.8 29.5 18.1 19.3 98.2 33.0 22.6 17.3 41.4 36.9 24.0 40.4 24.0 47.3 24.8 69.1 56.8 48.6 36.1 17.4 44.5 29.2 50.2 51.9 22.8 46.7 43.1 39.9 34.4 27.0 28.1 34.3 31.7 47.5 53.6 27.5 31.4 31.1 57.0 23.4 16.5 27.6 24.4 14.6 29.3 33.2 30.5 33.6 24.4 31.3 30.9 41.8 41.5 27.1 21.6 27.1 64.7 16.9 33.5 55.8 47.7 33.9 24.7 34.6 42.4 19.7 38.6 27.0 23.9 42.0 32.6 42.0 27.9 76.2 31.0 36.8 35.0 40.3 47.8 24.7 51.4 32.0 29.1 86.5 25.7 55.6 85.0 47.3 20.7 34.9 55.4 24.0 56.8 40.4 39.6 50.5 24.0 37.4 35.6 44.9 39.3 69.1 24.8 17.2 34.2 48.6 89.0 77.8 41.9 81.5 86.4 58.1 79.6 66.2 72.0 98.2 142.9 97.9 186.4 0.0 141.0 199.4 207.8 40.8 222.1 184.2 129.1 43.2 148.6 127.6 0.0 342.3 214.2 64.6 23.3 0.0 161.3 239.6 0.0 368.3 69.5 168.4 1164.8 58.6 187.2 128.6 256.8 324.7 171.1 178.8 0.0 61.0 328.2 0.0 106.6 426.0 108.1 113.7 802.0 509.2 101.6 233.2 140.9 103.9 294.1 77.5 0.0 SETD7 "KIAA1717, KMT7, SET7, SET7/9, Set9" ENSG00000145391 "SET domain containing lysine methyltransferase 7" Q8WTS6 4 139495941-139606699 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058111 Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA058111: AB_2683607" "prognostic unfavorable (8.28e-4)" "unprognostic (7.07e-2)" "unprognostic (4.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.92e-1)" "unprognostic (4.82e-2)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.71e-2)" "unprognostic (9.10e-2)" "unprognostic (6.44e-2)" "unprognostic (7.75e-2)" "unprognostic (1.37e-1)" "unprognostic (6.16e-3)" "unprognostic (1.17e-1)" "unprognostic (6.92e-2)" "unprognostic (6.56e-3)" 26.1 13.2 12.0 9.6 12.3 5.7 26.3 10.2 16.2 27.9 17.7 17.9 11.0 4.8 23.8 12.0 18.3 13.8 16.9 25.2 13.0 10.0 7.2 30.7 12.1 6.9 18.0 10.1 13.3 13.8 26.8 9.3 12.0 15.4 22.8 10.2 12.4 13.7 13.9 56.4 14.2 9.9 33.3 19.0 11.8 17.7 10.6 16.5 2.9 10.3 15.2 9.9 24.2 30.1 2.3 6.8 1.8 5.6 0.5 5.6 1.6 9.0 11.7 4.5 2.6 26.5 22.9 9.9 21.5 22.4 11.0 9.3 6.9 12.4 21.1 8.5 36.2 7.6 4.6 14.9 17.0 17.9 10.4 10.5 2.9 15.3 0.2 13.1 10.1 4.5 19.8 19.9 17.5 18.7 14.0 13.9 9.0 1.7 32.9 14.0 15.1 6.6 1.5 2.2 13.3 7.7 6.2 15.5 12.1 10.7 8.3 17.4 5.8 14.3 21.3 5.1 4.5 8.4 9.2 22.5 19.5 13.9 23.2 17.8 28.4 27.2 13.4 22.5 10.2 9.3 1.0 5.6 0.5 0.6 3.2 4.1 1.8 1.8 1.8 6.8 2.3 0.8 0.5 1.8 0.5 4.8 3.5 5.6 1.6 12.0 12.3 10.2 16.2 13.0 10.0 18.0 10.1 15.4 16.5 6.0 13.1 3.4 10.9 15.2 6.6 35.4 17.8 4.0 6.8 8.7 11.8 21.9 0.0 20.5 0.9 24.7 1.8 23.3 18.1 14.4 19.2 35.1 2.3 64.4 18.3 7.9 1.2 36.8 29.7 3.5 21.3 18.3 10.1 7.2 11.2 13.3 21.5 0.0 26.5 3.9 12.6 19.4 21.0 3.2 1.9 19.3 38.6 5.0 9.9 14.2 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: AB_2683731" "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.9 6.9 10.0 6.6 4.8 6.4 16.7 4.9 5.7 7.1 6.1 4.6 8.2 11.6 6.8 5.4 2.8 7.4 9.3 5.3 5.6 5.6 11.5 6.6 7.1 5.3 6.8 11.6 6.3 8.4 5.9 5.8 9.5 7.2 8.3 7.5 11.0 9.5 5.0 11.4 8.0 6.8 13.7 8.3 5.5 9.3 6.5 8.6 5.4 6.8 7.3 13.3 7.5 8.8 5.9 12.6 9.5 15.7 5.6 4.1 4.3 4.5 6.8 9.9 10.6 90.6 4.3 4.1 4.0 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 6.0 12.3 5.3 7.2 4.8 10.9 4.1 5.1 9.4 6.8 7.0 17.7 11.4 3.3 6.6 23.5 6.9 6.2 0.0 5.0 7.2 4.9 6.2 7.0 6.2 8.8 6.4 3.5 10.4 14.2 21.8 9.5 10.4 1.7 7.2 10.3 6.3 7.3 10.7 9.2 5.4 10.1 6.5 5.9 22.4 14.5 4.4 8.4 7.0 9.3 6.4 SETX "ALS4, AOA2, KIAA0625, SCAR1, Sen1" ENSG00000107290 Senataxin Q7Z333 9 132261356-132354985 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis" "Helicase, Hydrolase" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024105, HPA057269" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA024105: AB_2671437, HPA057269: AB_2683389" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (3.23e-1)" "unprognostic (2.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-2)" "unprognostic (4.86e-2)" "unprognostic (1.64e-2)" "unprognostic (2.06e-2)" "unprognostic (1.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.32e-1)" "unprognostic (6.76e-3)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (5.64e-3)" "unprognostic (6.42e-2)" 20.3 12.3 13.0 23.5 15.0 14.0 16.1 16.7 14.8 14.7 16.0 11.2 14.5 9.9 18.3 15.2 13.2 17.5 12.3 13.8 13.0 8.3 12.5 15.8 18.5 23.5 19.8 12.6 15.8 11.0 24.0 24.6 13.4 16.9 13.8 12.6 8.6 16.2 16.1 18.4 15.2 19.4 16.9 20.6 25.7 13.2 34.5 18.1 26.3 31.6 10.8 24.0 18.8 16.3 8.0 5.5 16.9 5.0 5.3 6.5 2.3 9.1 12.3 14.2 15.3 18.3 22.3 8.5 12.2 13.7 9.9 9.3 12.9 10.5 15.6 6.0 22.7 24.4 18.8 14.2 10.5 10.9 14.8 6.1 16.3 13.8 11.2 17.2 25.0 19.9 15.6 16.6 16.9 15.1 12.2 15.9 11.1 18.9 12.6 11.4 13.2 15.4 9.6 15.2 15.5 9.6 14.7 20.6 10.4 11.0 12.0 8.9 13.6 20.1 8.9 11.1 19.7 12.3 12.9 18.1 20.8 9.0 13.9 11.6 7.7 13.0 24.2 9.5 10.0 11.1 7.7 4.9 4.8 6.1 4.5 6.5 6.2 4.6 4.6 3.6 8.0 5.0 4.3 16.9 5.3 5.0 5.5 3.4 2.3 13.0 15.0 16.7 14.8 13.0 8.3 19.8 12.6 16.9 18.1 56.6 43.7 27.4 25.9 26.9 29.3 49.2 20.4 54.9 56.9 19.2 27.5 11.5 3.3 17.7 5.9 43.4 27.4 0.0 12.7 8.9 28.8 33.6 55.6 30.4 24.7 63.5 13.9 58.3 69.1 10.9 28.4 39.3 11.8 16.2 27.3 24.6 20.3 19.8 33.9 18.0 28.0 12.9 22.7 47.4 38.0 29.4 7.9 39.9 17.1 38.1 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261958-41309497 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 270.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1600000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 20.1 3.4 4.6 2.4 7.5 0.3 73.2 10.8 5.6 58.4 6.1 15.2 8.0 3.0 35.6 19.3 9.7 25.9 15.5 43.9 7.8 2.5 30.6 1.5 1.8 0.9 4.5 6.7 12.5 1.5 0.6 0.7 9.9 24.1 12.8 7.8 19.3 73.2 27.1 1.9 20.8 5.4 21.4 2.8 5.0 11.0 11.1 13.7 0.0 3.3 18.4 5.1 10.9 41.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.3 0.1 5.7 0.3 1.2 10.9 57.4 16.6 15.8 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.8 4.4 23.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.0 21.4 1.6 1.6 270.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 17.1 0.0 0.0 0.0 1.3 0.0 35.3 0.0 0.3 1.5 0.4 0.0 3.3 23.2 0.0 0.1 0.1 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 10.8 5.6 7.8 2.5 4.5 6.7 24.1 13.7 0.0 0.0 0.0 104.7 10.0 1.5 175.8 0.0 0.0 1.2 59.3 2.0 0.7 68.0 3.1 4.8 6.7 0.0 0.0 0.0 55.3 47.0 19.9 0.0 0.0 1.7 1.6 0.0 15.4 0.0 13.0 535.6 1.4 94.5 0.0 0.0 51.5 0.1 0.0 122.4 3.5 1.5 0.0 4.1 1.6 20.6 4.8 0.7 0.0 0.0 8.5 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.7 11.9 12.0 19.4 19.2 36.0 2.1 14.3 29.0 12.2 18.6 7.4 22.5 3.5 20.4 25.3 25.5 2.5 18.1 6.4 16.7 0.6 9.8 0.3 11.7 8.0 15.0 1.1 0.0 29.1 8.9 18.0 23.5 33.3 8.6 0.0 0.0 28.4 14.2 11.8 0.0 0.0 9.2 2.2 9.4 5.4 14.9 7.5 23.8 3.7 7.6 6.1 0.0 15.9 18.2 14.6 5.5 0.1 0.0 38.8 13.0 3.6 22.1 14.7 18.3 4.3 14.4 0.0 21.8 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 65.5 26.6 5.2 18.8 4.4 16.7 15.1 17.8 22.7 43.3 19.2 3.9 75.6 5.0 31.9 1.1 15.0 0.0 0.0 3.9 20.1 52.5 6.3 2.3 7.2 5.5 19.1 1.2 44.8 4.8 1.9 69.9 2.3 49.0 0.0 0.0 27.8 2.8 0.0 54.8 14.7 28.3 84.1 46.2 9.1 3.4 3.4 69.2 0.9 0.0 2.0 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 187.5;Late spermatids: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 11.1 11.4 7.9 11.8 12.5 9.9 15.5 20.9 11.0 19.5 17.1 10.6 16.9 11.6 21.4 10.2 9.0 17.6 11.1 10.7 7.9 6.8 9.8 12.9 11.1 17.2 16.5 7.1 31.5 17.7 8.6 9.4 8.4 10.8 13.1 6.9 12.1 14.8 20.0 36.1 12.2 13.4 21.4 13.4 11.6 13.5 35.6 14.4 17.6 19.5 9.0 10.4 17.1 25.1 25.4 27.6 18.8 18.2 19.5 36.1 20.4 7.0 12.0 9.2 6.0 6.4 6.3 16.8 4.8 5.4 12.6 11.9 13.8 6.4 21.3 12.0 3.7 7.6 8.3 7.0 8.4 3.6 6.8 13.3 13.2 7.4 18.3 15.6 11.8 14.9 6.7 11.5 7.5 7.6 6.8 4.7 13.6 11.1 10.9 4.4 23.6 13.4 23.2 12.7 5.2 11.7 21.0 6.0 18.5 6.3 10.7 14.9 6.9 7.4 14.2 7.9 3.7 11.7 9.8 3.3 8.7 7.4 5.0 8.3 12.7 18.4 12.4 6.2 20.1 7.0 5.0 18.2 18.8 22.3 15.6 26.9 22.2 31.2 27.2 18.3 25.4 36.1 27.8 5.6 19.5 12.5 27.6 29.6 20.4 7.9 12.5 20.9 11.0 7.9 6.8 16.5 7.1 10.8 14.4 14.9 11.8 6.7 16.2 0.0 6.1 0.0 5.1 12.0 13.6 17.4 13.7 15.2 8.3 9.9 187.5 3.6 9.3 0.0 11.3 10.4 9.5 6.7 5.8 14.3 12.7 0.0 3.5 6.2 12.9 270.5 28.4 12.1 0.0 11.8 9.2 11.2 11.3 12.2 20.5 18.8 13.9 19.4 0.0 8.4 19.2 0.0 17.6 13.1 14.0 11.1 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.5 0.0 0.0 0.0 0.0 26.7 17.3 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 0.0 0.0 0.0 0.3 0.1 74.6 1.6 0.0 0.0 0.0 7.0 21.6 0.0 10.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 12.7 5.1 0.0 0.0 36.0 1.1 0.0 0.0 0.0 0.7 6.5 0.3 0.0 0.4 18.3 24.1 0.0 0.1 2.1 2.5 0.0 0.1 0.0 0.2 0.4 SH3RF3 "FLJ00204, POSH2, SH3MD4" ENSG00000172985 "SH3 domain containing ring finger 3" Q8TEJ3 2 109129348-109504632 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 9.0;Horizontal cells: 9.5;Ito cells: 9.2;Sertoli cells: 12.9;Smooth muscle cells: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 14.1;RPMI-8226: 13.4;TIME: 15.6;U-266/84: 18.2" "Low region specificity" "Detected in many" "HPA044822, HPA048444" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA044822: AB_2679103, HPA048444: AB_2680396" "unprognostic (1.97e-1)" "unprognostic (8.84e-3)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (2.55e-1)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.57e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-2)" 17.4 5.6 2.7 3.4 4.4 0.6 18.3 1.7 5.4 5.3 3.6 3.3 2.5 1.0 5.5 2.2 3.4 4.8 5.6 6.4 3.0 2.1 2.5 0.8 6.0 2.9 4.3 1.5 3.0 1.8 0.6 2.6 6.5 3.8 3.4 1.6 4.6 2.4 5.9 6.4 2.9 2.3 4.6 2.8 2.0 2.7 4.3 2.9 1.5 3.4 3.6 4.0 4.6 3.4 0.4 0.4 1.8 0.2 0.0 0.6 0.3 0.0 0.0 0.1 1.5 6.4 4.9 0.0 2.8 8.3 2.2 0.8 0.7 0.0 0.0 2.2 2.0 0.5 0.0 0.1 1.2 0.9 0.0 2.8 0.0 0.1 0.0 14.1 0.0 0.0 8.5 2.0 9.7 4.4 1.2 7.8 1.5 0.0 8.0 4.9 0.0 0.0 4.3 0.7 0.0 8.1 1.7 0.0 13.4 0.0 0.0 0.5 1.7 0.0 0.0 0.3 0.1 0.1 0.0 15.6 2.8 8.3 7.9 3.6 2.7 18.2 0.0 0.0 4.2 3.8 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.6 1.8 0.0 0.0 0.4 0.0 0.3 2.7 4.4 1.7 3.3 3.0 2.1 4.3 1.5 3.8 2.9 0.0 0.0 0.0 0.2 1.6 0.1 9.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 2.0 3.8 0.0 0.0 0.2 0.1 4.1 0.2 0.0 0.0 3.6 9.5 1.7 9.2 3.7 3.6 2.0 0.5 5.0 0.0 0.2 0.8 0.1 0.0 2.8 0.8 0.0 12.9 10.8 0.7 6.6 0.6 0.1 0.0 0.0 0.0 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46580554-46621626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 1.5 0.8 1.0 17.3 3.0 18.9 0.9 2.4 1.3 0.8 2.2 0.6 0.3 1.3 1.5 2.0 5.7 0.4 1.1 1.5 1.0 0.7 5.0 0.3 1.7 11.2 0.7 0.7 1.2 0.3 0.2 0.8 2.8 0.7 0.9 2.5 0.3 2.6 0.3 1.4 3.8 2.3 1.9 1.1 9.9 1.4 14.1 0.9 22.9 0.6 3.0 12.9 2.0 1.6 4.6 2.0 1.8 5.4 0.3 3.4 2.1 15.3 16.4 6.2 7.5 1.3 3.2 8.6 31.4 12.4 30.7 14.3 7.8 10.1 13.5 14.2 14.3 12.4 10.2 13.6 10.2 38.0 8.6 9.1 14.8 12.4 13.2 0.0 13.0 18.9 0.6 0.6 22.5 9.2 3.0 16.0 7.1 6.1 14.3 33.3 10.2 11.6 10.8 4.8 7.2 17.5 21.2 41.6 21.6 6.3 4.8 2.6 3.4 21.7 11.5 4.9 5.6 6.3 10.7 9.2 22.5 14.6 21.7 24.9 11.3 14.9 21.6 10.3 14.0 22.6 0.3 0.8 1.8 0.5 1.3 0.1 4.6 0.8 0.4 1.2 1.9 0.1 0.3 0.8 0.3 5.4 2.0 3.4 2.1 1.0 3.0 2.4 1.3 1.0 0.7 0.7 0.7 0.7 0.9 0.0 1.4 0.0 0.5 1.4 0.2 1.4 2.5 0.0 2.3 0.0 0.0 3.1 0.0 0.3 6.4 0.3 0.4 0.0 0.0 24.1 1.0 0.4 0.0 0.0 10.7 0.0 0.0 2.5 2.9 1.5 0.6 3.9 1.7 2.8 0.2 1.0 0.1 0.0 0.4 0.0 0.3 0.0 0.5 27.0 30.1 0.5 3.1 0.7 0.6 0.9 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.2 0.8 1.6 2.8 6.1 5.1 2.5 3.0 4.6 4.7 5.4 1.2 12.5 4.5 7.1 2.8 4.7 1.1 3.2 2.5 2.7 1.1 6.2 1.5 1.7 10.0 4.9 0.7 3.2 5.1 1.8 3.6 2.2 3.8 2.1 14.7 17.5 8.1 2.5 5.6 7.5 7.1 0.9 1.7 6.5 5.8 2.8 8.6 1.8 1.1 1.8 1.3 3.2 0.1 1.3 2.2 5.7 3.5 1.9 3.5 2.0 7.3 2.9 9.4 5.1 3.5 3.7 9.6 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 0.0 9.6 8.9 2.4 2.9 68.0 8.9 2.5 1.4 3.4 8.7 17.7 5.7 11.6 1.4 1.2 3.5 5.4 0.0 2.7 2.7 3.6 2.6 3.5 44.5 1.5 3.2 8.1 4.3 0.3 0.6 4.6 1.1 3.3 0.0 4.0 11.9 1.9 2.9 6.0 27.0 42.5 6.5 5.7 7.9 6.4 2.5 3.9 11.4 2.9 1.3 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7" "Cell line enhanced" "Detected in many" "ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 20.7 3.7 4.9 6.4 4.3 3.7 15.0 7.5 6.6 11.1 11.6 3.6 7.9 3.5 10.1 39.1 9.4 9.5 9.2 7.0 3.5 2.4 12.2 19.5 21.1 7.0 3.5 4.7 13.6 5.7 4.5 6.7 9.7 3.3 11.6 6.1 4.6 7.7 9.7 3.6 11.0 6.8 10.5 1.8 6.9 14.4 15.4 3.4 3.5 8.6 10.3 5.5 9.7 9.4 0.6 5.9 13.7 8.7 2.2 2.2 2.5 4.0 0.2 1.7 0.8 35.6 6.9 3.1 1.5 3.0 0.6 0.8 2.3 1.8 0.5 4.2 1.7 0.3 12.5 1.7 1.4 0.4 0.3 2.3 0.8 2.2 1.0 4.3 1.4 2.9 4.6 4.7 0.2 0.9 0.6 4.8 0.2 0.4 0.7 0.2 18.8 0.1 4.1 4.1 8.6 1.9 7.1 0.3 0.4 1.0 0.5 3.5 3.9 0.8 8.3 1.5 2.4 2.2 4.1 1.1 0.8 1.7 4.4 0.0 1.3 1.2 0.1 2.0 4.8 0.6 7.2 8.7 13.7 2.1 7.3 1.5 0.5 1.0 2.2 5.9 0.6 0.5 1.1 1.7 2.2 7.2 1.0 0.3 2.5 4.9 4.3 7.5 6.6 3.5 2.4 3.5 4.7 3.3 3.4 17.9 43.8 4.5 9.1 10.4 0.8 2.5 38.2 0.0 7.9 3.5 0.0 24.4 0.0 3.1 0.4 20.2 2.5 0.0 6.4 10.1 17.3 4.2 25.3 25.9 29.3 1.6 4.1 131.3 31.9 2.4 17.5 32.9 21.9 45.1 16.0 1.5 3.7 33.6 13.4 3.4 1.0 6.5 12.8 1.1 3.4 6.8 7.3 15.9 9.1 2.6 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306870 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.7" "Group enriched" "Detected in many" 8 "Horizontal cells: 158.9;Intestinal endocrine cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 35.7 8.3 7.6 2.5 6.4 0.8 6.5 4.2 9.7 2.0 2.5 2.0 0.3 4.5 2.4 5.3 1.3 4.2 1.8 1.7 9.4 15.7 3.4 3.8 1.2 1.8 12.2 5.4 3.2 13.0 0.5 1.6 0.8 7.0 3.0 2.0 11.5 1.1 1.0 2.1 1.4 5.4 2.0 3.1 1.1 7.1 1.3 1.1 0.3 4.3 0.3 0.7 2.3 0.5 1.3 1.1 4.3 1.1 4.3 1.3 0.3 0.0 10.6 6.3 24.5 0.3 0.1 1.2 0.9 0.0 0.8 0.4 6.0 0.2 0.0 1.2 0.9 4.1 0.1 2.4 0.2 0.2 0.0 1.3 0.1 0.3 8.7 1.9 0.1 1.5 0.8 8.2 0.1 0.4 1.5 0.7 2.2 1.7 0.1 0.6 5.2 0.9 0.4 8.0 0.7 0.6 4.0 1.0 0.9 1.6 0.2 4.2 35.6 0.6 2.2 0.4 5.7 2.7 2.8 0.3 8.8 12.3 0.8 0.2 0.5 0.0 0.0 1.1 0.3 3.9 2.0 1.1 0.6 0.8 0.5 1.3 0.7 0.5 0.7 0.4 1.3 0.7 0.9 4.3 4.3 0.5 1.1 0.3 0.3 7.6 6.4 4.2 9.7 9.4 15.7 12.2 5.4 7.0 1.1 3.0 0.3 0.0 0.2 0.1 1.8 2.3 0.0 1.4 0.0 0.0 15.7 0.2 0.0 4.3 0.0 0.0 1.3 0.0 0.2 0.2 1.1 2.2 0.0 0.6 0.4 158.9 98.9 0.0 0.0 0.4 0.3 0.0 0.0 0.0 2.2 4.4 1.9 0.0 0.4 0.0 1.3 0.0 0.9 0.3 6.0 0.3 0.2 0.0 0.6 0.0 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLFN13 FLJ31952 ENSG00000154760 "Schlafen family member 13" Q68D06 17 35435096-35448837 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 50.6" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 22.9;Ciliated cells: 81.7;Club cells: 18.2;T-cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 8.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;HL-60: 46.9;Karpas-707: 13.7;REH: 26.9;U-266/70: 23.7" "HPA022532, HPA023064" Uncertain Approved "Cytokinetic bridge" Yes No "Cytokinetic bridge" "HPA022532: AB_1856615, HPA023064: AB_1856616" "unprognostic (1.11e-1)" "prognostic favorable (3.82e-4)" "unprognostic (4.73e-2)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (5.74e-2)" "unprognostic (9.38e-3)" "unprognostic (1.32e-2)" "unprognostic (3.34e-1)" "unprognostic (3.55e-1)" "unprognostic (5.06e-3)" "unprognostic (2.33e-1)" "unprognostic (1.33e-1)" "unprognostic (3.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 3.0 1.0 1.1 6.4 1.7 11.8 4.8 0.5 1.0 5.2 6.5 2.6 4.8 4.0 5.6 6.0 6.5 12.4 6.1 1.8 1.3 0.7 5.1 1.7 5.2 4.8 0.9 0.5 2.7 2.0 14.3 3.2 1.2 2.0 2.4 3.1 0.9 50.6 2.0 1.4 1.5 5.7 1.8 1.5 11.3 5.7 1.5 1.1 24.8 12.7 5.4 12.9 2.0 2.0 1.4 0.4 6.5 0.5 8.1 1.9 0.5 0.0 2.5 5.1 0.0 0.1 0.5 0.0 0.6 0.1 2.5 4.0 0.0 0.0 0.0 14.7 0.4 0.1 4.3 0.5 1.8 2.8 1.4 0.8 13.4 2.2 0.0 0.2 46.9 0.4 0.1 0.2 1.3 0.0 0.0 0.8 0.1 0.0 13.7 0.0 0.0 0.3 10.2 2.5 0.0 0.0 26.9 0.1 1.3 4.3 12.4 0.0 0.0 0.0 2.3 0.1 0.3 3.6 7.5 0.1 0.0 0.7 3.8 0.2 23.7 3.2 0.0 0.0 7.5 0.3 5.0 0.4 6.5 1.9 0.5 1.5 1.4 0.9 1.0 0.4 1.3 0.8 0.6 1.4 8.1 0.2 0.1 0.7 0.5 1.1 1.7 0.5 1.0 1.3 0.7 0.9 0.5 2.0 1.1 0.0 3.0 2.2 3.1 0.9 0.0 0.6 22.9 81.7 18.2 5.2 0.0 0.4 1.7 1.1 0.1 0.7 0.5 0.0 0.3 0.2 0.8 1.0 3.5 0.4 1.3 0.0 2.9 3.1 0.6 0.0 0.9 1.6 0.0 1.8 2.7 0.2 1.1 0.0 0.4 0.8 0.1 0.0 0.6 0.2 0.1 1.0 0.0 15.7 3.9 1.0 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 96.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.3 14.2 16.0 14.8 3.4 5.0 15.0 17.0 8.1 15.3 12.9 12.3 14.3 35.2 8.3 8.7 13.2 31.2 23.1 11.0 20.7 22.3 9.7 21.2 22.7 7.9 0.9 12.8 21.4 3.2 2.3 20.7 8.4 5.2 10.8 22.7 17.0 29.0 13.8 8.9 33.3 6.6 13.8 14.9 11.2 22.3 45.9 13.2 6.5 6.7 15.1 11.7 20.3 9.5 5.0 7.0 19.1 8.7 8.6 18.6 19.6 25.7 21.2 10.6 35.7 20.6 12.1 18.8 22.5 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 23.8 11.0 20.1 9.5 24.3 34.1 38.9 7.6 10.7 14.8 15.7 7.9 30.9 29.9 16.5 27.3 15.5 6.5 0.0 17.9 78.9 14.2 5.9 21.9 6.8 37.8 27.0 4.7 19.6 12.1 20.4 17.3 20.0 6.8 27.1 11.4 14.5 14.2 7.0 11.7 13.3 18.4 12.9 17.5 56.4 96.0 20.3 21.6 14.9 24.7 6.7 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 508.7;Late spermatids: 1038.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" "Cell line enhanced" "Detected in some" "A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.7 12.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 3.9 0.0 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.1 0.3 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 4.5 2.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 3.0 1.9 0.8 3.2 0.1 0.0 0.0 30.6 44.2 6.8 33.2 0.0 0.0 116.0 27.9 508.7 0.1 26.2 0.0 14.7 2.6 0.2 1.8 0.0 5.4 0.6 0.0 189.1 0.0 0.0 1038.8 6.1 1.0 0.0 2.8 36.2 0.0 37.4 84.2 1.8 15.7 0.0 6.5 0.1 4.9 2.1 0.0 3.4 0.0 3.1 8.4 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "GAMG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA049393: AB_2680744" "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favorable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.6 0.1 6.7 8.0 4.4 0.0 4.0 5.3 4.5 2.1 0.2 0.7 0.4 2.4 4.9 11.2 1.2 1.0 5.7 0.8 1.4 1.8 4.2 1.1 0.1 4.2 0.0 6.9 2.8 2.8 4.5 0.9 4.5 5.7 4.5 0.8 0.2 4.1 0.0 0.4 0.2 2.4 0.0 5.6 0.0 1.4 0.1 6.0 3.2 0.4 2.0 3.9 0.2 5.8 0.7 0.3 0.1 9.7 7.3 5.4 6.4 1.1 0.6 1.2 0.0 3.9 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 0.0 0.0 0.0 0.1 0.1 19.5 4.3 5.1 0.0 0.0 3.5 5.9 0.0 0.0 0.4 8.3 0.6 0.0 0.0 0.5 0.0 0.8 0.9 0.0 0.0 0.2 28.6 8.1 1.8 0.0 3.2 1.4 0.0 0.0 0.0 0.9 2.9 1.7 0.0 3.9 1.3 19.9 6.5 1.0 0.6 0.1 0.1 0.0 0.0 1.3 0.0 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.6 26.5 14.7 17.1 5.3 6.3 7.2 9.9 6.4 22.2 18.8 35.6 11.4 37.0 11.8 8.1 11.9 12.0 26.9 18.2 17.1 13.3 20.9 21.4 37.0 35.6 5.6 39.1 25.5 8.0 6.5 19.7 5.5 4.8 11.9 22.4 32.0 8.8 12.6 55.2 20.5 16.3 17.6 20.8 13.0 33.1 15.7 44.2 11.7 8.2 16.2 10.5 22.3 29.0 4.8 15.1 18.7 19.1 9.3 9.8 12.3 12.6 15.8 9.2 21.7 57.4 5.2 21.0 15.0 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 11.9 11.0 47.7 21.4 16.6 18.1 96.8 15.3 44.2 9.1 31.4 3.9 47.2 132.6 34.7 1.7 16.8 21.9 23.3 44.3 49.4 26.3 35.5 4.6 52.5 99.3 11.1 42.3 11.6 18.6 4.5 19.8 52.0 59.1 138.9 29.1 45.5 30.9 42.9 28.0 74.2 12.0 6.5 32.0 32.0 47.5 19.2 21.9 20.1 45.1 16.3 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box 10" P56693 22 37970686-37987422 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.4;salivary gland: 98.4" "Cell type enriched" "Detected in some" 12 "Melanocytes: 33.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 704 "SK-MEL-30: 62.9;WM-115: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB003171: AB_2195374, HPA068898: AB_2686054" 3.3 4.0 21.0 3.7 33.1 1.6 18.7 3.2 32.8 3.2 8.1 64.4 0.5 2.9 1.8 2.8 2.8 1.9 3.4 3.9 26.9 15.2 1.7 1.7 1.6 1.6 41.3 13.7 2.4 2.2 1.7 0.7 1.6 24.7 2.3 3.9 22.8 98.4 7.1 1.8 15.8 3.8 3.2 46.6 1.8 2.4 3.1 42.5 0.0 1.7 0.0 1.6 2.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 33.1 3.2 24.6 26.9 15.2 41.3 13.7 24.7 42.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Group enriched" "Detected in some" 7 "A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 41.8 1.0 0.6 0.3 0.0 0.1 3.2 0.5 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 0.1 47.0 0.0 18.8 0.1 1.1 1.3 0.1 0.5 0.1 0.0 0.1 0.9 0.0 18.6 0.2 4.2 1.3 0.0 0.8 0.9 0.3 0.0 0.3 0.2 0.5 1.3 0.1 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 1.9 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.5 0.6 1.5 0.6 1.1 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 0.0 0.0 0.0 39.1 185.8 11.0 2.8 0.0 10.7 5.7 1.8 13.7 0.3 1.7 0.0 0.1 1.6 0.2 0.0 0.4 1.5 6.1 15.1 0.0 0.0 0.4 9.5 1.2 1.8 2.7 0.6 29.1 1.1 25.3 1.8 0.0 33.2 0.3 0.0 34.6 0.0 6.2 32.3 8.9 0.4 8.7 148.4 0.9 0.0 0.2 76.9 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 163.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Group enriched" "Detected in some" 35 "EFO-21: 42.0;RPTEC TERT1: 118.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 118.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.9 10.4 12.6 0.0 8.9 1.2 2.5 1.4 0.0 0.0 2.0 2.6 3.3 3.3 1.3 1.0 19.8 0.0 1.8 3.1 18.3 5.0 2.3 0.0 1.6 1.6 16.0 3.7 0.3 1.2 4.0 0.0 0.0 0.0 18.6 163.5 4.5 10.5 28.3 0.8 29.7 6.5 5.4 0.2 0.6 0.0 4.1 5.0 35.1 8.0 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Yes No Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favorable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 12.1 8.0 6.1 6.7 6.3 8.0 10.5 18.1 13.4 12.5 13.1 10.1 27.1 12.1 4.6 18.3 6.4 15.0 16.3 10.1 19.0 5.3 4.8 34.4 6.2 6.0 5.4 3.5 11.4 5.2 5.0 8.1 9.1 7.1 17.5 8.4 6.7 5.9 7.1 10.5 9.1 11.9 4.0 19.2 7.2 9.9 6.3 4.1 14.4 27.3 5.9 7.5 6.5 21.8 6.8 11.3 26.8 6.4 11.0 11.5 8.2 4.2 4.1 3.3 5.5 8.2 7.6 12.4 6.5 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 26.8 23.5 25.0 21.1 28.7 13.3 7.3 10.2 24.1 27.3 45.4 33.4 10.3 1.7 21.2 1.4 32.3 28.5 46.7 14.2 10.9 16.6 24.2 49.7 6.6 21.7 4.8 12.7 57.1 63.4 1.5 13.6 29.2 18.6 15.4 36.9 10.3 24.7 28.1 14.9 9.1 18.8 32.3 8.6 6.7 16.0 25.5 5.5 22.7 27.5 47.7 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519098 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 16.7;Peritubular cells: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" Yes NA 44000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 10.7 2.1 3.3 4.9 1.8 0.1 8.1 3.5 1.9 33.0 18.4 1.6 6.3 2.1 33.1 15.2 9.8 11.0 30.9 10.6 1.4 0.6 2.5 1.8 5.8 1.2 1.2 1.6 17.0 1.8 0.3 13.4 2.5 3.0 6.8 3.2 4.7 1.9 15.7 4.7 3.8 5.8 23.8 3.2 7.3 6.9 5.7 1.4 0.5 2.4 4.2 1.6 19.3 10.9 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.2 18.9 0.0 17.8 4.0 2.5 3.0 0.2 0.0 0.7 0.2 18.0 0.8 0.0 0.0 0.0 1.3 0.0 0.1 3.1 0.8 0.0 3.7 0.1 5.6 8.9 0.0 3.3 0.0 17.6 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.4 0.6 0.0 0.1 0.4 0.9 0.1 2.0 0.0 1.9 0.2 0.2 0.0 0.3 0.3 0.2 0.7 7.2 0.8 1.0 0.7 2.8 0.2 0.0 0.1 19.3 0.2 3.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 1.8 3.5 1.9 1.4 0.6 1.2 1.6 3.0 1.4 3.0 1.1 0.0 0.2 1.6 5.4 1.8 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.1 0.4 1.5 1.6 0.0 0.0 0.1 6.0 0.3 0.0 0.0 1.2 3.2 0.0 3.7 0.0 0.4 16.7 1.1 1.7 1.0 0.6 3.2 0.1 0.0 14.9 0.0 1.9 0.0 5.7 0.7 1.1 1.6 0.0 0.0 1.7 0.1 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 549.3;Urothelial cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.4 5.5 5.0 3.4 6.3 8.3 2.1 15.9 17.3 8.7 8.9 4.8 3.2 7.1 25.1 13.3 17.8 9.1 3.8 21.2 12.2 17.5 4.3 6.3 4.1 5.9 4.7 10.8 4.2 6.8 25.0 11.5 10.6 34.5 16.3 7.7 7.4 24.4 10.0 2.0 17.6 5.0 7.7 2.6 18.1 6.1 3.2 14.0 15.2 3.3 2.7 6.1 7.2 3.3 4.6 10.7 3.8 5.5 16.3 19.0 7.2 11.2 17.8 14.8 7.3 10.2 19.3 9.6 30.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 113.2 27.8 121.1 549.3 161.6 3.0 25.4 5.1 52.2 81.9 19.2 9.8 44.4 28.2 110.3 36.3 19.4 29.1 0.0 82.8 19.7 31.9 134.1 39.1 7.7 15.8 0.0 6.9 16.5 16.2 8.8 5.5 19.9 33.7 55.1 27.8 8.1 75.9 56.1 2.5 9.7 25.2 6.5 55.6 45.1 29.6 118.9 55.8 186.8 10.0 279.4 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 41.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.1 3.2 0.4 0.0 1.5 1.4 21.0 0.3 1.1 0.1 0.1 8.4 8.3 12.5 5.7 2.0 6.5 10.4 23.4 14.7 0.0 10.8 19.1 18.0 7.9 7.9 1.4 37.6 1.5 2.0 8.8 0.0 9.9 4.4 4.1 17.2 8.0 11.8 3.5 8.1 38.7 35.0 18.8 6.2 1.2 28.0 11.6 16.1 9.5 14.8 7.8 8.6 5.5 5.0 0.2 17.0 6.4 9.9 0.1 3.8 4.0 11.4 13.5 9.1 14.2 13.9 3.4 41.0 1.9 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 20.8 14.1 8.6 27.8 0.0 0.0 1.1 5.1 12.0 14.8 10.4 0.0 44.8 3.3 4.4 0.4 0.4 0.9 0.0 6.3 28.5 4.9 17.5 10.5 3.0 10.7 0.0 1.2 0.6 10.1 0.0 3.1 7.2 0.0 9.0 6.4 0.0 8.6 3.5 2.1 1.2 0.0 6.5 2.9 1.1 2.3 0.0 49.4 17.5 6.3 15.3 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 64.4 19.5 8.5 39.3 42.0 29.1 13.2 21.1 29.6 17.8 22.2 10.6 52.4 10.1 18.3 30.2 17.3 32.8 5.1 24.4 11.9 16.5 8.2 6.5 12.8 9.9 27.2 15.9 20.8 23.0 24.0 16.0 27.9 36.2 26.2 18.7 20.6 45.4 28.6 14.2 13.5 18.7 11.6 50.2 9.9 10.9 8.7 65.0 24.3 7.1 10.0 12.2 26.5 56.1 25.9 19.9 56.3 26.5 21.6 16.5 23.6 40.4 18.1 30.9 23.5 15.1 27.1 30.1 52.6 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 53.6 29.1 34.1 31.9 30.0 26.4 8.5 76.5 34.8 25.0 85.5 13.7 39.0 16.6 71.5 2.7 41.8 53.0 23.3 48.6 78.8 43.6 38.3 53.1 70.4 61.1 41.3 57.0 43.0 64.9 5.8 64.5 46.7 50.6 84.8 54.5 25.7 53.3 63.1 44.6 36.9 12.1 51.8 39.4 16.8 23.6 36.6 39.0 50.0 78.0 31.5 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328774-133336398 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA023608: AB_1857671, HPA074622: AB_2686703" "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favorable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 14.8 16.8 19.9 15.0 22.7 16.2 15.7 16.4 25.8 13.9 16.2 14.0 11.9 21.7 18.6 10.9 17.4 18.5 15.9 13.9 19.1 17.9 14.5 16.2 12.6 17.6 19.6 22.9 27.4 23.1 16.5 11.8 12.5 24.6 15.8 13.1 11.6 18.3 19.5 47.3 17.8 22.3 18.0 23.6 18.8 13.6 16.5 19.8 8.6 14.4 11.1 13.5 15.3 19.1 7.7 8.9 3.9 4.7 4.6 8.5 3.6 4.1 6.4 5.0 7.4 3.1 2.9 8.3 6.5 3.9 5.8 3.7 10.1 7.1 11.9 5.1 3.6 4.3 12.5 6.4 6.9 2.2 7.9 7.2 8.2 7.4 6.0 5.6 13.8 7.1 4.1 6.1 6.1 5.7 5.3 3.0 11.7 17.8 6.5 5.2 10.7 11.2 11.4 14.5 16.8 11.7 11.8 6.9 12.1 5.1 4.0 10.5 8.9 6.4 10.5 5.7 3.2 9.2 7.8 6.2 13.4 7.1 6.7 8.9 4.8 6.8 15.5 5.0 9.5 7.8 3.9 4.7 1.9 6.8 4.4 7.0 7.1 6.2 6.1 4.9 7.7 8.5 7.0 1.3 4.6 3.7 8.9 5.0 3.6 19.9 22.7 16.4 25.8 19.1 17.9 19.6 22.9 24.6 19.8 41.7 23.5 25.1 10.6 21.1 24.6 26.3 30.6 17.4 35.2 21.0 5.9 26.9 18.3 29.0 1.1 20.3 37.7 0.0 16.8 19.1 14.3 11.8 24.3 29.2 18.5 20.6 32.3 12.9 11.1 2.4 25.6 14.2 6.8 21.6 37.2 16.4 23.6 28.1 26.2 11.9 20.1 0.0 17.0 18.9 21.0 24.1 15.9 16.6 47.0 10.5 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.3 12.7 12.0 13.7 6.9 8.9 12.3 14.0 12.4 17.2 20.8 9.6 8.1 31.3 10.8 8.7 14.7 12.7 17.8 8.0 28.0 11.0 17.3 21.7 10.8 6.9 8.2 34.1 22.3 6.2 9.1 17.1 13.2 10.4 10.5 15.0 20.9 43.6 14.7 5.0 40.5 19.8 6.8 10.1 7.8 24.2 30.8 25.4 10.1 14.0 15.4 12.0 22.5 7.3 13.5 8.7 21.1 28.5 7.7 13.7 12.5 16.3 21.5 23.8 29.6 38.8 10.0 21.1 12.3 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 38.7 37.9 23.1 41.1 52.0 74.2 24.8 35.7 28.1 37.5 33.2 102.1 49.4 14.9 23.6 8.9 34.9 15.6 23.3 19.1 45.9 33.8 46.2 15.1 37.5 27.9 58.8 28.3 38.6 41.9 10.7 24.7 37.6 23.6 86.6 31.9 41.7 22.6 10.5 24.1 24.5 76.3 12.9 32.5 100.7 141.1 62.7 58.1 39.9 33.0 48.2 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 164.4;Spermatogonia: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.2 4.9 32.3 11.6 13.1 20.9 15.7 8.8 7.3 12.0 12.4 9.0 8.2 11.1 9.7 11.8 9.4 7.1 5.7 9.4 16.2 19.7 9.8 22.3 4.9 17.9 10.6 16.7 14.6 13.1 15.1 6.7 6.9 13.0 12.1 22.4 17.3 6.0 15.3 4.8 16.7 20.0 17.7 9.8 6.0 12.2 24.6 7.8 12.7 11.2 19.3 17.3 10.5 6.1 12.6 35.9 4.8 47.3 9.2 10.6 12.0 8.5 14.2 5.8 7.1 8.0 6.8 11.4 10.0 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 8.9 4.6 32.1 27.2 0.0 5.5 0.0 28.1 13.4 17.0 19.2 2.0 47.5 46.4 41.3 113.1 20.3 12.5 93.5 21.4 53.4 17.5 19.3 10.5 31.8 64.1 6.4 17.5 31.3 40.5 49.2 39.7 28.7 0.0 64.1 23.7 13.2 34.6 28.5 50.5 34.8 13.5 58.2 0.0 164.4 149.9 0.0 51.5 20.0 30.2 25.4 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.4 21.2 32.5 18.6 1.7 3.6 18.3 28.9 15.5 33.2 22.0 23.5 30.8 32.5 12.3 15.7 38.6 17.2 34.3 21.0 33.8 14.3 18.6 27.5 17.6 21.6 1.6 37.2 23.4 1.5 1.4 20.9 12.1 7.3 25.2 26.8 24.8 25.7 31.4 20.8 49.0 53.3 35.1 21.8 27.9 34.8 23.0 13.0 18.8 38.6 25.3 15.9 17.4 11.0 8.1 25.5 21.6 21.6 14.7 19.4 23.2 17.5 43.5 18.0 23.9 52.1 11.2 36.0 27.4 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 0.0 7.9 16.0 0.5 1.9 1.0 2.2 0.0 0.0 4.5 8.7 7.9 3.3 0.0 2.1 43.8 2.5 2.0 23.3 0.6 16.5 2.6 1.0 4.7 4.3 35.7 4.8 1.2 4.9 20.5 49.1 2.6 21.9 0.0 12.6 3.1 1.4 1.9 3.5 2.5 1.8 3.2 6.5 1.0 69.6 47.8 1.3 3.3 15.3 5.7 1.3 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 13.9 10.6 12.5 19.9 18.4 14.2 12.9 17.3 20.1 15.1 14.7 4.3 17.3 16.8 15.2 9.7 16.0 11.5 18.1 11.1 12.0 7.6 13.6 18.7 15.8 19.0 14.4 13.6 20.9 30.5 9.3 24.3 18.5 13.6 16.4 13.4 3.9 12.3 11.4 31.5 14.5 17.8 18.1 22.1 18.4 13.0 8.0 13.6 13.1 13.2 12.9 12.2 28.1 17.1 24.1 14.3 22.3 9.2 9.0 16.3 2.7 3.9 3.1 4.2 4.2 4.1 16.2 7.6 4.4 3.3 5.7 4.1 10.6 10.7 9.5 8.5 4.3 1.9 11.7 4.9 6.9 6.3 2.6 2.0 9.7 17.5 6.3 4.1 8.8 5.2 4.5 7.5 4.5 7.4 9.0 7.1 5.0 6.6 18.8 7.8 1.2 7.4 17.0 3.2 2.9 2.4 3.5 4.7 8.1 6.5 6.3 3.0 6.3 2.6 9.6 3.0 6.1 11.9 2.2 6.9 8.6 5.7 12.9 6.5 8.4 9.5 8.0 3.1 9.4 2.9 17.4 9.2 14.8 10.0 6.5 10.0 19.5 13.8 10.9 6.2 24.1 16.3 13.6 22.3 9.0 5.2 14.3 9.4 2.7 12.5 18.4 17.3 20.1 12.0 7.6 14.4 13.6 13.6 13.6 83.4 80.4 125.3 241.5 216.9 84.2 23.0 129.9 91.0 139.9 27.9 37.3 149.3 38.1 80.3 12.9 79.2 61.0 0.0 125.2 151.7 105.8 205.9 100.6 46.5 62.1 65.2 105.6 52.2 91.2 12.3 119.0 105.3 75.9 66.7 101.9 39.6 109.2 66.6 63.6 64.8 75.6 71.1 94.7 37.0 70.9 177.4 134.6 106.5 115.9 265.8 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0" "Region enriched" "Detected in some" 5 "midbrain: 17.1" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 9.1 2.7 7.0 1.8 5.7 33.1 7.1 1.6 6.9 3.3 2.4 12.0 2.3 1.6 3.7 3.3 2.5 4.1 4.2 3.9 8.8 3.5 4.5 2.4 14.6 2.2 11.1 4.4 1.5 1.3 2.2 2.1 9.8 7.3 2.4 2.4 2.1 1.4 3.0 3.1 2.0 3.3 4.4 9.4 8.5 2.1 1.8 9.2 0.0 6.7 4.1 1.5 2.5 5.5 0.3 0.1 3.2 0.3 0.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 11.0 21.1 16.5 0.0 0.0 0.0 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 1.2 0.4 0.1 0.1 0.1 2.2 7.0 5.7 1.6 6.9 8.8 3.5 11.1 4.4 7.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 1.7 2.5 0.0 2.3 1.8 0.0 0.1 0.0 0.0 4.8 18.0 0.0 93.5 0.0 0.1 0.9 0.0 35.8 0.0 7.9 0.0 0.0 30.7 2.1 10.2 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.9 0.0 0.0 0.0 0.0 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 64.3" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.5 11.5 13.0 14.5 10.8 9.1 7.9 8.5 9.3 8.0 6.8 11.9 22.1 17.0 5.0 10.1 20.3 7.7 21.8 19.5 9.8 4.7 7.1 28.5 7.6 12.4 7.5 12.8 64.3 7.0 27.7 7.5 12.4 10.2 7.5 16.2 26.9 6.1 9.6 6.9 19.7 13.0 17.6 12.7 13.0 24.8 17.1 18.4 11.9 7.5 19.9 14.2 7.0 7.7 26.1 10.6 10.6 12.3 7.4 8.8 6.7 7.7 12.5 11.8 27.4 17.5 8.3 16.6 8.4 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 6.0 15.3 5.2 6.6 8.0 8.4 3.4 10.2 5.3 11.4 14.0 13.7 10.5 16.6 9.8 45.7 4.7 10.4 0.0 8.7 6.1 5.1 11.2 7.0 21.7 20.9 23.8 6.3 7.4 37.2 22.1 6.6 13.2 18.6 6.4 15.6 10.6 9.0 14.0 8.1 19.2 6.3 0.0 5.2 15.8 18.9 10.5 13.7 15.0 16.6 9.1 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 184.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.1 18.6 20.4 19.7 10.7 7.1 24.4 5.1 9.9 3.5 4.3 12.3 21.6 0.0 5.7 9.5 4.8 5.1 6.9 8.8 4.5 0.8 6.4 5.0 12.4 11.3 11.4 1.9 1.8 12.6 3.2 5.5 9.4 15.1 5.9 4.2 5.2 0.3 4.1 13.9 3.2 1.2 14.6 8.0 10.7 9.0 15.0 3.2 7.7 9.9 0.4 6.3 7.7 7.6 8.1 16.5 4.9 1.1 13.7 3.3 9.6 8.5 10.4 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 20.8 21.6 4.7 23.8 37.8 2.4 10.6 35.7 20.1 34.2 38.4 5.9 36.9 10.0 28.5 5.5 37.0 121.0 0.0 38.6 184.2 40.4 33.1 0.0 57.7 15.1 4.8 19.0 55.3 68.7 2.7 54.7 21.0 30.4 1.0 68.2 36.6 41.7 91.2 45.6 13.4 5.7 90.5 44.3 3.0 23.4 34.8 23.8 4.3 42.7 42.0 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629302-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 53.9;skin 1: 32.5" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1" "Region enriched" "Detected in single" 13 "olfactory region: 2.9" "Low region specificity" "Detected in many" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 0.7 0.2 0.4 0.0 16.1 0.4 0.9 17.3 2.4 0.2 7.7 0.0 3.7 3.4 19.6 1.6 2.0 0.4 1.4 0.2 0.7 0.1 2.8 0.0 0.2 0.5 0.3 1.6 0.0 0.6 53.9 0.4 5.7 0.7 1.9 19.7 7.9 1.0 32.5 0.3 0.6 0.4 0.1 0.3 0.7 0.2 0.3 4.2 21.0 10.1 2.1 11.1 0.1 0.2 0.8 0.1 0.2 0.2 0.0 2.9 3.7 0.0 0.0 0.0 0.0 45.8 4.7 8.6 6.0 1.1 0.7 0.0 0.0 0.3 3.1 3.2 10.0 6.4 1.3 4.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 5.1 1.7 1.7 0.0 0.0 1.9 0.0 0.7 0.0 38.8 4.7 0.2 2.2 2.3 4.9 0.0 0.0 1.6 0.0 2.3 1.2 0.0 3.1 73.8 4.8 7.1 20.6 1.0 0.0 3.9 0.1 2.0 3.5 0.0 0.0 0.0 0.9 0.0 27.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.1 0.0 0.7 0.4 0.4 0.9 1.4 0.2 0.2 0.5 0.4 0.2 0.0 7.4 0.0 26.2 117.7 0.4 0.9 0.0 5.3 4.5 8.7 0.0 77.5 0.0 0.2 0.2 1.0 0.0 0.0 0.0 49.1 11.3 18.8 0.0 0.0 6.8 0.0 2.9 1.3 0.3 0.0 0.0 0.9 20.3 0.0 1.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.5 130.6 88.3 0.0 1.7 12.8 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.4 0.2 2.7 2.7 0.0 0.0 1.9 9.4 0.0 0.0 0.0 0.0 0.3 0.0 10.8 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.3 1.2 26.7 19.3 8.3 0.0 1.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 6.0 20.8 0.0 45.7 1.4 0.0 2.2 25.5 0.0 12.5 75.0 0.0 23.2 26.6 2.2 0.1 0.1 75.7 0.0 1.3 1.2 0.6 33.2 0.0 0.2 4.3 0.0 9.8 0.0 5.4 0.0 0.3 2.1 6.8 0.0 37.4 0.4 4.7 34.0 0.0 23.2 0.0 0.0 0.1 0.0 0.2 2.9 16.9 0.0 34.7 33.5 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 731.6;Late spermatids: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 9.0 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.2 9.6 4.2 4.3 5.6 5.4 4.8 3.5 42.8 10.1 1.2 8.8 4.8 80.4 3.1 9.9 3.3 4.0 42.9 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.6 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.6 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 29.8 20.4 15.7 43.3 22.2 30.3 70.0 38.2 54.9 33.0 45.4 31.4 191.4 79.6 29.5 731.6 22.4 31.6 116.8 23.1 95.8 33.4 41.8 31.3 35.9 24.4 35.0 37.2 20.9 9.2 294.5 71.4 15.0 5.0 17.2 32.3 24.6 24.5 32.3 70.7 74.6 34.6 25.8 21.4 52.6 55.1 17.6 83.0 35.5 42.3 22.7 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 6.9 7.1 6.3 8.2 7.4 13.3 9.3 21.1 7.9 8.5 6.0 5.0 4.5 7.7 12.0 6.8 9.2 4.3 5.1 8.7 6.0 6.8 7.9 7.3 5.8 9.4 7.1 5.0 10.8 5.9 5.4 19.7 4.3 6.7 6.9 5.1 6.4 6.0 6.4 14.5 5.8 6.5 6.4 5.5 6.6 6.7 3.8 6.4 13.5 7.8 5.1 9.3 6.0 9.6 6.1 9.9 0.3 4.5 8.6 5.2 3.1 9.2 6.0 2.1 8.9 2.9 4.7 4.7 3.9 4.3 4.3 4.7 7.5 6.9 11.9 4.3 2.8 9.9 3.3 11.5 6.7 5.0 14.6 13.8 8.7 4.2 7.3 6.5 10.2 5.4 4.9 4.3 4.1 1.6 4.6 6.4 2.7 9.4 4.1 8.3 3.1 8.8 8.6 0.2 16.9 4.2 6.7 7.8 7.0 4.6 5.5 9.0 6.6 3.3 8.4 5.9 0.7 3.7 5.7 3.9 7.2 6.2 3.2 8.1 6.6 7.6 12.5 4.2 16.3 5.5 0.0 4.5 0.2 3.3 3.2 3.9 6.1 5.2 3.4 5.5 4.7 4.8 4.2 0.3 8.6 2.1 9.9 4.2 3.1 6.3 7.4 21.1 7.9 6.0 6.8 7.1 5.0 6.7 6.4 23.8 19.4 14.8 22.9 12.7 22.1 20.6 7.6 13.4 25.0 14.0 17.7 10.0 16.6 15.0 1.9 11.7 7.3 0.0 12.0 11.4 8.6 13.8 6.9 7.6 9.5 6.4 9.2 9.8 12.4 2.8 25.9 10.6 5.0 7.2 8.4 11.5 13.2 13.3 24.1 11.5 18.3 6.5 12.2 8.9 16.9 11.8 5.7 10.2 11.8 22.1 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232547968-232550592 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 3.9 5.9 13.3 9.2 15.3 19.4 8.9 10.1 11.7 5.4 5.1 10.7 2.0 5.9 8.5 10.1 5.6 7.4 6.9 4.9 13.8 8.2 10.1 5.0 6.9 12.5 9.1 8.0 13.2 5.8 6.3 21.2 6.5 8.6 8.3 6.7 8.3 7.3 7.9 7.5 13.6 6.8 4.3 8.8 11.1 8.1 9.7 10.8 14.2 9.6 4.8 10.6 5.5 5.9 7.1 3.8 7.0 4.8 4.5 9.8 1.9 6.9 5.2 11.3 16.7 4.2 5.5 8.5 5.0 2.8 6.1 7.0 6.6 7.9 11.5 3.8 3.7 6.5 6.6 9.3 2.9 9.5 7.0 8.1 10.3 15.3 7.5 2.6 8.6 6.9 6.1 2.7 6.4 4.0 6.4 3.8 14.3 8.1 12.2 5.3 10.5 10.5 17.3 6.7 4.1 6.3 9.7 10.2 5.2 3.6 8.3 13.5 13.5 5.5 4.8 5.2 8.7 7.2 8.4 6.5 10.2 10.5 6.5 5.1 10.9 7.6 10.8 5.9 8.6 6.4 4.0 4.8 5.3 6.7 4.3 6.1 4.9 6.5 4.3 3.4 7.1 9.8 7.7 7.0 4.5 4.8 3.8 4.5 1.9 13.3 15.3 10.1 11.7 13.8 8.2 9.1 8.0 8.6 10.8 8.9 3.8 2.7 3.6 1.1 4.9 1.2 2.5 0.0 2.3 3.5 7.9 1.8 0.0 1.9 1.3 1.6 2.1 0.0 1.3 1.0 1.9 2.0 0.0 0.6 1.3 6.4 1.2 1.3 1.5 0.0 4.4 2.7 1.7 2.8 1.9 8.2 1.4 3.2 1.8 0.6 6.2 6.5 0.8 2.8 6.1 1.8 1.1 3.5 3.3 2.4 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.5 21.3 11.4 20.6 32.9 24.5 14.0 11.3 18.8 13.5 15.1 11.4 24.4 14.0 15.7 15.4 22.7 20.2 17.7 14.6 10.7 13.3 39.0 20.9 18.5 19.3 21.7 16.2 25.0 20.3 29.6 8.1 16.9 18.9 18.5 18.2 17.1 21.2 21.2 17.3 11.8 17.2 17.6 38.9 7.2 14.5 14.5 21.7 27.2 22.6 15.4 14.1 15.6 16.6 22.5 20.5 15.7 21.5 14.7 14.3 14.7 9.5 12.4 20.1 29.7 15.1 12.1 20.4 11.7 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 23.8 33.2 37.0 49.5 58.8 44.9 33.5 22.9 16.0 28.4 40.1 31.4 64.8 16.6 54.9 5.7 52.5 22.0 0.0 37.4 54.4 51.9 46.9 24.3 51.6 29.9 65.2 25.9 53.4 45.9 8.8 68.1 37.2 25.3 39.7 23.1 57.0 28.6 23.2 59.1 32.7 43.7 71.1 42.7 85.4 85.7 48.4 76.1 47.2 25.4 34.6 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 65.2 47.4 76.9 55.0 63.8 62.3 53.0 54.0 42.6 51.8 51.5 38.5 47.3 42.7 38.6 46.9 67.6 25.6 67.0 60.9 57.9 52.5 57.1 80.5 102.1 98.1 49.7 91.3 54.0 57.0 65.5 48.9 47.7 50.8 65.3 76.4 43.0 45.7 73.8 67.6 106.2 124.3 102.5 71.0 76.5 30.4 48.2 72.3 89.0 88.5 25.3 64.3 60.8 44.5 81.2 74.5 42.9 135.7 48.8 44.0 79.1 67.9 105.3 76.3 112.4 102.9 56.4 88.3 45.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 223.4 369.4 511.1 446.0 636.3 196.3 594.9 570.7 348.0 349.2 854.9 100.1 706.5 1455.6 502.0 547.1 428.3 899.7 443.9 893.2 693.8 535.7 516.2 437.2 865.9 741.4 112.8 610.5 535.9 636.7 794.0 598.9 617.4 737.2 776.3 895.2 244.7 727.5 821.9 436.7 886.4 223.1 349.3 415.1 507.5 743.5 785.4 368.1 657.2 795.4 485.3 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.6 10.0 15.5 7.1 9.4 14.2 3.1 7.4 7.0 6.5 8.6 1.2 18.2 8.7 9.5 7.4 4.6 22.1 6.3 14.5 10.3 10.7 7.4 4.7 17.4 3.4 3.8 1.8 5.2 6.9 9.2 17.1 8.3 13.7 10.8 10.8 4.0 17.1 15.3 9.4 4.3 5.0 1.6 3.9 4.6 7.9 4.2 12.5 12.0 2.4 4.5 7.1 8.6 1.8 6.3 3.7 5.4 6.4 6.8 3.3 6.3 5.2 3.9 6.7 3.7 3.4 19.0 7.1 5.3 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 8.9 9.8 33.9 18.2 17.1 17.7 6.2 40.8 171.3 25.0 31.4 43.2 15.0 11.6 14.4 7.1 20.4 10.3 0.0 9.6 17.4 16.6 14.7 34.8 17.8 39.4 11.1 8.7 23.9 38.4 6.3 11.8 29.7 32.1 21.6 12.1 32.1 11.5 14.4 14.2 15.3 60.3 0.0 11.3 47.4 49.2 25.0 11.1 34.5 15.3 9.7 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 TMEM8A "M83, PGAP6, TMEM6, TMEM8" ENSG00000129925 "Transmembrane protein 8A" Q9HCN3 16 370773-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 67.7;Syncytiotrophoblasts: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA051281: AB_2681418, HPA064673: AB_2685317" "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 8.4 9.3 6.9 9.5 7.8 15.2 13.5 7.7 7.9 6.8 16.6 7.3 24.1 17.7 7.3 29.6 11.8 6.5 15.2 10.0 5.6 4.3 28.7 33.5 13.0 10.7 7.1 3.2 8.3 44.2 11.5 10.7 45.5 6.7 11.4 6.0 8.8 22.5 8.8 12.8 3.7 25.0 5.0 4.7 13.2 17.5 26.3 6.0 12.6 12.3 5.2 14.6 9.3 8.8 2.0 2.9 24.3 5.5 0.9 7.6 3.3 4.4 11.8 6.8 12.5 9.3 8.4 13.6 12.9 13.5 6.6 9.5 46.4 21.1 4.8 17.5 12.4 10.1 6.4 3.0 14.2 1.8 13.6 11.3 7.9 8.0 26.4 21.6 5.9 15.0 9.7 4.3 10.1 2.9 6.7 15.2 5.4 12.6 7.4 8.2 27.8 8.3 11.7 10.8 7.2 4.7 18.1 7.8 10.9 10.7 11.5 8.1 9.3 7.2 7.3 37.9 3.7 13.1 11.9 22.1 18.8 20.3 13.0 6.8 14.9 7.4 9.5 9.5 6.3 11.9 4.6 5.0 6.3 7.4 5.5 5.9 1.8 5.8 5.8 2.5 2.0 7.6 5.5 24.3 0.9 3.8 2.9 4.3 3.3 6.9 7.8 7.7 7.9 5.6 4.3 7.1 3.2 6.7 6.0 14.9 12.5 10.7 3.2 2.6 5.7 12.5 10.2 1.4 1.2 22.7 9.8 46.7 5.0 27.5 15.5 8.7 67.7 23.3 36.8 5.9 6.6 11.5 1.1 25.5 24.7 17.5 26.6 14.7 14.5 58.4 2.6 10.1 6.8 8.2 26.1 8.2 42.6 38.6 1.8 9.9 7.8 12.9 6.1 1.1 2.5 2.8 83.8 7.5 18.9 6.8 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.3 1.7 1.0 1.6 1.2 1.0 25.5 0.6 0.9 1.5 0.9 2.5 3.5 0.7 1.1 1.6 0.8 1.4 1.6 1.4 2.5 3.8 0.6 3.1 1.7 1.9 0.8 2.6 4.5 1.1 1.2 1.9 1.3 0.7 1.8 1.6 2.3 2.7 1.1 1.2 1.1 1.2 1.0 0.3 1.0 1.3 0.5 1.7 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 1.3 3.8 2.5 2.3 2.9 1.2 2.4 2.2 1.4 0.4 2.9 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 0.0 2.2 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 1.3 0.0 0.7 1.2 0.3 0.2 0.0 0.2 0.8 1.6 0.0 0.6 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.4 0.9 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.1 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 21.7 19.8 37.1 16.0 35.7 17.8 13.5 33.1 44.7 17.9 13.9 23.2 12.7 13.4 20.7 20.9 22.9 22.4 15.9 20.0 31.1 24.9 14.3 10.1 13.7 16.6 24.8 36.6 32.9 16.0 26.6 19.1 16.1 22.2 16.8 15.9 18.2 15.1 20.0 15.2 36.6 12.5 23.3 25.2 15.3 12.9 24.1 20.9 14.9 17.8 9.9 17.8 18.9 14.7 1.6 4.3 2.6 1.2 0.4 3.3 0.7 17.6 13.5 20.8 26.5 12.7 16.8 13.5 20.4 13.5 29.6 20.9 18.4 9.6 12.0 16.0 17.2 8.3 23.6 36.8 20.2 16.5 14.8 29.5 18.5 21.2 22.3 14.3 32.6 17.8 14.9 16.0 19.6 20.9 19.2 13.8 24.4 28.7 11.5 16.3 30.6 27.3 22.5 24.1 13.1 40.8 26.3 16.2 22.0 17.5 12.9 51.0 25.3 16.6 21.1 10.1 14.7 14.7 11.6 13.8 45.5 12.0 24.3 29.9 22.9 22.0 20.5 13.5 29.7 16.1 0.6 0.9 0.3 2.1 0.8 3.0 1.5 1.5 1.7 1.2 1.6 2.7 3.3 2.6 0.4 1.2 4.3 0.5 0.7 37.1 35.7 33.1 42.1 31.1 24.9 24.8 36.6 22.2 20.9 6.0 19.9 11.8 8.5 27.5 38.9 15.9 17.8 6.7 9.1 21.0 94.2 9.1 5.0 8.3 9.5 17.5 10.5 0.0 7.3 5.6 14.7 12.6 3.5 15.3 8.9 54.0 22.0 18.4 11.3 15.4 28.7 9.5 8.5 10.8 17.0 24.7 13.1 5.8 30.4 14.6 32.2 6.5 17.8 24.7 10.0 36.3 12.1 11.5 15.0 8.0 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 34.3 45.6 58.1 26.6 2.9 5.9 12.9 47.1 25.4 43.4 38.5 21.4 26.3 55.4 24.0 15.9 26.0 54.7 44.6 18.8 58.3 29.5 29.8 36.6 29.2 35.6 0.2 51.2 39.0 1.3 1.5 30.5 31.1 9.4 22.8 36.1 39.5 38.0 46.8 11.9 59.3 34.4 24.1 24.9 18.2 50.4 90.2 23.0 10.4 22.0 34.3 24.7 38.0 47.5 15.0 35.3 39.8 23.6 14.9 28.6 40.4 33.0 45.2 21.8 24.6 48.3 16.1 35.3 47.7 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 0.0 1.3 28.7 1.4 10.4 0.0 1.1 2.5 0.0 6.8 0.0 0.0 8.4 0.0 0.9 12.5 0.7 2.1 280.4 0.0 81.4 9.7 1.2 0.0 3.9 64.5 0.0 0.0 27.6 30.0 15.2 4.4 13.1 1.7 2.8 5.9 0.0 0.2 3.6 1.8 0.0 0.0 71.1 1.4 527.8 241.9 5.4 7.4 7.7 24.2 2.6 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687550 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.5 11.1 6.0 28.6 6.8 9.0 17.5 2.5 7.3 18.5 14.6 6.8 8.3 9.7 20.3 15.0 25.3 16.7 22.6 8.1 5.0 3.8 10.6 20.8 11.2 26.0 6.6 3.1 33.8 13.8 4.9 6.0 22.8 6.9 16.5 14.5 9.9 15.3 16.1 12.5 24.6 14.0 12.8 6.2 24.2 12.0 14.1 6.9 102.6 13.2 23.5 31.2 16.9 15.0 15.2 19.6 2.2 14.1 11.0 11.3 8.2 19.4 36.0 19.7 14.2 9.2 11.0 20.8 7.0 15.8 19.4 24.6 1.0 10.0 45.8 31.9 13.8 18.9 43.0 28.5 19.3 18.2 10.2 19.1 18.5 20.2 17.1 27.7 0.4 9.6 13.9 22.5 9.4 26.1 11.2 19.0 6.2 0.9 1.8 9.9 34.6 31.1 22.7 19.8 2.5 0.7 60.4 13.9 15.9 14.5 21.6 11.7 20.3 23.1 15.6 5.9 10.2 27.0 1.7 24.6 23.3 7.7 0.3 11.8 12.1 8.8 19.7 6.0 2.4 19.6 0.8 13.3 2.2 9.1 14.1 11.1 15.2 9.4 10.2 19.6 14.5 9.9 10.8 1.7 11.0 11.9 17.9 11.3 8.2 6.0 6.8 2.5 6.4 5.0 3.8 6.6 3.1 6.9 6.9 8.9 10.9 24.4 8.9 25.4 2.3 2.0 22.9 8.1 12.5 19.2 0.0 30.5 8.3 19.1 7.8 19.6 10.2 0.0 15.7 35.3 17.1 11.3 1.1 16.1 21.7 0.0 29.6 20.3 27.8 2.1 21.3 14.4 11.8 15.4 37.2 6.1 19.5 0.0 15.9 6.5 2.2 12.9 20.1 0.5 4.2 28.7 18.8 15.7 50.6 7.4 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRIM45 "FLJ13181, RNF99" ENSG00000134253 "Tripartite motif containing 45" Q9H8W5 1 117111060-117122587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 8.9;Cardiomyocytes: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030266, HPA054308" Uncertain Supported "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA030266: AB_10795476, HPA054308: AB_2682445" "prognostic favorable (1.58e-4)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (3.49e-1)" "unprognostic (5.70e-2)" "unprognostic (9.66e-2)" "unprognostic (2.19e-3)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.43e-2)" "unprognostic (3.05e-1)" "unprognostic (5.45e-2)" "unprognostic (7.09e-2)" "unprognostic (3.90e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.27e-2)" 2.3 5.4 6.3 1.4 3.6 1.9 4.9 2.4 7.2 3.4 4.5 5.8 8.0 3.8 9.0 8.0 3.3 9.4 9.3 12.4 3.9 2.6 3.8 1.1 2.6 0.9 2.6 7.5 8.5 8.9 7.3 8.8 9.4 4.5 8.3 2.3 6.0 3.4 7.4 26.6 5.9 3.1 13.3 3.4 2.4 6.1 5.4 4.1 0.7 9.9 9.0 2.1 6.3 4.5 0.4 0.7 0.6 0.4 2.8 2.2 0.0 3.2 2.9 12.1 5.7 1.0 2.8 9.2 3.6 1.5 2.5 2.5 1.3 2.9 0.1 2.7 1.7 2.7 2.9 2.8 2.9 3.4 1.8 2.9 1.9 8.9 1.5 1.8 1.7 2.8 3.6 2.9 4.2 3.0 4.7 3.1 3.5 2.3 2.4 2.3 14.0 1.0 2.1 6.6 1.8 2.6 4.6 24.0 0.7 3.4 2.9 9.2 2.4 2.9 2.7 2.2 12.0 4.7 2.3 1.0 3.5 5.1 2.1 3.1 6.8 2.5 0.2 4.6 1.6 9.0 0.6 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.1 0.7 0.4 0.2 0.2 0.5 2.8 0.1 0.3 2.2 0.0 6.3 3.6 2.4 7.2 3.9 2.6 2.6 7.5 4.5 4.1 8.9 2.4 0.0 1.8 1.0 1.7 11.2 2.5 1.4 2.3 1.8 3.9 2.2 1.7 1.5 4.1 1.4 0.1 0.0 2.8 1.2 1.5 0.4 0.0 0.0 0.7 1.6 1.7 2.5 0.8 1.9 1.7 0.0 0.0 0.0 0.9 1.7 2.1 0.0 1.8 0.2 1.3 0.0 1.7 6.3 4.3 1.4 0.9 0.0 0.9 0.7 TRMT11 "C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1" ENSG00000066651 "TRNA methyltransferase 11 homolog" Q7Z4G4 6 125986430-126039276 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030473 Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA030473: AB_2673493" "unprognostic (2.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.13e-2)" "unprognostic (7.62e-2)" "unprognostic (9.69e-2)" "unprognostic (2.12e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-2)" "unprognostic (5.73e-2)" "unprognostic (7.35e-2)" "unprognostic (1.06e-2)" "unprognostic (4.74e-3)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (2.06e-1)" 10.0 12.6 14.3 12.5 17.7 3.6 15.5 33.9 19.4 17.9 12.6 9.4 11.2 16.1 25.9 15.1 13.2 12.8 12.9 16.1 15.0 12.6 18.8 28.0 10.1 12.4 12.7 16.4 19.2 10.4 15.9 38.1 13.3 15.4 12.8 15.0 14.8 11.7 13.8 10.6 7.4 20.6 15.7 15.2 9.6 12.9 9.8 11.1 8.0 18.0 9.8 13.7 11.5 12.5 8.0 4.7 1.3 2.0 7.5 11.7 4.0 8.6 6.5 13.2 2.8 6.9 7.5 7.8 7.4 11.3 8.1 12.0 19.9 9.1 12.2 13.6 4.8 17.0 12.0 14.3 7.5 12.4 9.8 20.5 9.5 12.9 24.8 11.9 15.6 2.6 7.5 7.2 9.5 15.6 12.8 3.6 5.2 21.6 2.4 8.4 13.2 7.2 8.2 9.3 8.6 8.3 4.9 10.0 7.3 9.5 5.4 16.6 7.8 9.1 8.3 16.1 9.8 6.5 12.6 3.6 5.4 4.1 12.4 12.9 6.7 0.7 3.3 11.0 12.1 9.4 1.3 2.0 0.0 6.8 1.5 11.7 8.0 9.1 7.5 4.1 6.7 11.4 10.4 0.3 7.5 0.7 4.7 6.8 4.0 14.3 17.7 33.9 19.4 15.0 12.6 12.7 16.4 15.4 11.1 6.0 22.4 12.3 23.6 11.8 57.1 11.4 20.4 25.4 25.0 7.0 68.7 16.7 16.6 15.9 7.7 10.5 8.0 0.0 14.1 12.2 17.6 11.7 18.4 21.5 6.4 19.1 8.7 4.9 6.5 3.0 23.9 6.9 3.3 14.4 9.6 20.7 12.4 14.0 23.0 23.3 75.1 6.5 12.1 9.5 7.0 8.8 12.5 5.7 12.8 16.0 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126916-3150879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Yes No Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 15.2 16.9 17.5 17.8 20.7 8.7 18.2 14.5 22.7 12.9 13.2 13.2 17.4 11.1 18.4 14.7 15.9 12.2 15.6 13.9 17.1 16.0 21.1 16.1 13.7 19.0 17.5 15.6 14.6 13.9 14.3 31.0 19.0 21.3 23.9 16.4 10.1 13.2 13.1 14.8 15.3 12.5 15.3 19.3 20.5 15.5 13.5 15.1 22.1 20.9 10.6 19.8 17.8 13.0 15.1 10.5 29.0 12.0 15.1 16.6 7.4 12.0 17.4 13.5 7.7 16.1 13.8 14.4 13.8 11.5 13.8 14.3 16.1 14.8 22.0 9.2 13.3 22.0 8.7 17.8 12.4 17.6 16.3 8.6 20.4 18.6 16.1 21.5 21.6 16.6 12.9 17.6 14.2 4.8 11.6 13.6 17.0 15.9 9.2 23.7 22.5 13.9 19.5 10.6 18.0 12.7 13.3 18.2 21.4 18.4 18.0 7.7 11.1 20.0 14.5 11.5 19.0 13.4 12.3 11.1 15.6 13.6 16.1 17.7 9.5 18.9 27.7 11.7 19.4 17.4 29.0 8.8 22.5 12.1 11.8 11.9 15.1 15.0 12.7 10.5 9.5 16.6 14.3 11.7 15.1 12.0 9.6 11.1 7.4 17.5 20.7 14.5 22.7 17.1 16.0 17.5 15.6 21.3 15.1 14.9 8.3 13.9 18.6 13.2 12.9 12.1 2.5 10.7 13.6 17.4 13.7 21.8 38.1 16.1 1.5 22.5 9.6 0.0 8.7 14.3 13.9 19.8 22.0 7.8 11.6 9.5 8.1 10.4 12.9 1.9 10.0 11.3 6.8 18.0 9.7 15.8 10.1 8.6 8.1 25.6 16.8 0.0 17.7 20.0 16.9 11.4 23.7 13.8 11.5 18.2 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.6 8.8 9.1 2.3 21.0 13.9 5.9 5.8 7.6 3.1 3.1 6.1 19.6 3.3 12.8 13.2 3.8 7.6 2.4 12.2 4.4 8.7 6.5 4.4 7.3 2.5 20.8 4.4 7.8 12.3 14.5 6.0 12.7 9.4 8.1 1.7 3.2 9.6 9.9 7.3 3.4 2.6 1.9 6.6 2.8 4.2 60.0 8.5 12.7 7.4 3.1 7.8 6.2 9.1 4.5 2.2 17.1 6.9 11.1 5.0 4.1 2.7 3.0 11.9 2.6 1.6 13.5 3.0 7.6 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 44.7 25.9 22.0 37.5 10.0 39.9 4.2 22.9 25.4 21.6 29.6 39.3 16.4 8.3 31.1 0.9 23.2 21.6 0.0 34.1 12.3 23.7 26.6 43.9 17.4 19.7 20.6 25.4 20.3 15.6 2.1 23.9 24.1 30.4 24.4 20.3 54.9 31.7 21.0 16.3 15.9 55.1 19.4 23.6 8.7 4.8 11.0 20.5 14.9 21.2 28.5 TSTA3 "FX, P35B, SDR4E1" ENSG00000104522 "Tissue specific transplantation antigen P35B" Q13630 8 143612618-143618048 "Enzymes, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol Yes No 600000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favorable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 9.4 12.0 7.0 9.5 10.1 16.3 10.2 6.1 13.8 8.6 18.7 8.4 16.6 24.8 8.4 9.9 28.0 7.7 23.7 15.7 8.1 7.8 11.7 40.0 8.9 16.5 6.8 8.1 9.7 60.1 6.4 14.2 21.9 12.2 13.9 14.9 9.5 35.4 14.2 16.8 28.4 20.2 6.9 4.7 11.3 35.5 24.6 5.6 14.7 13.0 17.8 24.8 9.8 10.4 18.7 25.6 17.7 21.0 28.1 26.9 20.5 16.4 12.0 6.0 18.0 5.1 4.9 11.2 13.6 13.4 9.7 7.3 14.6 17.5 7.2 13.4 9.6 4.0 11.8 9.1 18.5 4.4 18.6 13.2 10.6 21.2 16.9 10.4 7.1 12.2 6.1 9.6 6.5 23.3 7.9 15.7 12.9 11.8 10.5 7.3 49.8 9.2 10.8 8.2 47.2 16.4 10.6 4.6 22.1 19.6 16.5 12.4 9.7 9.3 18.4 13.7 4.5 23.4 10.4 13.1 6.4 25.6 7.6 13.1 7.9 5.6 5.3 9.9 16.3 9.6 10.5 15.9 17.7 21.0 21.0 21.2 16.1 22.7 22.6 18.0 18.7 16.9 18.7 16.3 28.1 16.3 25.6 26.9 20.5 7.0 10.1 6.1 13.8 8.1 7.8 6.8 8.1 12.2 5.6 14.9 27.3 38.0 42.2 74.1 12.6 12.5 61.1 18.7 12.5 8.7 5.9 73.8 46.4 110.8 79.5 30.8 86.0 46.7 170.3 125.9 25.3 69.4 25.3 62.7 61.4 12.7 59.5 26.4 25.1 197.6 38.0 25.2 28.7 33.3 168.9 16.3 123.1 69.1 32.2 68.8 9.3 12.9 27.2 56.2 48.1 108.3 73.3 42.9 88.1 73.3 TTC21B "FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953843 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035494, HPA035495, HPA073293" Supported Supported Mitochondria Yes No Mitochondria "HPA035494: AB_2674650, HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 10.4 9.0 11.3 7.0 18.3 8.6 11.7 39.6 19.8 12.3 9.2 7.1 5.3 6.5 13.8 10.0 6.7 15.3 7.5 10.4 10.1 8.1 12.5 8.9 9.4 8.9 12.3 11.9 17.5 10.1 10.4 17.6 9.8 15.7 14.9 8.9 6.3 9.1 10.2 16.4 10.7 8.2 9.7 12.2 8.4 8.5 9.7 13.8 16.2 9.4 7.1 8.0 9.8 11.8 3.8 3.1 8.7 2.7 3.7 4.7 1.8 5.0 3.9 17.7 7.2 12.0 11.7 4.7 10.1 8.2 8.1 8.0 5.5 3.3 11.7 6.1 7.1 7.7 5.3 11.9 6.3 9.7 8.2 5.9 9.6 6.8 13.4 7.0 9.0 0.0 6.3 4.1 9.4 6.8 10.3 8.8 9.1 12.7 8.9 10.3 2.7 11.0 7.1 7.3 5.6 9.6 12.2 14.3 4.0 6.3 10.8 12.7 7.5 7.9 1.9 8.8 9.0 3.0 6.4 6.4 14.4 6.5 8.0 7.4 5.1 7.1 10.8 6.0 5.6 9.0 8.7 1.9 3.3 2.9 2.3 4.2 3.8 3.4 2.9 3.1 3.2 4.4 4.7 0.8 3.7 2.7 1.6 4.2 1.8 11.3 18.3 39.6 19.8 10.1 8.1 12.3 11.9 15.7 13.8 3.0 9.8 4.1 7.8 8.1 21.3 11.8 0.0 38.8 13.6 5.2 31.4 2.6 0.0 2.9 2.1 6.3 3.9 0.0 1.6 3.0 6.1 7.1 5.8 7.4 10.3 14.3 6.9 11.1 9.2 2.3 9.8 4.2 10.1 1.0 5.4 11.5 1.0 7.0 12.0 6.9 22.2 6.5 6.1 6.5 11.9 3.3 2.4 8.7 6.0 4.3 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Group enriched" "Detected in many" 5 "Erythroid cells: 397.1;Extravillous trophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.3 28.9 52.2 25.0 1.4 3.2 30.0 31.3 15.9 51.6 37.1 94.9 45.6 41.8 30.7 14.9 64.3 38.9 0.2 33.5 52.7 17.8 27.5 12.9 22.2 24.9 0.4 18.4 32.3 1.0 3.6 34.9 34.2 7.8 25.1 26.7 0.2 35.6 42.4 64.9 30.3 5.2 31.3 44.8 69.3 32.2 47.3 0.2 17.4 13.7 30.1 25.1 49.3 36.1 19.8 27.4 36.5 27.1 9.1 46.3 40.5 31.4 60.5 11.3 0.3 46.5 28.1 13.1 43.8 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 0.0 5.9 29.5 3.6 15.3 0.0 0.0 2.5 0.0 7.9 0.0 0.0 15.5 0.0 0.8 5.8 0.2 5.5 397.1 0.4 368.9 5.1 2.7 5.7 3.9 75.1 0.0 1.2 22.7 19.9 5.4 0.9 9.3 0.0 1.8 12.8 0.0 1.0 6.2 0.0 0.0 0.0 0.0 1.9 6.1 18.0 10.2 26.1 10.1 15.1 8.2 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.5 39.3 19.9 18.9 10.6 12.7 14.5 22.5 19.8 16.3 14.1 23.7 16.8 22.7 17.0 15.9 32.7 14.1 22.1 22.2 12.3 25.8 134.3 33.0 25.3 15.4 26.0 29.8 26.2 13.6 17.4 24.8 29.5 17.9 19.6 21.5 16.0 28.7 21.6 22.1 23.8 27.1 12.6 25.2 34.4 22.2 16.6 29.2 18.8 27.2 35.1 28.7 19.5 23.9 21.0 7.6 14.3 27.4 14.6 51.1 10.4 16.0 39.8 34.8 52.5 24.3 32.5 26.5 33.3 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 6.0 15.4 10.4 28.7 35.8 101.5 34.7 17.8 12.0 6.8 17.4 19.6 18.8 6.6 15.3 18.8 19.0 45.1 23.3 26.0 17.2 20.9 42.6 19.6 28.7 30.5 103.3 39.5 20.3 27.6 27.8 16.1 18.1 33.7 11.8 28.6 85.9 31.9 25.4 13.1 25.9 58.3 25.8 25.5 26.4 7.9 49.7 43.8 15.2 31.9 47.5 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 125.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 85.7;Hep G2: 99.2;U-2197: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 42000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 25.9 11.3 4.4 24.7 3.2 0.2 12.7 4.0 3.1 13.0 29.3 3.8 10.2 13.7 11.5 9.7 22.9 9.9 12.9 10.1 3.6 3.5 28.2 125.8 13.5 4.7 4.0 2.2 20.6 24.9 5.1 4.7 26.8 5.3 13.2 23.3 7.5 8.2 7.3 7.5 5.5 24.2 17.7 3.7 3.3 14.1 5.0 3.8 1.7 16.7 12.7 7.1 30.2 24.1 12.0 12.3 17.1 12.0 21.8 22.4 10.2 4.9 85.7 9.4 12.3 30.9 34.4 7.9 16.3 19.4 16.1 14.8 12.0 18.5 3.1 10.2 22.6 14.8 5.1 9.8 4.6 16.9 4.0 1.7 3.5 11.1 99.2 12.2 4.3 3.5 11.5 2.5 27.6 8.7 13.0 10.3 2.5 4.6 2.6 11.1 14.6 4.2 4.7 7.6 32.4 6.3 7.2 14.6 3.1 8.9 19.7 4.8 7.1 10.0 5.9 6.8 7.2 3.3 3.6 12.0 16.6 7.7 61.6 7.8 6.0 4.3 3.1 14.0 3.6 8.6 17.1 12.0 10.9 14.3 10.6 22.4 10.9 11.4 14.8 10.7 12.0 9.8 12.0 2.3 21.8 6.1 12.3 7.3 10.2 4.4 3.2 4.0 3.0 3.6 3.5 4.0 2.2 5.3 3.8 23.8 22.2 19.5 56.0 103.1 7.7 7.3 22.9 72.3 30.7 19.2 13.7 18.5 59.7 44.3 0.9 20.2 111.9 0.0 293.1 59.3 101.2 100.0 35.7 215.1 16.1 9.5 108.6 23.4 18.5 0.9 30.8 17.2 28.7 26.2 69.3 5.2 205.5 85.2 27.3 54.9 8.6 32.3 92.4 2.4 4.0 35.0 24.3 11.5 88.0 69.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes No "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: AB_2686358" "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 21.1 9.9 5.2 12.7 14.9 11.8 11.7 28.0 15.3 23.0 16.6 6.4 13.3 17.3 24.5 20.9 11.2 12.3 9.9 15.5 37.1 23.7 7.2 17.1 12.3 5.8 11.5 24.9 20.0 12.1 16.4 22.6 21.7 16.1 13.2 12.0 14.9 24.1 39.4 8.9 13.2 6.6 6.9 15.9 13.4 8.5 23.3 14.4 15.3 21.9 9.5 8.8 24.7 23.0 18.0 7.5 19.9 28.0 20.5 26.3 14.9 18.1 39.0 25.0 34.7 20.5 21.9 12.2 23.8 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 17.9 32.1 50.1 25.7 26.2 21.7 29.4 56.0 41.5 50.0 50.6 11.8 22.6 48.0 23.2 35.7 30.8 40.7 0.0 20.2 32.6 19.3 44.8 45.0 71.0 27.6 22.3 32.1 35.0 64.6 34.6 19.8 51.7 27.0 44.1 35.0 13.6 28.8 34.8 18.4 49.4 21.6 0.0 27.3 23.4 22.0 21.5 18.8 52.2 31.1 52.1 UNC119B "MGC5139, POC7B" ENSG00000175970 "Unc-119 lipid binding chaperone B" A6NIH7 12 120710435-120723640 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077812 Enhanced Approved "Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol" Yes No "Cytokinetic bridge, Mitotic spindle" "Mitochondria, Cytosol" "HPA077812: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.86e-3)" "unprognostic (6.71e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.26e-4)" "unprognostic (9.35e-2)" "prognostic favorable (6.69e-10)" "unprognostic (2.52e-2)" "unprognostic (7.73e-2)" "unprognostic (2.20e-1)" "unprognostic (5.42e-2)" 12.7 33.5 18.1 9.2 18.6 9.5 16.3 17.0 17.2 16.0 12.1 15.0 18.7 8.6 20.7 15.0 11.6 42.8 14.9 13.2 18.9 19.7 27.1 14.7 14.0 9.3 14.2 16.0 33.7 17.1 40.8 25.8 13.4 20.4 18.4 12.3 14.6 14.1 23.8 6.7 13.6 11.4 17.5 15.5 13.4 14.5 21.9 15.2 16.1 38.6 7.3 13.7 12.1 16.3 2.1 2.5 2.1 5.8 2.5 4.0 1.4 11.5 11.2 23.4 20.0 23.5 17.5 19.9 14.4 16.8 16.4 7.4 13.4 4.8 11.7 5.7 16.0 7.9 12.3 24.7 16.1 17.0 9.1 12.5 5.4 8.3 8.3 15.9 14.8 8.6 13.7 16.6 12.2 18.9 26.5 18.4 17.8 13.1 1.3 13.8 10.2 13.5 12.2 28.9 13.2 13.9 16.3 15.6 6.0 19.6 24.3 14.1 17.8 34.4 6.8 11.8 17.3 26.8 10.2 11.5 15.3 10.5 6.5 9.6 9.5 8.2 7.2 18.1 7.5 16.5 0.2 1.1 1.3 3.3 0.6 2.1 1.8 3.0 3.8 1.2 2.1 4.0 3.2 2.1 2.5 5.8 2.5 2.8 1.4 18.1 18.6 17.0 17.2 18.9 19.7 14.2 16.0 20.4 15.2 3.0 6.9 2.9 6.5 2.6 8.1 3.5 5.1 18.7 5.7 17.4 9.8 9.1 13.3 6.6 11.8 6.3 3.5 0.0 6.7 4.0 6.2 10.2 2.3 5.5 2.7 7.9 13.7 8.6 3.7 2.2 12.0 1.8 5.0 0.0 6.1 11.2 6.9 5.8 15.2 11.8 9.8 12.9 5.0 11.4 14.5 2.9 4.3 9.2 8.0 6.4 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.2 8.1 13.0 15.6 8.7 6.8 8.9 4.0 6.6 9.0 6.0 2.5 0.0 4.1 11.6 11.7 2.6 20.3 10.3 8.5 0.0 6.5 3.3 20.6 7.7 7.5 1.2 3.7 6.9 8.1 10.4 10.8 10.6 21.3 9.0 7.4 4.6 7.7 4.1 1.1 0.1 7.3 16.9 7.6 0.0 5.0 1.9 9.1 7.1 8.7 9.1 6.2 3.9 6.5 14.0 6.6 4.2 19.5 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.3 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 53.6 55.9 0.8 1.2 2.7 37.4 11.0 17.8 10.7 25.0 8.7 90.3 3.2 3.3 6.0 5.6 6.7 14.8 0.0 10.6 1.9 3.1 10.8 2.3 11.1 4.1 6.4 23.6 4.9 2.2 8.5 2.0 3.1 6.8 0.0 28.6 6.7 8.2 14.1 2.8 6.8 42.9 6.5 4.7 7.5 8.3 6.5 2.4 0.0 16.7 2.6 URI1 "C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI" ENSG00000105176 "URI1, prefoldin like chaperone" O94763 19 29923644-30016608 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Protein phosphatase inhibitor, Repressor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 391.0;Late spermatids: 335.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071709 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA071709: AB_2686434" "unprognostic (4.22e-2)" "unprognostic (2.75e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.96e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-3)" "unprognostic (8.12e-2)" "unprognostic (1.26e-2)" "unprognostic (4.42e-3)" "unprognostic (1.57e-1)" "unprognostic (3.71e-1)" "unprognostic (1.33e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" 16.4 21.2 19.7 15.9 21.5 17.8 21.0 21.7 19.8 18.4 18.0 18.9 16.6 12.9 19.7 19.4 20.5 17.7 14.2 17.5 19.2 16.5 16.6 22.9 13.0 20.7 22.7 15.4 26.3 21.8 21.8 28.8 15.0 21.1 22.6 18.8 12.7 16.7 18.5 45.0 25.3 17.7 15.7 28.3 18.7 14.0 69.2 22.8 21.0 32.1 14.5 20.3 18.6 17.2 6.6 3.1 3.8 2.5 3.7 6.2 1.4 22.7 31.0 14.6 22.6 10.4 15.2 24.6 14.9 12.6 10.9 12.6 16.3 15.1 35.5 29.6 17.3 8.7 16.2 30.8 19.1 24.9 24.6 17.6 32.2 15.4 21.0 15.0 31.0 13.8 13.3 26.2 9.5 35.8 11.8 8.1 21.2 38.2 10.0 13.7 19.5 20.2 13.1 13.6 29.7 9.5 20.0 27.1 14.3 7.2 27.1 23.5 18.5 17.0 20.7 21.8 16.2 8.6 19.6 10.5 27.0 24.0 13.1 22.5 27.6 29.7 24.0 13.3 27.4 16.2 3.8 2.4 3.2 5.7 2.5 4.8 3.5 5.1 5.8 2.0 6.6 6.2 6.1 0.3 3.7 2.3 3.1 3.8 1.4 19.7 21.5 21.7 19.8 19.2 16.5 22.7 15.4 21.1 22.8 41.7 32.1 25.5 69.0 50.6 54.2 48.9 40.8 46.8 36.4 38.4 23.6 16.4 89.5 13.7 391.0 26.4 17.0 0.0 23.9 21.7 30.1 73.3 29.0 41.9 13.6 49.3 27.7 27.6 28.0 335.1 40.6 27.0 30.4 9.0 34.9 44.1 17.2 24.6 38.9 64.7 59.6 12.9 29.4 63.7 50.0 64.4 11.0 35.4 30.6 76.8 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6, small subunit processome component" Q9NYH9 17 31860899-31901765 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 19.3 17.9 18.7 16.9 19.3 19.0 26.4 28.7 19.3 17.7 19.5 18.0 12.5 10.8 23.4 30.4 15.7 13.3 10.7 13.0 19.5 17.0 16.7 20.7 15.4 23.3 16.2 16.1 19.5 17.0 14.1 26.0 21.4 16.2 19.9 15.9 15.0 15.9 15.0 17.0 25.3 15.2 17.0 18.8 23.1 16.4 18.5 19.1 23.2 17.1 18.5 28.1 16.0 15.5 15.4 19.7 13.1 10.9 5.7 8.0 7.0 8.5 5.6 7.9 4.5 8.2 5.4 9.6 7.4 4.2 11.3 8.7 20.1 4.5 12.9 9.3 6.8 10.9 11.2 11.1 9.2 10.4 3.3 16.8 8.0 12.6 18.2 9.0 12.3 8.3 8.3 9.2 11.0 8.1 10.2 7.2 8.5 14.1 7.4 9.0 7.0 11.4 32.8 10.4 10.6 8.8 12.0 11.3 12.6 11.6 7.9 5.2 7.9 7.8 5.6 12.4 12.8 13.6 23.0 7.5 17.0 12.8 8.9 14.8 8.3 14.8 18.7 11.6 8.5 9.1 10.6 10.8 6.7 7.6 10.9 7.3 12.7 8.0 8.0 13.6 15.4 7.1 8.0 13.1 5.7 9.7 19.7 7.7 7.0 18.7 19.3 28.7 19.3 19.5 17.0 16.2 16.1 16.2 19.1 17.9 22.4 27.9 22.9 22.9 16.2 12.5 7.6 30.8 30.7 5.2 7.9 36.3 8.3 22.3 20.6 18.0 9.1 0.0 20.7 41.1 23.1 22.0 35.7 14.4 32.5 11.1 5.2 12.9 20.5 3.6 17.3 29.1 8.5 44.1 14.6 17.8 22.2 7.0 15.9 15.0 16.0 6.5 23.1 62.6 62.6 22.7 32.0 13.3 15.3 27.6 UXT "ART-27, STAP1" ENSG00000126756 "Ubiquitously expressed prefoldin like chaperone" Q9UBK9 X 47651798-47659161 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Chaperone, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050499, HPA058400" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA050499: AB_2681146, HPA058400: AB_2683706" "unprognostic (1.12e-1)" "unprognostic (3.85e-3)" "unprognostic (9.08e-2)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (2.31e-3)" "unprognostic (1.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (1.44e-1)" "unprognostic (8.11e-2)" "unprognostic (8.64e-2)" "unprognostic (4.09e-3)" 30.9 37.4 21.7 33.7 23.6 54.4 38.9 20.0 27.3 26.7 31.9 24.8 33.5 23.2 26.8 39.8 30.1 32.4 31.3 47.3 20.9 16.5 34.7 66.8 24.9 46.1 23.6 24.9 50.5 54.1 21.4 29.6 39.0 26.0 30.0 31.1 19.5 46.5 30.5 42.1 36.2 29.1 21.1 27.6 37.1 31.9 24.7 22.6 50.4 37.0 33.2 41.6 24.5 32.5 58.2 60.2 26.2 35.8 36.0 73.5 52.0 45.8 50.9 21.7 28.8 49.7 60.0 38.2 29.8 43.6 51.1 48.5 43.7 43.8 52.6 21.7 42.4 47.3 37.3 30.8 40.7 36.4 34.3 61.1 26.5 58.0 43.1 57.9 58.3 52.1 42.1 52.2 43.0 46.3 35.6 41.1 45.4 28.9 50.9 43.2 50.5 39.8 81.3 31.1 42.0 58.1 35.5 44.0 72.3 41.1 33.8 20.6 27.0 33.1 36.0 46.0 41.5 42.3 54.1 30.0 35.8 39.0 49.2 32.6 40.2 35.4 47.2 45.6 64.9 36.1 18.7 35.8 26.2 40.2 35.5 54.1 58.2 57.7 43.2 47.4 56.7 73.5 60.2 23.0 36.0 32.4 60.2 52.9 52.0 21.7 23.6 20.0 27.3 20.9 16.5 23.6 24.9 26.0 22.6 68.5 66.8 281.0 227.2 190.8 23.2 91.3 173.3 104.4 77.3 92.5 15.7 159.9 266.9 141.0 57.0 149.5 224.3 70.0 277.6 166.5 144.8 211.1 151.2 220.1 215.1 9.5 179.6 164.5 216.2 146.7 194.8 227.9 187.3 293.1 261.4 59.3 182.8 282.8 184.2 337.2 20.1 142.3 173.2 63.7 82.2 178.2 178.7 244.2 308.1 250.0 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Cell type enhanced" "Detected in single" 27 "Cardiomyocytes: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 7.7;WM-115: 5.8" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes NA "Nucleoli rim" Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.7 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556070-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: AB_2676115" "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 22.3 29.3 26.6 20.7 25.1 10.5 28.2 18.0 23.8 32.3 18.6 22.8 17.8 18.9 35.6 23.3 23.6 36.0 28.9 20.7 23.3 13.2 22.5 10.6 20.4 15.2 22.4 14.9 65.4 18.4 27.2 19.6 19.9 19.7 21.8 14.7 28.8 28.7 23.5 13.8 24.2 18.6 24.7 28.2 15.8 18.6 25.4 23.3 30.0 37.5 21.3 19.9 23.4 30.3 5.6 5.3 16.2 5.8 6.3 11.3 5.8 10.3 7.0 20.1 6.1 25.5 13.8 37.7 6.9 14.3 6.1 6.0 5.9 10.3 14.1 16.0 10.9 10.7 7.0 9.2 11.5 4.3 8.5 14.0 15.1 7.0 9.8 19.9 11.8 10.0 17.2 24.0 8.3 10.7 36.0 22.8 15.0 5.4 2.4 9.4 8.9 14.0 13.6 12.4 15.3 12.4 18.1 13.6 18.4 14.0 15.0 8.8 25.4 7.9 8.5 17.7 13.8 8.3 11.7 12.0 16.6 8.1 10.8 17.4 3.8 10.9 30.9 18.3 20.2 32.1 16.2 4.4 1.0 11.3 2.5 7.3 5.6 6.2 9.2 5.3 4.0 8.5 8.9 2.6 6.3 5.8 4.5 3.1 5.8 26.6 25.1 18.0 23.8 23.3 13.2 22.4 14.9 19.7 23.3 29.8 14.4 15.2 51.3 57.4 41.2 2.8 43.3 53.5 31.8 41.8 139.4 60.4 53.0 61.8 12.4 50.4 28.1 23.3 31.6 68.9 55.2 68.7 13.9 13.0 28.2 69.9 33.3 55.9 17.0 12.4 67.9 13.8 42.2 25.2 29.4 89.9 45.9 42.1 85.2 21.3 50.6 32.3 46.2 10.2 27.7 66.6 37.4 18.8 36.0 58.0 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.8 9.1 22.7 10.1 2.7 5.0 14.1 12.0 9.3 19.2 19.2 10.9 15.8 40.4 8.1 7.1 11.8 17.6 21.2 15.7 26.5 23.0 11.3 25.1 6.0 11.1 3.0 48.4 15.8 2.7 2.8 14.5 10.6 3.9 13.3 31.0 21.4 25.6 16.5 18.1 38.4 20.8 14.5 12.1 17.5 36.0 39.7 13.7 8.8 16.4 16.0 9.1 10.6 10.8 8.1 11.9 12.4 19.2 7.1 8.8 7.8 15.1 12.0 13.4 15.8 39.1 13.7 21.2 10.4 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 3.0 2.9 30.5 11.8 14.9 12.3 10.6 15.3 42.8 13.6 14.0 7.9 19.7 10.0 9.8 13.3 11.3 2.4 93.5 16.8 39.6 10.4 5.3 27.7 2.4 16.3 9.5 2.9 6.2 9.7 10.8 5.2 11.5 11.8 12.6 8.0 5.2 7.6 0.0 9.2 8.4 6.6 19.4 11.3 141.1 122.1 12.2 12.6 26.7 11.2 8.4 WDPCP "BBS15, C2orf86, fritz, hFrtz" ENSG00000143951 "WD repeat containing planar cell polarity effector" O95876 2 63121383-63827843 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 157.8;Alveolar cells type 2: 91.0;Ciliated cells: 161.9;Club cells: 104.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044144 Uncertain Approved "Cell Junctions" Yes No "Cell Junctions" "HPA044144: AB_10969458" "unprognostic (3.36e-1)" "unprognostic (3.22e-2)" "unprognostic (1.95e-1)" "unprognostic (7.07e-2)" "unprognostic (2.95e-1)" "unprognostic (6.88e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-3)" "unprognostic (7.22e-2)" "unprognostic (6.48e-2)" "unprognostic (1.93e-1)" "unprognostic (4.87e-2)" "unprognostic (2.34e-3)" "unprognostic (6.02e-2)" "unprognostic (1.97e-1)" "unprognostic (2.25e-3)" "unprognostic (2.00e-1)" 7.2 7.6 7.9 5.4 13.8 15.6 6.6 10.7 14.2 6.4 4.6 7.8 5.6 3.7 8.1 9.3 4.9 8.6 5.3 10.8 7.8 7.5 8.1 5.1 5.5 6.7 7.0 10.1 9.5 5.0 6.9 17.1 5.7 9.8 5.8 4.5 10.4 4.8 4.5 9.3 6.7 3.9 8.7 9.4 6.2 6.3 13.1 8.5 7.5 7.8 4.5 6.3 5.1 4.9 5.6 4.6 8.7 4.3 6.3 7.0 1.6 6.0 5.8 4.8 5.5 5.4 5.6 5.0 6.1 2.9 3.6 3.3 4.7 3.5 6.0 5.0 3.6 4.5 4.9 2.7 2.7 4.6 8.0 4.5 7.7 5.5 3.7 2.8 6.2 5.9 3.3 2.7 3.9 2.3 5.2 3.3 9.6 3.4 9.2 4.0 7.0 8.0 6.7 5.9 3.0 2.4 7.5 5.1 6.1 2.4 4.0 6.4 8.0 4.0 5.6 7.3 7.5 5.7 5.4 6.8 7.0 10.7 5.9 5.4 7.1 4.9 11.6 7.6 6.7 6.8 8.7 4.3 2.8 3.6 2.3 7.0 3.7 3.1 4.6 3.2 5.6 4.1 6.1 3.7 6.3 1.9 4.6 2.7 1.6 7.9 13.8 10.7 14.2 7.8 7.5 7.0 10.1 9.8 8.5 157.8 91.0 3.7 3.2 3.7 15.6 7.6 2.5 161.9 104.6 1.8 21.6 2.3 1.7 1.8 31.9 3.6 0.4 0.0 1.9 2.3 4.2 1.8 60.4 0.9 3.4 11.1 0.0 4.3 2.4 11.0 4.0 3.9 5.0 1.0 0.9 8.5 1.9 0.9 3.5 3.5 24.3 0.0 4.2 12.7 7.0 3.0 1.6 5.3 0.6 1.7 WIZ ZNF803 ENSG00000011451 "Widely interspaced zinc finger motifs" O95785 19 15419980-15449951 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 28.0 17.5 27.6 18.3 21.6 13.6 20.9 15.8 24.4 17.5 17.3 12.8 18.0 18.2 25.2 12.0 16.3 16.3 15.3 17.3 23.0 11.4 13.8 18.4 13.5 17.5 14.1 19.0 21.6 26.9 14.3 10.9 13.7 13.7 17.4 7.7 12.4 21.9 23.1 24.4 21.5 16.8 16.5 11.9 18.0 15.6 40.9 15.8 18.6 13.3 14.6 12.1 19.3 21.4 2.0 1.5 0.7 3.6 2.5 1.2 0.5 13.5 9.3 13.4 17.0 19.3 7.9 10.9 14.2 7.0 11.9 8.2 8.2 25.5 11.3 23.5 12.9 7.2 11.6 7.3 10.0 2.9 8.8 12.5 8.2 7.2 6.4 12.3 9.4 12.3 14.0 13.2 8.6 9.4 7.4 10.7 8.9 12.8 9.7 8.0 27.6 17.1 8.7 18.1 13.3 22.2 16.0 6.1 11.4 7.7 10.6 18.3 23.3 12.5 11.4 9.2 4.8 12.5 8.9 17.2 27.3 10.8 21.4 18.1 14.4 8.6 12.2 11.4 11.4 18.4 0.0 1.4 0.0 1.2 1.2 1.0 0.5 0.8 1.2 1.0 2.0 1.0 1.0 0.7 2.5 3.6 1.5 0.8 0.5 27.6 21.6 15.8 24.4 23.0 11.4 14.1 19.0 13.7 15.8 11.9 5.8 8.5 5.5 14.1 8.8 9.1 12.7 0.0 3.4 12.2 0.0 6.1 3.3 12.3 6.3 13.5 5.0 0.0 17.1 8.3 9.9 8.6 1.1 13.2 6.7 6.4 6.4 13.5 10.2 6.4 14.7 7.1 6.8 5.4 9.5 7.1 16.5 0.0 18.0 4.7 7.5 12.9 10.8 27.2 26.0 17.8 6.2 4.4 10.5 11.8 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Yes NA Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 2.0 0.1 0.2 0.5 2.8 6.3 0.2 2.5 10.4 33.1 34.2 0.2 3.0 0.5 0.8 3.8 11.9 1.2 0.0 0.5 3.8 4.5 0.1 0.7 0.3 0.4 15.2 0.4 3.1 2.9 0.0 4.4 0.1 0.1 2.7 9.6 0.2 10.8 1.0 0.1 2.2 8.8 0.2 0.1 0.8 4.3 0.1 0.2 0.0 1.9 0.2 0.2 1.2 0.2 5.5 0.2 0.3 12.1 0.3 0.4 0.3 0.9 0.2 1.6 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 56.6 31.7 5.4 5.3 4.6 0.2 1.6 12.7 36.1 50.0 0.0 0.0 0.1 0.0 1.1 3.1 24.8 8.1 23.3 1.7 3.5 8.7 2.7 46.3 13.6 15.0 0.0 1.7 28.8 16.4 0.6 33.6 22.5 5.0 3.6 8.4 1.0 6.2 0.0 25.8 0.2 0.3 19.4 3.9 0.3 0.6 2.4 0.3 13.8 6.6 5.4 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697357 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: AB_2683258" "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favorable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 18.7 17.5 20.1 17.1 21.0 10.6 17.4 26.8 20.8 20.3 25.2 17.2 11.7 20.6 25.5 15.4 18.9 15.0 19.5 12.9 17.2 15.3 24.9 24.2 14.8 16.7 18.6 17.5 17.2 14.5 23.0 23.1 12.8 17.7 20.3 13.6 16.4 16.1 21.7 43.3 16.3 22.2 27.5 17.1 16.2 25.1 6.4 15.8 15.7 31.5 11.9 21.6 22.0 16.4 22.2 23.4 12.7 15.8 19.7 21.6 11.3 23.0 5.4 8.1 10.0 9.9 9.7 5.6 6.3 10.0 11.5 7.8 14.1 19.4 13.0 6.1 6.9 7.7 11.6 6.4 7.6 9.8 8.9 12.9 10.2 11.8 7.8 10.8 12.1 12.4 8.4 8.2 5.3 5.5 7.8 12.8 10.8 14.1 10.2 6.3 7.2 15.7 14.6 5.5 22.0 9.0 16.0 17.3 11.0 18.3 9.0 11.4 11.5 9.0 6.9 8.1 6.4 10.1 7.3 8.0 4.0 10.1 15.9 13.6 18.1 14.5 8.2 10.0 8.7 7.9 6.0 13.3 12.7 16.2 13.1 18.7 19.5 17.7 15.6 13.5 22.2 21.6 18.6 1.5 19.7 15.8 23.4 18.3 11.3 20.1 21.0 26.8 20.8 17.2 15.3 18.6 17.5 17.7 15.8 23.8 31.5 27.5 17.4 15.3 99.5 29.1 50.9 34.8 40.9 21.0 76.6 27.4 102.8 31.2 1.2 29.2 16.9 0.0 33.5 8.3 24.2 16.3 29.0 40.6 30.4 79.4 21.5 17.8 17.5 2.6 40.9 29.8 13.5 49.5 21.3 71.6 24.5 21.0 44.6 38.3 99.8 32.3 31.9 12.8 16.4 16.4 11.7 25.3 26.3 20.2 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 6.6;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 16.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.9 4.1 3.8 9.4 6.1 6.2 6.2 4.5 6.3 5.8 6.6 5.7 3.1 16.9 5.9 5.7 6.9 5.2 9.5 7.1 8.7 10.4 9.3 13.7 5.5 4.3 4.5 11.1 7.0 6.2 5.9 5.8 10.1 4.0 4.7 8.0 11.4 9.5 5.9 6.8 15.8 7.5 9.3 4.0 4.6 10.0 5.3 7.0 7.1 6.8 6.4 5.6 5.8 6.2 14.4 5.5 4.3 12.1 4.6 4.7 4.7 3.9 9.8 4.6 3.6 17.3 6.1 8.8 7.8 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 11.9 7.8 15.9 6.2 9.0 17.3 3.3 7.6 8.1 5.7 3.5 29.5 7.0 3.3 6.8 1.3 4.5 5.5 0.0 7.9 9.4 7.3 5.9 9.2 5.0 6.9 9.5 9.2 3.1 12.6 1.1 6.6 8.9 8.5 22.6 11.1 8.1 5.5 3.5 6.0 6.1 63.1 0.0 4.2 4.6 29.8 8.4 6.5 14.9 7.8 5.8 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;SuSa: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.1 4.1 8.1 2.8 0.4 0.3 1.1 0.4 0.6 2.1 0.5 0.4 0.3 0.5 0.1 0.5 0.1 2.1 0.3 0.9 3.6 1.3 4.1 0.0 1.0 0.4 0.7 3.0 0.6 0.1 0.8 0.3 2.2 0.5 3.6 0.6 0.7 0.1 1.4 0.5 0.5 5.0 0.6 1.2 2.2 0.1 0.0 2.2 1.9 4.5 2.9 0.7 1.1 0.3 6.6 1.7 1.0 0.1 0.0 2.1 1.3 0.5 0.5 1.6 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 0.0 0.6 0.0 0.4 0.1 9.0 2.0 0.0 6.7 3.4 1.8 0.0 0.2 1.7 2.8 30.6 0.6 0.0 0.0 2.1 0.0 0.8 1.2 0.0 0.0 0.8 7.9 6.4 0.6 0.6 13.8 0.6 0.7 0.0 1.8 0.7 3.9 1.3 0.0 0.4 1.0 3.2 0.0 0.2 19.2 1.1 0.0 0.2 0.0 0.6 0.1 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA049112: AB_2680637" "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favorable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.7 6.4 4.3 8.3 3.9 2.4 3.6 2.7 2.3 0.0 1.8 4.3 1.9 2.5 3.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 2.0 2.3 0.0 0.9 2.3 0.8 3.2 6.3 6.6 1.5 0.0 0.4 3.8 5.6 0.0 0.0 0.0 7.9 4.6 0.0 0.0 10.7 0.6 2.0 0.0 6.6 6.2 7.5 1.6 1.4 4.0 6.3 0.0 0.6 6.3 2.8 7.3 3.6 1.5 2.9 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 0.0 0.3 0.0 0.8 0.2 10.6 2.0 0.0 0.0 0.0 0.0 5.9 0.7 3.3 1.2 0.6 2.2 0.0 0.0 0.8 1.3 2.1 0.4 5.7 1.1 0.4 6.4 1.2 1.3 0.0 0.0 2.0 0.4 0.0 0.0 0.1 3.1 0.2 0.2 2.1 2.2 5.2 6.5 1.5 5.6 4.1 0.0 0.1 0.5 0.1 0.4 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.2 6.8 18.1 19.8 18.7 22.8 6.8 10.4 12.7 6.2 6.3 4.1 8.8 10.5 13.3 11.6 11.0 7.7 10.4 9.0 12.0 10.1 6.4 8.5 8.3 10.6 10.6 16.1 10.2 15.3 14.4 8.4 28.3 17.0 13.7 12.5 19.5 9.2 12.3 12.3 15.3 9.6 7.3 17.4 8.6 9.1 9.2 9.4 10.5 14.6 21.1 25.2 16.2 21.3 18.3 10.8 10.8 10.8 20.6 13.7 13.4 15.9 10.5 10.7 18.5 10.9 9.3 11.6 17.9 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 23.8 39.4 30.6 38.6 13.4 91.6 37.3 142.7 161.9 56.9 43.6 141.4 32.1 13.3 46.0 35.7 43.9 59.0 0.0 38.3 12.7 32.9 84.1 33.6 124.6 17.1 84.2 212.3 35.6 28.8 14.6 47.5 27.1 38.8 27.9 82.8 74.9 41.8 84.2 50.2 23.0 68.3 19.4 22.2 28.9 14.6 18.7 55.2 18.7 98.9 47.9 ZNF202 "ZKSCAN10, ZSCAN42" ENSG00000166261 "Zinc finger protein 202" O95125 11 123724177-123741675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 15.9;Spermatocytes: 12.9;Spermatogonia: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059229 Approved "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "Nuclear bodies" "HPA059229: " "unprognostic (3.12e-2)" "unprognostic (7.75e-2)" "unprognostic (2.20e-2)" "unprognostic (4.49e-2)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.23e-1)" "unprognostic (1.74e-3)" "unprognostic (2.80e-1)" "unprognostic (9.48e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (9.93e-7)" "unprognostic (2.61e-2)" "unprognostic (2.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" 7.2 6.5 9.2 16.1 11.6 6.0 10.4 11.9 10.9 9.5 8.2 9.2 8.1 5.6 13.1 13.9 8.8 9.7 6.1 6.2 7.3 5.5 6.6 7.3 7.8 10.6 10.5 6.4 15.1 14.1 11.1 11.5 8.2 7.0 10.6 11.0 7.2 9.2 8.6 8.5 10.9 8.9 12.3 7.0 14.1 8.0 24.0 7.8 8.9 10.3 5.4 11.7 9.1 10.5 4.1 3.6 0.1 3.6 3.0 5.6 3.0 4.0 6.0 10.7 12.9 5.0 7.3 8.5 6.3 5.3 6.2 5.4 6.6 10.9 12.3 6.1 5.0 9.8 10.4 10.9 7.4 8.6 5.1 6.4 20.3 3.9 7.0 6.7 12.4 6.3 5.3 15.3 6.9 20.9 5.3 7.1 10.7 11.4 8.1 7.8 4.4 10.7 16.3 17.1 14.4 9.3 13.4 7.0 4.6 5.7 7.8 7.7 8.9 5.5 6.8 4.5 9.7 11.5 8.7 5.8 11.6 6.9 8.2 6.4 5.5 3.7 8.4 3.1 13.8 7.6 0.0 2.1 0.1 3.8 3.6 3.4 3.4 4.8 4.9 3.6 4.1 5.6 5.0 0.0 3.0 1.5 2.3 4.0 3.0 9.2 11.6 11.9 10.9 7.3 5.5 10.5 6.4 7.0 7.8 6.0 0.3 6.0 2.5 2.6 2.8 2.5 0.0 0.0 15.9 3.5 0.0 1.9 1.7 1.9 3.8 2.2 0.9 0.0 2.9 1.4 1.9 1.6 3.5 1.6 1.5 6.4 2.9 3.1 1.9 3.6 1.7 2.5 0.0 1.0 3.4 2.4 2.9 0.0 1.1 1.3 2.3 6.5 1.0 12.9 14.0 2.6 0.7 2.5 2.9 2.1 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.6 11.2 13.4 19.4 10.7 14.1 17.4 11.9 18.3 14.3 15.6 12.2 13.6 31.9 12.4 15.3 13.3 11.0 18.2 12.1 14.4 17.5 18.2 14.5 15.0 11.7 12.5 21.4 17.8 16.2 25.4 13.0 19.2 16.1 12.2 20.6 16.3 21.7 11.7 11.9 19.7 16.5 24.9 10.2 9.6 32.1 13.6 25.1 10.0 8.7 19.4 20.3 13.0 14.1 14.5 16.3 15.6 25.6 12.6 15.2 14.6 11.2 11.1 23.3 24.7 38.5 5.9 10.8 10.7 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 0.0 14.4 9.1 14.5 15.5 10.2 3.6 12.7 4.0 4.5 1.8 0.0 9.7 6.6 8.9 41.6 11.1 6.0 0.0 8.6 8.9 10.8 11.4 6.9 5.8 8.0 3.2 12.7 5.5 8.9 26.2 7.5 8.0 15.1 8.2 9.2 10.1 8.2 3.5 7.4 5.0 9.0 12.9 18.6 11.4 10.4 18.1 9.3 10.0 11.7 11.9 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059503 Approved "Vesicles,Cytokinetic bridge" Yes No "Vesicles, Cytokinetic bridge" "HPA059503: AB_2684043" "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favorable (9.85e-5)" 12.4 18.0 21.8 12.5 23.7 3.5 23.6 36.5 22.5 16.0 14.3 14.7 16.5 11.7 19.2 21.3 10.0 18.7 10.6 23.6 22.2 18.1 16.4 17.1 13.8 15.5 26.8 18.4 28.6 19.1 26.7 22.8 11.8 21.4 19.1 15.1 13.0 12.4 21.8 29.8 12.4 12.1 18.4 22.8 15.5 12.3 14.0 25.7 12.6 18.8 10.2 15.3 13.7 9.7 17.3 14.1 14.4 7.8 12.0 21.1 6.0 5.8 9.1 19.0 7.4 17.9 14.2 6.5 10.1 12.6 9.4 10.2 6.7 4.9 9.1 12.8 7.3 7.0 4.6 9.2 5.7 10.1 0.6 7.9 17.5 9.8 0.2 9.8 0.1 1.2 13.0 8.7 5.5 0.8 11.8 7.9 6.5 0.0 0.1 14.5 3.0 8.9 9.1 8.5 10.4 6.1 6.9 15.8 4.7 9.7 7.7 8.5 14.0 9.2 3.0 12.0 10.8 6.8 13.9 7.6 4.1 10.2 3.5 4.9 10.9 19.1 2.8 3.9 1.3 19.2 14.4 7.0 11.2 10.9 6.3 14.8 15.0 12.3 10.2 5.8 17.3 21.1 16.3 3.9 12.0 7.8 14.1 9.6 6.0 21.8 23.7 36.5 22.5 22.2 18.1 26.8 18.4 21.4 25.7 26.8 22.2 16.7 26.9 23.8 54.4 49.8 22.9 32.1 27.3 21.0 49.1 14.1 38.1 14.4 24.3 32.4 12.0 0.0 10.0 7.4 27.1 32.5 27.8 10.4 8.5 46.1 19.1 23.4 12.4 3.9 55.0 19.9 23.6 10.0 13.3 67.9 9.0 14.4 48.1 11.2 83.5 51.8 46.4 71.2 41.9 18.7 4.6 26.6 12.2 24.7 ZNF32 KOX30 ENSG00000169740 "Zinc finger protein 32" P17041 10 43643859-43648856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" Yes No "Nuclear bodies" Nucleoplasm "HPA039148: AB_2676365" "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favorable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 14.4 16.2 24.4 12.4 23.6 4.4 29.2 21.1 20.1 20.2 20.4 19.0 18.0 7.9 21.9 37.7 12.6 20.7 14.7 26.1 22.2 20.8 22.1 17.7 13.7 12.2 27.7 17.7 28.7 26.0 18.7 20.3 10.3 22.5 22.5 15.1 14.7 18.5 25.4 45.7 14.4 11.0 23.4 19.8 14.2 14.5 8.6 25.8 15.4 25.8 14.5 15.4 17.9 25.4 14.2 11.2 8.5 6.9 23.0 21.7 10.3 9.6 8.6 13.0 19.6 24.0 25.9 4.2 8.6 26.2 16.2 14.7 5.8 4.9 0.0 15.3 18.4 7.6 5.7 8.3 8.4 11.9 10.5 9.1 2.5 5.4 6.6 22.5 0.2 7.9 26.5 19.4 10.0 12.1 15.6 12.2 34.5 7.4 0.0 20.3 8.8 9.5 8.8 10.1 9.8 4.5 14.8 14.6 2.2 16.2 3.8 16.7 14.8 7.1 5.3 13.5 15.0 19.6 9.0 5.2 9.1 11.0 6.6 2.1 5.8 15.1 0.0 3.2 6.2 8.4 4.1 6.9 8.5 19.3 6.1 19.1 13.3 15.5 21.4 11.2 14.2 20.0 21.7 0.6 23.0 5.4 9.5 10.8 10.3 24.4 23.6 21.1 20.1 22.2 20.8 27.7 17.7 22.5 25.8 8.9 14.7 20.1 21.3 9.7 22.4 10.9 15.3 13.4 11.4 17.4 7.9 14.8 89.5 34.7 1.8 18.7 6.1 0.0 41.6 15.5 19.7 29.1 29.0 22.5 26.1 15.9 26.7 17.2 15.9 0.4 39.1 14.8 16.9 12.6 17.5 29.0 29.6 14.0 51.2 43.0 19.9 32.3 22.7 11.2 13.0 13.4 5.6 23.0 18.1 13.6 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.3 3.0 4.0 3.0 2.1 11.2 2.8 1.7 2.7 1.3 6.2 5.3 3.8 3.8 2.0 3.0 3.6 2.8 4.9 0.9 3.7 2.8 4.3 3.4 2.9 1.1 2.4 4.7 2.1 3.0 2.1 1.2 2.3 2.7 4.5 2.2 1.6 2.4 3.8 2.2 1.0 2.6 3.5 4.2 2.6 1.3 1.8 1.5 6.4 2.1 1.9 8.2 5.5 1.0 2.4 6.3 2.2 2.1 3.5 1.2 0.9 2.2 1.2 1.6 2.9 4.3 1.6 2.7 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 3.0 6.1 4.7 1.0 0.3 2.3 2.0 2.5 5.3 6.8 1.8 2.0 2.2 0.0 1.5 0.5 0.7 4.2 0.0 1.2 2.6 1.3 1.9 2.3 0.8 1.2 1.6 1.2 1.3 2.2 0.0 0.6 2.5 0.0 0.0 2.1 0.2 1.6 0.8 0.4 0.3 2.1 0.0 0.6 1.1 2.2 0.9 1.7 0.0 1.3 1.8 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.8 7.8 5.3 11.1 8.2 5.6 10.5 6.7 8.9 7.8 7.6 8.2 8.7 9.4 9.7 6.9 11.0 7.6 7.1 8.5 7.7 6.8 9.4 9.2 9.3 9.0 6.6 13.1 16.1 7.4 7.4 7.6 8.1 5.8 8.9 8.4 13.2 18.7 7.1 14.7 13.5 21.5 11.8 9.8 9.4 7.7 5.8 16.3 8.4 11.2 6.3 13.1 7.8 19.0 12.6 13.5 4.9 16.3 9.3 9.5 9.5 13.6 8.3 15.4 16.1 15.2 6.7 13.3 9.9 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 14.9 22.4 32.0 29.5 31.6 8.1 7.0 2.5 20.1 11.4 10.4 11.8 13.3 14.9 13.3 5.6 16.9 25.5 0.0 12.4 14.8 17.4 23.7 57.7 10.5 16.3 14.3 20.0 12.9 22.1 1.1 14.4 20.8 27.0 15.4 14.7 12.4 14.1 18.6 12.7 9.5 10.6 12.9 17.0 42.5 30.3 31.0 24.8 44.5 15.8 52.9 ZNF410 "APA-1, APA1" ENSG00000119725 "Zinc finger protein 410" Q86VK4 14 73886617-73932511 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 10.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002871 Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA002871: AB_1080712" "unprognostic (5.84e-2)" "unprognostic (5.04e-2)" "unprognostic (9.29e-2)" "unprognostic (6.36e-3)" "unprognostic (5.86e-4)" "unprognostic (4.91e-2)" "unprognostic (2.83e-3)" "unprognostic (2.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.79e-2)" "unprognostic (2.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.19e-1)" 24.2 22.6 14.2 12.9 18.6 37.9 22.3 21.5 20.8 20.2 20.2 21.8 19.2 14.3 28.8 33.8 24.0 19.4 17.7 15.4 13.7 12.8 22.7 20.7 19.5 17.3 15.7 12.5 30.9 19.1 17.2 27.0 32.7 16.6 21.7 18.5 20.2 18.0 21.7 14.5 26.4 20.8 21.7 14.5 20.6 18.6 37.2 15.9 28.3 26.0 17.2 30.5 20.4 20.5 26.5 27.3 43.5 28.2 34.0 33.2 30.5 18.7 15.0 18.2 19.9 19.8 17.3 22.2 21.7 24.4 38.2 35.1 16.1 16.8 15.6 9.4 26.9 12.6 17.5 17.8 21.8 35.8 22.7 11.1 14.9 14.2 12.0 29.4 12.2 20.1 15.9 30.9 18.7 36.2 17.1 20.1 19.0 15.5 14.0 18.2 35.8 18.4 20.7 6.5 23.3 17.9 16.5 20.9 10.0 23.9 18.2 17.2 22.1 23.9 22.2 22.3 15.9 21.0 21.5 14.0 27.3 25.8 15.6 19.2 19.3 34.4 19.8 17.3 14.0 22.6 35.1 27.6 43.5 31.4 25.7 33.2 23.6 32.1 31.0 27.3 26.5 28.3 28.8 21.2 34.0 28.2 18.2 27.1 30.5 14.2 18.6 21.5 20.8 13.7 12.8 15.7 12.5 16.6 15.9 0.0 1.9 2.2 1.2 0.6 1.5 1.2 0.0 0.0 4.5 0.0 3.9 1.5 0.0 1.0 2.6 1.1 1.6 0.0 0.8 1.1 1.2 0.9 10.4 0.0 1.0 1.6 0.0 1.8 1.0 0.0 1.1 2.6 1.7 0.0 0.7 0.9 1.1 0.6 0.4 0.3 4.6 0.0 2.3 2.3 1.9 1.0 2.2 4.9 0.6 1.3 ZNF426 MGC2663 ENSG00000130818 "Zinc finger protein 426" Q9BUY5 19 9523224-9538645 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029342 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA029342: AB_10603007" "unprognostic (3.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (6.62e-2)" "prognostic favorable (3.74e-4)" "unprognostic (4.34e-2)" "unprognostic (1.77e-2)" "unprognostic (4.75e-3)" "unprognostic (1.05e-3)" "unprognostic (8.89e-3)" "unprognostic (7.41e-3)" "prognostic favorable (2.57e-6)" "unprognostic (1.05e-1)" "unprognostic (3.17e-2)" "unprognostic (2.49e-1)" "prognostic favorable (1.81e-4)" 8.0 7.0 6.5 5.0 8.9 6.7 9.3 13.5 8.8 10.9 7.8 7.5 7.2 3.9 10.3 7.2 28.2 8.5 5.9 7.1 8.0 4.5 6.6 3.1 6.8 7.2 6.4 5.4 12.8 5.8 9.1 7.9 7.3 7.0 8.4 5.4 7.8 8.8 7.7 6.7 6.6 5.6 10.5 8.0 5.9 6.7 7.9 7.3 9.9 9.1 6.7 7.4 11.1 11.9 8.8 4.4 9.8 6.7 8.7 12.7 3.9 4.4 1.5 9.2 9.7 6.2 8.2 5.2 5.8 8.7 7.7 9.5 2.0 2.1 4.5 4.7 5.6 5.4 3.8 9.5 6.7 11.7 2.1 7.3 18.7 7.6 3.4 5.6 0.6 6.1 10.4 5.9 8.6 12.4 8.5 8.3 7.9 7.4 0.5 7.4 0.4 10.7 9.1 11.5 1.0 3.6 5.8 11.4 4.7 4.3 11.7 5.2 7.0 9.7 3.5 7.9 8.3 4.8 4.4 6.7 11.0 6.4 4.8 6.1 5.3 7.4 3.9 1.6 0.3 7.8 9.8 3.9 6.9 11.2 5.6 9.9 8.6 8.7 10.9 4.4 8.8 12.7 11.9 8.3 8.7 6.7 4.1 8.1 3.9 6.5 8.9 13.5 8.8 8.0 4.5 6.4 5.4 7.0 7.3 26.8 34.0 5.4 13.4 3.1 22.8 8.7 2.5 24.1 19.4 7.0 19.6 10.8 18.3 9.4 24.1 12.7 3.2 23.3 3.5 8.2 7.7 12.5 26.7 2.5 6.6 35.0 3.5 12.3 7.6 4.9 15.8 7.4 3.3 10.0 5.9 22.7 5.7 3.5 20.8 5.0 18.2 6.5 8.8 12.5 9.8 2.5 11.9 12.5 6.9 16.1 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.7 9.1 8.4 7.3 3.6 3.7 5.5 6.1 4.0 5.2 5.7 10.0 5.4 8.4 5.4 3.5 2.6 4.4 5.2 4.1 2.2 7.3 51.5 8.2 6.1 18.0 5.9 3.6 7.7 4.3 3.8 4.2 3.3 7.9 4.6 10.5 10.6 3.7 3.6 6.2 11.8 10.3 9.1 9.5 16.7 13.8 5.4 4.4 5.7 4.4 9.0 12.4 3.1 10.3 4.5 4.8 10.2 6.7 6.0 9.4 8.1 2.0 6.6 9.1 7.7 6.3 5.9 5.0 6.1 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 3.0 14.9 10.2 14.2 2.7 16.7 11.4 33.1 13.4 9.1 10.4 7.9 16.2 8.3 23.1 26.9 15.8 12.8 0.0 19.3 7.9 9.2 13.8 10.3 34.7 9.4 19.1 28.2 19.6 5.3 28.6 11.2 3.9 15.1 19.8 24.4 16.6 21.0 10.5 11.3 18.8 13.6 25.8 13.2 10.4 19.8 4.5 10.4 13.1 19.3 8.9 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 3.5 2.8 4.8 4.6 5.9 6.1 6.9 7.1 5.6 5.7 6.4 6.5 5.9 4.4 6.0 7.7 3.8 4.0 4.4 2.8 4.1 6.1 4.0 4.2 4.9 8.1 4.5 7.3 4.8 5.0 15.1 5.8 7.7 5.6 6.6 4.6 3.4 4.2 2.2 5.3 8.7 5.6 7.1 5.0 6.1 15.0 5.5 12.2 7.3 3.9 5.4 4.0 4.2 4.4 4.8 11.0 7.9 3.9 5.6 2.3 2.8 6.4 7.2 0.0 3.7 4.2 8.7 3.0 1.7 3.3 3.4 6.0 6.9 10.4 2.9 1.9 4.7 4.1 8.2 2.9 3.0 4.8 4.4 15.6 2.2 9.8 3.2 16.9 9.5 2.7 7.1 3.4 5.6 2.4 3.9 12.3 13.3 7.0 3.2 2.8 9.9 10.3 11.1 3.1 0.4 11.2 8.2 4.2 3.9 5.8 2.1 5.1 4.2 4.0 3.1 12.5 4.8 10.8 2.5 1.6 6.1 2.1 3.2 6.5 16.4 6.1 1.1 13.0 1.6 11.0 4.5 5.4 3.2 4.8 5.1 4.4 3.9 3.2 2.8 4.1 5.6 3.8 4.5 3.9 7.9 4.8 4.0 2.3 53.6 26.2 21.5 15.3 0.0 58.9 23.0 20.4 18.7 27.3 38.4 41.2 35.7 16.6 19.5 13.8 17.3 38.1 0.0 22.4 24.4 8.2 20.6 9.2 25.2 24.3 71.5 58.8 36.2 28.9 11.8 32.5 31.3 0.0 13.6 31.2 37.1 25.4 45.6 23.7 14.8 61.0 19.4 12.2 64.6 88.8 0.0 36.6 27.7 30.2 15.4 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475919 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Yes No Nucleoli "HPA049593: AB_2680828" "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 13.4 9.7 11.5 8.5 13.1 44.5 12.6 15.9 11.7 12.1 10.6 16.0 12.3 6.9 14.4 12.0 11.9 12.3 10.3 8.5 10.5 5.7 10.2 14.9 10.6 9.9 17.4 7.9 15.7 19.3 19.2 11.9 9.9 10.9 12.4 7.6 13.4 13.2 9.7 28.9 18.0 10.2 10.0 10.5 11.0 9.8 9.0 13.2 14.1 11.6 8.5 9.1 14.5 12.3 1.0 2.2 2.5 7.6 0.8 1.1 0.4 14.1 7.3 9.2 8.6 10.0 7.9 16.3 6.5 7.2 9.5 8.5 10.9 6.2 10.6 11.0 5.8 8.8 11.7 12.2 7.5 7.5 5.6 10.3 8.2 8.4 7.1 10.7 12.6 13.5 6.2 14.7 5.8 10.5 9.4 9.6 12.6 8.8 14.2 7.9 8.3 12.1 7.0 13.0 9.3 7.4 13.1 6.2 13.3 6.7 10.3 16.7 9.3 12.4 9.2 17.1 6.3 12.4 11.2 9.7 8.8 11.4 13.1 7.8 11.8 5.5 14.0 9.6 9.9 9.6 2.4 0.8 1.6 1.1 0.4 0.4 0.3 0.8 0.8 1.4 1.0 1.1 1.0 2.5 0.8 7.6 2.2 0.5 0.4 11.5 13.1 15.9 11.7 10.5 5.7 17.4 7.9 10.9 13.2 23.8 14.1 2.7 7.3 5.6 28.6 3.4 15.3 6.7 9.1 5.2 43.2 6.2 6.6 4.4 1.5 6.8 7.7 0.0 5.2 2.0 3.8 5.0 2.3 11.3 5.1 12.7 3.5 7.4 4.3 0.2 6.9 6.2 1.7 1.8 5.9 24.0 4.0 4.9 7.1 6.9 27.2 0.0 4.7 3.2 7.7 3.8 5.3 5.0 6.3 5.3